id	sid	tid	token	lemma	pos
bam-7960	1	1	therapeutic	therapeutic	ADJ
bam-7960	1	2	strategies	strategy	NOUN
bam-7960	1	3	against	against	ADP
bam-7960	1	4	cancer	cancer	NOUN
bam-7960	1	5	cachexia	cachexia	PROPN
bam-7960	1	6	eur	eur	PROPN
bam-7960	1	7	j	j	PROPN
bam-7960	1	8	transl	transl	PROPN
bam-7960	1	9	myol	myol	ADV
bam-7960	1	10	29	29	NUM
bam-7960	1	11	(	(	PUNCT
bam-7960	1	12	1	1	NUM
bam-7960	1	13	):	):	PUNCT
bam-7960	1	14	4	4	NUM
bam-7960	1	15	-	-	SYM
bam-7960	1	16	13	13	NUM
bam-7960	1	17	,	,	PUNCT
bam-7960	1	18	2019	2019	NUM
bam-7960	1	19	4	4	NUM
bam-7960	1	20	therapeutic	therapeutic	ADJ
bam-7960	1	21	strategies	strategy	NOUN
bam-7960	1	22	against	against	ADP
bam-7960	1	23	cancer	cancer	NOUN
bam-7960	1	24	cachexia	cachexia	PROPN
bam-7960	1	25	josep	josep	PROPN
bam-7960	1	26	m.	m.	PROPN
bam-7960	1	27	argilés	argilés	PROPN
bam-7960	1	28	(	(	PUNCT
bam-7960	1	29	1,2	1,2	NUM
bam-7960	1	30	)	)	PUNCT
bam-7960	1	31	,	,	PUNCT
bam-7960	1	32	francisco	francisco	PROPN
bam-7960	1	33	javier	javier	PROPN
bam-7960	1	34	lópez	lópez	PROPN
bam-7960	1	35	-	-	PUNCT
bam-7960	1	36	soriano	soriano	PROPN
bam-7960	1	37	(	(	PUNCT
bam-7960	1	38	1,2	1,2	NUM
bam-7960	1	39	)	)	PUNCT
bam-7960	1	40	,	,	PUNCT
bam-7960	1	41	britta	britta	NOUN
bam-7960	1	42	stemmler	stemmler	NOUN
bam-7960	1	43	(	(	PUNCT
bam-7960	1	44	3	3	NUM
bam-7960	1	45	)	)	PUNCT
bam-7960	1	46	,	,	PUNCT
bam-7960	1	47	sílvia	sílvia	NOUN
bam-7960	1	48	busquets	busquets	PROPN
bam-7960	1	49	(	(	PUNCT
bam-7960	1	50	1,2	1,2	NUM
bam-7960	1	51	)	)	PUNCT
bam-7960	1	52	(	(	PUNCT
bam-7960	1	53	1	1	X
bam-7960	1	54	)	)	PUNCT
bam-7960	1	55	cancer	cancer	NOUN
bam-7960	1	56	research	research	NOUN
bam-7960	1	57	group	group	NOUN
bam-7960	1	58	,	,	PUNCT
bam-7960	1	59	department	department	NOUN
bam-7960	1	60	of	of	ADP
bam-7960	1	61	biochemistry	biochemistry	NOUN
bam-7960	1	62	and	and	CCONJ
bam-7960	1	63	molecular	molecular	ADJ
bam-7960	1	64	biomedicine	biomedicine	NOUN
bam-7960	1	65	,	,	PUNCT
bam-7960	1	66	biology	biology	NOUN
bam-7960	1	67	faculty	faculty	NOUN
bam-7960	1	68	of	of	ADP
bam-7960	1	69	the	the	DET
bam-7960	1	70	barcelona	barcelona	PROPN
bam-7960	1	71	university	university	PROPN
bam-7960	1	72	,	,	PUNCT
bam-7960	1	73	barcelona	barcelona	PROPN
bam-7960	1	74	,	,	PUNCT
bam-7960	1	75	spain	spain	PROPN
bam-7960	1	76	;	;	PUNCT
bam-7960	1	77	(	(	PUNCT
bam-7960	1	78	2	2	X
bam-7960	1	79	)	)	PUNCT
bam-7960	1	80	biomedicine	biomedicine	NOUN
bam-7960	1	81	institute	institute	PROPN
bam-7960	1	82	,	,	PUNCT
bam-7960	1	83	barcelona	barcelona	PROPN
bam-7960	1	84	university	university	PROPN
bam-7960	1	85	(	(	PUNCT
bam-7960	1	86	ibub	ibub	PROPN
bam-7960	1	87	)	)	PUNCT
bam-7960	1	88	,	,	PUNCT
bam-7960	1	89	barcelona	barcelona	PROPN
bam-7960	1	90	,	,	PUNCT
bam-7960	1	91	spain	spain	PROPN
bam-7960	1	92	;	;	PUNCT
bam-7960	1	93	(	(	PUNCT
bam-7960	1	94	3	3	X
bam-7960	1	95	)	)	PUNCT
bam-7960	1	96	bsa	bsa	PROPN
bam-7960	1	97	nutrition	nutrition	PROPN
bam-7960	1	98	centre	centre	PROPN
bam-7960	1	99	,	,	PUNCT
bam-7960	1	100	barcelona	barcelona	PROPN
bam-7960	1	101	,	,	PUNCT
bam-7960	1	102	spain	spain	PROPN
bam-7960	1	103	this	this	DET
bam-7960	1	104	article	article	NOUN
bam-7960	1	105	is	be	AUX
bam-7960	1	106	distributed	distribute	VERB
bam-7960	1	107	under	under	ADP
bam-7960	1	108	the	the	DET
bam-7960	1	109	terms	term	NOUN
bam-7960	1	110	of	of	ADP
bam-7960	1	111	the	the	DET
bam-7960	1	112	creative	creative	ADJ
bam-7960	1	113	commons	common	NOUN
bam-7960	1	114	attribution	attribution	NOUN
bam-7960	1	115	noncommercial	noncommercial	ADJ
bam-7960	1	116	license	license	NOUN
bam-7960	1	117	(	(	PUNCT
bam-7960	1	118	cc	cc	NOUN
bam-7960	1	119	by	by	ADP
bam-7960	1	120	-	-	PUNCT
bam-7960	1	121	nc	nc	PROPN
bam-7960	1	122	4.0	4.0	NUM
bam-7960	1	123	)	)	PUNCT
bam-7960	1	124	which	which	PRON
bam-7960	1	125	permits	permit	VERB
bam-7960	1	126	any	any	DET
bam-7960	1	127	noncommercial	noncommercial	ADJ
bam-7960	1	128	use	use	NOUN
bam-7960	1	129	,	,	PUNCT
bam-7960	1	130	distribution	distribution	NOUN
bam-7960	1	131	,	,	PUNCT
bam-7960	1	132	and	and	CCONJ
bam-7960	1	133	reproduction	reproduction	NOUN
bam-7960	1	134	in	in	ADP
bam-7960	1	135	any	any	DET
bam-7960	1	136	medium	medium	NOUN
bam-7960	1	137	,	,	PUNCT
bam-7960	1	138	provided	provide	VERB
bam-7960	1	139	the	the	DET
bam-7960	1	140	original	original	ADJ
bam-7960	1	141	author(s	author(s	NOUN
bam-7960	1	142	)	)	PUNCT
bam-7960	1	143	and	and	CCONJ
bam-7960	1	144	source	source	NOUN
bam-7960	1	145	are	be	AUX
bam-7960	1	146	credited	credit	VERB
bam-7960	1	147	.	.	PUNCT
bam-7960	2	1	abstract	abstract	ADJ
bam-7960	2	2	cancer	cancer	NOUN
bam-7960	2	3	cachexia	cachexia	PROPN
bam-7960	2	4	has	have	VERB
bam-7960	2	5	two	two	NUM
bam-7960	2	6	main	main	ADJ
bam-7960	2	7	components	component	NOUN
bam-7960	2	8	:	:	PUNCT
bam-7960	2	9	anorexia	anorexia	ADJ
bam-7960	2	10	and	and	CCONJ
bam-7960	2	11	metabolic	metabolic	NOUN
bam-7960	2	12	alterations	alteration	NOUN
bam-7960	2	13	.	.	PUNCT
bam-7960	3	1	the	the	DET
bam-7960	3	2	main	main	ADJ
bam-7960	3	3	changes	change	NOUN
bam-7960	3	4	associated	associate	VERB
bam-7960	3	5	with	with	ADP
bam-7960	3	6	the	the	DET
bam-7960	3	7	development	development	NOUN
bam-7960	3	8	of	of	ADP
bam-7960	3	9	this	this	DET
bam-7960	3	10	multi	multi	ADJ
bam-7960	3	11	-	-	ADJ
bam-7960	3	12	organic	organic	ADJ
bam-7960	3	13	syndrome	syndrome	NOUN
bam-7960	3	14	are	be	AUX
bam-7960	3	15	glucose	glucose	NOUN
bam-7960	3	16	intolerance	intolerance	NOUN
bam-7960	3	17	,	,	PUNCT
bam-7960	3	18	fat	fat	ADJ
bam-7960	3	19	depletion	depletion	NOUN
bam-7960	3	20	and	and	CCONJ
bam-7960	3	21	muscle	muscle	NOUN
bam-7960	3	22	protein	protein	NOUN
bam-7960	3	23	hypercatabolism	hypercatabolism	NOUN
bam-7960	3	24	.	.	PUNCT
bam-7960	4	1	the	the	DET
bam-7960	4	2	aim	aim	NOUN
bam-7960	4	3	of	of	ADP
bam-7960	4	4	this	this	DET
bam-7960	4	5	paper	paper	NOUN
bam-7960	4	6	is	be	AUX
bam-7960	4	7	to	to	PART
bam-7960	4	8	review	review	VERB
bam-7960	4	9	the	the	DET
bam-7960	4	10	more	more	ADV
bam-7960	4	11	recent	recent	ADJ
bam-7960	4	12	therapeutic	therapeutic	ADJ
bam-7960	4	13	approaches	approach	NOUN
bam-7960	4	14	designed	design	VERB
bam-7960	4	15	to	to	PART
bam-7960	4	16	counteract	counteract	VERB
bam-7960	4	17	the	the	DET
bam-7960	4	18	wasting	wasting	NOUN
bam-7960	4	19	suffered	suffer	VERB
bam-7960	4	20	by	by	ADP
bam-7960	4	21	the	the	DET
bam-7960	4	22	cancer	cancer	NOUN
bam-7960	4	23	patient	patient	NOUN
bam-7960	4	24	with	with	ADP
bam-7960	4	25	cachexia	cachexia	PROPN
bam-7960	4	26	.	.	PUNCT
bam-7960	5	1	among	among	ADP
bam-7960	5	2	the	the	DET
bam-7960	5	3	most	most	ADV
bam-7960	5	4	promising	promising	ADJ
bam-7960	5	5	approaches	approach	NOUN
bam-7960	5	6	we	we	PRON
bam-7960	5	7	can	can	AUX
bam-7960	5	8	include	include	VERB
bam-7960	5	9	the	the	DET
bam-7960	5	10	use	use	NOUN
bam-7960	5	11	of	of	ADP
bam-7960	5	12	ghrelin	ghrelin	NOUN
bam-7960	5	13	agonists	agonist	NOUN
bam-7960	5	14	,	,	PUNCT
bam-7960	5	15	beta	beta	NOUN
bam-7960	5	16	-	-	PUNCT
bam-7960	5	17	blockers	blocker	NOUN
bam-7960	5	18	,	,	PUNCT
bam-7960	5	19	beta	beta	NOUN
bam-7960	5	20	-	-	PUNCT
bam-7960	5	21	adrenergic	adrenergic	ADJ
bam-7960	5	22	agonists	agonist	NOUN
bam-7960	5	23	,	,	PUNCT
bam-7960	5	24	androgen	androgen	NOUN
bam-7960	5	25	receptor	receptor	NOUN
bam-7960	5	26	agonists	agonist	NOUN
bam-7960	5	27	and	and	CCONJ
bam-7960	5	28	anti	anti	ADJ
bam-7960	5	29	-	-	ADJ
bam-7960	5	30	myostatin	myostatin	ADJ
bam-7960	5	31	peptides	peptide	NOUN
bam-7960	5	32	.	.	PUNCT
bam-7960	6	1	the	the	DET
bam-7960	6	2	multi	multi	ADJ
bam-7960	6	3	-	-	ADJ
bam-7960	6	4	targeted	targeted	ADJ
bam-7960	6	5	approach	approach	NOUN
bam-7960	6	6	seems	seem	VERB
bam-7960	6	7	essential	essential	ADJ
bam-7960	6	8	in	in	ADP
bam-7960	6	9	these	these	DET
bam-7960	6	10	treatments	treatment	NOUN
bam-7960	6	11	,	,	PUNCT
bam-7960	6	12	which	which	PRON
bam-7960	6	13	should	should	AUX
bam-7960	6	14	include	include	VERB
bam-7960	6	15	the	the	DET
bam-7960	6	16	combination	combination	NOUN
bam-7960	6	17	of	of	ADP
bam-7960	6	18	both	both	CCONJ
bam-7960	6	19	nutritional	nutritional	ADJ
bam-7960	6	20	support	support	NOUN
bam-7960	6	21	,	,	PUNCT
bam-7960	6	22	drugs	drug	NOUN
bam-7960	6	23	and	and	CCONJ
bam-7960	6	24	a	a	DET
bam-7960	6	25	suitable	suitable	ADJ
bam-7960	6	26	program	program	NOUN
bam-7960	6	27	of	of	ADP
bam-7960	6	28	physical	physical	ADJ
bam-7960	6	29	exercise	exercise	NOUN
bam-7960	6	30	,	,	PUNCT
bam-7960	6	31	in	in	ADP
bam-7960	6	32	order	order	NOUN
bam-7960	6	33	to	to	PART
bam-7960	6	34	ameliorate	ameliorate	VERB
bam-7960	6	35	both	both	PRON
bam-7960	6	36	anorexia	anorexia	ADJ
bam-7960	6	37	and	and	CCONJ
bam-7960	6	38	the	the	DET
bam-7960	6	39	metabolic	metabolic	NOUN
bam-7960	6	40	changes	change	NOUN
bam-7960	6	41	associated	associate	VERB
bam-7960	6	42	with	with	ADP
bam-7960	6	43	cachexia	cachexia	NOUN
bam-7960	6	44	.	.	PUNCT
bam-7960	7	1	in	in	ADP
bam-7960	7	2	addition	addition	NOUN
bam-7960	7	3	,	,	PUNCT
bam-7960	7	4	another	another	DET
bam-7960	7	5	very	very	ADV
bam-7960	7	6	important	important	ADJ
bam-7960	7	7	and	and	CCONJ
bam-7960	7	8	crucial	crucial	ADJ
bam-7960	7	9	aspect	aspect	NOUN
bam-7960	7	10	to	to	PART
bam-7960	7	11	be	be	AUX
bam-7960	7	12	taken	take	VERB
bam-7960	7	13	into	into	ADP
bam-7960	7	14	consideration	consideration	NOUN
bam-7960	7	15	in	in	ADP
bam-7960	7	16	the	the	DET
bam-7960	7	17	design	design	NOUN
bam-7960	7	18	of	of	ADP
bam-7960	7	19	clinical	clinical	ADJ
bam-7960	7	20	trials	trial	NOUN
bam-7960	7	21	for	for	ADP
bam-7960	7	22	the	the	DET
bam-7960	7	23	treatment	treatment	NOUN
bam-7960	7	24	of	of	ADP
bam-7960	7	25	cancer	cancer	NOUN
bam-7960	7	26	cachexia	cachexia	NOUN
bam-7960	7	27	is	be	AUX
bam-7960	7	28	to	to	ADP
bam-7960	7	29	staging	stage	VERB
bam-7960	7	30	cancer	cancer	NOUN
bam-7960	7	31	patients	patient	NOUN
bam-7960	7	32	in	in	ADP
bam-7960	7	33	relation	relation	NOUN
bam-7960	7	34	with	with	ADP
bam-7960	7	35	the	the	DET
bam-7960	7	36	degree	degree	NOUN
bam-7960	7	37	of	of	ADP
bam-7960	7	38	cachexia	cachexia	NOUN
bam-7960	7	39	,	,	PUNCT
bam-7960	7	40	in	in	ADP
bam-7960	7	41	order	order	NOUN
bam-7960	7	42	to	to	PART
bam-7960	7	43	start	start	VERB
bam-7960	7	44	as	as	ADV
bam-7960	7	45	early	early	ADV
bam-7960	7	46	as	as	ADP
bam-7960	7	47	possible	possible	ADJ
bam-7960	7	48	this	this	DET
bam-7960	7	49	triple	triple	ADJ
bam-7960	7	50	approach	approach	NOUN
bam-7960	7	51	in	in	ADP
bam-7960	7	52	the	the	DET
bam-7960	7	53	course	course	NOUN
bam-7960	7	54	of	of	ADP
bam-7960	7	55	the	the	DET
bam-7960	7	56	disease	disease	NOUN
bam-7960	7	57	,	,	PUNCT
bam-7960	7	58	even	even	ADV
bam-7960	7	59	before	before	SCONJ
bam-7960	7	60	the	the	DET
bam-7960	7	61	weight	weight	NOUN
bam-7960	7	62	loss	loss	NOUN
bam-7960	7	63	can	can	AUX
bam-7960	7	64	be	be	AUX
bam-7960	7	65	detected	detect	VERB
bam-7960	7	66	.	.	PUNCT
bam-7960	8	1	key	key	ADJ
bam-7960	8	2	words	word	NOUN
bam-7960	8	3	:	:	PUNCT
bam-7960	8	4	cancer	cancer	NOUN
bam-7960	8	5	cachexia	cachexia	NOUN
bam-7960	8	6	,	,	PUNCT
bam-7960	8	7	muscle	muscle	NOUN
bam-7960	8	8	wasting	wasting	NOUN
bam-7960	8	9	,	,	PUNCT
bam-7960	8	10	treatment	treatment	NOUN
bam-7960	8	11	,	,	PUNCT
bam-7960	8	12	multi	multi	ADJ
bam-7960	8	13	-	-	ADJ
bam-7960	8	14	targeted	target	VERB
bam-7960	8	15	approach	approach	NOUN
bam-7960	8	16	eur	eur	PROPN
bam-7960	8	17	j	j	PROPN
bam-7960	8	18	transl	transl	PROPN
bam-7960	8	19	myol	myol	ADV
bam-7960	8	20	29	29	NUM
bam-7960	8	21	(	(	PUNCT
bam-7960	8	22	1	1	NUM
bam-7960	8	23	):	):	PUNCT
bam-7960	8	24	4	4	NUM
bam-7960	8	25	-	-	SYM
bam-7960	8	26	13	13	NUM
bam-7960	8	27	,	,	PUNCT
bam-7960	8	28	2019	2019	NUM
bam-7960	8	29	cachexia	cachexia	NOUN
bam-7960	8	30	,	,	PUNCT
bam-7960	8	31	according	accord	VERB
bam-7960	8	32	to	to	ADP
bam-7960	8	33	an	an	DET
bam-7960	8	34	international	international	ADJ
bam-7960	8	35	consensus,1	consensus,1	ADJ
bam-7960	8	36	‘	'	PUNCT
bam-7960	8	37	‘	'	PUNCT
bam-7960	8	38	is	be	AUX
bam-7960	8	39	a	a	DET
bam-7960	8	40	complex	complex	ADJ
bam-7960	8	41	metabolic	metabolic	NOUN
bam-7960	8	42	syndrome	syndrome	NOUN
bam-7960	8	43	associated	associate	VERB
bam-7960	8	44	with	with	ADP
bam-7960	8	45	underlying	underlie	VERB
bam-7960	8	46	illness	illness	NOUN
bam-7960	8	47	and	and	CCONJ
bam-7960	8	48	characterized	characterize	VERB
bam-7960	8	49	by	by	ADP
bam-7960	8	50	loss	loss	NOUN
bam-7960	8	51	of	of	ADP
bam-7960	8	52	muscle	muscle	NOUN
bam-7960	8	53	with	with	ADP
bam-7960	8	54	or	or	CCONJ
bam-7960	8	55	without	without	ADP
bam-7960	8	56	loss	loss	NOUN
bam-7960	8	57	of	of	ADP
bam-7960	8	58	fat	fat	ADJ
bam-7960	8	59	mass	mass	PROPN
bam-7960	8	60	.	.	PUNCT
bam-7960	9	1	anorexia	anorexia	ADJ
bam-7960	9	2	,	,	PUNCT
bam-7960	9	3	inflammation	inflammation	NOUN
bam-7960	9	4	,	,	PUNCT
bam-7960	9	5	insulin	insulin	NOUN
bam-7960	9	6	resistance	resistance	NOUN
bam-7960	9	7	and	and	CCONJ
bam-7960	9	8	increased	increase	VERB
bam-7960	9	9	muscle	muscle	NOUN
bam-7960	9	10	protein	protein	NOUN
bam-7960	9	11	breakdown	breakdown	NOUN
bam-7960	9	12	are	be	AUX
bam-7960	9	13	frequently	frequently	ADV
bam-7960	9	14	associated	associate	VERB
bam-7960	9	15	with	with	ADP
bam-7960	9	16	cachexia	cachexia	NOUN
bam-7960	9	17	.	.	PUNCT
bam-7960	10	1	cachexia	cachexia	PROPN
bam-7960	10	2	is	be	AUX
bam-7960	10	3	distinct	distinct	ADJ
bam-7960	10	4	from	from	ADP
bam-7960	10	5	starvation	starvation	NOUN
bam-7960	10	6	,	,	PUNCT
bam-7960	10	7	age	age	NOUN
bam-7960	10	8	-	-	PUNCT
bam-7960	10	9	related	relate	VERB
bam-7960	10	10	loss	loss	NOUN
bam-7960	10	11	of	of	ADP
bam-7960	10	12	muscle	muscle	NOUN
bam-7960	10	13	mass	mass	PROPN
bam-7960	10	14	,	,	PUNCT
bam-7960	10	15	primary	primary	ADJ
bam-7960	10	16	depression	depression	NOUN
bam-7960	10	17	,	,	PUNCT
bam-7960	10	18	malabsorption	malabsorption	NOUN
bam-7960	10	19	and	and	CCONJ
bam-7960	10	20	hyperthyroidism	hyperthyroidism	NOUN
bam-7960	10	21	and	and	CCONJ
bam-7960	10	22	is	be	AUX
bam-7960	10	23	associated	associate	VERB
bam-7960	10	24	with	with	ADP
bam-7960	10	25	increased	increase	VERB
bam-7960	10	26	morbidity”.1	morbidity”.1	PUNCT
bam-7960	10	27	although	although	SCONJ
bam-7960	10	28	anorexia	anorexia	NOUN
bam-7960	10	29	represents	represent	VERB
bam-7960	10	30	a	a	DET
bam-7960	10	31	very	very	ADV
bam-7960	10	32	important	important	ADJ
bam-7960	10	33	event	event	NOUN
bam-7960	10	34	in	in	ADP
bam-7960	10	35	the	the	DET
bam-7960	10	36	development	development	NOUN
bam-7960	10	37	of	of	ADP
bam-7960	10	38	cachexia	cachexia	PROPN
bam-7960	10	39	,	,	PUNCT
bam-7960	10	40	it	it	PRON
bam-7960	10	41	has	have	AUX
bam-7960	10	42	been	be	AUX
bam-7960	10	43	proven	prove	VERB
bam-7960	10	44	that	that	SCONJ
bam-7960	10	45	total	total	ADJ
bam-7960	10	46	parenteral	parenteral	ADJ
bam-7960	10	47	nutrition	nutrition	NOUN
bam-7960	10	48	does	do	AUX
bam-7960	10	49	not	not	PART
bam-7960	10	50	stop	stop	VERB
bam-7960	10	51	the	the	DET
bam-7960	10	52	loss	loss	NOUN
bam-7960	10	53	of	of	ADP
bam-7960	10	54	body	body	NOUN
bam-7960	10	55	weight	weight	NOUN
bam-7960	10	56	.	.	PUNCT
bam-7960	11	1	therefore	therefore	ADV
bam-7960	11	2	,	,	PUNCT
bam-7960	11	3	it	it	PRON
bam-7960	11	4	seems	seem	VERB
bam-7960	11	5	quite	quite	ADV
bam-7960	11	6	evident	evident	ADJ
bam-7960	11	7	that	that	SCONJ
bam-7960	11	8	metabolic	metabolic	NOUN
bam-7960	11	9	alterations	alteration	NOUN
bam-7960	11	10	present	present	ADJ
bam-7960	11	11	in	in	ADP
bam-7960	11	12	the	the	DET
bam-7960	11	13	patient	patient	NOUN
bam-7960	11	14	(	(	PUNCT
bam-7960	11	15	increased	increase	VERB
bam-7960	11	16	energy	energy	NOUN
bam-7960	11	17	inefficiency	inefficiency	NOUN
bam-7960	11	18	,	,	PUNCT
bam-7960	11	19	insulin	insulin	NOUN
bam-7960	11	20	resistance	resistance	NOUN
bam-7960	11	21	and	and	CCONJ
bam-7960	11	22	abnormal	abnormal	ADJ
bam-7960	11	23	carbohydrate	carbohydrate	NOUN
bam-7960	11	24	metabolism	metabolism	NOUN
bam-7960	11	25	,	,	PUNCT
bam-7960	11	26	adipose	adipose	ADP
bam-7960	11	27	tissue	tissue	NOUN
bam-7960	11	28	dissolution	dissolution	NOUN
bam-7960	11	29	and	and	CCONJ
bam-7960	11	30	hypertriglyceridemia	hypertriglyceridemia	NOUN
bam-7960	11	31	,	,	PUNCT
bam-7960	11	32	and	and	CCONJ
bam-7960	11	33	muscle	muscle	NOUN
bam-7960	11	34	wasting	wasting	NOUN
bam-7960	11	35	)	)	PUNCT
bam-7960	11	36	have	have	VERB
bam-7960	11	37	a	a	DET
bam-7960	11	38	key	key	ADJ
bam-7960	11	39	role	role	NOUN
bam-7960	11	40	in	in	ADP
bam-7960	11	41	the	the	DET
bam-7960	11	42	development	development	NOUN
bam-7960	11	43	of	of	ADP
bam-7960	11	44	cachexia.2	cachexia.2	PROPN
bam-7960	11	45	moreover	moreover	ADV
bam-7960	11	46	,	,	PUNCT
bam-7960	11	47	some	some	PRON
bam-7960	11	48	of	of	ADP
bam-7960	11	49	the	the	DET
bam-7960	11	50	alterations	alteration	NOUN
bam-7960	11	51	are	be	AUX
bam-7960	11	52	also	also	ADV
bam-7960	11	53	a	a	DET
bam-7960	11	54	result	result	NOUN
bam-7960	11	55	of	of	ADP
bam-7960	11	56	the	the	DET
bam-7960	11	57	chemotherapeutic	chemotherapeutic	ADJ
bam-7960	11	58	treatment.3,4	treatment.3,4	ADJ
bam-7960	11	59	bearing	bearing	NOUN
bam-7960	11	60	this	this	PRON
bam-7960	11	61	in	in	ADP
bam-7960	11	62	mind	mind	NOUN
bam-7960	11	63	,	,	PUNCT
bam-7960	11	64	the	the	DET
bam-7960	11	65	development	development	NOUN
bam-7960	11	66	of	of	ADP
bam-7960	11	67	different	different	ADJ
bam-7960	11	68	therapeutic	therapeutic	ADJ
bam-7960	11	69	approaches	approach	NOUN
bam-7960	11	70	has	have	AUX
bam-7960	11	71	focused	focus	VERB
bam-7960	11	72	,	,	PUNCT
bam-7960	11	73	either	either	CCONJ
bam-7960	11	74	on	on	ADP
bam-7960	11	75	increasing	increase	VERB
bam-7960	11	76	food	food	NOUN
bam-7960	11	77	intake	intake	NOUN
bam-7960	11	78	or	or	CCONJ
bam-7960	11	79	on	on	ADP
bam-7960	11	80	reversing	reverse	VERB
bam-7960	11	81	catabolism	catabolism	NOUN
bam-7960	11	82	and	and	CCONJ
bam-7960	11	83	increasing	increase	VERB
bam-7960	11	84	the	the	DET
bam-7960	11	85	anabolic	anabolic	NOUN
bam-7960	11	86	drive	drive	NOUN
bam-7960	11	87	of	of	ADP
bam-7960	11	88	the	the	DET
bam-7960	11	89	cancer	cancer	NOUN
bam-7960	11	90	patient	patient	NOUN
bam-7960	11	91	.	.	PUNCT
bam-7960	12	1	drugs	drug	NOUN
bam-7960	12	2	modulating	modulate	VERB
bam-7960	12	3	cytokine	cytokine	NOUN
bam-7960	12	4	action	action	NOUN
bam-7960	12	5	tnf-	tnf-	NOUN
bam-7960	12	6	(	(	PUNCT
bam-7960	12	7	tumor	tumor	NOUN
bam-7960	12	8	necrosis	necrosis	NOUN
bam-7960	12	9	factor	factor	NOUN
bam-7960	12	10	alpha	alpha	NOUN
bam-7960	12	11	)	)	PUNCT
bam-7960	12	12	,	,	PUNCT
bam-7960	12	13	il-1	il-1	PUNCT
bam-7960	12	14	(	(	PUNCT
bam-7960	12	15	interleukin	interleukin	NOUN
bam-7960	12	16	1	1	NUM
bam-7960	12	17	)	)	PUNCT
bam-7960	12	18	,	,	PUNCT
bam-7960	12	19	il-6	il-6	PRON
bam-7960	12	20	(	(	PUNCT
bam-7960	12	21	interleukin	interleukin	NOUN
bam-7960	12	22	6	6	NUM
bam-7960	12	23	)	)	PUNCT
bam-7960	12	24	and	and	CCONJ
bam-7960	12	25	interferon	interferon	ADJ
bam-7960	12	26	-	-	PUNCT
bam-7960	12	27	gamma	gamma	NOUN
bam-7960	12	28	(	(	PUNCT
bam-7960	12	29	ifn-	ifn-	PROPN
bam-7960	12	30	)	)	PUNCT
bam-7960	12	31	are	be	AUX
bam-7960	12	32	the	the	DET
bam-7960	12	33	main	main	ADJ
bam-7960	12	34	cytokines	cytokine	NOUN
bam-7960	12	35	implicated	implicate	VERB
bam-7960	12	36	in	in	ADP
bam-7960	12	37	cachexia	cachexia	PROPN
bam-7960	12	38	.	.	PUNCT
bam-7960	13	1	interestingly	interestingly	ADV
bam-7960	13	2	,	,	PUNCT
bam-7960	13	3	these	these	DET
bam-7960	13	4	cytokines	cytokine	NOUN
bam-7960	13	5	share	share	VERB
bam-7960	13	6	the	the	DET
bam-7960	13	7	same	same	ADJ
bam-7960	13	8	metabolic	metabolic	NOUN
bam-7960	13	9	effects	effect	NOUN
bam-7960	13	10	and	and	CCONJ
bam-7960	13	11	their	their	PRON
bam-7960	13	12	activities	activity	NOUN
bam-7960	13	13	are	be	AUX
bam-7960	13	14	closely	closely	ADV
bam-7960	13	15	interrelated	interrelated	ADJ
bam-7960	13	16	.	.	PUNCT
bam-7960	14	1	in	in	ADP
bam-7960	14	2	many	many	ADJ
bam-7960	14	3	studies	study	NOUN
bam-7960	14	4	,	,	PUNCT
bam-7960	14	5	they	they	PRON
bam-7960	14	6	exhibit	exhibit	VERB
bam-7960	14	7	synergic	synergic	ADJ
bam-7960	14	8	effects	effect	NOUN
bam-7960	14	9	when	when	SCONJ
bam-7960	14	10	administered	administer	VERB
bam-7960	14	11	together	together	ADV
bam-7960	14	12	.	.	PUNCT
bam-7960	15	1	therefore	therefore	ADV
bam-7960	15	2	,	,	PUNCT
bam-7960	15	3	therapeutic	therapeutic	ADJ
bam-7960	15	4	strategies	strategy	NOUN
bam-7960	15	5	have	have	AUX
bam-7960	15	6	been	be	AUX
bam-7960	15	7	based	base	VERB
bam-7960	15	8	on	on	ADP
bam-7960	15	9	either	either	PRON
bam-7960	15	10	blocking	block	VERB
bam-7960	15	11	their	their	PRON
bam-7960	15	12	synthesis	synthesis	NOUN
bam-7960	15	13	or	or	CCONJ
bam-7960	15	14	their	their	PRON
bam-7960	15	15	action	action	NOUN
bam-7960	15	16	.	.	PUNCT
bam-7960	16	1	weight	weight	NOUN
bam-7960	16	2	loss	loss	NOUN
bam-7960	16	3	in	in	ADP
bam-7960	16	4	patients	patient	NOUN
bam-7960	16	5	with	with	ADP
bam-7960	16	6	esophageal	esophageal	ADJ
bam-7960	16	7	tumors	tumor	NOUN
bam-7960	16	8	is	be	AUX
bam-7960	16	9	related	relate	VERB
bam-7960	16	10	to	to	ADP
bam-7960	16	11	the	the	DET
bam-7960	16	12	levels	level	NOUN
bam-7960	16	13	of	of	ADP
bam-7960	16	14	the	the	DET
bam-7960	16	15	cytokines.5	cytokines.5	NOUN
bam-7960	16	16	in	in	ADP
bam-7960	16	17	fact	fact	NOUN
bam-7960	16	18	,	,	PUNCT
bam-7960	16	19	cytokines	cytokine	NOUN
bam-7960	16	20	are	be	AUX
bam-7960	16	21	able	able	ADJ
bam-7960	16	22	to	to	PART
bam-7960	16	23	act	act	VERB
bam-7960	16	24	on	on	ADP
bam-7960	16	25	multiple	multiple	ADJ
bam-7960	16	26	target	target	NOUN
bam-7960	16	27	sites	site	NOUN
bam-7960	16	28	such	such	ADJ
bam-7960	16	29	as	as	ADP
bam-7960	16	30	bone	bone	NOUN
bam-7960	16	31	marrow	marrow	NOUN
bam-7960	16	32	,	,	PUNCT
bam-7960	16	33	myocytes	myocyte	NOUN
bam-7960	16	34	,	,	PUNCT
bam-7960	16	35	hepatocytes	hepatocyte	NOUN
bam-7960	16	36	,	,	PUNCT
bam-7960	16	37	adipocytes	adipocyte	NOUN
bam-7960	16	38	,	,	PUNCT
bam-7960	16	39	endothelial	endothelial	ADJ
bam-7960	16	40	cells	cell	NOUN
bam-7960	16	41	and	and	CCONJ
bam-7960	16	42	neurons	neuron	NOUN
bam-7960	16	43	,	,	PUNCT
bam-7960	16	44	where	where	SCONJ
bam-7960	16	45	they	they	PRON
bam-7960	16	46	generate	generate	VERB
bam-7960	16	47	a	a	DET
bam-7960	16	48	complex	complex	ADJ
bam-7960	16	49	cascade	cascade	NOUN
bam-7960	16	50	of	of	ADP
bam-7960	16	51	responses	response	NOUN
bam-7960	16	52	leading	lead	VERB
bam-7960	16	53	to	to	ADP
bam-7960	16	54	the	the	DET
bam-7960	16	55	wasting	wasting	NOUN
bam-7960	16	56	associated	associate	VERB
bam-7960	16	57	with	with	ADP
bam-7960	16	58	cachexia	cachexia	PROPN
bam-7960	16	59	.	.	PUNCT
bam-7960	17	1	using	use	VERB
bam-7960	17	2	anti	anti	ADJ
bam-7960	17	3	-	-	ADJ
bam-7960	17	4	tnf	tnf	ADJ
bam-7960	17	5	strategies	strategy	NOUN
bam-7960	17	6	such	such	ADJ
bam-7960	17	7	as	as	ADP
bam-7960	17	8	etanercept	etanercept	NOUN
bam-7960	17	9	(	(	PUNCT
bam-7960	17	10	fusion	fusion	NOUN
bam-7960	17	11	protein	protein	NOUN
bam-7960	17	12	directed	direct	VERB
bam-7960	17	13	against	against	ADP
bam-7960	17	14	p75	p75	ADJ
bam-7960	17	15	tnf-	tnf-	NOUN
bam-7960	17	16	receptor	receptor	NOUN
bam-7960	17	17	)	)	PUNCT
bam-7960	17	18	has	have	AUX
bam-7960	17	19	led	lead	VERB
bam-7960	17	20	to	to	ADP
bam-7960	17	21	a	a	DET
bam-7960	17	22	poor	poor	ADJ
bam-7960	17	23	clinical	clinical	ADJ
bam-7960	17	24	outcome	outcome	NOUN
bam-7960	17	25	in	in	ADP
bam-7960	17	26	cancer	cancer	NOUN
bam-7960	17	27	patients	patient	NOUN
bam-7960	17	28	.	.	PUNCT
bam-7960	18	1	however	however	ADV
bam-7960	18	2	,	,	PUNCT
bam-7960	18	3	a	a	DET
bam-7960	18	4	clinical	clinical	ADJ
bam-7960	18	5	pilot	pilot	NOUN
bam-7960	18	6	study	study	NOUN
bam-7960	18	7	with	with	ADP
bam-7960	18	8	several	several	ADJ
bam-7960	18	9	advanced	advanced	ADJ
bam-7960	18	10	malignancies	malignancy	NOUN
bam-7960	18	11	involving	involve	VERB
bam-7960	18	12	patients	patient	NOUN
bam-7960	18	13	treated	treat	VERB
bam-7960	18	14	with	with	ADP
bam-7960	18	15	etanercept	etanercept	NOUN
bam-7960	18	16	combined	combine	VERB
bam-7960	18	17	with	with	ADP
bam-7960	18	18	an	an	DET
bam-7960	18	19	antitumor	antitumor	PROPN
bam-7960	18	20	agent	agent	NOUN
bam-7960	18	21	(	(	PUNCT
bam-7960	18	22	docetaxel),6	docetaxel),6	PROPN
bam-7960	18	23	showed	show	VERB
bam-7960	18	24	less	less	ADJ
bam-7960	18	25	fatigue	fatigue	NOUN
bam-7960	18	26	and	and	CCONJ
bam-7960	18	27	improved	improve	VERB
bam-7960	18	28	tolerability	tolerability	NOUN
bam-7960	18	29	of	of	ADP
bam-7960	18	30	the	the	DET
bam-7960	18	31	antitumoral	antitumoral	ADJ
bam-7960	18	32	treatment.7	treatment.7	NOUN
bam-7960	18	33	non	non	X
bam-7960	18	34	co	co	X
bam-7960	18	35	mmerc	mmerc	PROPN
bam-7960	18	36	ial	ial	PROPN
bam-7960	18	37	us	us	PROPN
bam-7960	18	38	e	e	NOUN
bam-7960	18	39	o	o	NOUN
bam-7960	18	40	nly	nly	ADV
bam-7960	18	41	therapeutic	therapeutic	ADJ
bam-7960	18	42	strategies	strategy	NOUN
bam-7960	18	43	against	against	ADP
bam-7960	18	44	cancer	cancer	NOUN
bam-7960	18	45	cachexia	cachexia	PROPN
bam-7960	18	46	eur	eur	PROPN
bam-7960	18	47	j	j	PROPN
bam-7960	18	48	transl	transl	PROPN
bam-7960	18	49	myol	myol	ADV
bam-7960	18	50	29	29	NUM
bam-7960	18	51	(	(	PUNCT
bam-7960	18	52	1	1	NUM
bam-7960	18	53	):	):	PUNCT
bam-7960	18	54	4	4	NUM
bam-7960	18	55	-	-	SYM
bam-7960	18	56	13	13	NUM
bam-7960	18	57	,	,	PUNCT
bam-7960	18	58	2019	2019	NUM
bam-7960	18	59	5	5	NUM
bam-7960	18	60	another	another	DET
bam-7960	18	61	phase	phase	NOUN
bam-7960	18	62	ii	ii	NOUN
bam-7960	18	63	trial	trial	NOUN
bam-7960	18	64	with	with	ADP
bam-7960	18	65	infliximab	infliximab	NOUN
bam-7960	18	66	an	an	DET
bam-7960	18	67	anti	anti	ADJ
bam-7960	18	68	-	-	ADJ
bam-7960	18	69	tnf-	tnf-	ADJ
bam-7960	18	70	monoclonal	monoclonal	NOUN
bam-7960	18	71	antibody	antibody	NOUN
bam-7960	18	72	was	be	AUX
bam-7960	18	73	unsuccessful	unsuccessful	ADJ
bam-7960	18	74	in	in	ADP
bam-7960	18	75	improving	improve	VERB
bam-7960	18	76	symptoms	symptom	NOUN
bam-7960	18	77	of	of	ADP
bam-7960	18	78	cachexia	cachexia	PROPN
bam-7960	18	79	(	(	PUNCT
bam-7960	18	80	lean	lean	ADJ
bam-7960	18	81	body	body	NOUN
bam-7960	18	82	mass	mass	NOUN
bam-7960	18	83	)	)	PUNCT
bam-7960	18	84	in	in	ADP
bam-7960	18	85	pancreatic	pancreatic	ADJ
bam-7960	18	86	cancer	cancer	NOUN
bam-7960	18	87	patients.8	patients.8	PROPN
bam-7960	18	88	survival	survival	NOUN
bam-7960	18	89	in	in	ADP
bam-7960	18	90	cancer	cancer	NOUN
bam-7960	18	91	patients	patient	NOUN
bam-7960	18	92	is	be	AUX
bam-7960	18	93	inversely	inversely	ADV
bam-7960	18	94	correlated	correlate	VERB
bam-7960	18	95	with	with	ADP
bam-7960	18	96	circulating	circulate	VERB
bam-7960	18	97	il-6	il-6	NUM
bam-7960	18	98	levels.9	levels.9	NOUN
bam-7960	18	99	in	in	ADP
bam-7960	18	100	a	a	DET
bam-7960	18	101	mouse	mouse	NOUN
bam-7960	18	102	model	model	NOUN
bam-7960	18	103	of	of	ADP
bam-7960	18	104	cancer	cancer	NOUN
bam-7960	18	105	cachexia	cachexia	PROPN
bam-7960	18	106	,	,	PUNCT
bam-7960	18	107	tocilizumab	tocilizumab	NOUN
bam-7960	18	108	,	,	PUNCT
bam-7960	18	109	an	an	DET
bam-7960	18	110	il-6	il-6	NOUN
bam-7960	18	111	monoclonal	monoclonal	NOUN
bam-7960	18	112	antibody	antibody	NOUN
bam-7960	18	113	,	,	PUNCT
bam-7960	18	114	improved	improve	VERB
bam-7960	18	115	cachexia.10	cachexia.10	ADP
bam-7960	18	116	a	a	DET
bam-7960	18	117	humanized	humanize	VERB
bam-7960	18	118	monoclonal	monoclonal	NOUN
bam-7960	18	119	anti	anti	ADJ
bam-7960	18	120	-	-	ADJ
bam-7960	18	121	il-6	il-6	ADJ
bam-7960	18	122	antibody	antibody	NOUN
bam-7960	18	123	increased	increase	VERB
bam-7960	18	124	hemoglobin	hemoglobin	NOUN
bam-7960	18	125	levels	level	NOUN
bam-7960	18	126	and	and	CCONJ
bam-7960	18	127	prevented	prevent	VERB
bam-7960	18	128	muscle	muscle	NOUN
bam-7960	18	129	wasting	waste	VERB
bam-7960	18	130	in	in	ADP
bam-7960	18	131	cancer	cancer	NOUN
bam-7960	18	132	patients.11	patients.11	NOUN
bam-7960	18	133	in	in	ADP
bam-7960	18	134	preclinical	preclinical	ADJ
bam-7960	18	135	and	and	CCONJ
bam-7960	18	136	in	in	ADP
bam-7960	18	137	a	a	DET
bam-7960	18	138	phase	phase	NOUN
bam-7960	18	139	ii	ii	NOUN
bam-7960	18	140	trial	trial	NOUN
bam-7960	18	141	,	,	PUNCT
bam-7960	18	142	ald518	ald518	NOUN
bam-7960	18	143	targeting	target	VERB
bam-7960	18	144	il-6	il-6	PRON
bam-7960	18	145	appears	appear	VERB
bam-7960	18	146	well	well	ADV
bam-7960	18	147	tolerated	tolerate	VERB
bam-7960	18	148	and	and	CCONJ
bam-7960	18	149	ameliorates	ameliorate	NOUN
bam-7960	18	150	nsclc	nsclc	NOUN
bam-7960	18	151	-	-	PUNCT
bam-7960	18	152	related	relate	VERB
bam-7960	18	153	anemia	anemia	NOUN
bam-7960	18	154	and	and	CCONJ
bam-7960	18	155	cachexia.12	cachexia.12	PROPN
bam-7960	18	156	on	on	ADP
bam-7960	18	157	the	the	DET
bam-7960	18	158	same	same	ADJ
bam-7960	18	159	lines	line	NOUN
bam-7960	18	160	,	,	PUNCT
bam-7960	18	161	a	a	DET
bam-7960	18	162	phase	phase	NOUN
bam-7960	18	163	ii	ii	NOUN
bam-7960	18	164	clinical	clinical	ADJ
bam-7960	18	165	trial	trial	NOUN
bam-7960	18	166	with	with	ADP
bam-7960	18	167	ruxolitinib	ruxolitinib	NOUN
bam-7960	18	168	an	an	DET
bam-7960	18	169	inhibitor	inhibitor	NOUN
bam-7960	18	170	of	of	ADP
bam-7960	18	171	janus	janus	PROPN
bam-7960	18	172	kinases	kinases	PROPN
bam-7960	18	173	(	(	PUNCT
bam-7960	18	174	jaks	jak	NOUN
bam-7960	18	175	)	)	PUNCT
bam-7960	18	176	activators	activator	NOUN
bam-7960	18	177	of	of	ADP
bam-7960	18	178	the	the	DET
bam-7960	18	179	stat	stat	NOUN
bam-7960	18	180	transcription	transcription	NOUN
bam-7960	18	181	factor	factor	NOUN
bam-7960	18	182	in	in	ADP
bam-7960	18	183	patients	patient	NOUN
bam-7960	18	184	with	with	ADP
bam-7960	18	185	tumorassociated	tumorassociate	VERB
bam-7960	18	186	chronic	chronic	NOUN
bam-7960	18	187	wasting	waste	VERB
bam-7960	18	188	diseases	disease	NOUN
bam-7960	18	189	is	be	AUX
bam-7960	18	190	now	now	ADV
bam-7960	18	191	on	on	ADP
bam-7960	18	192	-	-	PUNCT
bam-7960	18	193	going.13	going.13	NOUN
bam-7960	18	194	il-6	il-6	NOUN
bam-7960	18	195	intracellular	intracellular	NOUN
bam-7960	18	196	signaling	signal	VERB
bam-7960	18	197	pathway	pathway	NOUN
bam-7960	18	198	takes	take	VERB
bam-7960	18	199	place	place	NOUN
bam-7960	18	200	via	via	ADP
bam-7960	18	201	activation	activation	NOUN
bam-7960	18	202	of	of	ADP
bam-7960	18	203	the	the	DET
bam-7960	18	204	janus	janus	PROPN
bam-7960	18	205	kinases	kinase	NOUN
bam-7960	18	206	.	.	PUNCT
bam-7960	19	1	targeting	target	VERB
bam-7960	19	2	both	both	PRON
bam-7960	19	3	tnf-	tnf-	NOUN
bam-7960	19	4	and	and	CCONJ
bam-7960	19	5	il-6	il-6	NOUN
bam-7960	19	6	by	by	ADP
bam-7960	19	7	means	mean	NOUN
bam-7960	19	8	of	of	ADP
bam-7960	19	9	a	a	DET
bam-7960	19	10	broad	broad	ADJ
bam-7960	19	11	-	-	PUNCT
bam-7960	19	12	spectrum	spectrum	NOUN
bam-7960	19	13	peptide	peptide	ADJ
bam-7960	19	14	nucleic	nucleic	ADJ
bam-7960	19	15	acid	acid	NOUN
bam-7960	19	16	(	(	PUNCT
bam-7960	19	17	ohr118	ohr118	PROPN
bam-7960	19	18	,	,	PUNCT
bam-7960	19	19	ohr	ohr	PROPN
bam-7960	19	20	pharma	pharma	PROPN
bam-7960	19	21	)	)	PUNCT
bam-7960	19	22	,	,	PUNCT
bam-7960	19	23	resulted	result	VERB
bam-7960	19	24	in	in	ADP
bam-7960	19	25	an	an	DET
bam-7960	19	26	increase	increase	NOUN
bam-7960	19	27	in	in	ADP
bam-7960	19	28	both	both	PRON
bam-7960	19	29	body	body	NOUN
bam-7960	19	30	weight	weight	NOUN
bam-7960	19	31	and	and	CCONJ
bam-7960	19	32	physical	physical	ADJ
bam-7960	19	33	performance	performance	NOUN
bam-7960	19	34	in	in	ADP
bam-7960	19	35	patients	patient	NOUN
bam-7960	19	36	with	with	ADP
bam-7960	19	37	advanced	advanced	ADJ
bam-7960	19	38	cancer	cancer	NOUN
bam-7960	19	39	in	in	ADP
bam-7960	19	40	a	a	DET
bam-7960	19	41	phase	phase	NOUN
bam-7960	19	42	ii	ii	NOUN
bam-7960	19	43	trial.14,15	trial.14,15	NOUN
bam-7960	19	44	in	in	ADP
bam-7960	19	45	a	a	DET
bam-7960	19	46	preclinical	preclinical	ADJ
bam-7960	19	47	mouse	mouse	NOUN
bam-7960	19	48	model	model	NOUN
bam-7960	19	49	of	of	ADP
bam-7960	19	50	pancreatic	pancreatic	ADJ
bam-7960	19	51	cancer	cancer	NOUN
bam-7960	19	52	cachexia	cachexia	NOUN
bam-7960	19	53	,	,	PUNCT
bam-7960	19	54	greco	greco	PROPN
bam-7960	19	55	et	et	PROPN
bam-7960	19	56	al	al	PROPN
bam-7960	19	57	.	.	PROPN
bam-7960	19	58	have	have	AUX
bam-7960	19	59	described	describe	VERB
bam-7960	19	60	that	that	DET
bam-7960	19	61	blockade	blockade	NOUN
bam-7960	19	62	of	of	ADP
bam-7960	19	63	tgf-	tgf-	NOUN
bam-7960	19	64	,	,	PUNCT
bam-7960	19	65	lessens	lessen	VERB
bam-7960	19	66	cachexia	cachexia	NOUN
bam-7960	19	67	,	,	PUNCT
bam-7960	19	68	reducing	reduce	VERB
bam-7960	19	69	mortality	mortality	NOUN
bam-7960	19	70	and	and	CCONJ
bam-7960	19	71	metabolic	metabolic	NOUN
bam-7960	19	72	alterations.16	alterations.16	PROPN
bam-7960	19	73	in	in	ADP
bam-7960	19	74	fact	fact	NOUN
bam-7960	19	75	,	,	PUNCT
bam-7960	19	76	according	accord	VERB
bam-7960	19	77	to	to	ADP
bam-7960	19	78	waning	wane	VERB
bam-7960	19	79	,	,	PUNCT
bam-7960	19	80	tgf	tgf	PROPN
bam-7960	19	81	-	-	PUNCT
bam-7960	19	82	β	β	PROPN
bam-7960	19	83	mediates	mediate	NOUN
bam-7960	19	84	muscle	muscle	NOUN
bam-7960	19	85	weakness	weakness	NOUN
bam-7960	19	86	associated	associate	VERB
bam-7960	19	87	with	with	ADP
bam-7960	19	88	bone	bone	NOUN
bam-7960	19	89	metastases	metastasis	NOUN
bam-7960	19	90	in	in	ADP
bam-7960	19	91	mice.17	mice.17	NOUN
bam-7960	19	92	indeed	indeed	ADV
bam-7960	19	93	,	,	PUNCT
bam-7960	19	94	during	during	ADP
bam-7960	19	95	tumor	tumor	NOUN
bam-7960	19	96	-	-	PUNCT
bam-7960	19	97	induced	induce	VERB
bam-7960	19	98	bone	bone	NOUN
bam-7960	19	99	destruction	destruction	NOUN
bam-7960	19	100	,	,	PUNCT
bam-7960	19	101	tgf	tgf	PROPN
bam-7960	19	102	-	-	PUNCT
bam-7960	19	103	β	β	PROPN
bam-7960	19	104	upregulates	upregulate	VERB
bam-7960	19	105	nox4	nox4	PROPN
bam-7960	19	106	an	an	DET
bam-7960	19	107	nadph	nadph	ADJ
bam-7960	19	108	oxidase	oxidase	NOUN
bam-7960	19	109	resulting	result	VERB
bam-7960	19	110	in	in	ADP
bam-7960	19	111	alterations	alteration	NOUN
bam-7960	19	112	in	in	ADP
bam-7960	19	113	skeletal	skeletal	ADJ
bam-7960	19	114	muscle	muscle	NOUN
bam-7960	19	115	proteins	protein	NOUN
bam-7960	19	116	(	(	PUNCT
bam-7960	19	117	oxidation	oxidation	NOUN
bam-7960	19	118	)	)	PUNCT
bam-7960	19	119	.	.	PUNCT
bam-7960	20	1	among	among	ADP
bam-7960	20	2	these	these	DET
bam-7960	20	3	proteins	protein	NOUN
bam-7960	20	4	,	,	PUNCT
bam-7960	20	5	the	the	DET
bam-7960	20	6	ryanodine	ryanodine	NOUN
bam-7960	20	7	receptor	receptor	NOUN
bam-7960	20	8	/	/	SYM
bam-7960	20	9	calcium	calcium	NOUN
bam-7960	20	10	(	(	PUNCT
bam-7960	20	11	ca2	ca2	PROPN
bam-7960	20	12	+	+	NOUN
bam-7960	20	13	)	)	PUNCT
bam-7960	20	14	release	release	NOUN
bam-7960	20	15	channel	channel	NOUN
bam-7960	20	16	(	(	PUNCT
bam-7960	20	17	ryr1	ryr1	NOUN
bam-7960	20	18	)	)	PUNCT
bam-7960	20	19	is	be	AUX
bam-7960	20	20	oxidized	oxidize	VERB
bam-7960	20	21	.	.	PUNCT
bam-7960	21	1	the	the	DET
bam-7960	21	2	altered	altered	ADJ
bam-7960	21	3	ryr1	ryr1	NOUN
bam-7960	21	4	channels	channel	NOUN
bam-7960	21	5	leak	leak	VERB
bam-7960	21	6	ca2	ca2	PROPN
bam-7960	21	7	+	+	PROPN
bam-7960	21	8	,	,	PUNCT
bam-7960	21	9	resulting	result	VERB
bam-7960	21	10	in	in	ADP
bam-7960	21	11	lower	low	ADJ
bam-7960	21	12	intracellular	intracellular	ADJ
bam-7960	21	13	signaling	signal	VERB
bam-7960	21	14	required	require	VERB
bam-7960	21	15	for	for	ADP
bam-7960	21	16	adequate	adequate	ADJ
bam-7960	21	17	muscle	muscle	NOUN
bam-7960	21	18	contraction.17	contraction.17	PROPN
bam-7960	21	19	the	the	DET
bam-7960	21	20	production	production	NOUN
bam-7960	21	21	of	of	ADP
bam-7960	21	22	the	the	DET
bam-7960	21	23	cytokines	cytokine	NOUN
bam-7960	21	24	mentioned	mention	VERB
bam-7960	21	25	above	above	ADV
bam-7960	21	26	,	,	PUNCT
bam-7960	21	27	known	know	VERB
bam-7960	21	28	as	as	ADP
bam-7960	21	29	catabolic	catabolic	ADJ
bam-7960	21	30	proinflammatory	proinflammatory	ADJ
bam-7960	21	31	cytokines	cytokine	NOUN
bam-7960	21	32	,	,	PUNCT
bam-7960	21	33	is	be	AUX
bam-7960	21	34	not	not	PART
bam-7960	21	35	the	the	DET
bam-7960	21	36	only	only	ADJ
bam-7960	21	37	factor	factor	NOUN
bam-7960	21	38	involved	involve	VERB
bam-7960	21	39	in	in	ADP
bam-7960	21	40	the	the	DET
bam-7960	21	41	metabolic	metabolic	NOUN
bam-7960	21	42	changes	change	NOUN
bam-7960	21	43	associated	associate	VERB
bam-7960	21	44	with	with	ADP
bam-7960	21	45	cancer	cancer	NOUN
bam-7960	21	46	cachexia	cachexia	NOUN
bam-7960	21	47	.	.	PUNCT
bam-7960	22	1	indeed	indeed	ADV
bam-7960	22	2	,	,	PUNCT
bam-7960	22	3	the	the	DET
bam-7960	22	4	so	so	ADV
bam-7960	22	5	-	-	PUNCT
bam-7960	22	6	called	call	VERB
bam-7960	22	7	anti	anti	ADJ
bam-7960	22	8	-	-	ADJ
bam-7960	22	9	inflammatory	inflammatory	ADJ
bam-7960	22	10	cytokines	cytokine	NOUN
bam-7960	22	11	,	,	PUNCT
bam-7960	22	12	such	such	ADJ
bam-7960	22	13	as	as	ADP
bam-7960	22	14	il-4	il-4	NOUN
bam-7960	22	15	,	,	PUNCT
bam-7960	22	16	-10	-10	PUNCT
bam-7960	22	17	-12	-12	NOUN
bam-7960	22	18	and	and	CCONJ
bam-7960	22	19	-15	-15	NUM
bam-7960	22	20	,	,	PUNCT
bam-7960	22	21	are	be	AUX
bam-7960	22	22	also	also	ADV
bam-7960	22	23	involved	involve	VERB
bam-7960	22	24	.	.	PUNCT
bam-7960	23	1	indeed	indeed	ADV
bam-7960	23	2	,	,	PUNCT
bam-7960	23	3	il-15	il-15	PUNCT
bam-7960	23	4	has	have	AUX
bam-7960	23	5	been	be	AUX
bam-7960	23	6	reported	report	VERB
bam-7960	23	7	to	to	PART
bam-7960	23	8	be	be	AUX
bam-7960	23	9	an	an	DET
bam-7960	23	10	anabolic	anabolic	NOUN
bam-7960	23	11	factor	factor	NOUN
bam-7960	23	12	for	for	ADP
bam-7960	23	13	skeletal	skeletal	ADJ
bam-7960	23	14	muscle.18,19	muscle.18,19	NOUN
bam-7960	23	15	il-15	il-15	PUNCT
bam-7960	23	16	decreases	decrease	VERB
bam-7960	23	17	protein	protein	NOUN
bam-7960	23	18	degradation	degradation	NOUN
bam-7960	23	19	and	and	CCONJ
bam-7960	23	20	dna	dna	NOUN
bam-7960	23	21	fragmentation	fragmentation	NOUN
bam-7960	23	22	while	while	SCONJ
bam-7960	23	23	increases	increase	VERB
bam-7960	23	24	ucp3	ucp3	PROPN
bam-7960	23	25	(	(	PUNCT
bam-7960	23	26	uncoupling	uncouple	VERB
bam-7960	23	27	protein-3	protein-3	NOUN
bam-7960	23	28	)	)	PUNCT
bam-7960	23	29	expression	expression	NOUN
bam-7960	23	30	in	in	ADP
bam-7960	23	31	skeletal	skeletal	ADJ
bam-7960	23	32	muscle.18	muscle.18	VERB
bam-7960	23	33	the	the	DET
bam-7960	23	34	action	action	NOUN
bam-7960	23	35	of	of	ADP
bam-7960	23	36	the	the	DET
bam-7960	23	37	cytokine	cytokine	NOUN
bam-7960	23	38	is	be	AUX
bam-7960	23	39	directly	directly	ADV
bam-7960	23	40	upon	upon	SCONJ
bam-7960	23	41	skeletal	skeletal	ADJ
bam-7960	23	42	muscle.20	muscle.20	NOUN
bam-7960	23	43	pre	pre	ADJ
bam-7960	23	44	-	-	ADJ
bam-7960	23	45	clinical	clinical	ADJ
bam-7960	23	46	studies	study	NOUN
bam-7960	23	47	indicate	indicate	VERB
bam-7960	23	48	that	that	SCONJ
bam-7960	23	49	il-15	il-15	NOUN
bam-7960	23	50	leads	lead	VERB
bam-7960	23	51	to	to	ADP
bam-7960	23	52	an	an	DET
bam-7960	23	53	improvement	improvement	NOUN
bam-7960	23	54	of	of	ADP
bam-7960	23	55	muscle	muscle	NOUN
bam-7960	23	56	mass	mass	NOUN
bam-7960	23	57	and	and	CCONJ
bam-7960	23	58	performance	performance	NOUN
bam-7960	23	59	in	in	ADP
bam-7960	23	60	tumor	tumor	NOUN
bam-7960	23	61	-	-	PUNCT
bam-7960	23	62	bearing	bear	VERB
bam-7960	23	63	animals.19	animals.19	PROPN
bam-7960	23	64	martinezhernandez	martinezhernandez	PROPN
bam-7960	23	65	et	et	PROPN
bam-7960	23	66	al	al	PROPN
bam-7960	23	67	.	.	PROPN
bam-7960	23	68	have	have	AUX
bam-7960	23	69	demonstrated	demonstrate	VERB
bam-7960	23	70	a	a	DET
bam-7960	23	71	relevant	relevant	ADJ
bam-7960	23	72	association	association	NOUN
bam-7960	23	73	between	between	ADP
bam-7960	23	74	serum	serum	NOUN
bam-7960	23	75	il-15	il-15	NOUN
bam-7960	23	76	and	and	CCONJ
bam-7960	23	77	changes	change	NOUN
bam-7960	23	78	in	in	ADP
bam-7960	23	79	weight	weight	NOUN
bam-7960	23	80	and	and	CCONJ
bam-7960	23	81	muscle	muscle	NOUN
bam-7960	23	82	mass	mass	NOUN
bam-7960	23	83	in	in	ADP
bam-7960	23	84	cancer	cancer	NOUN
bam-7960	23	85	patients	patient	NOUN
bam-7960	23	86	,	,	PUNCT
bam-7960	23	87	suggesting	suggest	VERB
bam-7960	23	88	a	a	DET
bam-7960	23	89	possible	possible	ADJ
bam-7960	23	90	role	role	NOUN
bam-7960	23	91	of	of	ADP
bam-7960	23	92	the	the	DET
bam-7960	23	93	cytokine	cytokine	NOUN
bam-7960	23	94	as	as	ADP
bam-7960	23	95	a	a	DET
bam-7960	23	96	body	body	NOUN
bam-7960	23	97	composition	composition	NOUN
bam-7960	23	98	marker	marker	NOUN
bam-7960	23	99	in	in	ADP
bam-7960	23	100	weight	weight	NOUN
bam-7960	23	101	-	-	PUNCT
bam-7960	23	102	losing	lose	VERB
bam-7960	23	103	cancer	cancer	NOUN
bam-7960	23	104	patients.21	patients.21	NOUN
bam-7960	23	105	drugs	drug	NOUN
bam-7960	23	106	modulating	modulate	VERB
bam-7960	23	107	appetite	appetite	NOUN
bam-7960	23	108	in	in	ADP
bam-7960	23	109	humans	human	NOUN
bam-7960	23	110	,	,	PUNCT
bam-7960	23	111	megestrol	megestrol	NOUN
bam-7960	23	112	acetate	acetate	NOUN
bam-7960	23	113	a	a	DET
bam-7960	23	114	synthetic	synthetic	NOUN
bam-7960	23	115	,	,	PUNCT
bam-7960	23	116	orally	orally	ADV
bam-7960	23	117	active	active	ADJ
bam-7960	23	118	derivative	derivative	NOUN
bam-7960	23	119	of	of	ADP
bam-7960	23	120	the	the	DET
bam-7960	23	121	naturally	naturally	ADV
bam-7960	23	122	occurring	occur	VERB
bam-7960	23	123	hormone	hormone	NOUN
bam-7960	23	124	progesterone	progesterone	NOUN
bam-7960	23	125	improves	improve	VERB
bam-7960	23	126	appetite	appetite	NOUN
bam-7960	23	127	,	,	PUNCT
bam-7960	23	128	caloric	caloric	NOUN
bam-7960	23	129	intake	intake	NOUN
bam-7960	23	130	and	and	CCONJ
bam-7960	23	131	nutritional	nutritional	ADJ
bam-7960	23	132	status.22	status.22	NOUN
bam-7960	23	133	the	the	DET
bam-7960	23	134	mechanism	mechanism	NOUN
bam-7960	23	135	that	that	PRON
bam-7960	23	136	mediates	mediate	VERB
bam-7960	23	137	the	the	DET
bam-7960	23	138	weight	weight	NOUN
bam-7960	23	139	gain	gain	NOUN
bam-7960	23	140	is	be	AUX
bam-7960	23	141	mostly	mostly	ADV
bam-7960	23	142	unknown	unknown	ADJ
bam-7960	23	143	,	,	PUNCT
bam-7960	23	144	although	although	SCONJ
bam-7960	23	145	it	it	PRON
bam-7960	23	146	has	have	AUX
bam-7960	23	147	been	be	AUX
bam-7960	23	148	proposed	propose	VERB
bam-7960	23	149	that	that	SCONJ
bam-7960	23	150	it	it	PRON
bam-7960	23	151	may	may	AUX
bam-7960	23	152	be	be	AUX
bam-7960	23	153	partially	partially	ADV
bam-7960	23	154	mediated	mediate	VERB
bam-7960	23	155	by	by	ADP
bam-7960	23	156	neuropeptide	neuropeptide	NOUN
bam-7960	23	157	y	y	PROPN
bam-7960	23	158	(	(	PUNCT
bam-7960	23	159	npy	npy	PROPN
bam-7960	23	160	)	)	PUNCT
bam-7960	23	161	,	,	PUNCT
bam-7960	23	162	a	a	DET
bam-7960	23	163	potent	potent	ADJ
bam-7960	23	164	central	central	ADJ
bam-7960	23	165	appetite	appetite	NOUN
bam-7960	23	166	stimulant	stimulant	NOUN
bam-7960	23	167	.	.	PUNCT
bam-7960	24	1	interestingly	interestingly	ADV
bam-7960	24	2	,	,	PUNCT
bam-7960	24	3	in	in	ADP
bam-7960	24	4	experimental	experimental	ADJ
bam-7960	24	5	animals	animal	NOUN
bam-7960	24	6	,	,	PUNCT
bam-7960	24	7	megestrol	megestrol	NOUN
bam-7960	24	8	acetate	acetate	NOUN
bam-7960	24	9	increases	increase	VERB
bam-7960	24	10	not	not	PART
bam-7960	24	11	only	only	ADV
bam-7960	24	12	food	food	NOUN
bam-7960	24	13	intake	intake	NOUN
bam-7960	24	14	but	but	CCONJ
bam-7960	24	15	also	also	ADV
bam-7960	24	16	lean	lean	VERB
bam-7960	24	17	mass	mass	NOUN
bam-7960	24	18	and	and	CCONJ
bam-7960	24	19	physical	physical	ADJ
bam-7960	24	20	performance.23	performance.23	NOUN
bam-7960	24	21	nanocrystal	nanocrystal	ADJ
bam-7960	24	22	suspensions	suspension	NOUN
bam-7960	24	23	of	of	ADP
bam-7960	24	24	megestrol	megestrol	NOUN
bam-7960	24	25	acetate	acetate	NOUN
bam-7960	24	26	are	be	AUX
bam-7960	24	27	easy	easy	ADJ
bam-7960	24	28	to	to	PART
bam-7960	24	29	use	use	VERB
bam-7960	24	30	and	and	CCONJ
bam-7960	24	31	represent	represent	VERB
bam-7960	24	32	an	an	DET
bam-7960	24	33	improvement	improvement	NOUN
bam-7960	24	34	in	in	ADP
bam-7960	24	35	bioavailability.24	bioavailability.24	NOUN
bam-7960	24	36	megestrol	megestrol	NOUN
bam-7960	24	37	acetate	acetate	NOUN
bam-7960	24	38	is	be	AUX
bam-7960	24	39	the	the	DET
bam-7960	24	40	standard	standard	ADJ
bam-7960	24	41	drug	drug	NOUN
bam-7960	24	42	in	in	ADP
bam-7960	24	43	cancer	cancer	NOUN
bam-7960	24	44	cachexia	cachexia	NOUN
bam-7960	24	45	treatment	treatment	NOUN
bam-7960	24	46	in	in	ADP
bam-7960	24	47	many	many	ADJ
bam-7960	24	48	countries	country	NOUN
bam-7960	24	49	over	over	ADP
bam-7960	24	50	the	the	DET
bam-7960	24	51	world.25	world.25	NOUN
bam-7960	24	52	the	the	DET
bam-7960	24	53	orexigenic	orexigenic	ADJ
bam-7960	24	54	mediator	mediator	NOUN
bam-7960	24	55	ghrelin	ghrelin	NOUN
bam-7960	24	56	,	,	PUNCT
bam-7960	24	57	a	a	DET
bam-7960	24	58	novel	novel	ADJ
bam-7960	24	59	endogenous	endogenous	ADJ
bam-7960	24	60	ligand	ligand	NOUN
bam-7960	24	61	for	for	ADP
bam-7960	24	62	the	the	DET
bam-7960	24	63	growth	growth	NOUN
bam-7960	24	64	hormone	hormone	NOUN
bam-7960	24	65	secretagogue	secretagogue	NOUN
bam-7960	24	66	receptor	receptor	NOUN
bam-7960	24	67	,	,	PUNCT
bam-7960	24	68	and	and	CCONJ
bam-7960	24	69	secreted	secrete	VERB
bam-7960	24	70	by	by	ADP
bam-7960	24	71	the	the	DET
bam-7960	24	72	stomach	stomach	NOUN
bam-7960	24	73	and	and	CCONJ
bam-7960	24	74	pancreas	pancrea	NOUN
bam-7960	24	75	,	,	PUNCT
bam-7960	24	76	has	have	AUX
bam-7960	24	77	been	be	AUX
bam-7960	24	78	reported	report	VERB
bam-7960	24	79	as	as	ADP
bam-7960	24	80	having	have	VERB
bam-7960	24	81	a	a	DET
bam-7960	24	82	pivotal	pivotal	ADJ
bam-7960	24	83	role	role	NOUN
bam-7960	24	84	in	in	ADP
bam-7960	24	85	increasing	increase	VERB
bam-7960	24	86	appetite	appetite	NOUN
bam-7960	24	87	and	and	CCONJ
bam-7960	24	88	,	,	PUNCT
bam-7960	24	89	therefore	therefore	ADV
bam-7960	24	90	,	,	PUNCT
bam-7960	24	91	food	food	NOUN
bam-7960	24	92	intake	intake	NOUN
bam-7960	24	93	.	.	PUNCT
bam-7960	25	1	besides	besides	SCONJ
bam-7960	25	2	,	,	PUNCT
bam-7960	25	3	this	this	DET
bam-7960	25	4	peptide	peptide	NOUN
bam-7960	25	5	has	have	VERB
bam-7960	25	6	important	important	ADJ
bam-7960	25	7	metabolic	metabolic	NOUN
bam-7960	25	8	effects	effect	NOUN
bam-7960	25	9	and	and	CCONJ
bam-7960	25	10	regulates	regulate	VERB
bam-7960	25	11	energy	energy	NOUN
bam-7960	25	12	metabolism	metabolism	NOUN
bam-7960	25	13	through	through	ADP
bam-7960	25	14	growth	growth	NOUN
bam-7960	25	15	hormone	hormone	NOUN
bam-7960	25	16	-	-	PUNCT
bam-7960	25	17	dependent	dependent	ADJ
bam-7960	25	18	and	and	CCONJ
bam-7960	25	19	-independent	-independent	ADJ
bam-7960	25	20	mechanisms.26	mechanisms.26	NOUN
bam-7960	25	21	thus	thus	ADV
bam-7960	25	22	,	,	PUNCT
bam-7960	25	23	administration	administration	NOUN
bam-7960	25	24	of	of	ADP
bam-7960	25	25	ghrelin	ghrelin	NOUN
bam-7960	25	26	constitutes	constitute	VERB
bam-7960	25	27	a	a	DET
bam-7960	25	28	new	new	ADJ
bam-7960	25	29	therapeutic	therapeutic	ADJ
bam-7960	25	30	strategy	strategy	NOUN
bam-7960	25	31	for	for	ADP
bam-7960	25	32	the	the	DET
bam-7960	25	33	treatment	treatment	NOUN
bam-7960	25	34	of	of	ADP
bam-7960	25	35	cancer	cancer	NOUN
bam-7960	25	36	cachexia.27	cachexia.27	PROPN
bam-7960	25	37	pre	pre	ADJ
bam-7960	25	38	-	-	ADJ
bam-7960	25	39	clinical	clinical	ADJ
bam-7960	25	40	studies	study	NOUN
bam-7960	25	41	have	have	AUX
bam-7960	25	42	shown	show	VERB
bam-7960	25	43	that	that	SCONJ
bam-7960	25	44	ghrelin	ghrelin	NOUN
bam-7960	25	45	administration	administration	NOUN
bam-7960	25	46	to	to	ADP
bam-7960	25	47	cachectic	cachectic	ADJ
bam-7960	25	48	tumor	tumor	NOUN
bam-7960	25	49	-	-	PUNCT
bam-7960	25	50	bearing	bear	VERB
bam-7960	25	51	animals	animal	NOUN
bam-7960	25	52	results	result	VERB
bam-7960	25	53	in	in	ADP
bam-7960	25	54	an	an	DET
bam-7960	25	55	improvement	improvement	NOUN
bam-7960	25	56	in	in	ADP
bam-7960	25	57	both	both	CCONJ
bam-7960	25	58	appetite	appetite	NOUN
bam-7960	25	59	and	and	CCONJ
bam-7960	25	60	body	body	NOUN
bam-7960	25	61	weight	weight	NOUN
bam-7960	25	62	,	,	PUNCT
bam-7960	25	63	together	together	ADV
bam-7960	25	64	with	with	ADP
bam-7960	25	65	an	an	DET
bam-7960	25	66	improvement	improvement	NOUN
bam-7960	25	67	in	in	ADP
bam-7960	25	68	lean	lean	ADJ
bam-7960	25	69	body	body	NOUN
bam-7960	25	70	mass.28	mass.28	NOUN
bam-7960	25	71	in	in	ADP
bam-7960	25	72	addition	addition	NOUN
bam-7960	25	73	,	,	PUNCT
bam-7960	25	74	ghrelin	ghrelin	NOUN
bam-7960	25	75	administration	administration	NOUN
bam-7960	25	76	to	to	ADP
bam-7960	25	77	rats	rat	NOUN
bam-7960	25	78	prevents	prevent	VERB
bam-7960	25	79	cisplatininduced	cisplatininduced	ADJ
bam-7960	25	80	mechanical	mechanical	ADJ
bam-7960	25	81	hyperalgesia	hyperalgesia	NOUN
bam-7960	25	82	–	–	PUNCT
bam-7960	25	83	increased	increase	VERB
bam-7960	25	84	pain	pain	NOUN
bam-7960	25	85	sensitivity	sensitivity	NOUN
bam-7960	25	86	–	–	PUNCT
bam-7960	25	87	and	and	CCONJ
bam-7960	25	88	cachexia.29	cachexia.29	NOUN
bam-7960	25	89	in	in	ADP
bam-7960	25	90	fact	fact	NOUN
bam-7960	25	91	,	,	PUNCT
bam-7960	25	92	cisplatin	cisplatin	NOUN
bam-7960	25	93	-	-	PUNCT
bam-7960	25	94	induced	induce	VERB
bam-7960	25	95	anorexia	anorexia	NOUN
bam-7960	25	96	is	be	AUX
bam-7960	25	97	mediated	mediate	VERB
bam-7960	25	98	through	through	ADP
bam-7960	25	99	reduced	reduce	VERB
bam-7960	25	100	hypothalamic	hypothalamic	ADJ
bam-7960	25	101	ghrelin	ghrelin	NOUN
bam-7960	25	102	secretion	secretion	NOUN
bam-7960	25	103	.	.	PUNCT
bam-7960	26	1	in	in	ADP
bam-7960	26	2	addition	addition	NOUN
bam-7960	26	3	,	,	PUNCT
bam-7960	26	4	ghrelin	ghrelin	NOUN
bam-7960	26	5	seems	seem	VERB
bam-7960	26	6	to	to	PART
bam-7960	26	7	attenuate	attenuate	VERB
bam-7960	26	8	gastrointestinal	gastrointestinal	ADJ
bam-7960	26	9	epithelial	epithelial	ADJ
bam-7960	26	10	damage	damage	NOUN
bam-7960	26	11	induced	induce	VERB
bam-7960	26	12	by	by	ADP
bam-7960	26	13	doxorubicin.30	doxorubicin.30	NOUN
bam-7960	26	14	these	these	DET
bam-7960	26	15	results	result	NOUN
bam-7960	26	16	support	support	VERB
bam-7960	26	17	ghrelin	ghrelin	NOUN
bam-7960	26	18	as	as	ADP
bam-7960	26	19	a	a	DET
bam-7960	26	20	protective	protective	ADJ
bam-7960	26	21	factor	factor	NOUN
bam-7960	26	22	against	against	ADP
bam-7960	26	23	the	the	DET
bam-7960	26	24	toxic	toxic	ADJ
bam-7960	26	25	effects	effect	NOUN
bam-7960	26	26	of	of	ADP
bam-7960	26	27	chemotherapeutic	chemotherapeutic	ADJ
bam-7960	26	28	agents	agent	NOUN
bam-7960	26	29	.	.	PUNCT
bam-7960	27	1	several	several	ADJ
bam-7960	27	2	clinical	clinical	ADJ
bam-7960	27	3	trials	trial	NOUN
bam-7960	27	4	with	with	ADP
bam-7960	27	5	ghrelin	ghrelin	NOUN
bam-7960	27	6	or	or	CCONJ
bam-7960	27	7	ghrelin	ghrelin	NOUN
bam-7960	27	8	mimetics	mimetic	NOUN
bam-7960	27	9	have	have	AUX
bam-7960	27	10	been	be	AUX
bam-7960	27	11	performed	perform	VERB
bam-7960	27	12	or	or	CCONJ
bam-7960	27	13	are	be	AUX
bam-7960	27	14	currently	currently	ADV
bam-7960	27	15	ongoing	ongoing	ADJ
bam-7960	27	16	.	.	PUNCT
bam-7960	28	1	a	a	DET
bam-7960	28	2	couple	couple	NOUN
bam-7960	28	3	of	of	ADP
bam-7960	28	4	phase	phase	NOUN
bam-7960	28	5	ii	ii	PROPN
bam-7960	28	6	randomized	randomize	VERB
bam-7960	28	7	,	,	PUNCT
bam-7960	28	8	placebo	placebo	NOUN
bam-7960	28	9	-	-	PUNCT
bam-7960	28	10	controlled	control	VERB
bam-7960	28	11	,	,	PUNCT
bam-7960	28	12	double	double	ADJ
bam-7960	28	13	-	-	PUNCT
bam-7960	28	14	blind	blind	ADJ
bam-7960	28	15	studies	study	NOUN
bam-7960	28	16	using	use	VERB
bam-7960	28	17	an	an	DET
bam-7960	28	18	oral	oral	ADJ
bam-7960	28	19	ghrelin	ghrelin	NOUN
bam-7960	28	20	mimetic	mimetic	NOUN
bam-7960	28	21	,	,	PUNCT
bam-7960	28	22	anamorelin	anamorelin	PROPN
bam-7960	28	23	(	(	PUNCT
bam-7960	28	24	helsinn	helsinn	NOUN
bam-7960	28	25	therapeutics	therapeutic	NOUN
bam-7960	28	26	)	)	PUNCT
bam-7960	28	27	,	,	PUNCT
bam-7960	28	28	a	a	DET
bam-7960	28	29	ghrelin	ghrelin	NOUN
bam-7960	28	30	receptor	receptor	NOUN
bam-7960	28	31	agonist	agonist	NOUN
bam-7960	28	32	that	that	PRON
bam-7960	28	33	can	can	AUX
bam-7960	28	34	be	be	AUX
bam-7960	28	35	administered	administer	VERB
bam-7960	28	36	orally	orally	ADV
bam-7960	28	37	,	,	PUNCT
bam-7960	28	38	have	have	AUX
bam-7960	28	39	led	lead	VERB
bam-7960	28	40	to	to	ADP
bam-7960	28	41	positive	positive	ADJ
bam-7960	28	42	results	result	NOUN
bam-7960	28	43	in	in	ADP
bam-7960	28	44	non	non	ADJ
bam-7960	28	45	-	-	ADJ
bam-7960	28	46	small	small	ADJ
bam-7960	28	47	cell	cell	NOUN
bam-7960	28	48	lung	lung	NOUN
bam-7960	28	49	cancer	cancer	NOUN
bam-7960	28	50	(	(	PUNCT
bam-7960	28	51	nsclc	nsclc	NOUN
bam-7960	28	52	)	)	PUNCT
bam-7960	28	53	patients	patient	NOUN
bam-7960	28	54	showing	show	VERB
bam-7960	28	55	an	an	DET
bam-7960	28	56	improvement	improvement	NOUN
bam-7960	28	57	in	in	ADP
bam-7960	28	58	lean	lean	ADJ
bam-7960	28	59	body	body	NOUN
bam-7960	28	60	mass	mass	NOUN
bam-7960	28	61	,	,	PUNCT
bam-7960	28	62	total	total	ADJ
bam-7960	28	63	body	body	NOUN
bam-7960	28	64	mass	mass	NOUN
bam-7960	28	65	and	and	CCONJ
bam-7960	28	66	hand	hand	NOUN
bam-7960	28	67	grip	grip	NOUN
bam-7960	28	68	strength.31	strength.31	PROPN
bam-7960	28	69	however	however	ADV
bam-7960	28	70	,	,	PUNCT
bam-7960	28	71	two	two	NUM
bam-7960	28	72	double	double	ADJ
bam-7960	28	73	-	-	PUNCT
bam-7960	28	74	blinded	blind	VERB
bam-7960	28	75	phase	phase	NOUN
bam-7960	28	76	ii	ii	NOUN
bam-7960	28	77	trials	trial	NOUN
bam-7960	28	78	(	(	PUNCT
bam-7960	28	79	romana	romana	PROPN
bam-7960	28	80	1	1	NUM
bam-7960	28	81	&	&	CCONJ
bam-7960	28	82	2	2	NUM
bam-7960	28	83	)	)	PUNCT
bam-7960	28	84	in	in	ADP
bam-7960	28	85	incurable	incurable	ADJ
bam-7960	28	86	stage	stage	NOUN
bam-7960	28	87	ii	ii	PROPN
bam-7960	28	88	/	/	SYM
bam-7960	28	89	iv	iv	NUM
bam-7960	28	90	nsclc	nsclc	NOUN
bam-7960	28	91	patients	patient	NOUN
bam-7960	28	92	,	,	PUNCT
bam-7960	28	93	showed	show	VERB
bam-7960	28	94	that	that	SCONJ
bam-7960	28	95	anamorelin	anamorelin	PROPN
bam-7960	28	96	(	(	PUNCT
bam-7960	28	97	100	100	NUM
bam-7960	28	98	mg	mg	NUM
bam-7960	28	99	/	/	SYM
bam-7960	28	100	day	day	NOUN
bam-7960	28	101	for	for	ADP
bam-7960	28	102	12	12	NUM
bam-7960	28	103	weeks	week	NOUN
bam-7960	28	104	)	)	PUNCT
bam-7960	28	105	increased	increase	VERB
bam-7960	28	106	body	body	NOUN
bam-7960	28	107	weight	weight	NOUN
bam-7960	28	108	,	,	PUNCT
bam-7960	28	109	improved	improve	VERB
bam-7960	28	110	faact	faact	NOUN
bam-7960	28	111	anorexia	anorexia	PROPN
bam-7960	28	112	/	/	SYM
bam-7960	28	113	cachexia	cachexia	NOUN
bam-7960	28	114	scores,31,32	scores,31,32	PROPN
bam-7960	28	115	but	but	CCONJ
bam-7960	28	116	failed	fail	VERB
bam-7960	28	117	to	to	PART
bam-7960	28	118	improve	improve	VERB
bam-7960	28	119	handgrip	handgrip	NOUN
bam-7960	28	120	strength.33	strength.33	NOUN
bam-7960	28	121	in	in	ADP
bam-7960	28	122	a	a	DET
bam-7960	28	123	post	post	X
bam-7960	28	124	hoc	hoc	X
bam-7960	28	125	analysis	analysis	NOUN
bam-7960	28	126	of	of	ADP
bam-7960	28	127	the	the	DET
bam-7960	28	128	two	two	NUM
bam-7960	28	129	phase	phase	NOUN
bam-7960	28	130	ii	ii	NOUN
bam-7960	28	131	studies	study	NOUN
bam-7960	28	132	,	,	PUNCT
bam-7960	28	133	temel	temel	PROPN
bam-7960	28	134	et	et	PROPN
bam-7960	28	135	al	al	PROPN
bam-7960	28	136	.	.	PROPN
bam-7960	28	137	concluded	conclude	VERB
bam-7960	28	138	that	that	SCONJ
bam-7960	28	139	anamorelin	anamorelin	PROPN
bam-7960	28	140	increased	increase	VERB
bam-7960	28	141	both	both	CCONJ
bam-7960	28	142	lean	lean	ADJ
bam-7960	28	143	and	and	CCONJ
bam-7960	28	144	fat	fat	ADJ
bam-7960	28	145	mass	mass	NOUN
bam-7960	28	146	as	as	ADV
bam-7960	28	147	well	well	ADV
bam-7960	28	148	as	as	ADP
bam-7960	28	149	decreased	decrease	VERB
bam-7960	28	150	muscle	muscle	NOUN
bam-7960	28	151	fatigue.33	fatigue.33	PROPN
bam-7960	28	152	interestingly	interestingly	ADV
bam-7960	28	153	,	,	PUNCT
bam-7960	28	154	takayama	takayama	PROPN
bam-7960	28	155	et	et	PROPN
bam-7960	28	156	al	al	PROPN
bam-7960	28	157	.	.	PROPN
bam-7960	28	158	reported	report	VERB
bam-7960	28	159	,	,	PUNCT
bam-7960	28	160	in	in	ADP
bam-7960	28	161	a	a	DET
bam-7960	28	162	phase	phase	NOUN
bam-7960	28	163	-	-	PUNCT
bam-7960	28	164	ii	ii	NOUN
bam-7960	28	165	randomized	randomize	VERB
bam-7960	28	166	trial	trial	NOUN
bam-7960	28	167	where	where	SCONJ
bam-7960	28	168	nsclc	nsclc	NOUN
bam-7960	28	169	patients	patient	NOUN
bam-7960	28	170	were	be	AUX
bam-7960	28	171	daily	daily	ADV
bam-7960	28	172	given	give	VERB
bam-7960	28	173	100	100	NUM
bam-7960	28	174	mg	mg	ADP
bam-7960	28	175	of	of	ADP
bam-7960	28	176	anamorelin	anamorelin	PROPN
bam-7960	28	177	,	,	PUNCT
bam-7960	28	178	an	an	DET
bam-7960	28	179	increase	increase	NOUN
bam-7960	28	180	in	in	ADP
bam-7960	28	181	lean	lean	ADJ
bam-7960	28	182	body	body	NOUN
bam-7960	28	183	mass	mass	NOUN
bam-7960	28	184	,	,	PUNCT
bam-7960	28	185	appetite	appetite	NOUN
bam-7960	28	186	,	,	PUNCT
bam-7960	28	187	quality	quality	NOUN
bam-7960	28	188	of	of	ADP
bam-7960	28	189	life	life	NOUN
bam-7960	28	190	and	and	CCONJ
bam-7960	28	191	performance	performance	NOUN
bam-7960	28	192	status	status	NOUN
bam-7960	28	193	following	follow	VERB
bam-7960	28	194	anamorelin	anamorelin	PROPN
bam-7960	28	195	administration.34	administration.34	PROPN
bam-7960	28	196	in	in	ADP
bam-7960	28	197	addition	addition	NOUN
bam-7960	28	198	,	,	PUNCT
bam-7960	28	199	significant	significant	ADJ
bam-7960	28	200	elevations	elevation	NOUN
bam-7960	28	201	in	in	ADP
bam-7960	28	202	both	both	PRON
bam-7960	28	203	igf-1	igf-1	NOUN
bam-7960	28	204	and	and	CCONJ
bam-7960	28	205	igfbp-3	igfbp-3	NUM
bam-7960	28	206	plasma	plasma	NOUN
bam-7960	28	207	concentrations	concentration	NOUN
bam-7960	28	208	were	be	AUX
bam-7960	28	209	observed	observe	VERB
bam-7960	28	210	,	,	PUNCT
bam-7960	28	211	suggesting	suggest	VERB
bam-7960	28	212	an	an	DET
bam-7960	28	213	improvement	improvement	NOUN
bam-7960	28	214	in	in	ADP
bam-7960	28	215	protein	protein	NOUN
bam-7960	28	216	synthesis	synthesis	NOUN
bam-7960	28	217	.	.	PUNCT
bam-7960	29	1	another	another	DET
bam-7960	29	2	appetite	appetite	ADJ
bam-7960	29	3	stimulant	stimulant	NOUN
bam-7960	29	4	involved	involve	VERB
bam-7960	29	5	in	in	ADP
bam-7960	29	6	clinical	clinical	ADJ
bam-7960	29	7	trials	trial	NOUN
bam-7960	29	8	is	be	AUX
bam-7960	29	9	aezs-130	aezs-130	ADJ
bam-7960	29	10	–	–	PUNCT
bam-7960	29	11	non	non	X
bam-7960	29	12	co	co	X
bam-7960	29	13	mmerc	mmerc	PROPN
bam-7960	29	14	ial	ial	PROPN
bam-7960	29	15	us	us	PROPN
bam-7960	29	16	e	e	NOUN
bam-7960	29	17	o	o	NOUN
bam-7960	29	18	nly	nly	ADV
bam-7960	29	19	therapeutic	therapeutic	ADJ
bam-7960	29	20	strategies	strategy	NOUN
bam-7960	29	21	against	against	ADP
bam-7960	29	22	cancer	cancer	NOUN
bam-7960	29	23	cachexia	cachexia	PROPN
bam-7960	29	24	eur	eur	PROPN
bam-7960	29	25	j	j	PROPN
bam-7960	29	26	transl	transl	PROPN
bam-7960	29	27	myol	myol	ADV
bam-7960	29	28	29	29	NUM
bam-7960	29	29	(	(	PUNCT
bam-7960	29	30	1	1	NUM
bam-7960	29	31	):	):	PUNCT
bam-7960	29	32	4	4	NUM
bam-7960	29	33	-	-	SYM
bam-7960	29	34	13	13	NUM
bam-7960	29	35	,	,	PUNCT
bam-7960	29	36	2019	2019	NUM
bam-7960	29	37	6	6	NUM
bam-7960	29	38	macimorelin	macimorelin	NOUN
bam-7960	29	39	-	-	PUNCT
bam-7960	29	40	,	,	PUNCT
bam-7960	29	41	an	an	DET
bam-7960	29	42	oral	oral	ADJ
bam-7960	29	43	peptidomimetic	peptidomimetic	ADJ
bam-7960	29	44	growth	growth	NOUN
bam-7960	29	45	hormone	hormone	NOUN
bam-7960	29	46	secretagogue	secretagogue	NOUN
bam-7960	29	47	(	(	PUNCT
bam-7960	29	48	aeterna	aeterna	NOUN
bam-7960	29	49	zentaris	zentaris	PROPN
bam-7960	29	50	)	)	PUNCT
bam-7960	29	51	,	,	PUNCT
bam-7960	29	52	now	now	ADV
bam-7960	29	53	in	in	ADP
bam-7960	29	54	phase	phase	NOUN
bam-7960	29	55	ii	ii	NOUN
bam-7960	29	56	,	,	PUNCT
bam-7960	29	57	and	and	CCONJ
bam-7960	29	58	the	the	DET
bam-7960	29	59	endpoints	endpoint	NOUN
bam-7960	29	60	of	of	ADP
bam-7960	29	61	the	the	DET
bam-7960	29	62	trial	trial	NOUN
bam-7960	29	63	being	be	AUX
bam-7960	29	64	changes	change	NOUN
bam-7960	29	65	in	in	ADP
bam-7960	29	66	body	body	NOUN
bam-7960	29	67	weight	weight	NOUN
bam-7960	29	68	,	,	PUNCT
bam-7960	29	69	igf1	igf1	PROPN
bam-7960	29	70	levels	level	NOUN
bam-7960	29	71	and	and	CCONJ
bam-7960	29	72	quality	quality	NOUN
bam-7960	29	73	of	of	ADP
bam-7960	29	74	life.35	life.35	ADV
bam-7960	29	75	finally	finally	ADV
bam-7960	29	76	,	,	PUNCT
bam-7960	29	77	asubio	asubio	PROPN
bam-7960	29	78	pharmaceuticals	pharmaceuticals	PROPN
bam-7960	29	79	is	be	AUX
bam-7960	29	80	involved	involve	VERB
bam-7960	29	81	in	in	ADP
bam-7960	29	82	a	a	DET
bam-7960	29	83	phase	phase	NOUN
bam-7960	29	84	-	-	PUNCT
bam-7960	29	85	ii	ii	NOUN
bam-7960	29	86	clinical	clinical	ADJ
bam-7960	29	87	trial	trial	NOUN
bam-7960	29	88	with	with	ADP
bam-7960	29	89	synthetic	synthetic	ADJ
bam-7960	29	90	human	human	ADJ
bam-7960	29	91	ghrelin	ghrelin	NOUN
bam-7960	29	92	(	(	PUNCT
bam-7960	29	93	sun11031	sun11031	NOUN
bam-7960	29	94	)	)	PUNCT
bam-7960	29	95	in	in	ADP
bam-7960	29	96	copd	copd	NOUN
bam-7960	29	97	patients.36	patients.36	NOUN
bam-7960	29	98	drugs	drug	NOUN
bam-7960	29	99	acting	act	VERB
bam-7960	29	100	on	on	ADP
bam-7960	29	101	other	other	ADJ
bam-7960	29	102	metabolic	metabolic	NOUN
bam-7960	29	103	targets	target	NOUN
bam-7960	29	104	pre	pre	ADJ
bam-7960	29	105	-	-	ADJ
bam-7960	29	106	clinical	clinical	ADJ
bam-7960	29	107	studies	study	NOUN
bam-7960	29	108	using	use	VERB
bam-7960	29	109	formoterol	formoterol	NOUN
bam-7960	29	110	a	a	DET
bam-7960	29	111	2	2	ADJ
bam-7960	29	112	-	-	PUNCT
bam-7960	29	113	adrenergic	adrenergic	NOUN
bam-7960	29	114	agonist	agonist	NOUN
bam-7960	29	115	with	with	ADP
bam-7960	29	116	low	low	ADJ
bam-7960	29	117	cardiac	cardiac	ADJ
bam-7960	29	118	toxicity	toxicity	NOUN
bam-7960	29	119	have	have	AUX
bam-7960	29	120	shown	show	VERB
bam-7960	29	121	that	that	SCONJ
bam-7960	29	122	the	the	DET
bam-7960	29	123	drug	drug	NOUN
bam-7960	29	124	can	can	AUX
bam-7960	29	125	reverse	reverse	VERB
bam-7960	29	126	muscle	muscle	NOUN
bam-7960	29	127	wasting	waste	VERB
bam-7960	29	128	associated	associate	VERB
bam-7960	29	129	with	with	ADP
bam-7960	29	130	cancer	cancer	NOUN
bam-7960	29	131	.	.	PUNCT
bam-7960	30	1	37,38	37,38	NOUN
bam-7960	30	2	.	.	PUNCT
bam-7960	31	1	essentially	essentially	ADV
bam-7960	31	2	,	,	PUNCT
bam-7960	31	3	formoterol	formoterol	NOUN
bam-7960	31	4	treatment	treatment	NOUN
bam-7960	31	5	increases	increase	VERB
bam-7960	31	6	the	the	DET
bam-7960	31	7	rate	rate	NOUN
bam-7960	31	8	of	of	ADP
bam-7960	31	9	protein	protein	NOUN
bam-7960	31	10	synthesis	synthesis	NOUN
bam-7960	31	11	while	while	SCONJ
bam-7960	31	12	inhibiting	inhibit	VERB
bam-7960	31	13	the	the	DET
bam-7960	31	14	rate	rate	NOUN
bam-7960	31	15	of	of	ADP
bam-7960	31	16	muscle	muscle	NOUN
bam-7960	31	17	proteolysis	proteolysis	NOUN
bam-7960	31	18	.	.	PUNCT
bam-7960	32	1	interestingly	interestingly	ADV
bam-7960	32	2	,	,	PUNCT
bam-7960	32	3	this	this	DET
bam-7960	32	4	2	2	ADJ
bam-7960	32	5	-	-	PUNCT
bam-7960	32	6	agonist	agonist	NOUN
bam-7960	32	7	is	be	AUX
bam-7960	32	8	also	also	ADV
bam-7960	32	9	able	able	ADJ
bam-7960	32	10	to	to	PART
bam-7960	32	11	diminish	diminish	VERB
bam-7960	32	12	the	the	DET
bam-7960	32	13	increased	increase	VERB
bam-7960	32	14	rate	rate	NOUN
bam-7960	32	15	of	of	ADP
bam-7960	32	16	muscle	muscle	NOUN
bam-7960	32	17	apoptosis	apoptosis	NOUN
bam-7960	32	18	present	present	NOUN
bam-7960	32	19	in	in	ADP
bam-7960	32	20	tumor	tumor	NOUN
bam-7960	32	21	-	-	PUNCT
bam-7960	32	22	bearing	bear	VERB
bam-7960	32	23	animals	animal	NOUN
bam-7960	32	24	,	,	PUNCT
bam-7960	32	25	together	together	ADV
bam-7960	32	26	with	with	ADP
bam-7960	32	27	facilitating	facilitate	VERB
bam-7960	32	28	muscle	muscle	NOUN
bam-7960	32	29	regeneration	regeneration	NOUN
bam-7960	32	30	by	by	ADP
bam-7960	32	31	stimulating	stimulate	VERB
bam-7960	32	32	satellite	satellite	NOUN
bam-7960	32	33	cells.38,39	cells.38,39	NOUN
bam-7960	32	34	a	a	DET
bam-7960	32	35	combination	combination	NOUN
bam-7960	32	36	treatment	treatment	NOUN
bam-7960	32	37	of	of	ADP
bam-7960	32	38	formoterol	formoterol	NOUN
bam-7960	32	39	and	and	CCONJ
bam-7960	32	40	soluble	soluble	ADJ
bam-7960	32	41	myostatin	myostatin	ADJ
bam-7960	32	42	receptor	receptor	NOUN
bam-7960	32	43	actriib	actriib	NOUN
bam-7960	32	44	has	have	AUX
bam-7960	32	45	been	be	AUX
bam-7960	32	46	able	able	ADJ
bam-7960	32	47	to	to	PART
bam-7960	32	48	completely	completely	ADV
bam-7960	32	49	reserve	reserve	VERB
bam-7960	32	50	muscle	muscle	NOUN
bam-7960	32	51	wasting	waste	VERB
bam-7960	32	52	in	in	ADP
bam-7960	32	53	tumor	tumor	NOUN
bam-7960	32	54	-	-	PUNCT
bam-7960	32	55	bearing	bearing	NOUN
bam-7960	32	56	rats,40	rats,40	VERB
bam-7960	32	57	the	the	DET
bam-7960	32	58	results	result	NOUN
bam-7960	32	59	emphasizing	emphasize	VERB
bam-7960	32	60	the	the	DET
bam-7960	32	61	importance	importance	NOUN
bam-7960	32	62	of	of	ADP
bam-7960	32	63	combining	combine	VERB
bam-7960	32	64	drugs	drug	NOUN
bam-7960	32	65	in	in	ADP
bam-7960	32	66	the	the	DET
bam-7960	32	67	treatment	treatment	NOUN
bam-7960	32	68	of	of	ADP
bam-7960	32	69	cancer	cancer	NOUN
bam-7960	32	70	cachexia	cachexia	NOUN
bam-7960	32	71	.	.	PUNCT
bam-7960	33	1	a	a	DET
bam-7960	33	2	phase	phase	NOUN
bam-7960	33	3	-	-	PUNCT
bam-7960	33	4	iia	iia	NOUN
bam-7960	33	5	study	study	NOUN
bam-7960	33	6	investigating	investigate	VERB
bam-7960	33	7	the	the	DET
bam-7960	33	8	effects	effect	NOUN
bam-7960	33	9	of	of	ADP
bam-7960	33	10	a	a	DET
bam-7960	33	11	combination	combination	NOUN
bam-7960	33	12	of	of	ADP
bam-7960	33	13	formoterol	formoterol	NOUN
bam-7960	33	14	and	and	CCONJ
bam-7960	33	15	megestrol	megestrol	PROPN
bam-7960	33	16	acetate	acetate	NOUN
bam-7960	33	17	(	(	PUNCT
bam-7960	33	18	apd209	apd209	PROPN
bam-7960	33	19	)	)	PUNCT
bam-7960	33	20	in	in	ADP
bam-7960	33	21	13	13	NUM
bam-7960	33	22	cachectic	cachectic	ADJ
bam-7960	33	23	cancer	cancer	NOUN
bam-7960	33	24	patients	patient	NOUN
bam-7960	33	25	has	have	AUX
bam-7960	33	26	been	be	AUX
bam-7960	33	27	undertaken	undertake	VERB
bam-7960	33	28	by	by	ADP
bam-7960	33	29	acacia	acacia	NOUN
bam-7960	33	30	pharma.41	pharma.41	NOUN
bam-7960	33	31	six	six	NUM
bam-7960	33	32	of	of	ADP
bam-7960	33	33	the	the	DET
bam-7960	33	34	seven	seven	NUM
bam-7960	33	35	patients	patient	NOUN
bam-7960	33	36	that	that	PRON
bam-7960	33	37	completed	complete	VERB
bam-7960	33	38	the	the	DET
bam-7960	33	39	treatment	treatment	NOUN
bam-7960	33	40	period	period	NOUN
bam-7960	33	41	showed	show	VERB
bam-7960	33	42	improved	improve	VERB
bam-7960	33	43	muscle	muscle	NOUN
bam-7960	33	44	size	size	NOUN
bam-7960	33	45	and	and	CCONJ
bam-7960	33	46	strength	strength	NOUN
bam-7960	33	47	,	,	PUNCT
bam-7960	33	48	and	and	CCONJ
bam-7960	33	49	three	three	NUM
bam-7960	33	50	patients	patient	NOUN
bam-7960	33	51	had	have	VERB
bam-7960	33	52	improved	improve	VERB
bam-7960	33	53	levels	level	NOUN
bam-7960	33	54	of	of	ADP
bam-7960	33	55	daily	daily	ADJ
bam-7960	33	56	physical	physical	ADJ
bam-7960	33	57	activity.41	activity.41	PROPN
bam-7960	33	58	erythropoietin	erythropoietin	NOUN
bam-7960	33	59	(	(	PUNCT
bam-7960	33	60	epo	epo	PROPN
bam-7960	33	61	)	)	PUNCT
bam-7960	33	62	administration	administration	NOUN
bam-7960	33	63	to	to	ADP
bam-7960	33	64	cancer	cancer	NOUN
bam-7960	33	65	patients	patient	NOUN
bam-7960	33	66	with	with	ADP
bam-7960	33	67	subnormal	subnormal	ADJ
bam-7960	33	68	or	or	CCONJ
bam-7960	33	69	even	even	ADV
bam-7960	33	70	normal	normal	ADJ
bam-7960	33	71	hemoglobin	hemoglobin	NOUN
bam-7960	33	72	levels	level	NOUN
bam-7960	33	73	-	-	PUNCT
bam-7960	33	74	results	result	VERB
bam-7960	33	75	in	in	ADP
bam-7960	33	76	clinical	clinical	ADJ
bam-7960	33	77	benefit	benefit	NOUN
bam-7960	33	78	.	.	PUNCT
bam-7960	34	1	interestingly	interestingly	ADV
bam-7960	34	2	,	,	PUNCT
bam-7960	34	3	kanzaki	kanzaki	PROPN
bam-7960	34	4	et	et	PROPN
bam-7960	34	5	al	al	PROPN
bam-7960	34	6	.	.	PROPN
bam-7960	34	7	have	have	AUX
bam-7960	34	8	shown	show	VERB
bam-7960	34	9	that	that	SCONJ
bam-7960	34	10	epo	epo	PROPN
bam-7960	34	11	--in	--in	VERB
bam-7960	34	12	a	a	DET
bam-7960	34	13	pre	pre	ADJ
bam-7960	34	14	-	-	ADJ
bam-7960	34	15	clinical	clinical	ADJ
bam-7960	34	16	cancer	cancer	NOUN
bam-7960	34	17	cachexia	cachexia	PROPN
bam-7960	34	18	model	model	NOUN
bam-7960	34	19	-	-	PUNCT
bam-7960	34	20	decreases	decrease	VERB
bam-7960	34	21	the	the	DET
bam-7960	34	22	production	production	NOUN
bam-7960	34	23	of	of	ADP
bam-7960	34	24	the	the	DET
bam-7960	34	25	pro	pro	ADJ
bam-7960	34	26	-	-	ADJ
bam-7960	34	27	cachectic	cachectic	ADJ
bam-7960	34	28	cytokine	cytokine	NOUN
bam-7960	34	29	il-6.42	il-6.42	NOUN
bam-7960	34	30	this	this	PRON
bam-7960	34	31	may	may	AUX
bam-7960	34	32	be	be	AUX
bam-7960	34	33	linked	link	VERB
bam-7960	34	34	with	with	ADP
bam-7960	34	35	the	the	DET
bam-7960	34	36	attenuation	attenuation	NOUN
bam-7960	34	37	of	of	ADP
bam-7960	34	38	cachectic	cachectic	ADJ
bam-7960	34	39	manifestations	manifestation	NOUN
bam-7960	34	40	.	.	PUNCT
bam-7960	35	1	epo	epo	PROPN
bam-7960	35	2	treatment	treatment	NOUN
bam-7960	35	3	also	also	ADV
bam-7960	35	4	improves	improve	VERB
bam-7960	35	5	metabolic	metabolic	NOUN
bam-7960	35	6	and	and	CCONJ
bam-7960	35	7	exercise	exercise	NOUN
bam-7960	35	8	capacity	capacity	NOUN
bam-7960	35	9	via	via	ADP
bam-7960	35	10	an	an	DET
bam-7960	35	11	increased	increase	VERB
bam-7960	35	12	erythrocyte	erythrocyte	NOUN
bam-7960	35	13	count.42	count.42	NOUN
bam-7960	35	14	in	in	ADP
bam-7960	35	15	a	a	DET
bam-7960	35	16	pre	pre	ADJ
bam-7960	35	17	-	-	ADJ
bam-7960	35	18	clinical	clinical	ADJ
bam-7960	35	19	mouse	mouse	NOUN
bam-7960	35	20	model	model	NOUN
bam-7960	35	21	of	of	ADP
bam-7960	35	22	cancer	cancer	NOUN
bam-7960	35	23	cachexia	cachexia	PROPN
bam-7960	35	24	,	,	PUNCT
bam-7960	35	25	the	the	DET
bam-7960	35	26	combination	combination	NOUN
bam-7960	35	27	of	of	ADP
bam-7960	35	28	epo	epo	PROPN
bam-7960	35	29	administration	administration	NOUN
bam-7960	35	30	and	and	CCONJ
bam-7960	35	31	aerobic	aerobic	ADJ
bam-7960	35	32	exercise	exercise	NOUN
bam-7960	35	33	has	have	AUX
bam-7960	35	34	led	lead	VERB
bam-7960	35	35	to	to	ADP
bam-7960	35	36	a	a	DET
bam-7960	35	37	significant	significant	ADJ
bam-7960	35	38	decrease	decrease	NOUN
bam-7960	35	39	of	of	ADP
bam-7960	35	40	muscle	muscle	NOUN
bam-7960	35	41	wasting.43	wasting.43	ADJ
bam-7960	35	42	patients	patient	NOUN
bam-7960	35	43	with	with	ADP
bam-7960	35	44	cancer	cancer	NOUN
bam-7960	35	45	cachexia	cachexia	NOUN
bam-7960	35	46	have	have	VERB
bam-7960	35	47	major	major	ADJ
bam-7960	35	48	abnormalities	abnormality	NOUN
bam-7960	35	49	in	in	ADP
bam-7960	35	50	heart	heart	NOUN
bam-7960	35	51	mass	mass	NOUN
bam-7960	35	52	and	and	CCONJ
bam-7960	35	53	function	function	NOUN
bam-7960	35	54	,	,	PUNCT
bam-7960	35	55	the	the	DET
bam-7960	35	56	so	so	ADV
bam-7960	35	57	-	-	PUNCT
bam-7960	35	58	called	call	VERB
bam-7960	35	59	cardiac	cardiac	ADJ
bam-7960	35	60	cachexia	cachexia	NOUN
bam-7960	35	61	.	.	PUNCT
bam-7960	36	1	in	in	ADP
bam-7960	36	2	fact	fact	NOUN
bam-7960	36	3	,	,	PUNCT
bam-7960	36	4	cardiac	cardiac	ADJ
bam-7960	36	5	arrest	arrest	NOUN
bam-7960	36	6	is	be	AUX
bam-7960	36	7	the	the	DET
bam-7960	36	8	main	main	ADJ
bam-7960	36	9	cause	cause	NOUN
bam-7960	36	10	of	of	ADP
bam-7960	36	11	death	death	NOUN
bam-7960	36	12	at	at	ADP
bam-7960	36	13	autopsy	autopsy	ADJ
bam-7960	36	14	associated	associate	VERB
bam-7960	36	15	with	with	ADP
bam-7960	36	16	cancer	cancer	NOUN
bam-7960	36	17	.	.	PUNCT
bam-7960	37	1	from	from	ADP
bam-7960	37	2	this	this	DET
bam-7960	37	3	point	point	NOUN
bam-7960	37	4	of	of	ADP
bam-7960	37	5	view	view	NOUN
bam-7960	37	6	,	,	PUNCT
bam-7960	37	7	several	several	ADJ
bam-7960	37	8	drugs	drug	NOUN
bam-7960	37	9	have	have	AUX
bam-7960	37	10	been	be	AUX
bam-7960	37	11	used	use	VERB
bam-7960	37	12	to	to	PART
bam-7960	37	13	counteract	counteract	VERB
bam-7960	37	14	cardiac	cardiac	ADJ
bam-7960	37	15	cachexia	cachexia	NOUN
bam-7960	37	16	associated	associate	VERB
bam-7960	37	17	with	with	ADP
bam-7960	37	18	cancer	cancer	NOUN
bam-7960	37	19	.	.	PUNCT
bam-7960	38	1	inhibitors	inhibitor	NOUN
bam-7960	38	2	of	of	ADP
bam-7960	38	3	the	the	DET
bam-7960	38	4	angiotensinconverting	angiotensinconverte	VERB
bam-7960	38	5	enzyme	enzyme	NOUN
bam-7960	38	6	(	(	PUNCT
bam-7960	38	7	ace	ace	NOUN
bam-7960	38	8	)	)	PUNCT
bam-7960	38	9	have	have	AUX
bam-7960	38	10	been	be	AUX
bam-7960	38	11	tested	test	VERB
bam-7960	38	12	in	in	ADP
bam-7960	38	13	preclinical	preclinical	ADJ
bam-7960	38	14	models	model	NOUN
bam-7960	38	15	with	with	ADP
bam-7960	38	16	success	success	NOUN
bam-7960	38	17	in	in	ADP
bam-7960	38	18	increasing	increase	VERB
bam-7960	38	19	both	both	CCONJ
bam-7960	38	20	muscle	muscle	NOUN
bam-7960	38	21	and	and	CCONJ
bam-7960	38	22	fat	fat	ADJ
bam-7960	38	23	mass.44,45	mass.44,45	NOUN
bam-7960	38	24	some	some	DET
bam-7960	38	25	evidence	evidence	NOUN
bam-7960	38	26	also	also	ADV
bam-7960	38	27	exists	exist	VERB
bam-7960	38	28	concerning	concern	VERB
bam-7960	38	29	the	the	DET
bam-7960	38	30	potential	potential	NOUN
bam-7960	38	31	of	of	ADP
bam-7960	38	32	ace	ace	ADJ
bam-7960	38	33	inhibitors	inhibitor	NOUN
bam-7960	38	34	to	to	PART
bam-7960	38	35	ameliorate	ameliorate	VERB
bam-7960	38	36	cancer	cancer	NOUN
bam-7960	38	37	cachexia	cachexia	NOUN
bam-7960	38	38	in	in	ADP
bam-7960	38	39	nsclc	nsclc	NOUN
bam-7960	38	40	patients.46	patients.46	PROPN
bam-7960	38	41	angiotensin	angiotensin	NOUN
bam-7960	38	42	receptor	receptor	NOUN
bam-7960	38	43	blockers	blocker	NOUN
bam-7960	38	44	can	can	AUX
bam-7960	38	45	also	also	ADV
bam-7960	38	46	be	be	AUX
bam-7960	38	47	used	use	VERB
bam-7960	38	48	in	in	ADP
bam-7960	38	49	the	the	DET
bam-7960	38	50	treatment	treatment	NOUN
bam-7960	38	51	of	of	ADP
bam-7960	38	52	cachexia	cachexia	NOUN
bam-7960	38	53	.	.	PUNCT
bam-7960	39	1	thus	thus	ADV
bam-7960	39	2	,	,	PUNCT
bam-7960	39	3	one	one	NUM
bam-7960	39	4	of	of	ADP
bam-7960	39	5	this	this	DET
bam-7960	39	6	compounds	compound	NOUN
bam-7960	39	7	,	,	PUNCT
bam-7960	39	8	telmisartan	telmisartan	PROPN
bam-7960	39	9	,	,	PUNCT
bam-7960	39	10	can	can	AUX
bam-7960	39	11	be	be	AUX
bam-7960	39	12	used	use	VERB
bam-7960	39	13	as	as	ADP
bam-7960	39	14	an	an	DET
bam-7960	39	15	add	add	VERB
bam-7960	39	16	-	-	PUNCT
bam-7960	39	17	on	on	ADP
bam-7960	39	18	therapy	therapy	NOUN
bam-7960	39	19	with	with	ADP
bam-7960	39	20	5	5	NUM
bam-7960	39	21	-	-	PUNCT
bam-7960	39	22	fluorouracil,47	fluorouracil,47	NOUN
bam-7960	39	23	or	or	CCONJ
bam-7960	39	24	cisplatin,48	cisplatin,48	NOUN
bam-7960	39	25	or	or	CCONJ
bam-7960	39	26	other	other	ADJ
bam-7960	39	27	traditional	traditional	ADJ
bam-7960	39	28	chemotherapeutic	chemotherapeutic	ADJ
bam-7960	39	29	agents	agent	NOUN
bam-7960	39	30	.	.	PUNCT
bam-7960	40	1	telmisartan	telmisartan	PROPN
bam-7960	40	2	inhibits	inhibit	VERB
bam-7960	40	3	tnf--induced	tnf--induced	NOUN
bam-7960	40	4	il-6	il-6	NOUN
bam-7960	40	5	expression	expression	NOUN
bam-7960	40	6	at	at	ADP
bam-7960	40	7	the	the	DET
bam-7960	40	8	transcriptional	transcriptional	ADJ
bam-7960	40	9	level	level	NOUN
bam-7960	40	10	through	through	ADP
bam-7960	40	11	the	the	DET
bam-7960	40	12	activation	activation	NOUN
bam-7960	40	13	of	of	ADP
bam-7960	40	14	ppar	ppar	NOUN
bam-7960	40	15	-	-	PUNCT
bam-7960	40	16	γ.49	γ.49	NOUN
bam-7960	40	17	nf	nf	ADV
bam-7960	40	18	-	-	PUNCT
bam-7960	40	19	κb	κb	NOUN
bam-7960	40	20	signaling	signaling	NOUN
bam-7960	40	21	plays	play	VERB
bam-7960	40	22	an	an	DET
bam-7960	40	23	important	important	ADJ
bam-7960	40	24	role	role	NOUN
bam-7960	40	25	during	during	ADP
bam-7960	40	26	skeletal	skeletal	ADJ
bam-7960	40	27	muscle	muscle	NOUN
bam-7960	40	28	atrophy	atrophy	NOUN
bam-7960	40	29	and	and	CCONJ
bam-7960	40	30	fat	fat	ADJ
bam-7960	40	31	lipolysis	lipolysis	NOUN
bam-7960	40	32	.	.	PUNCT
bam-7960	41	1	on	on	ADP
bam-7960	41	2	these	these	DET
bam-7960	41	3	lines	line	NOUN
bam-7960	41	4	,	,	PUNCT
bam-7960	41	5	pyrrolidine	pyrrolidine	ADJ
bam-7960	41	6	dithiocarbamate	dithiocarbamate	NOUN
bam-7960	41	7	(	(	PUNCT
bam-7960	41	8	pdtc	pdtc	ADV
bam-7960	41	9	,	,	PUNCT
bam-7960	41	10	an	an	DET
bam-7960	41	11	inhibitor	inhibitor	NOUN
bam-7960	41	12	of	of	ADP
bam-7960	41	13	the	the	DET
bam-7960	41	14	transcription	transcription	NOUN
bam-7960	41	15	factor	factor	NOUN
bam-7960	41	16	)	)	PUNCT
bam-7960	41	17	is	be	AUX
bam-7960	41	18	able	able	ADJ
bam-7960	41	19	to	to	PART
bam-7960	41	20	attenuate	attenuate	VERB
bam-7960	41	21	attenuated	attenuated	ADJ
bam-7960	41	22	cancer	cancer	NOUN
bam-7960	41	23	cachexia	cachexia	NOUN
bam-7960	41	24	symptom	symptom	NOUN
bam-7960	41	25	in	in	ADP
bam-7960	41	26	c26	c26	NOUN
bam-7960	41	27	tumor	tumor	NOUN
bam-7960	41	28	-	-	PUNCT
bam-7960	41	29	bearing	bear	VERB
bam-7960	41	30	mice	mice	NOUN
bam-7960	41	31	models	model	NOUN
bam-7960	41	32	in	in	ADP
bam-7960	41	33	vivo	vivo	NOUN
bam-7960	41	34	without	without	ADP
bam-7960	41	35	influencing	influence	VERB
bam-7960	41	36	tumor	tumor	NOUN
bam-7960	41	37	volume	volume	NOUN
bam-7960	41	38	interfering	interfere	VERB
bam-7960	41	39	with	with	ADP
bam-7960	41	40	muscle	muscle	NOUN
bam-7960	41	41	atrophy	atrophy	NOUN
bam-7960	41	42	and	and	CCONJ
bam-7960	41	43	fat	fat	ADJ
bam-7960	41	44	lipolysis.50	lipolysis.50	NOUN
bam-7960	41	45	beta	beta	NOUN
bam-7960	41	46	-	-	PUNCT
bam-7960	41	47	blockers	blocker	NOUN
bam-7960	41	48	can	can	AUX
bam-7960	41	49	reduce	reduce	VERB
bam-7960	41	50	body	body	NOUN
bam-7960	41	51	energy	energy	NOUN
bam-7960	41	52	expenditure	expenditure	NOUN
bam-7960	41	53	and	and	CCONJ
bam-7960	41	54	improve	improve	VERB
bam-7960	41	55	the	the	DET
bam-7960	41	56	efficiency	efficiency	NOUN
bam-7960	41	57	of	of	ADP
bam-7960	41	58	substrate	substrate	NOUN
bam-7960	41	59	utilization	utilization	NOUN
bam-7960	41	60	.	.	PUNCT
bam-7960	42	1	some	some	PRON
bam-7960	42	2	of	of	ADP
bam-7960	42	3	them	they	PRON
bam-7960	42	4	do	do	AUX
bam-7960	42	5	combine	combine	VERB
bam-7960	42	6	many	many	ADJ
bam-7960	42	7	different	different	ADJ
bam-7960	42	8	pharmacological	pharmacological	ADJ
bam-7960	42	9	effects	effect	NOUN
bam-7960	42	10	.	.	PUNCT
bam-7960	43	1	espindolol	espindolol	PROPN
bam-7960	43	2	(	(	PUNCT
bam-7960	43	3	mt-102	mt-102	PROPN
bam-7960	43	4	,	,	PUNCT
bam-7960	43	5	psioxus	psioxus	NOUN
bam-7960	43	6	therapeutics	therapeutic	NOUN
bam-7960	43	7	)	)	PUNCT
bam-7960	43	8	is	be	AUX
bam-7960	43	9	a	a	DET
bam-7960	43	10	nonspecific	nonspecific	ADJ
bam-7960	43	11	β1	β1	NOUN
bam-7960	43	12	/	/	SYM
bam-7960	43	13	β2	β2	NOUN
bam-7960	43	14	adrenergic	adrenergic	ADJ
bam-7960	43	15	receptor	receptor	NOUN
bam-7960	43	16	antagonist	antagonist	NOUN
bam-7960	43	17	that	that	PRON
bam-7960	43	18	exhibits	exhibit	VERB
bam-7960	43	19	effects	effect	NOUN
bam-7960	43	20	through	through	ADP
bam-7960	43	21	β	β	NOUN
bam-7960	43	22	and	and	CCONJ
bam-7960	43	23	central	central	ADJ
bam-7960	43	24	5	5	NUM
bam-7960	43	25	-	-	PUNCT
bam-7960	43	26	ht1α	ht1α	PROPN
bam-7960	43	27	receptors	receptor	NOUN
bam-7960	43	28	to	to	PART
bam-7960	43	29	demonstrate	demonstrate	VERB
bam-7960	43	30	pro	pro	ADJ
bam-7960	43	31	-	-	ADJ
bam-7960	43	32	anabolic	anabolic	ADJ
bam-7960	43	33	,	,	PUNCT
bam-7960	43	34	anti	anti	ADJ
bam-7960	43	35	-	-	ADJ
bam-7960	43	36	catabolic	catabolic	ADJ
bam-7960	43	37	,	,	PUNCT
bam-7960	43	38	and	and	CCONJ
bam-7960	43	39	appetitestimulating	appetitestimulate	VERB
bam-7960	43	40	actions.51	actions.51	NOUN
bam-7960	43	41	the	the	DET
bam-7960	43	42	act	act	PROPN
bam-7960	43	43	-	-	PUNCT
bam-7960	43	44	one	one	NUM
bam-7960	43	45	trial	trial	NOUN
bam-7960	43	46	showed	show	VERB
bam-7960	43	47	that	that	SCONJ
bam-7960	43	48	espindolol	espindolol	VERB
bam-7960	43	49	10	10	NUM
bam-7960	43	50	 	 	SPACE
bam-7960	43	51	mg	mg	PROPN
bam-7960	43	52	twice	twice	ADV
bam-7960	43	53	daily	daily	ADV
bam-7960	43	54	was	be	AUX
bam-7960	43	55	able	able	ADJ
bam-7960	43	56	to	to	PART
bam-7960	43	57	revert	revert	VERB
bam-7960	43	58	weight	weight	NOUN
bam-7960	43	59	loss	loss	NOUN
bam-7960	43	60	,	,	PUNCT
bam-7960	43	61	improve	improve	VERB
bam-7960	43	62	fat	fat	ADJ
bam-7960	43	63	-	-	PUNCT
bam-7960	43	64	free	free	ADJ
bam-7960	43	65	mass	mass	NOUN
bam-7960	43	66	,	,	PUNCT
bam-7960	43	67	and	and	CCONJ
bam-7960	43	68	maintain	maintain	VERB
bam-7960	43	69	fat	fat	ADJ
bam-7960	43	70	mass	mass	NOUN
bam-7960	43	71	and	and	CCONJ
bam-7960	43	72	improve	improve	VERB
bam-7960	43	73	handgrip	handgrip	NOUN
bam-7960	43	74	strength	strength	NOUN
bam-7960	43	75	in	in	ADP
bam-7960	43	76	cachectic	cachectic	ADJ
bam-7960	43	77	patients	patient	NOUN
bam-7960	43	78	with	with	ADP
bam-7960	43	79	nonsmall	nonsmall	NOUN
bam-7960	43	80	cell	cell	NOUN
bam-7960	43	81	lung	lung	NOUN
bam-7960	43	82	cancer	cancer	NOUN
bam-7960	43	83	or	or	CCONJ
bam-7960	43	84	colorectal	colorectal	ADJ
bam-7960	43	85	cancer.52	cancer.52	NOUN
bam-7960	43	86	vt-122	vt-122	PROPN
bam-7960	43	87	combines	combine	VERB
bam-7960	43	88	a	a	DET
bam-7960	43	89	non	non	ADJ
bam-7960	43	90	-	-	ADJ
bam-7960	43	91	selective	selective	ADJ
bam-7960	43	92	beta	beta	NOUN
bam-7960	43	93	-	-	PUNCT
bam-7960	43	94	blocker	blocker	NOUN
bam-7960	43	95	,	,	PUNCT
bam-7960	43	96	propranolol	propranolol	NOUN
bam-7960	43	97	used	use	VERB
bam-7960	43	98	in	in	ADP
bam-7960	43	99	controlling	control	VERB
bam-7960	43	100	high	high	ADJ
bam-7960	43	101	blood	blood	NOUN
bam-7960	43	102	pressure	pressure	NOUN
bam-7960	43	103	and	and	CCONJ
bam-7960	43	104	etodolac	etodolac	NOUN
bam-7960	43	105	,	,	PUNCT
bam-7960	43	106	a	a	DET
bam-7960	43	107	cox-2	cox-2	ADJ
bam-7960	43	108	inhibitor	inhibitor	NOUN
bam-7960	43	109	.	.	PUNCT
bam-7960	44	1	data	datum	NOUN
bam-7960	44	2	from	from	ADP
bam-7960	44	3	a	a	DET
bam-7960	44	4	phase	phase	NOUN
bam-7960	44	5	ii	ii	NOUN
bam-7960	44	6	clinical	clinical	ADJ
bam-7960	44	7	study	study	NOUN
bam-7960	44	8	clearly	clearly	ADV
bam-7960	44	9	show	show	VERB
bam-7960	44	10	an	an	DET
bam-7960	44	11	improvement	improvement	NOUN
bam-7960	44	12	in	in	ADP
bam-7960	44	13	lean	lean	ADJ
bam-7960	44	14	body	body	NOUN
bam-7960	44	15	mass	mass	NOUN
bam-7960	44	16	in	in	ADP
bam-7960	44	17	nonsmall	nonsmall	NOUN
bam-7960	44	18	cell	cell	NOUN
bam-7960	44	19	lung	lung	NOUN
bam-7960	44	20	cancer	cancer	NOUN
bam-7960	44	21	patients.53	patients.53	NOUN
bam-7960	44	22	even	even	ADV
bam-7960	44	23	though	though	SCONJ
bam-7960	44	24	derivatives	derivative	NOUN
bam-7960	44	25	of	of	ADP
bam-7960	44	26	gonadal	gonadal	NOUN
bam-7960	44	27	steroids	steroid	NOUN
bam-7960	44	28	have	have	VERB
bam-7960	44	29	important	important	ADJ
bam-7960	44	30	side	side	NOUN
bam-7960	44	31	effects	effect	NOUN
bam-7960	44	32	,	,	PUNCT
bam-7960	44	33	such	such	ADJ
bam-7960	44	34	as	as	ADP
bam-7960	44	35	masculinization	masculinization	NOUN
bam-7960	44	36	,	,	PUNCT
bam-7960	44	37	fluid	fluid	ADJ
bam-7960	44	38	retention	retention	NOUN
bam-7960	44	39	and	and	CCONJ
bam-7960	44	40	hepatic	hepatic	NOUN
bam-7960	44	41	toxicity	toxicity	NOUN
bam-7960	44	42	,	,	PUNCT
bam-7960	44	43	treatment	treatment	NOUN
bam-7960	44	44	with	with	ADP
bam-7960	44	45	these	these	DET
bam-7960	44	46	drugs	drug	NOUN
bam-7960	44	47	facilitates	facilitate	VERB
bam-7960	44	48	nitrogen	nitrogen	NOUN
bam-7960	44	49	protein	protein	NOUN
bam-7960	44	50	accumulation	accumulation	NOUN
bam-7960	44	51	,	,	PUNCT
bam-7960	44	52	therefore	therefore	ADV
bam-7960	44	53	counteracting	counteract	VERB
bam-7960	44	54	the	the	DET
bam-7960	44	55	progressive	progressive	ADJ
bam-7960	44	56	nitrogen	nitrogen	NOUN
bam-7960	44	57	loss	loss	NOUN
bam-7960	44	58	associated	associate	VERB
bam-7960	44	59	with	with	ADP
bam-7960	44	60	muscle	muscle	NOUN
bam-7960	44	61	wasting	waste	VERB
bam-7960	44	62	.	.	PUNCT
bam-7960	45	1	in	in	ADP
bam-7960	45	2	fact	fact	NOUN
bam-7960	45	3	,	,	PUNCT
bam-7960	45	4	non	non	ADJ
bam-7960	45	5	-	-	ADJ
bam-7960	45	6	steroidal	steroidal	ADJ
bam-7960	45	7	selective	selective	ADJ
bam-7960	45	8	androgen	androgen	NOUN
bam-7960	45	9	receptor	receptor	NOUN
bam-7960	45	10	modulators	modulator	NOUN
bam-7960	45	11	(	(	PUNCT
bam-7960	45	12	sarms	sarm	NOUN
bam-7960	45	13	)	)	PUNCT
bam-7960	45	14	hold	hold	VERB
bam-7960	45	15	promise	promise	NOUN
bam-7960	45	16	as	as	ADP
bam-7960	45	17	a	a	DET
bam-7960	45	18	new	new	ADJ
bam-7960	45	19	class	class	NOUN
bam-7960	45	20	of	of	ADP
bam-7960	45	21	function	function	NOUN
bam-7960	45	22	promoting	promote	VERB
bam-7960	45	23	anabolic	anabolic	NOUN
bam-7960	45	24	therapies	therapy	NOUN
bam-7960	45	25	for	for	ADP
bam-7960	45	26	several	several	ADJ
bam-7960	45	27	clinical	clinical	ADJ
bam-7960	45	28	conditions	condition	NOUN
bam-7960	45	29	that	that	PRON
bam-7960	45	30	manifest	manifest	VERB
bam-7960	45	31	muscle	muscle	NOUN
bam-7960	45	32	wasting	waste	VERB
bam-7960	45	33	.	.	PUNCT
bam-7960	46	1	in	in	ADP
bam-7960	46	2	a	a	DET
bam-7960	46	3	phase	phase	NOUN
bam-7960	46	4	iib	iib	NOUN
bam-7960	46	5	,	,	PUNCT
bam-7960	46	6	double	double	ADJ
bam-7960	46	7	-	-	PUNCT
bam-7960	46	8	blind	blind	ADJ
bam-7960	46	9	,	,	PUNCT
bam-7960	46	10	placebo	placebo	NOUN
bam-7960	46	11	-	-	PUNCT
bam-7960	46	12	controlled	control	VERB
bam-7960	46	13	study	study	NOUN
bam-7960	46	14	,	,	PUNCT
bam-7960	46	15	involving	involve	VERB
bam-7960	46	16	nonsmall	nonsmall	ADJ
bam-7960	46	17	-	-	PUNCT
bam-7960	46	18	cell	cell	NOUN
bam-7960	46	19	lung	lung	NOUN
bam-7960	46	20	cancer	cancer	NOUN
bam-7960	46	21	(	(	PUNCT
bam-7960	46	22	nsclc	nsclc	NOUN
bam-7960	46	23	)	)	PUNCT
bam-7960	46	24	,	,	PUNCT
bam-7960	46	25	colorectal	colorectal	ADJ
bam-7960	46	26	cancer	cancer	NOUN
bam-7960	46	27	,	,	PUNCT
bam-7960	46	28	nonhodgkin	nonhodgkin	NOUN
bam-7960	46	29	’s	’s	PART
bam-7960	46	30	lymphoma	lymphoma	NOUN
bam-7960	46	31	,	,	PUNCT
bam-7960	46	32	chronic	chronic	ADJ
bam-7960	46	33	lymphocytic	lymphocytic	ADJ
bam-7960	46	34	leukemia	leukemia	NOUN
bam-7960	46	35	,	,	PUNCT
bam-7960	46	36	or	or	CCONJ
bam-7960	46	37	breast	breast	NOUN
bam-7960	46	38	cancer	cancer	NOUN
bam-7960	46	39	patients	patient	NOUN
bam-7960	46	40	,	,	PUNCT
bam-7960	46	41	enobosarm	enobosarm	ADJ
bam-7960	46	42	treatment	treatment	NOUN
bam-7960	46	43	led	lead	VERB
bam-7960	46	44	to	to	ADP
bam-7960	46	45	significant	significant	ADJ
bam-7960	46	46	improvements	improvement	NOUN
bam-7960	46	47	in	in	ADP
bam-7960	46	48	lean	lean	ADJ
bam-7960	46	49	body	body	NOUN
bam-7960	46	50	mass	mass	NOUN
bam-7960	46	51	,	,	PUNCT
bam-7960	46	52	physical	physical	ADJ
bam-7960	46	53	function	function	NOUN
bam-7960	46	54	,	,	PUNCT
bam-7960	46	55	and	and	CCONJ
bam-7960	46	56	quality	quality	NOUN
bam-7960	46	57	of	of	ADP
bam-7960	46	58	life54	life54	NOUN
bam-7960	46	59	.	.	PUNCT
bam-7960	47	1	these	these	DET
bam-7960	47	2	positive	positive	ADJ
bam-7960	47	3	results	result	NOUN
bam-7960	47	4	have	have	AUX
bam-7960	47	5	led	lead	VERB
bam-7960	47	6	to	to	ADP
bam-7960	47	7	the	the	DET
bam-7960	47	8	design	design	NOUN
bam-7960	47	9	of	of	ADP
bam-7960	47	10	phase	phase	NOUN
bam-7960	47	11	iii	iii	NUM
bam-7960	47	12	trials	trial	NOUN
bam-7960	47	13	.	.	PUNCT
bam-7960	48	1	on	on	ADP
bam-7960	48	2	these	these	DET
bam-7960	48	3	lines	line	NOUN
bam-7960	48	4	,	,	PUNCT
bam-7960	48	5	crawford	crawford	PROPN
bam-7960	48	6	et	et	PROPN
bam-7960	48	7	al	al	PROPN
bam-7960	48	8	.	.	PROPN
bam-7960	48	9	reported	report	VERB
bam-7960	48	10	a	a	DET
bam-7960	48	11	study	study	NOUN
bam-7960	48	12	design	design	NOUN
bam-7960	48	13	and	and	CCONJ
bam-7960	48	14	rationale	rationale	NOUN
bam-7960	48	15	for	for	ADP
bam-7960	48	16	the	the	DET
bam-7960	48	17	phase	phase	NOUN
bam-7960	48	18	iii	iii	NUM
bam-7960	48	19	clinical	clinical	ADJ
bam-7960	48	20	development	development	NOUN
bam-7960	48	21	program	program	NOUN
bam-7960	48	22	of	of	ADP
bam-7960	48	23	enobosarm	enobosarm	PROPN
bam-7960	48	24	,	,	PUNCT
bam-7960	48	25	for	for	ADP
bam-7960	48	26	the	the	DET
bam-7960	48	27	prevention	prevention	NOUN
bam-7960	48	28	and	and	CCONJ
bam-7960	48	29	treatment	treatment	NOUN
bam-7960	48	30	of	of	ADP
bam-7960	48	31	muscle	muscle	NOUN
bam-7960	48	32	wasting	waste	VERB
bam-7960	48	33	in	in	ADP
bam-7960	48	34	oncology	oncology	NOUN
bam-7960	48	35	patients	patient	NOUN
bam-7960	48	36	(	(	PUNCT
bam-7960	48	37	power	power	NOUN
bam-7960	48	38	trials).55	trials).55	NOUN
bam-7960	48	39	to	to	PART
bam-7960	48	40	assess	assess	VERB
bam-7960	48	41	enobosarm	enobosarm	PROPN
bam-7960	48	42	’s	’s	PART
bam-7960	48	43	effect	effect	NOUN
bam-7960	48	44	on	on	ADP
bam-7960	48	45	both	both	DET
bam-7960	48	46	prevention	prevention	NOUN
bam-7960	48	47	and	and	CCONJ
bam-7960	48	48	treatment	treatment	NOUN
bam-7960	48	49	of	of	ADP
bam-7960	48	50	muscle	muscle	NOUN
bam-7960	48	51	wasting	waste	VERB
bam-7960	48	52	,	,	PUNCT
bam-7960	48	53	in	in	ADP
bam-7960	48	54	each	each	DET
bam-7960	48	55	pivotal	pivotal	ADJ
bam-7960	48	56	power	power	NOUN
bam-7960	48	57	trial	trial	NOUN
bam-7960	48	58	,	,	PUNCT
bam-7960	48	59	subjects	subject	NOUN
bam-7960	48	60	will	will	AUX
bam-7960	48	61	receive	receive	VERB
bam-7960	48	62	placebo	placebo	NOUN
bam-7960	48	63	or	or	CCONJ
bam-7960	48	64	enobosarm	enobosarm	NOUN
bam-7960	48	65	3	3	NUM
bam-7960	48	66	mg	mg	ADV
bam-7960	48	67	orally	orally	ADV
bam-7960	48	68	once	once	ADV
bam-7960	48	69	daily	daily	ADV
bam-7960	48	70	for	for	ADP
bam-7960	48	71	147	147	NUM
bam-7960	48	72	days	day	NOUN
bam-7960	48	73	.	.	PUNCT
bam-7960	49	1	physical	physical	ADJ
bam-7960	49	2	function	function	NOUN
bam-7960	49	3	will	will	AUX
bam-7960	49	4	be	be	AUX
bam-7960	49	5	assessed	assess	VERB
bam-7960	49	6	as	as	ADP
bam-7960	49	7	stair	stair	NOUN
bam-7960	49	8	climb	climb	NOUN
bam-7960	49	9	power	power	NOUN
bam-7960	49	10	,	,	PUNCT
bam-7960	49	11	and	and	CCONJ
bam-7960	49	12	lean	lean	ADJ
bam-7960	49	13	body	body	NOUN
bam-7960	49	14	mass	mass	NOUN
bam-7960	49	15	assessed	assess	VERB
bam-7960	49	16	by	by	ADP
bam-7960	49	17	dual	dual	ADJ
bam-7960	49	18	-	-	PUNCT
bam-7960	49	19	energy	energy	NOUN
bam-7960	49	20	x	x	NOUN
bam-7960	49	21	-	-	NOUN
bam-7960	49	22	ray	ray	NOUN
bam-7960	49	23	absorptiometry	absorptiometry	NOUN
bam-7960	49	24	(	(	PUNCT
bam-7960	49	25	dxa	dxa	PROPN
bam-7960	49	26	)	)	PUNCT
bam-7960	49	27	,	,	PUNCT
bam-7960	49	28	these	these	PRON
bam-7960	49	29	being	be	AUX
bam-7960	49	30	the	the	DET
bam-7960	49	31	co	co	ADJ
bam-7960	49	32	-	-	ADJ
bam-7960	49	33	primary	primary	ADJ
bam-7960	49	34	efficacy	efficacy	NOUN
bam-7960	49	35	endpoints	endpoint	NOUN
bam-7960	49	36	in	in	ADP
bam-7960	49	37	both	both	DET
bam-7960	49	38	trials	trial	NOUN
bam-7960	49	39	assessed	assess	VERB
bam-7960	49	40	at	at	ADP
bam-7960	49	41	day	day	NOUN
bam-7960	49	42	84.55	84.55	NUM
bam-7960	49	43	preliminary	preliminary	ADJ
bam-7960	49	44	data	datum	NOUN
bam-7960	49	45	report	report	VERB
bam-7960	49	46	an	an	DET
bam-7960	49	47	increase	increase	NOUN
bam-7960	49	48	in	in	ADP
bam-7960	49	49	lean	lean	ADJ
bam-7960	49	50	body	body	NOUN
bam-7960	49	51	mass	mass	NOUN
bam-7960	49	52	and	and	CCONJ
bam-7960	49	53	improvement	improvement	NOUN
bam-7960	49	54	in	in	ADP
bam-7960	49	55	scp	scp	PROPN
bam-7960	49	56	(	(	PUNCT
bam-7960	49	57	power1	power1	NOUN
bam-7960	49	58	)	)	PUNCT
bam-7960	49	59	.	.	PUNCT
bam-7960	50	1	power2	power2	PROPN
bam-7960	50	2	also	also	ADV
bam-7960	50	3	shows	show	VERB
bam-7960	50	4	an	an	DET
bam-7960	50	5	increase	increase	NOUN
bam-7960	50	6	in	in	ADP
bam-7960	50	7	lean	lean	ADJ
bam-7960	50	8	body	body	NOUN
bam-7960	50	9	mass	mass	NOUN
bam-7960	50	10	,	,	PUNCT
bam-7960	50	11	while	while	SCONJ
bam-7960	50	12	no	no	DET
bam-7960	50	13	clinical	clinical	ADJ
bam-7960	50	14	improvement	improvement	NOUN
bam-7960	50	15	in	in	ADP
bam-7960	50	16	the	the	DET
bam-7960	50	17	stair	stair	NOUN
bam-7960	50	18	climb	climb	NOUN
bam-7960	50	19	power	power	NOUN
bam-7960	50	20	test	test	NOUN
bam-7960	50	21	and	and	CCONJ
bam-7960	50	22	handgrip	handgrip	NOUN
bam-7960	50	23	strength	strength	NOUN
bam-7960	50	24	is	be	AUX
bam-7960	50	25	seen.56	seen.56	VERB
bam-7960	50	26	myostatin	myostatin	NOUN
bam-7960	50	27	,	,	PUNCT
bam-7960	50	28	a	a	DET
bam-7960	50	29	tgf-	tgf-	ADJ
bam-7960	50	30	super	super	ADJ
bam-7960	50	31	-	-	ADJ
bam-7960	50	32	family	family	ADJ
bam-7960	50	33	member	member	NOUN
bam-7960	50	34	,	,	PUNCT
bam-7960	50	35	is	be	AUX
bam-7960	50	36	a	a	DET
bam-7960	50	37	negative	negative	ADJ
bam-7960	50	38	regulator	regulator	NOUN
bam-7960	50	39	of	of	ADP
bam-7960	50	40	muscle	muscle	NOUN
bam-7960	50	41	growth	growth	NOUN
bam-7960	50	42	and	and	CCONJ
bam-7960	50	43	development	development	NOUN
bam-7960	50	44	.	.	PUNCT
bam-7960	51	1	in	in	ADP
bam-7960	51	2	fact	fact	NOUN
bam-7960	51	3	,	,	PUNCT
bam-7960	51	4	non	non	X
bam-7960	51	5	co	co	PROPN
bam-7960	51	6	mmerc	mmerc	PROPN
bam-7960	51	7	ial	ial	PROPN
bam-7960	51	8	us	us	PROPN
bam-7960	51	9	e	e	NOUN
bam-7960	51	10	o	o	NOUN
bam-7960	51	11	nly	nly	ADV
bam-7960	51	12	therapeutic	therapeutic	ADJ
bam-7960	51	13	strategies	strategy	NOUN
bam-7960	51	14	against	against	ADP
bam-7960	51	15	cancer	cancer	NOUN
bam-7960	51	16	cachexia	cachexia	PROPN
bam-7960	51	17	eur	eur	PROPN
bam-7960	51	18	j	j	PROPN
bam-7960	51	19	transl	transl	PROPN
bam-7960	51	20	myol	myol	ADV
bam-7960	51	21	29	29	NUM
bam-7960	51	22	(	(	PUNCT
bam-7960	51	23	1	1	NUM
bam-7960	51	24	):	):	PUNCT
bam-7960	51	25	4	4	NUM
bam-7960	51	26	-	-	SYM
bam-7960	51	27	13	13	NUM
bam-7960	51	28	,	,	PUNCT
bam-7960	51	29	2019	2019	NUM
bam-7960	51	30	7	7	NUM
bam-7960	51	31	myostatin	myostatin	ADJ
bam-7960	51	32	inhibitors	inhibitor	NOUN
bam-7960	51	33	induce	induce	VERB
bam-7960	51	34	muscle	muscle	NOUN
bam-7960	51	35	hypertrophy	hypertrophy	NOUN
bam-7960	51	36	specially	specially	ADV
bam-7960	51	37	through	through	ADP
bam-7960	51	38	effects	effect	NOUN
bam-7960	51	39	on	on	ADP
bam-7960	51	40	myofibrillar	myofibrillar	ADJ
bam-7960	51	41	protein	protein	NOUN
bam-7960	51	42	synthesis	synthesis	NOUN
bam-7960	51	43	rather	rather	ADV
bam-7960	51	44	than	than	ADP
bam-7960	51	45	through	through	ADP
bam-7960	51	46	an	an	DET
bam-7960	51	47	stimulation	stimulation	NOUN
bam-7960	51	48	of	of	ADP
bam-7960	51	49	satellite	satellite	NOUN
bam-7960	51	50	cell	cell	NOUN
bam-7960	51	51	proliferation.57,58	proliferation.57,58	NOUN
bam-7960	51	52	bearing	bear	VERB
bam-7960	51	53	this	this	PRON
bam-7960	51	54	in	in	ADP
bam-7960	51	55	mind	mind	NOUN
bam-7960	51	56	,	,	PUNCT
bam-7960	51	57	anti	anti	ADJ
bam-7960	51	58	-	-	ADJ
bam-7960	51	59	myostatin	myostatin	ADJ
bam-7960	51	60	strategies	strategy	NOUN
bam-7960	51	61	have	have	AUX
bam-7960	51	62	been	be	AUX
bam-7960	51	63	used	use	VERB
bam-7960	51	64	in	in	ADP
bam-7960	51	65	clinical	clinical	ADJ
bam-7960	51	66	trials	trial	NOUN
bam-7960	51	67	involving	involve	VERB
bam-7960	51	68	cachectic	cachectic	ADJ
bam-7960	51	69	patients	patient	NOUN
bam-7960	51	70	.	.	PUNCT
bam-7960	52	1	from	from	ADP
bam-7960	52	2	this	this	DET
bam-7960	52	3	point	point	NOUN
bam-7960	52	4	of	of	ADP
bam-7960	52	5	view	view	NOUN
bam-7960	52	6	,	,	PUNCT
bam-7960	52	7	a	a	DET
bam-7960	52	8	phase	phase	NOUN
bam-7960	52	9	ii	ii	NOUN
bam-7960	52	10	study	study	NOUN
bam-7960	52	11	in	in	ADP
bam-7960	52	12	sarcopenic	sarcopenic	ADJ
bam-7960	52	13	patients	patient	NOUN
bam-7960	52	14	has	have	AUX
bam-7960	52	15	been	be	AUX
bam-7960	52	16	undertaken	undertake	VERB
bam-7960	52	17	using	use	VERB
bam-7960	52	18	amg745	amg745	PROPN
bam-7960	52	19	,	,	PUNCT
bam-7960	52	20	a	a	DET
bam-7960	52	21	peptibody	peptibody	NOUN
bam-7960	52	22	against	against	ADP
bam-7960	52	23	myostatin.59	myostatin.59	NOUN
bam-7960	52	24	similarly	similarly	ADV
bam-7960	52	25	,	,	PUNCT
bam-7960	52	26	acceleron	acceleron	ADJ
bam-7960	52	27	pharma	pharma	PROPN
bam-7960	52	28	has	have	AUX
bam-7960	52	29	performed	perform	VERB
bam-7960	52	30	a	a	DET
bam-7960	52	31	phase	phase	NOUN
bam-7960	52	32	i	i	PRON
bam-7960	52	33	study	study	VERB
bam-7960	52	34	with	with	ADP
bam-7960	52	35	ace031	ace031	PROPN
bam-7960	52	36	,	,	PUNCT
bam-7960	52	37	a	a	DET
bam-7960	52	38	soluble	soluble	ADJ
bam-7960	52	39	activin	activin	NOUN
bam-7960	52	40	receptor	receptor	NOUN
bam-7960	52	41	type	type	NOUN
bam-7960	52	42	iib.60	iib.60	NOUN
bam-7960	52	43	bimagrumab	bimagrumab	NOUN
bam-7960	52	44	or	or	CCONJ
bam-7960	52	45	bym338	bym338	PROPN
bam-7960	52	46	,	,	PUNCT
bam-7960	52	47	an	an	DET
bam-7960	52	48	activin	activin	PROPN
bam-7960	52	49	ii	ii	PROPN
bam-7960	52	50	receptor	receptor	NOUN
bam-7960	52	51	antibody	antibody	NOUN
bam-7960	52	52	,	,	PUNCT
bam-7960	52	53	has	have	AUX
bam-7960	52	54	also	also	ADV
bam-7960	52	55	been	be	AUX
bam-7960	52	56	studied	study	VERB
bam-7960	52	57	in	in	ADP
bam-7960	52	58	relation	relation	NOUN
bam-7960	52	59	with	with	ADP
bam-7960	52	60	cachexia	cachexia	NOUN
bam-7960	52	61	in	in	ADP
bam-7960	52	62	patients	patient	NOUN
bam-7960	52	63	with	with	ADP
bam-7960	52	64	inclusion	inclusion	NOUN
bam-7960	52	65	myositis.61	myositis.61	NOUN
bam-7960	52	66	bym338	bym338	PROPN
bam-7960	52	67	is	be	AUX
bam-7960	52	68	able	able	ADJ
bam-7960	52	69	to	to	PART
bam-7960	52	70	bind	bind	VERB
bam-7960	52	71	actriib	actriib	ADJ
bam-7960	52	72	200	200	NUM
bam-7960	52	73	-	-	PUNCT
bam-7960	52	74	times	time	NOUN
bam-7960	52	75	better	well	ADJ
bam-7960	52	76	than	than	ADP
bam-7960	52	77	actriia	actriia	ADJ
bam-7960	52	78	,	,	PUNCT
bam-7960	52	79	promoting	promote	VERB
bam-7960	52	80	skeletal	skeletal	ADJ
bam-7960	52	81	muscle	muscle	NOUN
bam-7960	52	82	hypertrophy	hypertrophy	NOUN
bam-7960	52	83	when	when	SCONJ
bam-7960	52	84	administered	administer	VERB
bam-7960	52	85	in	in	ADP
bam-7960	52	86	vivo	vivo	NOUN
bam-7960	52	87	.	.	PUNCT
bam-7960	53	1	when	when	SCONJ
bam-7960	53	2	administered	administer	VERB
bam-7960	53	3	in	in	ADP
bam-7960	53	4	association	association	NOUN
bam-7960	53	5	with	with	ADP
bam-7960	53	6	glucocorticoids	glucocorticoid	NOUN
bam-7960	53	7	,	,	PUNCT
bam-7960	53	8	bym338	bym338	PROPN
bam-7960	53	9	was	be	AUX
bam-7960	53	10	able	able	ADJ
bam-7960	53	11	to	to	PART
bam-7960	53	12	prevent	prevent	VERB
bam-7960	53	13	skeletal	skeletal	ADJ
bam-7960	53	14	muscle	muscle	NOUN
bam-7960	53	15	mass	mass	NOUN
bam-7960	53	16	loss	loss	NOUN
bam-7960	53	17	and	and	CCONJ
bam-7960	53	18	preserved	preserve	VERB
bam-7960	53	19	muscle	muscle	NOUN
bam-7960	53	20	function	function	NOUN
bam-7960	53	21	,	,	PUNCT
bam-7960	53	22	facilitating	facilitate	VERB
bam-7960	53	23	the	the	DET
bam-7960	53	24	recovery	recovery	NOUN
bam-7960	53	25	from	from	ADP
bam-7960	53	26	muscle	muscle	NOUN
bam-7960	53	27	atrophy.62	atrophy.62	NOUN
bam-7960	53	28	a	a	DET
bam-7960	53	29	humanized	humanize	VERB
bam-7960	53	30	monoclonal	monoclonal	NOUN
bam-7960	53	31	antibody	antibody	NOUN
bam-7960	53	32	ly2495655	ly2495655	NOUN
bam-7960	53	33	has	have	AUX
bam-7960	53	34	been	be	AUX
bam-7960	53	35	used	use	VERB
bam-7960	53	36	in	in	ADP
bam-7960	53	37	sarcopenic	sarcopenic	ADJ
bam-7960	53	38	patients	patient	NOUN
bam-7960	53	39	in	in	ADP
bam-7960	53	40	a	a	DET
bam-7960	53	41	phase	phase	NOUN
bam-7960	53	42	ii	ii	NOUN
bam-7960	53	43	trial	trial	NOUN
bam-7960	53	44	,	,	PUNCT
bam-7960	53	45	involving	involve	VERB
bam-7960	53	46	subjects	subject	NOUN
bam-7960	53	47	who	who	PRON
bam-7960	53	48	recently	recently	ADV
bam-7960	53	49	reported	report	VERB
bam-7960	53	50	falls	fall	NOUN
bam-7960	53	51	and	and	CCONJ
bam-7960	53	52	low	low	ADJ
bam-7960	53	53	muscle	muscle	NOUN
bam-7960	53	54	strength	strength	NOUN
bam-7960	53	55	and	and	CCONJ
bam-7960	53	56	power.63	power.63	ADJ
bam-7960	53	57	patients	patient	NOUN
bam-7960	53	58	receiving	receive	VERB
bam-7960	53	59	the	the	DET
bam-7960	53	60	antibody	antibody	NOUN
bam-7960	53	61	showed	show	VERB
bam-7960	53	62	an	an	DET
bam-7960	53	63	increase	increase	NOUN
bam-7960	53	64	in	in	ADP
bam-7960	53	65	lean	lean	ADJ
bam-7960	53	66	mass	mass	NOUN
bam-7960	53	67	and	and	CCONJ
bam-7960	53	68	a	a	DET
bam-7960	53	69	significant	significant	ADJ
bam-7960	53	70	improvement	improvement	NOUN
bam-7960	53	71	of	of	ADP
bam-7960	53	72	muscle	muscle	NOUN
bam-7960	53	73	power	power	NOUN
bam-7960	53	74	expressed	express	VERB
bam-7960	53	75	as	as	ADP
bam-7960	53	76	improved	improved	ADJ
bam-7960	53	77	stair	stair	NOUN
bam-7960	53	78	-	-	PUNCT
bam-7960	53	79	climbing	climbing	NOUN
bam-7960	53	80	time	time	NOUN
bam-7960	53	81	,	,	PUNCT
bam-7960	53	82	fast	fast	ADJ
bam-7960	53	83	gait	gait	NOUN
bam-7960	53	84	speed	speed	NOUN
bam-7960	53	85	,	,	PUNCT
bam-7960	53	86	and	and	CCONJ
bam-7960	53	87	chair	chair	NOUN
bam-7960	53	88	rise	rise	VERB
bam-7960	53	89	with	with	ADP
bam-7960	53	90	arms	arm	NOUN
bam-7960	53	91	.	.	PUNCT
bam-7960	54	1	a	a	DET
bam-7960	54	2	phase	phase	NOUN
bam-7960	54	3	ii	ii	NOUN
bam-7960	54	4	study	study	NOUN
bam-7960	54	5	is	be	AUX
bam-7960	54	6	now	now	ADV
bam-7960	54	7	being	be	AUX
bam-7960	54	8	held	hold	VERB
bam-7960	54	9	in	in	ADP
bam-7960	54	10	pancreatic	pancreatic	ADJ
bam-7960	54	11	cancer	cancer	NOUN
bam-7960	54	12	patients	patient	NOUN
bam-7960	54	13	although	although	SCONJ
bam-7960	54	14	no	no	DET
bam-7960	54	15	results	result	NOUN
bam-7960	54	16	are	be	AUX
bam-7960	54	17	yet	yet	ADV
bam-7960	54	18	available.64	available.64	NOUN
bam-7960	54	19	increased	increase	VERB
bam-7960	54	20	proteolysis	proteolysis	NOUN
bam-7960	54	21	in	in	ADP
bam-7960	54	22	skeletal	skeletal	ADJ
bam-7960	54	23	muscle	muscle	NOUN
bam-7960	54	24	during	during	ADP
bam-7960	54	25	cachexia	cachexia	NOUN
bam-7960	54	26	involves	involve	VERB
bam-7960	54	27	activation	activation	NOUN
bam-7960	54	28	of	of	ADP
bam-7960	54	29	the	the	DET
bam-7960	54	30	ubiquitin	ubiquitin	ADJ
bam-7960	54	31	/	/	SYM
bam-7960	54	32	proteasome	proteasome	NOUN
bam-7960	54	33	system	system	NOUN
bam-7960	54	34	in	in	ADP
bam-7960	54	35	muscle.2	muscle.2	NOUN
bam-7960	54	36	taking	take	VERB
bam-7960	54	37	this	this	PRON
bam-7960	54	38	into	into	ADP
bam-7960	54	39	consideration	consideration	NOUN
bam-7960	54	40	,	,	PUNCT
bam-7960	54	41	inhibitors	inhibitor	NOUN
bam-7960	54	42	of	of	ADP
bam-7960	54	43	this	this	DET
bam-7960	54	44	proteolytic	proteolytic	ADJ
bam-7960	54	45	system	system	NOUN
bam-7960	54	46	such	such	ADJ
bam-7960	54	47	as	as	ADP
bam-7960	54	48	peptide	peptide	ADJ
bam-7960	54	49	aldehyde	aldehyde	NOUN
bam-7960	54	50	,	,	PUNCT
bam-7960	54	51	lactacystin	lactacystin	NOUN
bam-7960	54	52	and	and	CCONJ
bam-7960	54	53	-lactone	-lactone	PROPN
bam-7960	54	54	–	–	PUNCT
bam-7960	54	55	which	which	PRON
bam-7960	54	56	effectively	effectively	ADV
bam-7960	54	57	can	can	AUX
bam-7960	54	58	block	block	VERB
bam-7960	54	59	up	up	ADP
bam-7960	54	60	to	to	PART
bam-7960	54	61	90	90	NUM
bam-7960	54	62	%	%	NOUN
bam-7960	54	63	of	of	ADP
bam-7960	54	64	the	the	DET
bam-7960	54	65	degradation	degradation	NOUN
bam-7960	54	66	of	of	ADP
bam-7960	54	67	normal	normal	ADJ
bam-7960	54	68	proteins	protein	NOUN
bam-7960	54	69	and	and	CCONJ
bam-7960	54	70	short	short	ADV
bam-7960	54	71	-	-	PUNCT
bam-7960	54	72	lived	live	VERB
bam-7960	54	73	proteins	protein	NOUN
bam-7960	54	74	in	in	ADP
bam-7960	54	75	the	the	DET
bam-7960	54	76	cells	cell	NOUN
bam-7960	54	77	could	could	AUX
bam-7960	54	78	be	be	AUX
bam-7960	54	79	potential	potential	ADJ
bam-7960	54	80	drugs	drug	NOUN
bam-7960	54	81	for	for	ADP
bam-7960	54	82	the	the	DET
bam-7960	54	83	treatment	treatment	NOUN
bam-7960	54	84	of	of	ADP
bam-7960	54	85	muscle	muscle	NOUN
bam-7960	55	1	wasting.65	wasting.65	PROPN
bam-7960	55	2	however	however	ADV
bam-7960	55	3	,	,	PUNCT
bam-7960	55	4	the	the	DET
bam-7960	55	5	toxicity	toxicity	NOUN
bam-7960	55	6	of	of	ADP
bam-7960	55	7	such	such	ADJ
bam-7960	55	8	compounds	compound	NOUN
bam-7960	55	9	is	be	AUX
bam-7960	55	10	fairly	fairly	ADV
bam-7960	55	11	high	high	ADJ
bam-7960	55	12	,	,	PUNCT
bam-7960	55	13	since	since	SCONJ
bam-7960	55	14	they	they	PRON
bam-7960	55	15	are	be	AUX
bam-7960	55	16	not	not	PART
bam-7960	55	17	specific	specific	ADJ
bam-7960	55	18	inhibitors	inhibitor	NOUN
bam-7960	55	19	of	of	ADP
bam-7960	55	20	the	the	DET
bam-7960	55	21	proteolytic	proteolytic	ADJ
bam-7960	55	22	system	system	NOUN
bam-7960	55	23	in	in	ADP
bam-7960	55	24	muscle	muscle	NOUN
bam-7960	55	25	tissue	tissue	NOUN
bam-7960	55	26	.	.	PUNCT
bam-7960	56	1	bearing	bear	VERB
bam-7960	56	2	this	this	PRON
bam-7960	56	3	in	in	ADP
bam-7960	56	4	mind	mind	NOUN
bam-7960	56	5	,	,	PUNCT
bam-7960	56	6	a	a	DET
bam-7960	56	7	drug	drug	NOUN
bam-7960	56	8	that	that	PRON
bam-7960	56	9	could	could	AUX
bam-7960	56	10	specifically	specifically	ADV
bam-7960	56	11	block	block	VERB
bam-7960	56	12	myofibrillar	myofibrillar	ADJ
bam-7960	56	13	protein	protein	NOUN
bam-7960	56	14	degradation	degradation	NOUN
bam-7960	56	15	is	be	AUX
bam-7960	56	16	still	still	ADV
bam-7960	56	17	waiting	wait	VERB
bam-7960	56	18	to	to	PART
bam-7960	56	19	be	be	AUX
bam-7960	56	20	found	find	VERB
bam-7960	56	21	.	.	PUNCT
bam-7960	57	1	inhibitors	inhibitor	NOUN
bam-7960	57	2	of	of	ADP
bam-7960	57	3	the	the	DET
bam-7960	57	4	proteasome	proteasome	NOUN
bam-7960	57	5	have	have	AUX
bam-7960	57	6	been	be	AUX
bam-7960	57	7	used	use	VERB
bam-7960	57	8	as	as	ADP
bam-7960	57	9	anti	anti	ADJ
bam-7960	57	10	-	-	ADJ
bam-7960	57	11	cancer	cancer	ADJ
bam-7960	57	12	drugs	drug	NOUN
bam-7960	57	13	since	since	SCONJ
bam-7960	57	14	the	the	DET
bam-7960	57	15	proteasome	proteasome	NOUN
bam-7960	57	16	has	have	VERB
bam-7960	57	17	a	a	DET
bam-7960	57	18	main	main	ADJ
bam-7960	57	19	role	role	NOUN
bam-7960	57	20	in	in	ADP
bam-7960	57	21	cell	cell	NOUN
bam-7960	57	22	division	division	NOUN
bam-7960	57	23	in	in	ADP
bam-7960	57	24	multiple	multiple	ADJ
bam-7960	57	25	myeloma	myeloma	NOUN
bam-7960	57	26	patients	patient	NOUN
bam-7960	57	27	.	.	PUNCT
bam-7960	58	1	the	the	DET
bam-7960	58	2	use	use	NOUN
bam-7960	58	3	of	of	ADP
bam-7960	58	4	these	these	DET
bam-7960	58	5	drugs	drug	NOUN
bam-7960	58	6	has	have	AUX
bam-7960	58	7	led	lead	VERB
bam-7960	58	8	to	to	ADP
bam-7960	58	9	contradictory	contradictory	ADJ
bam-7960	58	10	results	result	NOUN
bam-7960	58	11	in	in	ADP
bam-7960	58	12	the	the	DET
bam-7960	58	13	treatment	treatment	NOUN
bam-7960	58	14	of	of	ADP
bam-7960	58	15	muscle	muscle	NOUN
bam-7960	58	16	wasting	waste	VERB
bam-7960	58	17	in	in	ADP
bam-7960	58	18	pre	pre	ADJ
bam-7960	58	19	-	-	ADJ
bam-7960	58	20	clinical	clinical	ADJ
bam-7960	58	21	models	model	NOUN
bam-7960	58	22	.	.	PUNCT
bam-7960	59	1	thus	thus	ADV
bam-7960	59	2	,	,	PUNCT
bam-7960	59	3	bortezomib	bortezomib	PROPN
bam-7960	59	4	did	do	AUX
bam-7960	59	5	not	not	PART
bam-7960	59	6	show	show	VERB
bam-7960	59	7	any	any	DET
bam-7960	59	8	significant	significant	ADJ
bam-7960	59	9	effects	effect	NOUN
bam-7960	59	10	in	in	ADP
bam-7960	59	11	the	the	DET
bam-7960	59	12	treatment	treatment	NOUN
bam-7960	59	13	of	of	ADP
bam-7960	59	14	cancer	cancer	NOUN
bam-7960	59	15	cachexia	cachexia	NOUN
bam-7960	59	16	in	in	ADP
bam-7960	59	17	rats	rat	NOUN
bam-7960	59	18	bearing	bear	VERB
bam-7960	59	19	the	the	DET
bam-7960	59	20	cachectic	cachectic	PROPN
bam-7960	59	21	yoshida	yoshida	PROPN
bam-7960	59	22	hepatoma	hepatoma	PROPN
bam-7960	59	23	ah-130	ah-130	PROPN
bam-7960	59	24	ascites	ascite	NOUN
bam-7960	59	25	tumor	tumor	VERB
bam-7960	59	26	model.66	model.66	NOUN
bam-7960	59	27	conversely	conversely	ADV
bam-7960	59	28	,	,	PUNCT
bam-7960	59	29	carfilzomib	carfilzomib	NOUN
bam-7960	59	30	inhibits	inhibit	VERB
bam-7960	59	31	skeletal	skeletal	ADJ
bam-7960	59	32	muscle	muscle	NOUN
bam-7960	59	33	proteolysis	proteolysis	NOUN
bam-7960	59	34	and	and	CCONJ
bam-7960	59	35	apoptosis	apoptosis	NOUN
bam-7960	59	36	reducing	reduce	VERB
bam-7960	59	37	cachexia	cachexia	NOUN
bam-7960	59	38	in	in	ADP
bam-7960	59	39	a	a	DET
bam-7960	59	40	preclinical	preclinical	ADJ
bam-7960	59	41	mouse	mouse	NOUN
bam-7960	59	42	model.67	model.67	VERB
bam-7960	59	43	a	a	DET
bam-7960	59	44	phase	phase	NOUN
bam-7960	59	45	ib	ib	NOUN
bam-7960	59	46	investigation	investigation	NOUN
bam-7960	59	47	showed	show	VERB
bam-7960	59	48	promising	promising	ADJ
bam-7960	59	49	results	result	NOUN
bam-7960	59	50	with	with	ADP
bam-7960	59	51	the	the	DET
bam-7960	59	52	mek	mek	PROPN
bam-7960	59	53	inhibitor	inhibitor	NOUN
bam-7960	59	54	binimetinib	binimetinib	NOUN
bam-7960	59	55	in	in	ADP
bam-7960	59	56	patients	patient	NOUN
bam-7960	59	57	with	with	ADP
bam-7960	59	58	advanced	advanced	ADJ
bam-7960	59	59	or	or	CCONJ
bam-7960	59	60	metastatic	metastatic	ADJ
bam-7960	59	61	biliary	biliary	ADJ
bam-7960	59	62	tract	tract	NOUN
bam-7960	59	63	cancer.68	cancer.68	NOUN
bam-7960	59	64	cancer	cancer	NOUN
bam-7960	59	65	cachexia	cachexia	NOUN
bam-7960	59	66	and	and	CCONJ
bam-7960	59	67	type	type	PROPN
bam-7960	59	68	ii	ii	PROPN
bam-7960	59	69	diabetes	diabetes	NOUN
bam-7960	59	70	share	share	VERB
bam-7960	59	71	common	common	ADJ
bam-7960	59	72	metabolic	metabolic	NOUN
bam-7960	59	73	characteristics	characteristic	NOUN
bam-7960	59	74	,	,	PUNCT
bam-7960	59	75	including	include	VERB
bam-7960	59	76	weight	weight	NOUN
bam-7960	59	77	loss	loss	NOUN
bam-7960	59	78	,	,	PUNCT
bam-7960	59	79	insulin	insulin	NOUN
bam-7960	59	80	resistance	resistance	NOUN
bam-7960	59	81	and	and	CCONJ
bam-7960	59	82	increased	increase	VERB
bam-7960	59	83	hepatic	hepatic	ADJ
bam-7960	59	84	gluconeogenesis	gluconeogenesis	NOUN
bam-7960	59	85	.	.	PUNCT
bam-7960	60	1	from	from	ADP
bam-7960	60	2	this	this	DET
bam-7960	60	3	point	point	NOUN
bam-7960	60	4	of	of	ADP
bam-7960	60	5	view	view	NOUN
bam-7960	60	6	,	,	PUNCT
bam-7960	60	7	recent	recent	ADJ
bam-7960	60	8	interest	interest	NOUN
bam-7960	60	9	has	have	AUX
bam-7960	60	10	developed	develop	VERB
bam-7960	60	11	around	around	ADP
bam-7960	60	12	anti	anti	ADJ
bam-7960	60	13	-	-	ADJ
bam-7960	60	14	diabetic	diabetic	ADJ
bam-7960	60	15	drugs	drug	NOUN
bam-7960	60	16	such	such	ADJ
bam-7960	60	17	as	as	ADP
bam-7960	60	18	metformin	metformin	NOUN
bam-7960	60	19	for	for	ADP
bam-7960	60	20	the	the	DET
bam-7960	60	21	treatment	treatment	NOUN
bam-7960	60	22	of	of	ADP
bam-7960	60	23	muscle	muscle	NOUN
bam-7960	60	24	wasting	waste	VERB
bam-7960	60	25	in	in	ADP
bam-7960	60	26	cancer	cancer	NOUN
bam-7960	60	27	.	.	PUNCT
bam-7960	61	1	an	an	DET
bam-7960	61	2	interesting	interesting	ADJ
bam-7960	61	3	study	study	NOUN
bam-7960	61	4	reveals	reveal	VERB
bam-7960	61	5	that	that	SCONJ
bam-7960	61	6	metformin	metformin	NOUN
bam-7960	61	7	improves	improve	VERB
bam-7960	61	8	protein	protein	NOUN
bam-7960	61	9	metabolism	metabolism	NOUN
bam-7960	61	10	in	in	ADP
bam-7960	61	11	skeletal	skeletal	ADJ
bam-7960	61	12	muscle	muscle	NOUN
bam-7960	61	13	in	in	ADP
bam-7960	61	14	tumor	tumor	NOUN
bam-7960	61	15	-	-	PUNCT
bam-7960	61	16	bearing	bear	VERB
bam-7960	61	17	rats.69	rats.69	NOUN
bam-7960	61	18	a	a	DET
bam-7960	61	19	very	very	ADV
bam-7960	61	20	innovative	innovative	ADJ
bam-7960	61	21	and	and	CCONJ
bam-7960	61	22	revolutionary	revolutionary	ADJ
bam-7960	61	23	strategy	strategy	NOUN
bam-7960	61	24	to	to	PART
bam-7960	61	25	fight	fight	VERB
bam-7960	61	26	muscle	muscle	NOUN
bam-7960	61	27	wasting	waste	VERB
bam-7960	61	28	in	in	ADP
bam-7960	61	29	cancer	cancer	NOUN
bam-7960	61	30	is	be	AUX
bam-7960	61	31	the	the	DET
bam-7960	61	32	use	use	NOUN
bam-7960	61	33	of	of	ADP
bam-7960	61	34	stem	stem	NOUN
bam-7960	61	35	cells	cell	NOUN
bam-7960	61	36	with	with	ADP
bam-7960	61	37	the	the	DET
bam-7960	61	38	aim	aim	NOUN
bam-7960	61	39	of	of	ADP
bam-7960	61	40	replacing	replace	VERB
bam-7960	61	41	degenerated	degenerated	ADJ
bam-7960	61	42	muscle	muscle	NOUN
bam-7960	61	43	tissue.70	tissue.70	NOUN
bam-7960	61	44	while	while	SCONJ
bam-7960	61	45	adult	adult	NOUN
bam-7960	61	46	stem	stem	NOUN
bam-7960	61	47	cells	cell	NOUN
bam-7960	61	48	are	be	AUX
bam-7960	61	49	tissue	tissue	NOUN
bam-7960	61	50	-	-	PUNCT
bam-7960	61	51	specific	specific	ADJ
bam-7960	61	52	and	and	CCONJ
bam-7960	61	53	have	have	VERB
bam-7960	61	54	limited	limit	VERB
bam-7960	61	55	capacity	capacity	NOUN
bam-7960	61	56	to	to	PART
bam-7960	61	57	be	be	AUX
bam-7960	61	58	expanded	expand	VERB
bam-7960	61	59	,	,	PUNCT
bam-7960	61	60	ex	ex	X
bam-7960	61	61	vivo	vivo	ADJ
bam-7960	61	62	pluripotent	pluripotent	ADJ
bam-7960	61	63	stem	stem	NOUN
bam-7960	61	64	cells	cell	NOUN
bam-7960	61	65	can	can	AUX
bam-7960	61	66	differentiate	differentiate	VERB
bam-7960	61	67	into	into	ADP
bam-7960	61	68	any	any	DET
bam-7960	61	69	cell	cell	NOUN
bam-7960	61	70	type	type	NOUN
bam-7960	61	71	while	while	SCONJ
bam-7960	61	72	possessing	possess	VERB
bam-7960	61	73	unlimited	unlimited	ADV
bam-7960	61	74	in	in	ADP
bam-7960	61	75	vitro	vitro	X
bam-7960	61	76	self	self	NOUN
bam-7960	61	77	-	-	PUNCT
bam-7960	61	78	renewal	renewal	NOUN
bam-7960	61	79	.	.	PUNCT
bam-7960	62	1	scott	scott	PROPN
bam-7960	62	2	et	et	PROPN
bam-7960	62	3	al	al	PROPN
bam-7960	62	4	.	.	PROPN
bam-7960	62	5	described	describe	VERB
bam-7960	62	6	a	a	DET
bam-7960	62	7	methodology	methodology	NOUN
bam-7960	62	8	for	for	ADP
bam-7960	62	9	large	large	ADJ
bam-7960	62	10	-	-	PUNCT
bam-7960	62	11	scale	scale	NOUN
bam-7960	62	12	isolation	isolation	NOUN
bam-7960	62	13	of	of	ADP
bam-7960	62	14	satellite	satellite	NOUN
bam-7960	62	15	cells	cell	NOUN
bam-7960	62	16	from	from	ADP
bam-7960	62	17	skeletal	skeletal	ADJ
bam-7960	62	18	muscle70	muscle70	NOUN
bam-7960	62	19	,	,	PUNCT
bam-7960	62	20	which	which	PRON
bam-7960	62	21	could	could	AUX
bam-7960	62	22	then	then	ADV
bam-7960	62	23	be	be	AUX
bam-7960	62	24	applied	apply	VERB
bam-7960	62	25	as	as	ADP
bam-7960	62	26	a	a	DET
bam-7960	62	27	therapeutic	therapeutic	ADJ
bam-7960	62	28	strategy	strategy	NOUN
bam-7960	62	29	to	to	PART
bam-7960	62	30	stimulate	stimulate	VERB
bam-7960	62	31	muscle	muscle	NOUN
bam-7960	62	32	regeneration.71	regeneration.71	NOUN
bam-7960	62	33	another	another	DET
bam-7960	62	34	interesting	interesting	ADJ
bam-7960	62	35	approach	approach	NOUN
bam-7960	62	36	that	that	PRON
bam-7960	62	37	has	have	AUX
bam-7960	62	38	led	lead	VERB
bam-7960	62	39	to	to	ADP
bam-7960	62	40	promising	promise	VERB
bam-7960	62	41	results	result	NOUN
bam-7960	62	42	in	in	ADP
bam-7960	62	43	pre	pre	ADJ
bam-7960	62	44	-	-	ADJ
bam-7960	62	45	clinical	clinical	ADJ
bam-7960	62	46	models	model	NOUN
bam-7960	62	47	of	of	ADP
bam-7960	62	48	cancer	cancer	NOUN
bam-7960	62	49	cachexia	cachexia	PROPN
bam-7960	62	50	is	be	AUX
bam-7960	62	51	the	the	DET
bam-7960	62	52	use	use	NOUN
bam-7960	62	53	of	of	ADP
bam-7960	62	54	statins	statin	NOUN
bam-7960	62	55	such	such	ADJ
bam-7960	62	56	as	as	ADP
bam-7960	62	57	simvastatin	simvastatin	NOUN
bam-7960	62	58	.	.	PUNCT
bam-7960	63	1	indeed	indeed	ADV
bam-7960	63	2	,	,	PUNCT
bam-7960	63	3	in	in	ADP
bam-7960	63	4	a	a	DET
bam-7960	63	5	study	study	NOUN
bam-7960	63	6	involving	involve	VERB
bam-7960	63	7	the	the	DET
bam-7960	63	8	cachectic	cachectic	PROPN
bam-7960	63	9	yoshida	yoshida	PROPN
bam-7960	63	10	ah-130	ah-130	PROPN
bam-7960	63	11	ascites	ascite	NOUN
bam-7960	63	12	hepatoma	hepatoma	VERB
bam-7960	63	13	has	have	AUX
bam-7960	63	14	shown	show	VERB
bam-7960	63	15	that	that	SCONJ
bam-7960	63	16	simvastatin	simvastatin	PROPN
bam-7960	63	17	attenuated	attenuate	VERB
bam-7960	63	18	body	body	NOUN
bam-7960	63	19	weight	weight	NOUN
bam-7960	63	20	loss	loss	NOUN
bam-7960	63	21	and	and	CCONJ
bam-7960	63	22	preserved	preserve	VERB
bam-7960	63	23	muscle	muscle	NOUN
bam-7960	63	24	mass.72	mass.72	VERB
bam-7960	63	25	the	the	DET
bam-7960	63	26	use	use	NOUN
bam-7960	63	27	of	of	ADP
bam-7960	63	28	nutrition	nutrition	NOUN
bam-7960	63	29	nutrition	nutrition	NOUN
bam-7960	63	30	is	be	AUX
bam-7960	63	31	an	an	DET
bam-7960	63	32	essential	essential	ADJ
bam-7960	63	33	element	element	NOUN
bam-7960	63	34	in	in	ADP
bam-7960	63	35	cancer	cancer	NOUN
bam-7960	63	36	care	care	NOUN
bam-7960	63	37	,	,	PUNCT
bam-7960	63	38	and	and	CCONJ
bam-7960	63	39	patients	patient	NOUN
bam-7960	63	40	report	report	VERB
bam-7960	63	41	a	a	DET
bam-7960	63	42	high	high	ADJ
bam-7960	63	43	interest	interest	NOUN
bam-7960	63	44	and	and	CCONJ
bam-7960	63	45	need	need	VERB
bam-7960	63	46	;	;	PUNCT
bam-7960	63	47	however	however	ADV
bam-7960	63	48	,	,	PUNCT
bam-7960	63	49	a	a	DET
bam-7960	63	50	recent	recent	ADJ
bam-7960	63	51	study	study	NOUN
bam-7960	63	52	has	have	AUX
bam-7960	63	53	shown	show	VERB
bam-7960	63	54	that	that	SCONJ
bam-7960	63	55	many	many	ADJ
bam-7960	63	56	patients	patient	NOUN
bam-7960	63	57	do	do	AUX
bam-7960	63	58	not	not	PART
bam-7960	63	59	have	have	VERB
bam-7960	63	60	access	access	NOUN
bam-7960	63	61	to	to	ADP
bam-7960	63	62	high	high	ADJ
bam-7960	63	63	-	-	PUNCT
bam-7960	63	64	quality	quality	NOUN
bam-7960	63	65	nutrition	nutrition	NOUN
bam-7960	63	66	therapy	therapy	NOUN
bam-7960	63	67	either	either	CCONJ
bam-7960	63	68	during	during	ADP
bam-7960	63	69	or	or	CCONJ
bam-7960	63	70	after	after	ADP
bam-7960	63	71	cancer	cancer	NOUN
bam-7960	63	72	treatment.73	treatment.73	NOUN
bam-7960	63	73	while	while	SCONJ
bam-7960	63	74	some	some	DET
bam-7960	63	75	studies	study	NOUN
bam-7960	63	76	demonstrate	demonstrate	VERB
bam-7960	63	77	a	a	DET
bam-7960	63	78	beneficial	beneficial	ADJ
bam-7960	63	79	effect	effect	NOUN
bam-7960	63	80	for	for	ADP
bam-7960	63	81	nutritional	nutritional	ADJ
bam-7960	63	82	advice,74,75	advice,74,75	NOUN
bam-7960	63	83	other	other	ADJ
bam-7960	63	84	studies	study	NOUN
bam-7960	63	85	shown	show	VERB
bam-7960	63	86	a	a	DET
bam-7960	63	87	two	two	NUM
bam-7960	63	88	-	-	PUNCT
bam-7960	63	89	year	year	NOUN
bam-7960	63	90	randomized	randomize	VERB
bam-7960	63	91	controlled	control	VERB
bam-7960	63	92	trial	trial	NOUN
bam-7960	63	93	that	that	PRON
bam-7960	63	94	early	early	ADJ
bam-7960	63	95	dietary	dietary	ADJ
bam-7960	63	96	counseling	counseling	NOUN
bam-7960	63	97	was	be	AUX
bam-7960	63	98	efficient	efficient	ADJ
bam-7960	63	99	in	in	ADP
bam-7960	63	100	increasing	increase	VERB
bam-7960	63	101	intake	intake	NOUN
bam-7960	63	102	but	but	CCONJ
bam-7960	63	103	had	have	VERB
bam-7960	63	104	no	no	DET
bam-7960	63	105	beneficial	beneficial	ADJ
bam-7960	63	106	effect	effect	NOUN
bam-7960	63	107	on	on	ADP
bam-7960	63	108	mortality	mortality	NOUN
bam-7960	63	109	or	or	CCONJ
bam-7960	63	110	secondary	secondary	ADJ
bam-7960	63	111	outcomes.76	outcomes.76	NOUN
bam-7960	63	112	while	while	SCONJ
bam-7960	63	113	standard	standard	ADJ
bam-7960	63	114	nutrition	nutrition	NOUN
bam-7960	63	115	supplements	supplement	NOUN
bam-7960	63	116	have	have	AUX
bam-7960	63	117	not	not	PART
bam-7960	63	118	led	lead	VERB
bam-7960	63	119	to	to	ADP
bam-7960	63	120	positive	positive	ADJ
bam-7960	63	121	results	result	NOUN
bam-7960	63	122	in	in	ADP
bam-7960	63	123	cancer	cancer	NOUN
bam-7960	63	124	cachexia	cachexia	NOUN
bam-7960	63	125	,	,	PUNCT
bam-7960	63	126	the	the	DET
bam-7960	63	127	use	use	NOUN
bam-7960	63	128	of	of	ADP
bam-7960	63	129	nutrients	nutrient	NOUN
bam-7960	63	130	in	in	ADP
bam-7960	63	131	combination	combination	NOUN
bam-7960	63	132	with	with	ADP
bam-7960	63	133	nutraceuticals	nutraceutical	NOUN
bam-7960	63	134	the	the	DET
bam-7960	63	135	socalled	socalle	VERB
bam-7960	63	136	specialized	specialized	ADJ
bam-7960	63	137	nutrition	nutrition	NOUN
bam-7960	63	138	has	have	AUX
bam-7960	63	139	given	give	VERB
bam-7960	63	140	more	more	ADV
bam-7960	63	141	positive	positive	ADJ
bam-7960	63	142	results	result	NOUN
bam-7960	63	143	.	.	PUNCT
bam-7960	64	1	omega3	omega3	NOUN
bam-7960	64	2	-	-	PUNCT
bam-7960	64	3	polyunsaturated	polyunsaturate	VERB
bam-7960	64	4	fatty	fatty	NOUN
bam-7960	64	5	acids	acid	NOUN
bam-7960	64	6	(	(	PUNCT
bam-7960	64	7	pufa	pufa	NOUN
bam-7960	64	8	)	)	PUNCT
bam-7960	64	9	,	,	PUNCT
bam-7960	64	10	present	present	ADJ
bam-7960	64	11	in	in	ADP
bam-7960	64	12	large	large	ADJ
bam-7960	64	13	amounts	amount	NOUN
bam-7960	64	14	in	in	ADP
bam-7960	64	15	fish	fish	NOUN
bam-7960	64	16	oil	oil	NOUN
bam-7960	64	17	,	,	PUNCT
bam-7960	64	18	have	have	AUX
bam-7960	64	19	been	be	AUX
bam-7960	64	20	proposed	propose	VERB
bam-7960	64	21	as	as	ADP
bam-7960	64	22	very	very	ADV
bam-7960	64	23	active	active	ADJ
bam-7960	64	24	in	in	ADP
bam-7960	64	25	reducing	reduce	VERB
bam-7960	64	26	either	either	CCONJ
bam-7960	64	27	tumor	tumor	NOUN
bam-7960	64	28	growth	growth	NOUN
bam-7960	64	29	or	or	CCONJ
bam-7960	64	30	muscle	muscle	NOUN
bam-7960	64	31	wasting	waste	VERB
bam-7960	64	32	.	.	PUNCT
bam-7960	65	1	an	an	DET
bam-7960	65	2	improvement	improvement	NOUN
bam-7960	65	3	in	in	ADP
bam-7960	65	4	the	the	DET
bam-7960	65	5	lean	lean	ADJ
bam-7960	65	6	body	body	NOUN
bam-7960	65	7	mass	mass	NOUN
bam-7960	65	8	and	and	CCONJ
bam-7960	65	9	improved	improve	VERB
bam-7960	65	10	quality	quality	NOUN
bam-7960	65	11	of	of	ADP
bam-7960	65	12	life	life	NOUN
bam-7960	65	13	was	be	AUX
bam-7960	65	14	observed	observe	VERB
bam-7960	65	15	in	in	ADP
bam-7960	65	16	a	a	DET
bam-7960	65	17	randomized	randomize	VERB
bam-7960	65	18	doubled	double	VERB
bam-7960	65	19	blind	blind	ADJ
bam-7960	65	20	trial	trial	NOUN
bam-7960	65	21	using	use	VERB
bam-7960	65	22	a	a	DET
bam-7960	65	23	protein	protein	NOUN
bam-7960	65	24	and	and	CCONJ
bam-7960	65	25	energy	energy	NOUN
bam-7960	65	26	dense	dense	ADJ
bam-7960	65	27	omega3	omega3	NOUN
bam-7960	65	28	-	-	PUNCT
bam-7960	65	29	fatty	fatty	NOUN
bam-7960	65	30	acid	acid	NOUN
bam-7960	65	31	-	-	PUNCT
bam-7960	65	32	enriched	enrich	VERB
bam-7960	65	33	oral	oral	ADJ
bam-7960	65	34	supplement,77	supplement,77	NOUN
bam-7960	65	35	provided	provide	VERB
bam-7960	65	36	that	that	SCONJ
bam-7960	65	37	its	its	PRON
bam-7960	65	38	consumption	consumption	NOUN
bam-7960	65	39	was	be	AUX
bam-7960	65	40	equal	equal	ADJ
bam-7960	65	41	or	or	CCONJ
bam-7960	65	42	superior	superior	ADJ
bam-7960	65	43	to	to	ADP
bam-7960	65	44	2.2	2.2	NUM
bam-7960	65	45	g	g	ADP
bam-7960	65	46	eicosapentaenoic	eicosapentaenoic	ADJ
bam-7960	65	47	acid	acid	NOUN
bam-7960	65	48	(	(	PUNCT
bam-7960	65	49	epa)/day	epa)/day	PROPN
bam-7960	65	50	.	.	PUNCT
bam-7960	66	1	however	however	ADV
bam-7960	66	2	,	,	PUNCT
bam-7960	66	3	data	datum	NOUN
bam-7960	66	4	arising	arise	VERB
bam-7960	66	5	from	from	ADP
bam-7960	66	6	a	a	DET
bam-7960	66	7	large	large	ADJ
bam-7960	66	8	,	,	PUNCT
bam-7960	66	9	multicentre	multicentre	ADJ
bam-7960	66	10	,	,	PUNCT
bam-7960	66	11	double	double	ADJ
bam-7960	66	12	-	-	PUNCT
bam-7960	66	13	blind	blind	ADJ
bam-7960	66	14	placebocontrolled	placebocontrolle	VERB
bam-7960	66	15	trial	trial	NOUN
bam-7960	66	16	indicate	indicate	VERB
bam-7960	66	17	that	that	SCONJ
bam-7960	66	18	epa	epa	PROPN
bam-7960	66	19	administration	administration	NOUN
bam-7960	66	20	alone	alone	ADV
bam-7960	66	21	is	be	AUX
bam-7960	66	22	not	not	PART
bam-7960	66	23	successful	successful	ADJ
bam-7960	66	24	in	in	ADP
bam-7960	66	25	the	the	DET
bam-7960	66	26	treatment	treatment	NOUN
bam-7960	66	27	of	of	ADP
bam-7960	66	28	weight	weight	NOUN
bam-7960	66	29	losing	lose	VERB
bam-7960	66	30	patients	patient	NOUN
bam-7960	66	31	with	with	ADP
bam-7960	66	32	advanced	advanced	ADJ
bam-7960	66	33	gastrointestinal	gastrointestinal	ADJ
bam-7960	66	34	or	or	CCONJ
bam-7960	66	35	lung	lung	NOUN
bam-7960	66	36	cancer.78	cancer.78	NOUN
bam-7960	66	37	moreover	moreover	ADV
bam-7960	66	38	,	,	PUNCT
bam-7960	66	39	a	a	DET
bam-7960	66	40	meta	meta	ADJ
bam-7960	66	41	-	-	PUNCT
bam-7960	66	42	analysis	analysis	NOUN
bam-7960	66	43	based	base	VERB
bam-7960	66	44	on	on	ADP
bam-7960	66	45	five	five	NUM
bam-7960	66	46	trials	trial	NOUN
bam-7960	66	47	concluded	conclude	VERB
bam-7960	66	48	that	that	SCONJ
bam-7960	66	49	there	there	PRON
bam-7960	66	50	were	be	VERB
bam-7960	66	51	insufficient	insufficient	ADJ
bam-7960	66	52	data	datum	NOUN
bam-7960	66	53	to	to	PART
bam-7960	66	54	establish	establish	VERB
bam-7960	66	55	whether	whether	SCONJ
bam-7960	66	56	oral	oral	ADJ
bam-7960	66	57	epa	epa	NOUN
bam-7960	66	58	was	be	AUX
bam-7960	66	59	better	well	ADJ
bam-7960	66	60	than	than	ADP
bam-7960	66	61	placebo.79	placebo.79	NOUN
bam-7960	66	62	comparisons	comparison	NOUN
bam-7960	66	63	of	of	ADP
bam-7960	66	64	epa	epa	PROPN
bam-7960	66	65	combined	combine	VERB
bam-7960	66	66	with	with	ADP
bam-7960	66	67	a	a	DET
bam-7960	66	68	protein	protein	NOUN
bam-7960	66	69	energy	energy	NOUN
bam-7960	66	70	supplementation	supplementation	NOUN
bam-7960	66	71	versus	versus	ADP
bam-7960	66	72	a	a	DET
bam-7960	66	73	protein	protein	NOUN
bam-7960	66	74	energy	energy	NOUN
bam-7960	66	75	supplementation	supplementation	NOUN
bam-7960	66	76	(	(	PUNCT
bam-7960	66	77	without	without	ADP
bam-7960	66	78	epa	epa	PROPN
bam-7960	66	79	)	)	PUNCT
bam-7960	66	80	in	in	ADP
bam-7960	66	81	the	the	DET
bam-7960	66	82	presence	presence	NOUN
bam-7960	66	83	of	of	ADP
bam-7960	66	84	megestrol	megestrol	NOUN
bam-7960	66	85	acetate	acetate	NOUN
bam-7960	66	86	provided	provide	VERB
bam-7960	66	87	no	no	DET
bam-7960	66	88	evidence	evidence	NOUN
bam-7960	66	89	that	that	SCONJ
bam-7960	66	90	epa	epa	PROPN
bam-7960	66	91	improves	improve	VERB
bam-7960	66	92	symptoms	symptom	NOUN
bam-7960	66	93	associated	associate	VERB
bam-7960	66	94	with	with	ADP
bam-7960	66	95	the	the	DET
bam-7960	66	96	cachexia	cachexia	PROPN
bam-7960	66	97	syndrome	syndrome	NOUN
bam-7960	66	98	often	often	ADV
bam-7960	66	99	seen	see	VERB
bam-7960	66	100	in	in	ADP
bam-7960	66	101	patients	patient	NOUN
bam-7960	66	102	with	with	ADP
bam-7960	66	103	advanced	advanced	ADJ
bam-7960	66	104	cancer.80	cancer.80	NOUN
bam-7960	66	105	in	in	ADP
bam-7960	66	106	spite	spite	NOUN
bam-7960	66	107	of	of	ADP
bam-7960	66	108	this	this	PRON
bam-7960	66	109	,	,	PUNCT
bam-7960	66	110	several	several	ADJ
bam-7960	66	111	recent	recent	ADJ
bam-7960	66	112	trials	trial	NOUN
bam-7960	66	113	suggest	suggest	VERB
bam-7960	66	114	that	that	SCONJ
bam-7960	66	115	epaenriched	epaenriche	VERB
bam-7960	66	116	nutrition	nutrition	NOUN
bam-7960	66	117	results	result	NOUN
bam-7960	66	118	in	in	ADP
bam-7960	66	119	positive	positive	ADJ
bam-7960	66	120	outcomes	outcome	NOUN
bam-7960	66	121	in	in	ADP
bam-7960	66	122	cancer	cancer	NOUN
bam-7960	66	123	patients.81–83	patients.81–83	X
bam-7960	66	124	non	non	X
bam-7960	66	125	co	co	X
bam-7960	66	126	mmerc	mmerc	PROPN
bam-7960	66	127	ial	ial	PROPN
bam-7960	66	128	us	us	PROPN
bam-7960	66	129	e	e	NOUN
bam-7960	66	130	o	o	NOUN
bam-7960	66	131	nly	nly	ADV
bam-7960	66	132	therapeutic	therapeutic	ADJ
bam-7960	66	133	strategies	strategy	NOUN
bam-7960	66	134	against	against	ADP
bam-7960	66	135	cancer	cancer	NOUN
bam-7960	66	136	cachexia	cachexia	PROPN
bam-7960	66	137	eur	eur	PROPN
bam-7960	66	138	j	j	PROPN
bam-7960	66	139	transl	transl	PROPN
bam-7960	66	140	myol	myol	ADV
bam-7960	66	141	29	29	NUM
bam-7960	66	142	(	(	PUNCT
bam-7960	66	143	1	1	NUM
bam-7960	66	144	):	):	PUNCT
bam-7960	66	145	4	4	NUM
bam-7960	66	146	-	-	SYM
bam-7960	66	147	13	13	NUM
bam-7960	66	148	,	,	PUNCT
bam-7960	66	149	2019	2019	NUM
bam-7960	66	150	8	8	NUM
bam-7960	66	151	a	a	DET
bam-7960	66	152	multitarget	multitarget	NOUN
bam-7960	66	153	approach	approach	NOUN
bam-7960	66	154	including	include	VERB
bam-7960	66	155	physical	physical	ADJ
bam-7960	66	156	exercise	exercise	NOUN
bam-7960	66	157	during	during	ADP
bam-7960	66	158	the	the	DET
bam-7960	66	159	last	last	ADJ
bam-7960	66	160	years	year	NOUN
bam-7960	66	161	,	,	PUNCT
bam-7960	66	162	it	it	PRON
bam-7960	66	163	has	have	AUX
bam-7960	66	164	become	become	VERB
bam-7960	66	165	apparent	apparent	ADJ
bam-7960	66	166	that	that	SCONJ
bam-7960	66	167	a	a	DET
bam-7960	66	168	combination	combination	NOUN
bam-7960	66	169	of	of	ADP
bam-7960	66	170	nutrition	nutrition	NOUN
bam-7960	66	171	,	,	PUNCT
bam-7960	66	172	nutraceuticals	nutraceutical	NOUN
bam-7960	66	173	and	and	CCONJ
bam-7960	66	174	drugs	drug	NOUN
bam-7960	66	175	is	be	AUX
bam-7960	66	176	a	a	DET
bam-7960	66	177	much	much	ADV
bam-7960	66	178	-	-	PUNCT
bam-7960	66	179	preferred	prefer	VERB
bam-7960	66	180	therapeutic	therapeutic	ADJ
bam-7960	66	181	approach	approach	NOUN
bam-7960	66	182	than	than	ADP
bam-7960	66	183	just	just	ADV
bam-7960	66	184	looking	look	VERB
bam-7960	66	185	for	for	ADP
bam-7960	66	186	a	a	DET
bam-7960	66	187	single	single	ADJ
bam-7960	66	188	drug	drug	NOUN
bam-7960	66	189	"	"	PUNCT
bam-7960	66	190	magic	magic	ADJ
bam-7960	66	191	bullet	bullet	NOUN
bam-7960	66	192	"	"	PUNCT
bam-7960	66	193	.	.	PUNCT
bam-7960	67	1	in	in	ADP
bam-7960	67	2	fact	fact	NOUN
bam-7960	67	3	,	,	PUNCT
bam-7960	67	4	the	the	DET
bam-7960	67	5	treatment	treatment	NOUN
bam-7960	67	6	of	of	ADP
bam-7960	67	7	cancer	cancer	NOUN
bam-7960	67	8	cachexia	cachexia	PROPN
bam-7960	67	9	has	have	VERB
bam-7960	67	10	to	to	PART
bam-7960	67	11	involve	involve	VERB
bam-7960	67	12	,	,	PUNCT
bam-7960	67	13	not	not	PART
bam-7960	67	14	only	only	ADV
bam-7960	67	15	drugs	drug	NOUN
bam-7960	67	16	and/or	and/or	CCONJ
bam-7960	67	17	nutrients	nutrient	NOUN
bam-7960	67	18	,	,	PUNCT
bam-7960	67	19	but	but	CCONJ
bam-7960	67	20	also	also	ADV
bam-7960	67	21	a	a	DET
bam-7960	67	22	possibilistic	possibilistic	ADJ
bam-7960	67	23	program	program	NOUN
bam-7960	67	24	of	of	ADP
bam-7960	67	25	physical	physical	ADJ
bam-7960	67	26	exercise84–86	exercise84–86	PROPN
bam-7960	67	27	.	.	PUNCT
bam-7960	68	1	indeed	indeed	ADV
bam-7960	68	2	,	,	PUNCT
bam-7960	68	3	in	in	ADP
bam-7960	68	4	cancer	cancer	NOUN
bam-7960	68	5	patients	patient	NOUN
bam-7960	68	6	either	either	CCONJ
bam-7960	68	7	suffering	suffer	VERB
bam-7960	68	8	from	from	ADP
bam-7960	68	9	cachexia	cachexia	NOUN
bam-7960	68	10	or	or	CCONJ
bam-7960	68	11	not	not	PART
bam-7960	68	12	an	an	DET
bam-7960	68	13	exercise	exercise	NOUN
bam-7960	68	14	program	program	NOUN
bam-7960	68	15	can	can	AUX
bam-7960	68	16	improve	improve	VERB
bam-7960	68	17	their	their	PRON
bam-7960	68	18	quality	quality	NOUN
bam-7960	68	19	of	of	ADP
bam-7960	68	20	life.87,88	life.87,88	NOUN
bam-7960	68	21	this	this	PRON
bam-7960	68	22	is	be	AUX
bam-7960	68	23	accomplished	accomplish	VERB
bam-7960	68	24	by	by	ADP
bam-7960	68	25	inducing	induce	VERB
bam-7960	68	26	metabolic	metabolic	NOUN
bam-7960	68	27	alterations	alteration	NOUN
bam-7960	68	28	that	that	PRON
bam-7960	68	29	result	result	VERB
bam-7960	68	30	in	in	ADP
bam-7960	68	31	changes	change	NOUN
bam-7960	68	32	in	in	ADP
bam-7960	68	33	body	body	NOUN
bam-7960	68	34	composition	composition	NOUN
bam-7960	68	35	.	.	PUNCT
bam-7960	69	1	a	a	DET
bam-7960	69	2	study	study	NOUN
bam-7960	69	3	has	have	AUX
bam-7960	69	4	shown	show	VERB
bam-7960	69	5	clear	clear	ADJ
bam-7960	69	6	benefits	benefit	NOUN
bam-7960	69	7	on	on	ADP
bam-7960	69	8	cachectic	cachectic	ADJ
bam-7960	69	9	cancer	cancer	NOUN
bam-7960	69	10	(	(	PUNCT
bam-7960	69	11	head	head	NOUN
bam-7960	69	12	and	and	CCONJ
bam-7960	69	13	neck	neck	NOUN
bam-7960	69	14	)	)	PUNCT
bam-7960	69	15	patients	patient	NOUN
bam-7960	69	16	of	of	ADP
bam-7960	69	17	an	an	DET
bam-7960	69	18	exercise	exercise	NOUN
bam-7960	69	19	program	program	NOUN
bam-7960	69	20	(	(	PUNCT
bam-7960	69	21	12	12	NUM
bam-7960	69	22	weeks	week	NOUN
bam-7960	69	23	:	:	PUNCT
bam-7960	69	24	2–3	2–3	NUM
bam-7960	69	25	sets	set	NOUN
bam-7960	69	26	of	of	ADP
bam-7960	69	27	8–15	8–15	PROPN
bam-7960	69	28	repetition	repetition	NOUN
bam-7960	69	29	maximum	maximum	NOUN
bam-7960	69	30	of	of	ADP
bam-7960	69	31	seven	seven	NUM
bam-7960	69	32	conventional	conventional	ADJ
bam-7960	69	33	exercises).89	exercises).89	PROPN
bam-7960	69	34	indeed	indeed	ADV
bam-7960	69	35	,	,	PUNCT
bam-7960	69	36	with	with	ADP
bam-7960	69	37	an	an	DET
bam-7960	69	38	increase	increase	NOUN
bam-7960	69	39	of	of	ADP
bam-7960	69	40	4.2	4.2	NUM
bam-7960	69	41	%	%	NOUN
bam-7960	69	42	of	of	ADP
bam-7960	69	43	lean	lean	ADJ
bam-7960	69	44	body	body	NOUN
bam-7960	69	45	mass	mass	NOUN
bam-7960	69	46	,	,	PUNCT
bam-7960	69	47	enhanced	enhance	VERB
bam-7960	69	48	muscle	muscle	NOUN
bam-7960	69	49	strength	strength	NOUN
bam-7960	69	50	and	and	CCONJ
bam-7960	69	51	quality	quality	NOUN
bam-7960	69	52	of	of	ADP
bam-7960	69	53	life	life	NOUN
bam-7960	69	54	were	be	AUX
bam-7960	69	55	observed.89	observed.89	NOUN
bam-7960	69	56	similarly	similarly	ADV
bam-7960	69	57	,	,	PUNCT
bam-7960	69	58	in	in	ADP
bam-7960	69	59	the	the	DET
bam-7960	69	60	same	same	ADJ
bam-7960	69	61	type	type	NOUN
bam-7960	69	62	of	of	ADP
bam-7960	69	63	cancer	cancer	NOUN
bam-7960	69	64	patients	patient	NOUN
bam-7960	69	65	,	,	PUNCT
bam-7960	69	66	mcneely	mcneely	ADV
bam-7960	69	67	et	et	PROPN
bam-7960	69	68	al	al	PROPN
bam-7960	69	69	.	.	PROPN
bam-7960	69	70	demonstrated	demonstrate	VERB
bam-7960	69	71	improved	improved	ADJ
bam-7960	69	72	shoulder	shoulder	NOUN
bam-7960	69	73	muscle	muscle	NOUN
bam-7960	69	74	function	function	NOUN
bam-7960	69	75	following	follow	VERB
bam-7960	69	76	resistance	resistance	NOUN
bam-7960	69	77	exercise	exercise	NOUN
bam-7960	69	78	training.90	training.90	PROPN
bam-7960	69	79	exercise	exercise	NOUN
bam-7960	69	80	programs	program	NOUN
bam-7960	69	81	have	have	AUX
bam-7960	69	82	also	also	ADV
bam-7960	69	83	been	be	AUX
bam-7960	69	84	able	able	ADJ
bam-7960	69	85	to	to	PART
bam-7960	69	86	increase	increase	VERB
bam-7960	69	87	muscle	muscle	NOUN
bam-7960	69	88	strength	strength	NOUN
bam-7960	69	89	and	and	CCONJ
bam-7960	69	90	endurance	endurance	NOUN
bam-7960	69	91	,	,	PUNCT
bam-7960	69	92	the	the	DET
bam-7960	69	93	six	six	NUM
bam-7960	69	94	-	-	PUNCT
bam-7960	69	95	minute	minute	NOUN
bam-7960	69	96	walk	walk	NOUN
bam-7960	69	97	distance	distance	NOUN
bam-7960	69	98	,	,	PUNCT
bam-7960	69	99	up	up	ADP
bam-7960	69	100	-	-	PUNCT
bam-7960	69	101	and	and	CCONJ
bam-7960	69	102	-	-	PUNCT
bam-7960	69	103	go	go	VERB
bam-7960	69	104	time	time	NOUN
bam-7960	69	105	,	,	PUNCT
bam-7960	69	106	the	the	DET
bam-7960	69	107	number	number	NOUN
bam-7960	69	108	of	of	ADP
bam-7960	69	109	arm	arm	NOUN
bam-7960	69	110	curls	curl	NOUN
bam-7960	69	111	,	,	PUNCT
bam-7960	69	112	and	and	CCONJ
bam-7960	69	113	the	the	DET
bam-7960	69	114	number	number	NOUN
bam-7960	69	115	of	of	ADP
bam-7960	69	116	chair	chair	NOUN
bam-7960	69	117	stands	stand	VERB
bam-7960	69	118	,	,	PUNCT
bam-7960	69	119	in	in	ADP
bam-7960	69	120	lung	lung	NOUN
bam-7960	69	121	cancer	cancer	NOUN
bam-7960	69	122	patients.91	patients.91	PROPN
bam-7960	69	123	a	a	DET
bam-7960	69	124	systematic	systematic	ADJ
bam-7960	69	125	review	review	NOUN
bam-7960	69	126	reports	report	VERB
bam-7960	69	127	beneficial	beneficial	ADJ
bam-7960	69	128	effects	effect	NOUN
bam-7960	69	129	for	for	ADP
bam-7960	69	130	breast	breast	NOUN
bam-7960	69	131	cancer	cancer	NOUN
bam-7960	69	132	survivors.92	survivors.92	PROPN
bam-7960	69	133	concerning	concern	VERB
bam-7960	69	134	the	the	DET
bam-7960	69	135	mechanisms	mechanism	NOUN
bam-7960	69	136	involved	involve	VERB
bam-7960	69	137	in	in	ADP
bam-7960	69	138	the	the	DET
bam-7960	69	139	effects	effect	NOUN
bam-7960	69	140	of	of	ADP
bam-7960	69	141	exercise	exercise	NOUN
bam-7960	69	142	training	training	NOUN
bam-7960	69	143	programs	program	NOUN
bam-7960	69	144	,	,	PUNCT
bam-7960	69	145	it	it	PRON
bam-7960	69	146	seems	seem	VERB
bam-7960	69	147	very	very	ADV
bam-7960	69	148	clear	clear	ADJ
bam-7960	69	149	that	that	SCONJ
bam-7960	69	150	an	an	DET
bam-7960	69	151	anti	anti	ADJ
bam-7960	69	152	-	-	ADJ
bam-7960	69	153	inflammatory	inflammatory	ADJ
bam-7960	69	154	status	status	NOUN
bam-7960	69	155	is	be	AUX
bam-7960	69	156	accomplished	accomplish	VERB
bam-7960	69	157	with	with	ADP
bam-7960	69	158	decreases	decrease	NOUN
bam-7960	69	159	in	in	ADP
bam-7960	69	160	pro	pro	ADJ
bam-7960	69	161	-	-	ADJ
bam-7960	69	162	inflammatory	inflammatory	ADJ
bam-7960	69	163	cytokines	cytokine	NOUN
bam-7960	69	164	such	such	ADJ
bam-7960	69	165	as	as	ADP
bam-7960	69	166	tnf-	tnf-	NOUN
bam-7960	69	167	and	and	CCONJ
bam-7960	69	168	increases	increase	NOUN
bam-7960	69	169	in	in	ADP
bam-7960	69	170	il-10	il-10	PRON
bam-7960	69	171	,	,	PUNCT
bam-7960	69	172	a	a	DET
bam-7960	69	173	clear	clear	ADJ
bam-7960	69	174	anti	anti	ADJ
bam-7960	69	175	-	-	ADJ
bam-7960	69	176	inflammatory	inflammatory	ADJ
bam-7960	69	177	cytokine.87	cytokine.87	ADJ
bam-7960	69	178	the	the	DET
bam-7960	69	179	decrease	decrease	NOUN
bam-7960	69	180	in	in	ADP
bam-7960	69	181	inflammatory	inflammatory	ADJ
bam-7960	69	182	status	status	NOUN
bam-7960	69	183	is	be	AUX
bam-7960	69	184	accompanied	accompany	VERB
bam-7960	69	185	by	by	ADP
bam-7960	69	186	a	a	DET
bam-7960	69	187	reduction	reduction	NOUN
bam-7960	69	188	in	in	ADP
bam-7960	69	189	oxidative	oxidative	ADJ
bam-7960	69	190	stress.87	stress.87	VERB
bam-7960	69	191	elevations	elevation	NOUN
bam-7960	69	192	in	in	ADP
bam-7960	69	193	igf-1	igf-1	NOUN
bam-7960	69	194	and	and	CCONJ
bam-7960	69	195	pgc-1	pgc-1	VERB
bam-7960	69	196	alpha	alpha	NOUN
bam-7960	69	197	in	in	ADP
bam-7960	69	198	skeletal	skeletal	ADJ
bam-7960	69	199	muscle	muscle	NOUN
bam-7960	69	200	have	have	AUX
bam-7960	69	201	also	also	ADV
bam-7960	69	202	been	be	AUX
bam-7960	69	203	associated	associate	VERB
bam-7960	69	204	with	with	ADP
bam-7960	69	205	the	the	DET
bam-7960	69	206	beneficial	beneficial	ADJ
bam-7960	69	207	effects	effect	NOUN
bam-7960	69	208	of	of	ADP
bam-7960	69	209	exercise	exercise	NOUN
bam-7960	69	210	on	on	ADP
bam-7960	69	211	cancer.87	cancer.87	PROPN
bam-7960	69	212	muscaritoli	muscaritoli	PROPN
bam-7960	69	213	et	et	PROPN
bam-7960	69	214	al	al	PROPN
bam-7960	69	215	.	.	PROPN
bam-7960	69	216	have	have	AUX
bam-7960	69	217	defined	define	VERB
bam-7960	69	218	the	the	DET
bam-7960	69	219	so	so	ADV
bam-7960	69	220	-	-	PUNCT
bam-7960	69	221	called	call	VERB
bam-7960	69	222	target	target	NOUN
bam-7960	69	223	approach	approach	NOUN
bam-7960	69	224	,	,	PUNCT
bam-7960	69	225	which	which	PRON
bam-7960	69	226	is	be	AUX
bam-7960	69	227	a	a	DET
bam-7960	69	228	good	good	ADJ
bam-7960	69	229	way	way	NOUN
bam-7960	69	230	of	of	ADP
bam-7960	69	231	interpreting	interpret	VERB
bam-7960	69	232	the	the	DET
bam-7960	69	233	multimodal	multimodal	NOUN
bam-7960	69	234	approach.93	approach.93	NOUN
bam-7960	69	235	it	it	PRON
bam-7960	69	236	actually	actually	ADV
bam-7960	69	237	integrates	integrate	VERB
bam-7960	69	238	active	active	ADJ
bam-7960	69	239	interventions	intervention	NOUN
bam-7960	69	240	and	and	CCONJ
bam-7960	69	241	research	research	NOUN
bam-7960	69	242	programs	program	NOUN
bam-7960	69	243	related	relate	VERB
bam-7960	69	244	to	to	ADP
bam-7960	69	245	the	the	DET
bam-7960	69	246	onset	onset	NOUN
bam-7960	69	247	and	and	CCONJ
bam-7960	69	248	progression	progression	NOUN
bam-7960	69	249	of	of	ADP
bam-7960	69	250	cancer	cancer	NOUN
bam-7960	69	251	cachexia	cachexia	NOUN
bam-7960	69	252	.	.	PUNCT
bam-7960	70	1	this	this	DET
bam-7960	70	2	approach	approach	NOUN
bam-7960	70	3	includes	include	VERB
bam-7960	70	4	teaching	teaching	NOUN
bam-7960	70	5	(	(	PUNCT
bam-7960	70	6	nutrition	nutrition	NOUN
bam-7960	70	7	,	,	PUNCT
bam-7960	70	8	metabolic	metabolic	NOUN
bam-7960	70	9	alterations	alteration	NOUN
bam-7960	70	10	in	in	ADP
bam-7960	70	11	cancer	cancer	NOUN
bam-7960	70	12	)	)	PUNCT
bam-7960	70	13	,	,	PUNCT
bam-7960	70	14	awareness	awareness	NOUN
bam-7960	70	15	(	(	PUNCT
bam-7960	70	16	of	of	ADP
bam-7960	70	17	the	the	DET
bam-7960	70	18	negative	negative	ADJ
bam-7960	70	19	impact	impact	NOUN
bam-7960	70	20	of	of	ADP
bam-7960	70	21	cancer	cancer	NOUN
bam-7960	70	22	cachexia	cachexia	NOUN
bam-7960	70	23	)	)	PUNCT
bam-7960	70	24	,	,	PUNCT
bam-7960	70	25	recognition	recognition	NOUN
bam-7960	70	26	(	(	PUNCT
bam-7960	70	27	diagnosis	diagnosis	NOUN
bam-7960	70	28	and	and	CCONJ
bam-7960	70	29	staging	staging	NOUN
bam-7960	70	30	)	)	PUNCT
bam-7960	70	31	,	,	PUNCT
bam-7960	70	32	genetics	genetic	NOUN
bam-7960	70	33	(	(	PUNCT
bam-7960	70	34	inherited	inherit	VERB
bam-7960	70	35	susceptibility	susceptibility	NOUN
bam-7960	70	36	)	)	PUNCT
bam-7960	70	37	,	,	PUNCT
bam-7960	70	38	exercise	exercise	NOUN
bam-7960	70	39	(	(	PUNCT
bam-7960	70	40	physical	physical	ADJ
bam-7960	70	41	activity	activity	NOUN
bam-7960	70	42	)	)	PUNCT
bam-7960	70	43	and	and	CCONJ
bam-7960	70	44	treatment.93	treatment.93	VERB
bam-7960	70	45	the	the	DET
bam-7960	70	46	menac	menac	NOUN
bam-7960	70	47	(	(	PUNCT
bam-7960	70	48	multimodality	multimodality	NOUN
bam-7960	70	49	exercise	exercise	NOUN
bam-7960	70	50	/	/	SYM
bam-7960	70	51	nutrition	nutrition	NOUN
bam-7960	70	52	anti	anti	ADJ
bam-7960	70	53	-	-	ADJ
bam-7960	70	54	inflammatory	inflammatory	ADJ
bam-7960	70	55	treatment	treatment	NOUN
bam-7960	70	56	for	for	ADP
bam-7960	70	57	cachexia	cachexia	NOUN
bam-7960	70	58	)	)	PUNCT
bam-7960	70	59	trial,94	trial,94	NOUN
bam-7960	70	60	represents	represent	VERB
bam-7960	70	61	an	an	DET
bam-7960	70	62	excellent	excellent	ADJ
bam-7960	70	63	example	example	NOUN
bam-7960	70	64	of	of	ADP
bam-7960	70	65	a	a	DET
bam-7960	70	66	multimodal	multimodal	NOUN
bam-7960	70	67	approach	approach	NOUN
bam-7960	70	68	.	.	PUNCT
bam-7960	71	1	this	this	DET
bam-7960	71	2	on	on	ADP
bam-7960	71	3	-	-	PUNCT
bam-7960	71	4	going	go	VERB
bam-7960	71	5	phase	phase	NOUN
bam-7960	71	6	iii	iii	NOUN
bam-7960	71	7	trial	trial	NOUN
bam-7960	71	8	is	be	AUX
bam-7960	71	9	enrolling	enrol	VERB
bam-7960	71	10	both	both	PRON
bam-7960	71	11	lung	lung	NOUN
bam-7960	71	12	,	,	PUNCT
bam-7960	71	13	cholangioand	cholangioand	NOUN
bam-7960	71	14	pancreatic	pancreatic	ADJ
bam-7960	71	15	carcinoma	carcinoma	NOUN
bam-7960	71	16	cancer	cancer	NOUN
bam-7960	71	17	patients	patient	NOUN
bam-7960	71	18	and	and	CCONJ
bam-7960	71	19	includes	include	VERB
bam-7960	71	20	nutritional	nutritional	ADJ
bam-7960	71	21	counseling	counseling	NOUN
bam-7960	71	22	,	,	PUNCT
bam-7960	71	23	oral	oral	ADJ
bam-7960	71	24	nutrition	nutrition	NOUN
bam-7960	71	25	supplementation	supplementation	NOUN
bam-7960	71	26	(	(	PUNCT
bam-7960	71	27	including	include	VERB
bam-7960	71	28	epa	epa	PROPN
bam-7960	71	29	)	)	PUNCT
bam-7960	71	30	,	,	PUNCT
bam-7960	71	31	a	a	DET
bam-7960	71	32	physical	physical	ADJ
bam-7960	71	33	exercise	exercise	NOUN
bam-7960	71	34	program	program	NOUN
bam-7960	71	35	and	and	CCONJ
bam-7960	71	36	an	an	DET
bam-7960	71	37	anti	anti	ADJ
bam-7960	71	38	-	-	ADJ
bam-7960	71	39	inflammatory	inflammatory	ADJ
bam-7960	71	40	(	(	PUNCT
bam-7960	71	41	ibuprofen	ibuprofen	NOUN
bam-7960	71	42	)	)	PUNCT
bam-7960	71	43	treatment.95	treatment.95	PROPN
bam-7960	71	44	a	a	DET
bam-7960	71	45	combined	combine	VERB
bam-7960	71	46	multitargeted	multitargete	VERB
bam-7960	71	47	approach	approach	NOUN
bam-7960	71	48	in	in	ADP
bam-7960	71	49	a	a	DET
bam-7960	71	50	randomized	randomized	ADJ
bam-7960	71	51	placebo	placebo	NOUN
bam-7960	71	52	-	-	PUNCT
bam-7960	71	53	controlled	control	VERB
bam-7960	71	54	trial	trial	NOUN
bam-7960	71	55	,	,	PUNCT
bam-7960	71	56	using	use	VERB
bam-7960	71	57	celecoxib	celecoxib	NOUN
bam-7960	71	58	,	,	PUNCT
bam-7960	71	59	lcarnitine	lcarnitine	NOUN
bam-7960	71	60	,	,	PUNCT
bam-7960	71	61	curcumin	curcumin	NOUN
bam-7960	71	62	and	and	CCONJ
bam-7960	71	63	lactoferrin	lactoferrin	NOUN
bam-7960	71	64	,	,	PUNCT
bam-7960	71	65	was	be	AUX
bam-7960	71	66	able	able	ADJ
bam-7960	71	67	to	to	PART
bam-7960	71	68	improve	improve	VERB
bam-7960	71	69	the	the	DET
bam-7960	71	70	nutritional	nutritional	ADJ
bam-7960	71	71	and	and	CCONJ
bam-7960	71	72	immunometabolic	immunometabolic	ADJ
bam-7960	71	73	alterations	alteration	NOUN
bam-7960	71	74	of	of	ADP
bam-7960	71	75	cachexia	cachexia	NOUN
bam-7960	71	76	,	,	PUNCT
bam-7960	71	77	ameliorate	ameliorate	VERB
bam-7960	71	78	the	the	DET
bam-7960	71	79	patient	patient	ADJ
bam-7960	71	80	quality	quality	NOUN
bam-7960	71	81	of	of	ADP
bam-7960	71	82	life	life	NOUN
bam-7960	71	83	and	and	CCONJ
bam-7960	71	84	correct	correct	ADJ
bam-7960	71	85	cancer	cancer	NOUN
bam-7960	71	86	-	-	PUNCT
bam-7960	71	87	related	relate	VERB
bam-7960	71	88	anemia.96	anemia.96	PROPN
bam-7960	71	89	practical	practical	ADJ
bam-7960	71	90	(	(	PUNCT
bam-7960	71	91	individual	individual	ADJ
bam-7960	71	92	reports	report	NOUN
bam-7960	71	93	)	)	PUNCT
bam-7960	71	94	multimodal	multimodal	NOUN
bam-7960	71	95	care	care	NOUN
bam-7960	71	96	programs	program	NOUN
bam-7960	71	97	for	for	ADP
bam-7960	71	98	cancer	cancer	NOUN
bam-7960	71	99	cachexia	cachexia	NOUN
bam-7960	71	100	have	have	AUX
bam-7960	71	101	been	be	AUX
bam-7960	71	102	recently	recently	ADV
bam-7960	71	103	published.97	published.97	NOUN
bam-7960	71	104	another	another	DET
bam-7960	71	105	critical	critical	ADJ
bam-7960	71	106	factor	factor	NOUN
bam-7960	71	107	that	that	PRON
bam-7960	71	108	may	may	AUX
bam-7960	71	109	positively	positively	ADV
bam-7960	71	110	contribute	contribute	VERB
bam-7960	71	111	to	to	ADP
bam-7960	71	112	cancer	cancer	NOUN
bam-7960	71	113	cachexia	cachexia	NOUN
bam-7960	71	114	treatment	treatment	NOUN
bam-7960	71	115	is	be	AUX
bam-7960	71	116	a	a	DET
bam-7960	71	117	proper	proper	ADJ
bam-7960	71	118	staging	staging	NOUN
bam-7960	71	119	of	of	ADP
bam-7960	71	120	the	the	DET
bam-7960	71	121	cachectic	cachectic	ADJ
bam-7960	71	122	condition	condition	NOUN
bam-7960	71	123	in	in	ADP
bam-7960	71	124	cancer	cancer	NOUN
bam-7960	71	125	patients.27	patients.27	PROPN
bam-7960	71	126	this	this	PRON
bam-7960	71	127	would	would	AUX
bam-7960	71	128	allow	allow	VERB
bam-7960	71	129	for	for	ADP
bam-7960	71	130	adequate	adequate	ADJ
bam-7960	71	131	treatment	treatment	NOUN
bam-7960	71	132	at	at	ADP
bam-7960	71	133	the	the	DET
bam-7960	71	134	different	different	ADJ
bam-7960	71	135	phases	phase	NOUN
bam-7960	71	136	of	of	ADP
bam-7960	71	137	cachexia.98	cachexia.98	NOUN
bam-7960	71	138	timing	timing	NOUN
bam-7960	71	139	is	be	AUX
bam-7960	71	140	very	very	ADV
bam-7960	71	141	important	important	ADJ
bam-7960	71	142	and	and	CCONJ
bam-7960	71	143	has	have	VERB
bam-7960	71	144	to	to	PART
bam-7960	71	145	be	be	AUX
bam-7960	71	146	carefully	carefully	ADV
bam-7960	71	147	considered	consider	VERB
bam-7960	71	148	when	when	SCONJ
bam-7960	71	149	designing	design	VERB
bam-7960	71	150	the	the	DET
bam-7960	71	151	therapeutic	therapeutic	ADJ
bam-7960	71	152	approach	approach	NOUN
bam-7960	71	153	.	.	PUNCT
bam-7960	72	1	any	any	DET
bam-7960	72	2	nutritional	nutritional	ADJ
bam-7960	72	3	/	/	SYM
bam-7960	72	4	metabolic/	metabolic/	NUM
bam-7960	72	5	pharmacological	pharmacological	ADJ
bam-7960	72	6	support	support	NOUN
bam-7960	72	7	should	should	AUX
bam-7960	72	8	be	be	AUX
bam-7960	72	9	started	start	VERB
bam-7960	72	10	early	early	ADV
bam-7960	72	11	in	in	ADP
bam-7960	72	12	the	the	DET
bam-7960	72	13	course	course	NOUN
bam-7960	72	14	of	of	ADP
bam-7960	72	15	the	the	DET
bam-7960	72	16	disease	disease	NOUN
bam-7960	72	17	,	,	PUNCT
bam-7960	72	18	before	before	SCONJ
bam-7960	72	19	severe	severe	ADJ
bam-7960	72	20	weight	weight	NOUN
bam-7960	72	21	loss	loss	NOUN
bam-7960	72	22	occurs	occur	VERB
bam-7960	72	23	,	,	PUNCT
bam-7960	72	24	and	and	CCONJ
bam-7960	72	25	appropriate	appropriate	ADJ
bam-7960	72	26	treatment	treatment	NOUN
bam-7960	72	27	should	should	AUX
bam-7960	72	28	be	be	AUX
bam-7960	72	29	applied	apply	VERB
bam-7960	72	30	at	at	ADP
bam-7960	72	31	every	every	DET
bam-7960	72	32	phase	phase	NOUN
bam-7960	72	33	of	of	ADP
bam-7960	72	34	the	the	DET
bam-7960	72	35	cachectic	cachectic	ADJ
bam-7960	72	36	syndrome	syndrome	NOUN
bam-7960	72	37	.	.	PUNCT
bam-7960	73	1	more	more	ADJ
bam-7960	73	2	research	research	NOUN
bam-7960	73	3	should	should	AUX
bam-7960	73	4	also	also	ADV
bam-7960	73	5	be	be	AUX
bam-7960	73	6	devoted	devote	VERB
bam-7960	73	7	to	to	ADP
bam-7960	73	8	finding	find	VERB
bam-7960	73	9	new	new	ADJ
bam-7960	73	10	biomarkers	biomarker	NOUN
bam-7960	73	11	for	for	ADP
bam-7960	73	12	cancer	cancer	NOUN
bam-7960	73	13	cachexia	cachexia	NOUN
bam-7960	73	14	.	.	PUNCT
bam-7960	74	1	indeed	indeed	ADV
bam-7960	74	2	,	,	PUNCT
bam-7960	74	3	many	many	ADJ
bam-7960	74	4	cancer	cancer	NOUN
bam-7960	74	5	patients	patient	NOUN
bam-7960	74	6	are	be	AUX
bam-7960	74	7	treated	treat	VERB
bam-7960	74	8	only	only	ADV
bam-7960	74	9	when	when	SCONJ
bam-7960	74	10	a	a	DET
bam-7960	74	11	significant	significant	ADJ
bam-7960	74	12	amount	amount	NOUN
bam-7960	74	13	of	of	ADP
bam-7960	74	14	weight	weight	NOUN
bam-7960	74	15	loss	loss	NOUN
bam-7960	74	16	is	be	AUX
bam-7960	74	17	detected	detect	VERB
bam-7960	74	18	,	,	PUNCT
bam-7960	74	19	or	or	CCONJ
bam-7960	74	20	when	when	SCONJ
bam-7960	74	21	the	the	DET
bam-7960	74	22	patients	patient	NOUN
bam-7960	74	23	suffer	suffer	VERB
bam-7960	74	24	from	from	ADP
bam-7960	74	25	certain	certain	ADJ
bam-7960	74	26	limitations	limitation	NOUN
bam-7960	74	27	in	in	ADP
bam-7960	74	28	their	their	PRON
bam-7960	74	29	daily	daily	ADJ
bam-7960	74	30	living	living	NOUN
bam-7960	74	31	activities	activity	NOUN
bam-7960	74	32	.	.	PUNCT
bam-7960	75	1	biomarkers	biomarker	NOUN
bam-7960	75	2	may	may	AUX
bam-7960	75	3	serve	serve	VERB
bam-7960	75	4	to	to	PART
bam-7960	75	5	detect	detect	VERB
bam-7960	75	6	the	the	DET
bam-7960	75	7	changes	change	NOUN
bam-7960	75	8	before	before	ADP
bam-7960	75	9	any	any	DET
bam-7960	75	10	clinical	clinical	ADJ
bam-7960	75	11	manifestations	manifestation	NOUN
bam-7960	75	12	arise	arise	VERB
bam-7960	75	13	,	,	PUNCT
bam-7960	75	14	facilitating	facilitate	VERB
bam-7960	75	15	treatment	treatment	NOUN
bam-7960	75	16	and	and	CCONJ
bam-7960	75	17	,	,	PUNCT
bam-7960	75	18	possibly	possibly	ADV
bam-7960	75	19	,	,	PUNCT
bam-7960	75	20	improving	improve	VERB
bam-7960	75	21	prognosis	prognosis	NOUN
bam-7960	75	22	.	.	PUNCT
bam-7960	76	1	progress	progress	NOUN
bam-7960	76	2	has	have	AUX
bam-7960	76	3	undoubtedly	undoubtedly	ADV
bam-7960	76	4	been	be	AUX
bam-7960	76	5	made	make	VERB
bam-7960	76	6	involving	involve	VERB
bam-7960	76	7	biomarkers,99	biomarkers,99	NOUN
bam-7960	76	8	but	but	CCONJ
bam-7960	76	9	more	more	ADJ
bam-7960	76	10	research	research	NOUN
bam-7960	76	11	is	be	AUX
bam-7960	76	12	needed	need	VERB
bam-7960	76	13	in	in	ADP
bam-7960	76	14	this	this	DET
bam-7960	76	15	field	field	NOUN
bam-7960	76	16	to	to	PART
bam-7960	76	17	find	find	VERB
bam-7960	76	18	an	an	DET
bam-7960	76	19	easily	easily	ADV
bam-7960	76	20	measurable	measurable	ADJ
bam-7960	76	21	either	either	CCONJ
bam-7960	76	22	plasmatic	plasmatic	ADJ
bam-7960	76	23	or	or	CCONJ
bam-7960	76	24	urinary	urinary	ADJ
bam-7960	76	25	early	early	ADJ
bam-7960	76	26	and	and	CCONJ
bam-7960	76	27	specific	specific	ADJ
bam-7960	76	28	muscle	muscle	NOUN
bam-7960	76	29	-	-	PUNCT
bam-7960	76	30	wasting	waste	VERB
bam-7960	76	31	biomarker	biomarker	NOUN
bam-7960	76	32	.	.	PUNCT
bam-7960	77	1	another	another	DET
bam-7960	77	2	key	key	ADJ
bam-7960	77	3	aspect	aspect	NOUN
bam-7960	77	4	to	to	PART
bam-7960	77	5	consider	consider	VERB
bam-7960	77	6	is	be	AUX
bam-7960	77	7	the	the	DET
bam-7960	77	8	design	design	NOUN
bam-7960	77	9	of	of	ADP
bam-7960	77	10	appropriate	appropriate	ADJ
bam-7960	77	11	trials	trial	NOUN
bam-7960	77	12	.	.	PUNCT
bam-7960	78	1	indeed	indeed	ADV
bam-7960	78	2	,	,	PUNCT
bam-7960	78	3	on	on	ADP
bam-7960	78	4	-	-	PUNCT
bam-7960	78	5	going	go	VERB
bam-7960	78	6	trials	trial	NOUN
bam-7960	78	7	have	have	VERB
bam-7960	78	8	a	a	DET
bam-7960	78	9	rather	rather	ADV
bam-7960	78	10	heterogeneous	heterogeneous	ADJ
bam-7960	78	11	design	design	NOUN
bam-7960	78	12	and	and	CCONJ
bam-7960	78	13	include	include	VERB
bam-7960	78	14	an	an	DET
bam-7960	78	15	excessively	excessively	ADV
bam-7960	78	16	wide	wide	ADJ
bam-7960	78	17	span	span	NOUN
bam-7960	78	18	of	of	ADP
bam-7960	78	19	different	different	ADJ
bam-7960	78	20	types	type	NOUN
bam-7960	78	21	of	of	ADP
bam-7960	78	22	tumors	tumor	NOUN
bam-7960	78	23	with	with	ADP
bam-7960	78	24	different	different	ADJ
bam-7960	78	25	degrees	degree	NOUN
bam-7960	78	26	of	of	ADP
bam-7960	78	27	cachexia	cachexia	NOUN
bam-7960	78	28	.	.	PUNCT
bam-7960	79	1	in	in	ADP
bam-7960	79	2	fact	fact	NOUN
bam-7960	79	3	,	,	PUNCT
bam-7960	79	4	a	a	DET
bam-7960	79	5	unified	unified	ADJ
bam-7960	79	6	approach	approach	NOUN
bam-7960	79	7	is	be	AUX
bam-7960	79	8	requested	request	VERB
bam-7960	79	9	in	in	ADP
bam-7960	79	10	a	a	DET
bam-7960	79	11	recent	recent	ADJ
bam-7960	79	12	consensus	consensus	NOUN
bam-7960	79	13	document.100	document.100	NOUN
bam-7960	79	14	many	many	ADJ
bam-7960	79	15	of	of	ADP
bam-7960	79	16	the	the	DET
bam-7960	79	17	most	most	ADV
bam-7960	79	18	promising	promising	ADJ
bam-7960	79	19	drug	drug	NOUN
bam-7960	79	20	candidates	candidate	NOUN
bam-7960	79	21	are	be	AUX
bam-7960	79	22	entirely	entirely	ADV
bam-7960	79	23	new	new	ADJ
bam-7960	79	24	molecules	molecule	NOUN
bam-7960	79	25	and	and	CCONJ
bam-7960	79	26	,	,	PUNCT
bam-7960	79	27	therefore	therefore	ADV
bam-7960	79	28	,	,	PUNCT
bam-7960	79	29	particular	particular	ADJ
bam-7960	79	30	attention	attention	NOUN
bam-7960	79	31	has	have	VERB
bam-7960	79	32	to	to	PART
bam-7960	79	33	be	be	AUX
bam-7960	79	34	focused	focus	VERB
bam-7960	79	35	on	on	ADP
bam-7960	79	36	safety	safety	NOUN
bam-7960	79	37	issues	issue	NOUN
bam-7960	79	38	and	and	CCONJ
bam-7960	79	39	not	not	PART
bam-7960	79	40	just	just	ADV
bam-7960	79	41	side	side	NOUN
bam-7960	79	42	effects	effect	NOUN
bam-7960	79	43	,	,	PUNCT
bam-7960	79	44	but	but	CCONJ
bam-7960	79	45	also	also	ADV
bam-7960	79	46	long	long	ADJ
bam-7960	79	47	-	-	PUNCT
bam-7960	79	48	term	term	NOUN
bam-7960	79	49	treatment	treatment	NOUN
bam-7960	79	50	associated	associate	VERB
bam-7960	79	51	problems	problem	NOUN
bam-7960	79	52	,	,	PUNCT
bam-7960	79	53	together	together	ADV
bam-7960	79	54	with	with	ADP
bam-7960	79	55	the	the	DET
bam-7960	79	56	issue	issue	NOUN
bam-7960	79	57	of	of	ADP
bam-7960	79	58	interaction	interaction	NOUN
bam-7960	79	59	with	with	ADP
bam-7960	79	60	other	other	ADJ
bam-7960	79	61	drugs	drug	NOUN
bam-7960	79	62	.	.	PUNCT
bam-7960	80	1	this	this	DET
bam-7960	80	2	last	last	ADJ
bam-7960	80	3	point	point	NOUN
bam-7960	80	4	is	be	AUX
bam-7960	80	5	particularly	particularly	ADV
bam-7960	80	6	relevant	relevant	ADJ
bam-7960	80	7	since	since	SCONJ
bam-7960	80	8	,	,	PUNCT
bam-7960	80	9	as	as	SCONJ
bam-7960	80	10	we	we	PRON
bam-7960	80	11	have	have	AUX
bam-7960	80	12	mentioned	mention	VERB
bam-7960	80	13	,	,	PUNCT
bam-7960	80	14	the	the	DET
bam-7960	80	15	ideal	ideal	ADJ
bam-7960	80	16	treatment	treatment	NOUN
bam-7960	80	17	for	for	ADP
bam-7960	80	18	cancer	cancer	NOUN
bam-7960	80	19	cachexia	cachexia	NOUN
bam-7960	80	20	is	be	AUX
bam-7960	80	21	multimodal	multimodal	ADJ
bam-7960	80	22	,	,	PUNCT
bam-7960	80	23	involving	involve	VERB
bam-7960	80	24	different	different	ADJ
bam-7960	80	25	drugs	drug	NOUN
bam-7960	80	26	and	and	CCONJ
bam-7960	80	27	nutraceuticals	nutraceutical	NOUN
bam-7960	80	28	.	.	PUNCT
bam-7960	81	1	endpoints	endpoint	NOUN
bam-7960	81	2	–	–	PUNCT
bam-7960	81	3	particularly	particularly	ADV
bam-7960	81	4	primary	primary	ADJ
bam-7960	81	5	ones	one	NOUN
bam-7960	81	6	are	be	AUX
bam-7960	81	7	also	also	ADV
bam-7960	81	8	essential	essential	ADJ
bam-7960	81	9	.	.	PUNCT
bam-7960	82	1	lean	lean	ADJ
bam-7960	82	2	body	body	NOUN
bam-7960	82	3	mass	mass	NOUN
bam-7960	82	4	or	or	CCONJ
bam-7960	82	5	,	,	PUNCT
bam-7960	82	6	even	even	ADV
bam-7960	82	7	better	well	ADJ
bam-7960	82	8	,	,	PUNCT
bam-7960	82	9	muscle	muscle	NOUN
bam-7960	82	10	mass	mass	NOUN
bam-7960	82	11	,	,	PUNCT
bam-7960	82	12	together	together	ADV
bam-7960	82	13	with	with	ADP
bam-7960	82	14	a	a	DET
bam-7960	82	15	measurement	measurement	NOUN
bam-7960	82	16	of	of	ADP
bam-7960	82	17	function	function	NOUN
bam-7960	82	18	,	,	PUNCT
bam-7960	82	19	such	such	ADJ
bam-7960	82	20	as	as	ADP
bam-7960	82	21	total	total	ADJ
bam-7960	82	22	daily	daily	ADJ
bam-7960	82	23	physical	physical	ADJ
bam-7960	82	24	activity	activity	NOUN
bam-7960	82	25	are	be	AUX
bam-7960	82	26	good	good	ADJ
bam-7960	82	27	candidates	candidate	NOUN
bam-7960	82	28	.	.	PUNCT
bam-7960	83	1	in	in	ADP
bam-7960	83	2	conclusion	conclusion	NOUN
bam-7960	83	3	,	,	PUNCT
bam-7960	83	4	the	the	DET
bam-7960	83	5	future	future	ADJ
bam-7960	83	6	multimodal	multimodal	NOUN
bam-7960	83	7	treatment	treatment	NOUN
bam-7960	83	8	of	of	ADP
bam-7960	83	9	the	the	DET
bam-7960	83	10	cachectic	cachectic	ADJ
bam-7960	83	11	syndrome	syndrome	NOUN
bam-7960	83	12	will	will	AUX
bam-7960	83	13	no	no	ADV
bam-7960	83	14	doubt	doubt	ADV
bam-7960	83	15	combine	combine	VERB
bam-7960	83	16	different	different	ADJ
bam-7960	83	17	approaches	approach	NOUN
bam-7960	83	18	to	to	PART
bam-7960	83	19	efficiently	efficiently	ADV
bam-7960	83	20	counteract	counteract	VERB
bam-7960	83	21	metabolic	metabolic	NOUN
bam-7960	83	22	alterations	alteration	NOUN
bam-7960	83	23	while	while	SCONJ
bam-7960	83	24	improving	improve	VERB
bam-7960	83	25	the	the	DET
bam-7960	83	26	energy	energy	NOUN
bam-7960	83	27	intake	intake	NOUN
bam-7960	83	28	of	of	ADP
bam-7960	83	29	the	the	DET
bam-7960	83	30	patients	patient	NOUN
bam-7960	83	31	.	.	PUNCT
bam-7960	84	1	defining	define	VERB
bam-7960	84	2	this	this	DET
bam-7960	84	3	therapeutic	therapeutic	ADJ
bam-7960	84	4	multimodal	multimodal	NOUN
bam-7960	84	5	combination	combination	NOUN
bam-7960	84	6	of	of	ADP
bam-7960	84	7	factors	factor	NOUN
bam-7960	84	8	is	be	AUX
bam-7960	84	9	an	an	DET
bam-7960	84	10	exciting	exciting	ADJ
bam-7960	84	11	project	project	NOUN
bam-7960	84	12	that	that	PRON
bam-7960	84	13	will	will	AUX
bam-7960	84	14	stimulate	stimulate	VERB
bam-7960	84	15	many	many	ADJ
bam-7960	84	16	scientific	scientific	ADJ
bam-7960	84	17	efforts	effort	NOUN
bam-7960	84	18	.	.	PUNCT
bam-7960	85	1	list	list	NOUN
bam-7960	85	2	of	of	ADP
bam-7960	85	3	acronyms	acronym	NOUN
bam-7960	85	4	ace	ace	VERB
bam-7960	85	5	angiotensin	angiotensin	NOUN
bam-7960	85	6	-	-	PUNCT
bam-7960	85	7	converting	convert	VERB
bam-7960	85	8	enzyme	enzyme	NOUN
bam-7960	85	9	bym338	bym338	NOUN
bam-7960	85	10	bimagrumab	bimagrumab	NOUN
bam-7960	85	11	copd	copd	PROPN
bam-7960	85	12	chronic	chronic	PROPN
bam-7960	85	13	obstructive	obstructive	ADJ
bam-7960	85	14	pulmonary	pulmonary	ADJ
bam-7960	85	15	disease	disease	NOUN
bam-7960	85	16	dxa	dxa	VERB
bam-7960	85	17	dual	dual	ADJ
bam-7960	85	18	-	-	PUNCT
bam-7960	85	19	energy	energy	NOUN
bam-7960	85	20	x	x	NOUN
bam-7960	85	21	-	-	NOUN
bam-7960	85	22	ray	ray	NOUN
bam-7960	85	23	absorptiometry	absorptiometry	NOUN
bam-7960	85	24	epa	epa	PROPN
bam-7960	85	25	eicosapentaenoic	eicosapentaenoic	PROPN
bam-7960	85	26	acid	acid	PROPN
bam-7960	85	27	epo	epo	PROPN
bam-7960	85	28	erythropoietin	erythropoietin	PROPN
bam-7960	85	29	faact	faact	NOUN
bam-7960	85	30	functional	functional	ADJ
bam-7960	85	31	assessment	assessment	NOUN
bam-7960	85	32	of	of	ADP
bam-7960	85	33	anorexia	anorexia	ADJ
bam-7960	85	34	cachexia	cachexia	NOUN
bam-7960	85	35	therapy	therapy	NOUN
bam-7960	85	36	ifn-	ifn-	PROPN
bam-7960	85	37	interferon	interferon	PROPN
bam-7960	85	38	-	-	PUNCT
bam-7960	85	39	gamma	gamma	NOUN
bam-7960	85	40	non	non	ADJ
bam-7960	85	41	co	co	PROPN
bam-7960	85	42	mmerc	mmerc	PROPN
bam-7960	85	43	ial	ial	PROPN
bam-7960	86	1	us	us	PROPN
bam-7960	86	2	e	e	NOUN
bam-7960	86	3	o	o	NOUN
bam-7960	86	4	nly	nly	ADV
bam-7960	86	5	therapeutic	therapeutic	ADJ
bam-7960	86	6	strategies	strategy	NOUN
bam-7960	86	7	against	against	ADP
bam-7960	86	8	cancer	cancer	NOUN
bam-7960	86	9	cachexia	cachexia	PROPN
bam-7960	86	10	eur	eur	PROPN
bam-7960	86	11	j	j	PROPN
bam-7960	86	12	transl	transl	PROPN
bam-7960	86	13	myol	myol	ADV
bam-7960	86	14	29	29	NUM
bam-7960	86	15	(	(	PUNCT
bam-7960	86	16	1	1	NUM
bam-7960	86	17	):	):	PUNCT
bam-7960	86	18	4	4	NUM
bam-7960	86	19	-	-	SYM
bam-7960	86	20	13	13	NUM
bam-7960	86	21	,	,	PUNCT
bam-7960	86	22	2019	2019	NUM
bam-7960	86	23	9	9	NUM
bam-7960	86	24	il-1	il-1	ADP
bam-7960	86	25	interleukin	interleukin	NOUN
bam-7960	86	26	1	1	NUM
bam-7960	86	27	il-6	il-6	NOUN
bam-7960	86	28	interleukin	interleukin	NOUN
bam-7960	86	29	6	6	NUM
bam-7960	86	30	il-10	il-10	NOUN
bam-7960	86	31	interleukin	interleukin	NOUN
bam-7960	86	32	10	10	NUM
bam-7960	86	33	menac	menac	NOUN
bam-7960	86	34	multimodality	multimodality	NOUN
bam-7960	86	35	exercise	exercise	NOUN
bam-7960	86	36	/	/	SYM
bam-7960	86	37	nutrition	nutrition	NOUN
bam-7960	86	38	antiinflammatory	antiinflammatory	NOUN
bam-7960	86	39	treatment	treatment	NOUN
bam-7960	86	40	for	for	ADP
bam-7960	86	41	cachexia	cachexia	PROPN
bam-7960	86	42	npy	npy	PROPN
bam-7960	86	43	neuropeptide	neuropeptide	PROPN
bam-7960	86	44	y	y	PROPN
bam-7960	86	45	nsclc	nsclc	PROPN
bam-7960	86	46	non	non	ADJ
bam-7960	86	47	-	-	ADJ
bam-7960	86	48	small	small	ADJ
bam-7960	86	49	cell	cell	NOUN
bam-7960	86	50	lung	lung	NOUN
bam-7960	86	51	cancer	cancer	NOUN
bam-7960	86	52	pdtc	pdtc	PROPN
bam-7960	86	53	pyrrolidine	pyrrolidine	PROPN
bam-7960	86	54	dithiocarbamate	dithiocarbamate	VERB
bam-7960	86	55	pufa	pufa	PROPN
bam-7960	86	56	polyunsaturated	polyunsaturate	VERB
bam-7960	86	57	fatty	fatty	NOUN
bam-7960	86	58	acids	acid	NOUN
bam-7960	86	59	sarm	sarm	PROPN
bam-7960	86	60	selective	selective	ADJ
bam-7960	86	61	androgen	androgen	NOUN
bam-7960	86	62	receptor	receptor	NOUN
bam-7960	86	63	modulators	modulator	NOUN
bam-7960	86	64	tnf-	tnf-	NOUN
bam-7960	86	65	tumor	tumor	NOUN
bam-7960	86	66	necrosis	necrosis	NOUN
bam-7960	86	67	factor	factor	NOUN
bam-7960	86	68	alpha	alpha	NOUN
bam-7960	86	69	ucp3	ucp3	PROPN
bam-7960	86	70	uncoupling	uncouple	VERB
bam-7960	86	71	protein-3	protein-3	PROPN
bam-7960	86	72	author	author	NOUN
bam-7960	86	73	’s	’s	PART
bam-7960	86	74	contributions	contribution	NOUN
bam-7960	86	75	each	each	DET
bam-7960	86	76	author	author	NOUN
bam-7960	86	77	has	have	AUX
bam-7960	86	78	participated	participate	VERB
bam-7960	86	79	sufficiently	sufficiently	ADV
bam-7960	86	80	,	,	PUNCT
bam-7960	86	81	intellectually	intellectually	ADV
bam-7960	86	82	or	or	CCONJ
bam-7960	86	83	practically	practically	ADV
bam-7960	86	84	,	,	PUNCT
bam-7960	86	85	in	in	ADP
bam-7960	86	86	the	the	DET
bam-7960	86	87	work	work	NOUN
bam-7960	86	88	to	to	PART
bam-7960	86	89	take	take	VERB
bam-7960	86	90	public	public	ADJ
bam-7960	86	91	responsibility	responsibility	NOUN
bam-7960	86	92	for	for	ADP
bam-7960	86	93	the	the	DET
bam-7960	86	94	content	content	NOUN
bam-7960	86	95	of	of	ADP
bam-7960	86	96	the	the	DET
bam-7960	86	97	article	article	NOUN
bam-7960	86	98	,	,	PUNCT
bam-7960	86	99	including	include	VERB
bam-7960	86	100	the	the	DET
bam-7960	86	101	conception	conception	NOUN
bam-7960	86	102	and	and	CCONJ
bam-7960	86	103	design	design	NOUN
bam-7960	86	104	.	.	PUNCT
bam-7960	87	1	jma	jma	PROPN
bam-7960	87	2	,	,	PUNCT
bam-7960	87	3	fjl	fjl	PROPN
bam-7960	87	4	-	-	PUNCT
bam-7960	87	5	s	s	PROPN
bam-7960	87	6	,	,	PUNCT
bam-7960	87	7	bs	bs	PROPN
bam-7960	87	8	,	,	PUNCT
bam-7960	87	9	sb	sb	PROPN
bam-7960	87	10	conceived	conceive	VERB
bam-7960	87	11	the	the	DET
bam-7960	87	12	content	content	NOUN
bam-7960	87	13	of	of	ADP
bam-7960	87	14	the	the	DET
bam-7960	87	15	review	review	NOUN
bam-7960	87	16	,	,	PUNCT
bam-7960	87	17	drafted	draft	VERB
bam-7960	87	18	the	the	DET
bam-7960	87	19	manuscript	manuscript	NOUN
bam-7960	87	20	and	and	CCONJ
bam-7960	87	21	revised	revise	VERB
bam-7960	87	22	critically	critically	ADV
bam-7960	87	23	it	it	PRON
bam-7960	87	24	.	.	PUNCT
bam-7960	88	1	all	all	DET
bam-7960	88	2	authors	author	NOUN
bam-7960	88	3	have	have	AUX
bam-7960	88	4	read	read	VERB
bam-7960	88	5	and	and	CCONJ
bam-7960	88	6	approved	approve	VERB
bam-7960	88	7	the	the	DET
bam-7960	88	8	final	final	ADJ
bam-7960	88	9	manuscript	manuscript	NOUN
bam-7960	88	10	.	.	PUNCT
bam-7960	89	1	acknowledgments	acknowledgment	NOUN
bam-7960	89	2	funding	fund	VERB
bam-7960	89	3	this	this	DET
bam-7960	89	4	work	work	NOUN
bam-7960	89	5	was	be	AUX
bam-7960	89	6	supported	support	VERB
bam-7960	89	7	by	by	ADP
bam-7960	89	8	a	a	DET
bam-7960	89	9	grant	grant	NOUN
bam-7960	89	10	from	from	ADP
bam-7960	89	11	the	the	DET
bam-7960	89	12	ministerio	ministerio	PROPN
bam-7960	89	13	de	de	PROPN
bam-7960	89	14	ciencia	ciencia	PROPN
bam-7960	89	15	y	y	PROPN
bam-7960	89	16	tecnología	tecnología	PROPN
bam-7960	89	17	(	(	PUNCT
bam-7960	89	18	mcyt	mcyt	PROPN
bam-7960	89	19	)	)	PUNCT
bam-7960	89	20	(	(	PUNCT
bam-7960	89	21	saf201565589	saf201565589	NOUN
bam-7960	89	22	)	)	PUNCT
bam-7960	89	23	.	.	PUNCT
bam-7960	90	1	conflict	conflict	NOUN
bam-7960	90	2	of	of	ADP
bam-7960	90	3	interest	interest	NOUN
bam-7960	90	4	all	all	DET
bam-7960	90	5	authors	author	NOUN
bam-7960	90	6	of	of	ADP
bam-7960	90	7	this	this	DET
bam-7960	90	8	research	research	NOUN
bam-7960	90	9	have	have	AUX
bam-7960	90	10	not	not	PART
bam-7960	90	11	conflict	conflict	NOUN
bam-7960	90	12	of	of	ADP
bam-7960	90	13	interest	interest	NOUN
bam-7960	90	14	related	relate	VERB
bam-7960	90	15	with	with	ADP
bam-7960	90	16	employment	employment	NOUN
bam-7960	90	17	,	,	PUNCT
bam-7960	90	18	consultancies	consultancy	NOUN
bam-7960	90	19	,	,	PUNCT
bam-7960	90	20	stock	stock	NOUN
bam-7960	90	21	ownership	ownership	NOUN
bam-7960	90	22	,	,	PUNCT
bam-7960	90	23	honoraria	honorarium	NOUN
bam-7960	90	24	,	,	PUNCT
bam-7960	90	25	paid	pay	VERB
bam-7960	90	26	expert	expert	ADJ
bam-7960	90	27	testimony	testimony	NOUN
bam-7960	90	28	,	,	PUNCT
bam-7960	90	29	patent	patent	NOUN
bam-7960	90	30	applications	application	NOUN
bam-7960	90	31	/	/	SYM
bam-7960	90	32	registrations	registration	NOUN
bam-7960	90	33	,	,	PUNCT
bam-7960	90	34	and	and	CCONJ
bam-7960	90	35	grants	grant	NOUN
bam-7960	90	36	or	or	CCONJ
bam-7960	90	37	other	other	ADJ
bam-7960	90	38	funding	funding	NOUN
bam-7960	90	39	.	.	PUNCT
bam-7960	91	1	ethical	ethical	ADJ
bam-7960	91	2	publication	publication	NOUN
bam-7960	91	3	statement	statement	NOUN
bam-7960	91	4	we	we	PRON
bam-7960	91	5	confirm	confirm	VERB
bam-7960	91	6	that	that	SCONJ
bam-7960	91	7	we	we	PRON
bam-7960	91	8	have	have	AUX
bam-7960	91	9	read	read	VERB
bam-7960	91	10	the	the	DET
bam-7960	91	11	journal	journal	NOUN
bam-7960	91	12	’s	’s	PART
bam-7960	91	13	position	position	NOUN
bam-7960	91	14	on	on	ADP
bam-7960	91	15	issues	issue	NOUN
bam-7960	91	16	involved	involve	VERB
bam-7960	91	17	in	in	ADP
bam-7960	91	18	ethical	ethical	ADJ
bam-7960	91	19	publication	publication	NOUN
bam-7960	91	20	and	and	CCONJ
bam-7960	91	21	affirm	affirm	NOUN
bam-7960	91	22	that	that	SCONJ
bam-7960	91	23	this	this	DET
bam-7960	91	24	report	report	NOUN
bam-7960	91	25	is	be	AUX
bam-7960	91	26	consistent	consistent	ADJ
bam-7960	91	27	with	with	ADP
bam-7960	91	28	those	those	DET
bam-7960	91	29	guidelines	guideline	NOUN
bam-7960	91	30	.	.	PUNCT
bam-7960	92	1	corresponding	correspond	VERB
bam-7960	92	2	author	author	NOUN
bam-7960	92	3	sílvia	sílvia	PROPN
bam-7960	92	4	busquets	busquet	NOUN
bam-7960	92	5	,	,	PUNCT
bam-7960	92	6	cancer	cancer	NOUN
bam-7960	92	7	research	research	NOUN
bam-7960	92	8	group	group	NOUN
bam-7960	92	9	,	,	PUNCT
bam-7960	92	10	department	department	NOUN
bam-7960	92	11	of	of	ADP
bam-7960	92	12	biochemistry	biochemistry	NOUN
bam-7960	92	13	and	and	CCONJ
bam-7960	92	14	molecular	molecular	ADJ
bam-7960	92	15	biomedicine	biomedicine	NOUN
bam-7960	92	16	,	,	PUNCT
bam-7960	92	17	biology	biology	NOUN
bam-7960	92	18	faculty	faculty	NOUN
bam-7960	92	19	of	of	ADP
bam-7960	92	20	the	the	DET
bam-7960	92	21	barcelona	barcelona	PROPN
bam-7960	92	22	university	university	PROPN
bam-7960	92	23	,	,	PUNCT
bam-7960	92	24	diagonal	diagonal	ADJ
bam-7960	92	25	643	643	NUM
bam-7960	92	26	,	,	PUNCT
bam-7960	92	27	08028	08028	NUM
bam-7960	92	28	barcelona	barcelona	PROPN
bam-7960	92	29	,	,	PUNCT
bam-7960	92	30	spain	spain	PROPN
bam-7960	92	31	.	.	PUNCT
bam-7960	93	1	phone	phone	NOUN
bam-7960	93	2	/	/	SYM
bam-7960	93	3	fax	fax	NOUN
bam-7960	93	4	:	:	PUNCT
bam-7960	93	5	+34	+34	ADJ
bam-7960	93	6	-	-	PUNCT
bam-7960	93	7	934021002	934021002	NUM
bam-7960	93	8	email	email	NOUN
bam-7960	93	9	:	:	PUNCT
bam-7960	93	10	silviabusquets@ub.edu	silviabusquets@ub.edu	PROPN
bam-7960	93	11	e	e	NOUN
bam-7960	93	12	-	-	NOUN
bam-7960	93	13	mails	mail	NOUN
bam-7960	93	14	of	of	ADP
bam-7960	93	15	co	co	NOUN
bam-7960	93	16	-	-	NOUN
bam-7960	93	17	authors	author	NOUN
bam-7960	93	18	josep	josep	PROPN
bam-7960	93	19	m.	m.	PROPN
bam-7960	93	20	argilés	argilés	PROPN
bam-7960	93	21	:	:	PUNCT
bam-7960	93	22	jargiles@ub.edu	jargiles@ub.edu	PROPN
bam-7960	93	23	francisco	francisco	PROPN
bam-7960	93	24	javier	javier	PROPN
bam-7960	93	25	lópez	lópez	PROPN
bam-7960	93	26	-	-	PUNCT
bam-7960	93	27	soriano	soriano	NOUN
bam-7960	93	28	:	:	PUNCT
bam-7960	93	29	flopez@ub.edu	flopez@ub.edu	PROPN
bam-7960	93	30	britta	britta	NOUN
bam-7960	93	31	stemmler	stemmler	NOUN
bam-7960	93	32	:	:	PUNCT
bam-7960	94	1	brittastemmler@telefonica.net	brittastemmler@telefonica.net	PROPN
bam-7960	94	2	references	reference	NOUN
bam-7960	94	3	1	1	NUM
bam-7960	94	4	.	.	PUNCT
bam-7960	95	1	evans	evans	PROPN
bam-7960	95	2	wj	wj	PROPN
bam-7960	95	3	,	,	PUNCT
bam-7960	95	4	morley	morley	PROPN
bam-7960	95	5	je	je	PROPN
bam-7960	95	6	,	,	PUNCT
bam-7960	95	7	argilés	argilés	PROPN
bam-7960	95	8	j	j	PROPN
bam-7960	95	9	,	,	PUNCT
bam-7960	95	10	et	et	PROPN
bam-7960	95	11	al	al	PROPN
bam-7960	95	12	.	.	PUNCT
bam-7960	96	1	cachexia	cachexia	PROPN
bam-7960	96	2	:	:	PUNCT
bam-7960	96	3	a	a	DET
bam-7960	96	4	new	new	ADJ
bam-7960	96	5	definition	definition	NOUN
bam-7960	96	6	.	.	PUNCT
bam-7960	97	1	clin	clin	PROPN
bam-7960	97	2	nutr	nutr	PROPN
bam-7960	97	3	2008;27:793–9	2008;27:793–9	NUM
bam-7960	97	4	.	.	PUNCT
bam-7960	98	1	2	2	X
bam-7960	98	2	.	.	NUM
bam-7960	98	3	argilés	argilés	PROPN
bam-7960	98	4	jm	jm	PROPN
bam-7960	98	5	,	,	PUNCT
bam-7960	98	6	busquets	busquets	PROPN
bam-7960	98	7	s	s	PROPN
bam-7960	98	8	,	,	PUNCT
bam-7960	98	9	stemmler	stemmler	PROPN
bam-7960	98	10	b	b	PROPN
bam-7960	98	11	,	,	PUNCT
bam-7960	98	12	lópezsoriano	lópezsoriano	ADJ
bam-7960	98	13	fj	fj	PROPN
bam-7960	98	14	.	.	PUNCT
bam-7960	99	1	cancer	cancer	NOUN
bam-7960	99	2	cachexia	cachexia	NOUN
bam-7960	99	3	:	:	PUNCT
bam-7960	99	4	understanding	understand	VERB
bam-7960	99	5	the	the	DET
bam-7960	99	6	molecular	molecular	ADJ
bam-7960	99	7	basis	basis	NOUN
bam-7960	99	8	.	.	PUNCT
bam-7960	100	1	nat	nat	PROPN
bam-7960	100	2	rev	rev	VERB
bam-7960	100	3	cancer	cancer	NOUN
bam-7960	100	4	2014;14:754–62	2014;14:754–62	NUM
bam-7960	100	5	.	.	NOUN
bam-7960	100	6	3	3	X
bam-7960	100	7	.	.	X
bam-7960	101	1	coletti	coletti	PROPN
bam-7960	101	2	d.	d.	PROPN
bam-7960	101	3	chemotherapy	chemotherapy	PROPN
bam-7960	101	4	-	-	PUNCT
bam-7960	101	5	induced	induce	VERB
bam-7960	101	6	muscle	muscle	NOUN
bam-7960	101	7	wasting	waste	VERB
bam-7960	101	8	:	:	PUNCT
bam-7960	101	9	an	an	DET
bam-7960	101	10	update	update	NOUN
bam-7960	101	11	.	.	PUNCT
bam-7960	102	1	eur	eur	PROPN
bam-7960	102	2	j	j	PROPN
bam-7960	102	3	transl	transl	PROPN
bam-7960	102	4	myol	myol	ADV
bam-7960	102	5	2018;28:7587	2018;28:7587	NUM
bam-7960	102	6	.	.	PUNCT
bam-7960	103	1	4	4	NUM
bam-7960	103	2	.	.	X
bam-7960	103	3	damrauer	damrauer	PROPN
bam-7960	103	4	js	js	PROPN
bam-7960	103	5	,	,	PUNCT
bam-7960	103	6	stadler	stadler	VERB
bam-7960	103	7	me	i	PRON
bam-7960	103	8	,	,	PUNCT
bam-7960	103	9	acharyya	acharyya	PROPN
bam-7960	103	10	s	s	PROPN
bam-7960	103	11	,	,	PUNCT
bam-7960	103	12	et	et	PROPN
bam-7960	103	13	al	al	PROPN
bam-7960	103	14	.	.	PUNCT
bam-7960	104	1	chemotherapy	chemotherapy	NOUN
bam-7960	104	2	-	-	ADJ
bam-7960	104	3	induced	induce	VERB
bam-7960	104	4	muscle	muscle	NOUN
bam-7960	104	5	wasting	waste	VERB
bam-7960	104	6	:	:	PUNCT
bam-7960	104	7	association	association	NOUN
bam-7960	104	8	with	with	ADP
bam-7960	104	9	nf	nf	PROPN
bam-7960	104	10	-	-	PUNCT
bam-7960	104	11	κb	κb	NOUN
bam-7960	104	12	and	and	CCONJ
bam-7960	104	13	cancer	cancer	NOUN
bam-7960	104	14	cachexia	cachexia	NOUN
bam-7960	104	15	.	.	PUNCT
bam-7960	105	1	eur	eur	PROPN
bam-7960	105	2	j	j	PROPN
bam-7960	105	3	transl	transl	PROPN
bam-7960	105	4	myol	myol	PROPN
bam-7960	105	5	2018;28:7590	2018;28:7590	NUM
bam-7960	105	6	.	.	PROPN
bam-7960	105	7	5	5	NUM
bam-7960	105	8	.	.	X
bam-7960	105	9	lu	lu	PROPN
bam-7960	106	1	z	z	PROPN
bam-7960	106	2	-	-	PUNCT
bam-7960	106	3	h	h	PROPN
bam-7960	106	4	,	,	PUNCT
bam-7960	106	5	yang	yang	PROPN
bam-7960	106	6	l	l	PROPN
bam-7960	106	7	,	,	PUNCT
bam-7960	106	8	yu	yu	PROPN
bam-7960	106	9	j	j	PROPN
bam-7960	106	10	-	-	PUNCT
bam-7960	106	11	w	w	PROPN
bam-7960	106	12	,	,	PUNCT
bam-7960	106	13	et	et	PROPN
bam-7960	106	14	al	al	PROPN
bam-7960	106	15	.	.	PUNCT
bam-7960	106	16	weight	weight	NOUN
bam-7960	106	17	loss	loss	NOUN
bam-7960	106	18	correlates	correlate	VERB
bam-7960	106	19	with	with	ADP
bam-7960	106	20	macrophage	macrophage	ADJ
bam-7960	106	21	inhibitory	inhibitory	ADJ
bam-7960	106	22	cytokine-1	cytokine-1	NOUN
bam-7960	106	23	expression	expression	NOUN
bam-7960	106	24	and	and	CCONJ
bam-7960	106	25	might	might	AUX
bam-7960	106	26	influence	influence	VERB
bam-7960	106	27	outcome	outcome	VERB
bam-7960	106	28	in	in	ADP
bam-7960	106	29	patients	patient	NOUN
bam-7960	106	30	with	with	ADP
bam-7960	106	31	advanced	advanced	ADJ
bam-7960	106	32	esophageal	esophageal	ADJ
bam-7960	106	33	squamous	squamous	ADJ
bam-7960	106	34	cell	cell	NOUN
bam-7960	106	35	carcinoma	carcinoma	NOUN
bam-7960	106	36	.	.	PUNCT
bam-7960	107	1	asian	asian	PROPN
bam-7960	107	2	pac	pac	PROPN
bam-7960	107	3	j	j	PROPN
bam-7960	107	4	cancer	cancer	PROPN
bam-7960	107	5	prev	prev	PROPN
bam-7960	107	6	2014;15:6047	2014;15:6047	NUM
bam-7960	107	7	–	–	PUNCT
bam-7960	107	8	52	52	NUM
bam-7960	107	9	.	.	NOUN
bam-7960	107	10	6	6	NUM
bam-7960	107	11	.	.	NOUN
bam-7960	107	12	phase	phase	NOUN
bam-7960	107	13	i	i	PRON
bam-7960	107	14	and	and	CCONJ
bam-7960	107	15	biological	biological	ADJ
bam-7960	107	16	study	study	NOUN
bam-7960	107	17	of	of	ADP
bam-7960	107	18	etanercept	etanercept	NOUN
bam-7960	107	19	and	and	CCONJ
bam-7960	107	20	weekly	weekly	ADJ
bam-7960	107	21	docetaxel	docetaxel	NOUN
bam-7960	107	22	in	in	ADP
bam-7960	107	23	patients	patient	NOUN
bam-7960	107	24	with	with	ADP
bam-7960	107	25	advanced	advanced	ADJ
bam-7960	107	26	solid	solid	ADJ
bam-7960	107	27	tumors	tumor	NOUN
bam-7960	107	28	full	full	ADJ
bam-7960	107	29	text	text	NOUN
bam-7960	107	30	view	view	NOUN
bam-7960	107	31	clinicaltrials.gov	clinicaltrials.gov	X
bam-7960	107	32	.	.	PUNCT
bam-7960	108	1	https://clinicaltrials.gov/ct2/show/nct00201812	https://clinicaltrials.gov/ct2/show/nct00201812	PROPN
bam-7960	108	2	.	.	PUNCT
bam-7960	109	1	accessed	access	VERB
bam-7960	109	2	10	10	NUM
bam-7960	109	3	april	april	PROPN
bam-7960	109	4	2017	2017	NUM
bam-7960	109	5	.	.	PUNCT
bam-7960	110	1	7	7	X
bam-7960	110	2	.	.	X
bam-7960	110	3	monk	monk	PROPN
bam-7960	110	4	jp	jp	PROPN
bam-7960	110	5	,	,	PUNCT
bam-7960	110	6	phillips	phillips	PROPN
bam-7960	110	7	g	g	NOUN
bam-7960	110	8	,	,	PUNCT
bam-7960	110	9	waite	waite	PROPN
bam-7960	110	10	r	r	PROPN
bam-7960	110	11	,	,	PUNCT
bam-7960	110	12	et	et	PROPN
bam-7960	110	13	al	al	PROPN
bam-7960	110	14	.	.	PROPN
bam-7960	110	15	assessment	assessment	NOUN
bam-7960	110	16	of	of	ADP
bam-7960	110	17	tumor	tumor	NOUN
bam-7960	110	18	necrosis	necrosis	NOUN
bam-7960	110	19	factor	factor	NOUN
bam-7960	110	20	alpha	alpha	NOUN
bam-7960	110	21	blockade	blockade	NOUN
bam-7960	110	22	as	as	ADP
bam-7960	110	23	an	an	DET
bam-7960	110	24	intervention	intervention	NOUN
bam-7960	110	25	to	to	PART
bam-7960	110	26	improve	improve	VERB
bam-7960	110	27	tolerability	tolerability	NOUN
bam-7960	110	28	of	of	ADP
bam-7960	110	29	doseintensive	doseintensive	ADJ
bam-7960	110	30	chemotherapy	chemotherapy	NOUN
bam-7960	110	31	in	in	ADP
bam-7960	110	32	cancer	cancer	NOUN
bam-7960	110	33	patients	patient	NOUN
bam-7960	110	34	.	.	PUNCT
bam-7960	111	1	j	j	PROPN
bam-7960	111	2	clin	clin	PROPN
bam-7960	111	3	oncol	oncol	PROPN
bam-7960	111	4	2006;24:1852–1859	2006;24:1852–1859	PROPN
bam-7960	111	5	.	.	PUNCT
bam-7960	111	6	8	8	NUM
bam-7960	111	7	.	.	PUNCT
bam-7960	112	1	jatoi	jatoi	PROPN
bam-7960	112	2	a	a	PROPN
bam-7960	112	3	,	,	PUNCT
bam-7960	112	4	ritter	ritter	PROPN
bam-7960	112	5	hl	hl	PROPN
bam-7960	112	6	,	,	PUNCT
bam-7960	112	7	dueck	dueck	PROPN
bam-7960	112	8	a	a	X
bam-7960	112	9	,	,	PUNCT
bam-7960	112	10	et	et	PROPN
bam-7960	112	11	al	al	PROPN
bam-7960	112	12	.	.	PUNCT
bam-7960	113	1	a	a	DET
bam-7960	113	2	placebocontrolled	placebocontrolle	VERB
bam-7960	113	3	,	,	PUNCT
bam-7960	113	4	double	double	ADJ
bam-7960	113	5	-	-	PUNCT
bam-7960	113	6	blind	blind	ADJ
bam-7960	113	7	trial	trial	NOUN
bam-7960	113	8	of	of	ADP
bam-7960	113	9	infliximab	infliximab	NOUN
bam-7960	113	10	for	for	ADP
bam-7960	113	11	cancer	cancer	NOUN
bam-7960	113	12	-	-	PUNCT
bam-7960	113	13	associated	associate	VERB
bam-7960	113	14	weight	weight	NOUN
bam-7960	113	15	loss	loss	NOUN
bam-7960	113	16	in	in	ADP
bam-7960	113	17	elderly	elderly	ADJ
bam-7960	113	18	and/or	and/or	CCONJ
bam-7960	113	19	poor	poor	ADJ
bam-7960	113	20	performance	performance	NOUN
bam-7960	113	21	non	non	ADJ
bam-7960	113	22	-	-	ADJ
bam-7960	113	23	small	small	ADJ
bam-7960	113	24	cell	cell	NOUN
bam-7960	113	25	lung	lung	NOUN
bam-7960	113	26	cancer	cancer	NOUN
bam-7960	113	27	patients	patient	NOUN
bam-7960	113	28	(	(	PUNCT
bam-7960	113	29	n01c9	n01c9	PROPN
bam-7960	113	30	)	)	PUNCT
bam-7960	113	31	.	.	PUNCT
bam-7960	114	1	lung	lung	NOUN
bam-7960	114	2	cancer	cancer	NOUN
bam-7960	114	3	2010;68:234–239	2010;68:234–239	NUM
bam-7960	114	4	.	.	PROPN
bam-7960	115	1	9	9	NUM
bam-7960	115	2	.	.	X
bam-7960	115	3	ando	ando	PROPN
bam-7960	115	4	k	k	PROPN
bam-7960	115	5	,	,	PUNCT
bam-7960	115	6	takahashi	takahashi	PROPN
bam-7960	115	7	f	f	PROPN
bam-7960	115	8	,	,	PUNCT
bam-7960	115	9	kato	kato	PROPN
bam-7960	115	10	m	m	PROPN
bam-7960	115	11	,	,	PUNCT
bam-7960	115	12	et	et	PROPN
bam-7960	115	13	al	al	PROPN
bam-7960	115	14	.	.	PROPN
bam-7960	115	15	tocilizumab	tocilizumab	PROPN
bam-7960	115	16	,	,	PUNCT
bam-7960	115	17	a	a	DET
bam-7960	115	18	proposed	propose	VERB
bam-7960	115	19	therapy	therapy	NOUN
bam-7960	115	20	for	for	ADP
bam-7960	115	21	the	the	DET
bam-7960	115	22	cachexia	cachexia	NOUN
bam-7960	115	23	of	of	ADP
bam-7960	115	24	interleukin6	interleukin6	NOUN
bam-7960	115	25	-	-	PUNCT
bam-7960	115	26	expressing	express	VERB
bam-7960	115	27	lung	lung	NOUN
bam-7960	115	28	cancer	cancer	NOUN
bam-7960	115	29	.	.	PUNCT
bam-7960	116	1	plos	plos	PROPN
bam-7960	116	2	one	one	NUM
bam-7960	116	3	2014;9	2014;9	NUM
bam-7960	116	4	:	:	PUNCT
bam-7960	116	5	e102436	e102436	NOUN
bam-7960	116	6	.	.	PUNCT
bam-7960	117	1	10	10	NUM
bam-7960	117	2	.	.	PUNCT
bam-7960	118	1	ando	ando	PROPN
bam-7960	118	2	k	k	PROPN
bam-7960	118	3	,	,	PUNCT
bam-7960	118	4	takahashi	takahashi	PROPN
bam-7960	118	5	f	f	PROPN
bam-7960	118	6	,	,	PUNCT
bam-7960	118	7	kato	kato	PROPN
bam-7960	118	8	m	m	PROPN
bam-7960	118	9	,	,	PUNCT
bam-7960	118	10	et	et	PROPN
bam-7960	118	11	al	al	PROPN
bam-7960	118	12	.	.	PROPN
bam-7960	118	13	tocilizumab	tocilizumab	PROPN
bam-7960	118	14	,	,	PUNCT
bam-7960	118	15	a	a	DET
bam-7960	118	16	proposed	propose	VERB
bam-7960	118	17	therapy	therapy	NOUN
bam-7960	118	18	for	for	ADP
bam-7960	118	19	the	the	DET
bam-7960	118	20	cachexia	cachexia	NOUN
bam-7960	118	21	of	of	ADP
bam-7960	118	22	interleukin6expressing	interleukin6expresse	VERB
bam-7960	118	23	lung	lung	NOUN
bam-7960	118	24	cancer	cancer	NOUN
bam-7960	118	25	.	.	PUNCT
bam-7960	119	1	plos	plos	PROPN
bam-7960	119	2	one	one	NUM
bam-7960	119	3	2014;9	2014;9	NUM
bam-7960	119	4	:	:	PUNCT
bam-7960	119	5	e102436	e102436	NOUN
bam-7960	119	6	.	.	X
bam-7960	120	1	11	11	NUM
bam-7960	120	2	.	.	PUNCT
bam-7960	121	1	effect	effect	NOUN
bam-7960	121	2	of	of	ADP
bam-7960	121	3	ald518	ald518	NOUN
bam-7960	121	4	,	,	PUNCT
bam-7960	121	5	a	a	DET
bam-7960	121	6	humanized	humanize	VERB
bam-7960	121	7	anti	anti	ADJ
bam-7960	121	8	-	-	ADJ
bam-7960	121	9	il-6	il-6	ADJ
bam-7960	121	10	antibody	antibody	NOUN
bam-7960	121	11	,	,	PUNCT
bam-7960	121	12	on	on	ADP
bam-7960	121	13	lean	lean	ADJ
bam-7960	121	14	body	body	NOUN
bam-7960	121	15	mass	mass	NOUN
bam-7960	121	16	loss	loss	NOUN
bam-7960	121	17	and	and	CCONJ
bam-7960	121	18	symptoms	symptom	NOUN
bam-7960	121	19	in	in	ADP
bam-7960	121	20	patients	patient	NOUN
bam-7960	121	21	with	with	ADP
bam-7960	121	22	advanced	advanced	ADJ
bam-7960	121	23	non	non	ADJ
bam-7960	121	24	-	-	ADJ
bam-7960	121	25	small	small	ADJ
bam-7960	121	26	cell	cell	NOUN
bam-7960	121	27	lung	lung	NOUN
bam-7960	121	28	cancer	cancer	NOUN
bam-7960	121	29	(	(	PUNCT
bam-7960	121	30	nsclc	nsclc	NOUN
bam-7960	121	31	):	):	PUNCT
bam-7960	121	32	results	result	NOUN
bam-7960	121	33	of	of	ADP
bam-7960	121	34	a	a	DET
bam-7960	121	35	phase	phase	NOUN
bam-7960	121	36	ii	ii	NOUN
bam-7960	121	37	randomized	randomize	VERB
bam-7960	121	38	,	,	PUNCT
bam-7960	121	39	double	double	ADJ
bam-7960	121	40	-	-	PUNCT
bam-7960	121	41	blind	blind	ADJ
bam-7960	121	42	safety	safety	NOUN
bam-7960	121	43	and	and	CCONJ
bam-7960	121	44	efficacy	efficacy	NOUN
bam-7960	121	45	trial	trial	NOUN
bam-7960	121	46	.	.	PUNCT
bam-7960	122	1	|	|	ADV
bam-7960	122	2	2010	2010	NUM
bam-7960	122	3	asco	asco	ADJ
bam-7960	122	4	annual	annual	ADJ
bam-7960	122	5	meeting	meeting	NOUN
bam-7960	122	6	|	|	ADV
bam-7960	122	7	abstracts	abstract	VERB
bam-7960	122	8	|	|	ADV
bam-7960	122	9	meeting	meet	VERB
bam-7960	122	10	library	library	NOUN
bam-7960	122	11	.	.	PUNCT
bam-7960	123	1	http://meetinglibrary.asco.org/content/50646-74	http://meetinglibrary.asco.org/content/50646-74	PROPN
bam-7960	123	2	.	.	PUNCT
bam-7960	124	1	accessed	access	VERB
bam-7960	124	2	10	10	NUM
bam-7960	124	3	april	april	PROPN
bam-7960	124	4	2017	2017	NUM
bam-7960	124	5	.	.	PUNCT
bam-7960	125	1	12	12	NUM
bam-7960	125	2	.	.	PUNCT
bam-7960	126	1	ald518	ald518	PROPN
bam-7960	126	2	,	,	PUNCT
bam-7960	126	3	a	a	DET
bam-7960	126	4	humanized	humanize	VERB
bam-7960	126	5	anti	anti	ADJ
bam-7960	126	6	-	-	ADJ
bam-7960	126	7	il-6	il-6	ADJ
bam-7960	126	8	antibody	antibody	NOUN
bam-7960	126	9	,	,	PUNCT
bam-7960	126	10	treats	treat	VERB
bam-7960	126	11	anemia	anemia	NOUN
bam-7960	126	12	in	in	ADP
bam-7960	126	13	patients	patient	NOUN
bam-7960	126	14	with	with	ADP
bam-7960	126	15	advanced	advanced	ADJ
bam-7960	126	16	non	non	ADJ
bam-7960	126	17	-	-	ADJ
bam-7960	126	18	small	small	ADJ
bam-7960	126	19	cell	cell	NOUN
bam-7960	126	20	lung	lung	NOUN
bam-7960	126	21	cancer	cancer	NOUN
bam-7960	126	22	(	(	PUNCT
bam-7960	126	23	nsclc	nsclc	NOUN
bam-7960	126	24	):	):	PUNCT
bam-7960	126	25	results	result	NOUN
bam-7960	126	26	of	of	ADP
bam-7960	126	27	a	a	DET
bam-7960	126	28	phase	phase	NOUN
bam-7960	126	29	ii	ii	NOUN
bam-7960	126	30	,	,	PUNCT
bam-7960	126	31	randomized	randomize	VERB
bam-7960	126	32	,	,	PUNCT
bam-7960	126	33	double	double	ADJ
bam-7960	126	34	-	-	PUNCT
bam-7960	126	35	blind	blind	ADJ
bam-7960	126	36	,	,	PUNCT
bam-7960	126	37	placebo	placebo	NOUN
bam-7960	126	38	-	-	PUNCT
bam-7960	126	39	controlled	control	VERB
bam-7960	126	40	trial	trial	NOUN
bam-7960	126	41	.	.	PUNCT
bam-7960	127	1	|	|	ADV
bam-7960	127	2	2010	2010	NUM
bam-7960	127	3	asco	asco	ADJ
bam-7960	127	4	annual	annual	ADJ
bam-7960	127	5	meeting	meeting	NOUN
bam-7960	127	6	|	|	ADV
bam-7960	127	7	abstracts	abstract	VERB
bam-7960	127	8	|	|	ADV
bam-7960	127	9	meeting	meet	VERB
bam-7960	127	10	library	library	NOUN
bam-7960	127	11	.	.	PUNCT
bam-7960	128	1	http://meetinglibrary.asco.org/content/	http://meetinglibrary.asco.org/content/	PROPN
bam-7960	128	2	49753	49753	NUM
bam-7960	128	3	-	-	SYM
bam-7960	128	4	74	74	NUM
bam-7960	128	5	.	.	PUNCT
bam-7960	128	6	accessed	access	VERB
bam-7960	128	7	10	10	NUM
bam-7960	128	8	april	april	PROPN
bam-7960	128	9	2017	2017	NUM
bam-7960	128	10	.	.	PUNCT
bam-7960	129	1	13	13	NUM
bam-7960	129	2	.	.	PUNCT
bam-7960	129	3	mesa	mesa	PROPN
bam-7960	129	4	ra	ra	PROPN
bam-7960	129	5	,	,	PUNCT
bam-7960	129	6	verstovsek	verstovsek	PROPN
bam-7960	129	7	s	s	PART
bam-7960	129	8	,	,	PUNCT
bam-7960	129	9	gupta	gupta	PROPN
bam-7960	129	10	v	v	NOUN
bam-7960	129	11	,	,	PUNCT
bam-7960	129	12	et	et	PROPN
bam-7960	129	13	al	al	PROPN
bam-7960	129	14	.	.	PUNCT
bam-7960	130	1	effects	effect	NOUN
bam-7960	130	2	of	of	ADP
bam-7960	130	3	ruxolitinib	ruxolitinib	NOUN
bam-7960	130	4	treatment	treatment	NOUN
bam-7960	130	5	on	on	ADP
bam-7960	130	6	metabolic	metabolic	NOUN
bam-7960	130	7	and	and	CCONJ
bam-7960	130	8	nutritional	nutritional	ADJ
bam-7960	130	9	parameters	parameter	NOUN
bam-7960	130	10	in	in	ADP
bam-7960	130	11	patients	patient	NOUN
bam-7960	130	12	with	with	ADP
bam-7960	130	13	myelofibrosis	myelofibrosis	NOUN
bam-7960	130	14	from	from	ADP
bam-7960	130	15	comfort	comfort	NOUN
bam-7960	130	16	-	-	PUNCT
bam-7960	130	17	i.	i.	NOUN
bam-7960	130	18	clin	clin	PROPN
bam-7960	130	19	lymphoma	lymphoma	PROPN
bam-7960	130	20	myeloma	myeloma	PROPN
bam-7960	130	21	leuk	leuk	PROPN
bam-7960	130	22	2015;15:214–221	2015;15:214–221	PROPN
bam-7960	130	23	.	.	PUNCT
bam-7960	131	1	14	14	NUM
bam-7960	131	2	.	.	PUNCT
bam-7960	132	1	chasen	chasen	PROPN
bam-7960	132	2	m.	m.	PROPN
bam-7960	132	3	phase	phase	PROPN
bam-7960	132	4	ii	ii	PROPN
bam-7960	132	5	data	datum	NOUN
bam-7960	132	6	on	on	ADP
bam-7960	132	7	ohr	ohr	PROPN
bam-7960	132	8	/	/	SYM
bam-7960	132	9	avr118	avr118	PROPN
bam-7960	132	10	in	in	ADP
bam-7960	132	11	advanced	advanced	ADJ
bam-7960	132	12	cancer	cancer	NOUN
bam-7960	132	13	patients	patient	NOUN
bam-7960	132	14	with	with	ADP
bam-7960	132	15	cachexia	cachexia	PROPN
bam-7960	132	16	.	.	PUNCT
bam-7960	133	1	int	int	NOUN
bam-7960	133	2	.	.	PUNCT
bam-7960	134	1	cachexia	cachexia	PROPN
bam-7960	134	2	conf	conf	NOUN
bam-7960	134	3	.	.	PUNCT
bam-7960	135	1	kobe	kobe	PROPN
bam-7960	135	2	,	,	PUNCT
bam-7960	135	3	japan	japan	PROPN
bam-7960	135	4	.	.	PUNCT
bam-7960	136	1	2013http://www	2013http://www	NUM
bam-7960	136	2	.	.	NUM
bam-7960	136	3	ohrpharmaceutical.com/media-center/pressreleases/detail/94/phase-ii-data-on-ohravr118-inadvanced-cancer-patients	ohrpharmaceutical.com/media-center/pressreleases/detail/94/phase-ii-data-on-ohravr118-inadvanced-cancer-patient	NOUN
bam-7960	136	4	.	.	PUNCT
bam-7960	137	1	15	15	NUM
bam-7960	137	2	.	.	PUNCT
bam-7960	138	1	chasen	chasen	PROPN
bam-7960	138	2	m	m	PROPN
bam-7960	138	3	,	,	PUNCT
bam-7960	138	4	hirschman	hirschman	PROPN
bam-7960	138	5	sz	sz	PROPN
bam-7960	138	6	,	,	PUNCT
bam-7960	138	7	bhargava	bhargava	PROPN
bam-7960	138	8	r.	r.	PROPN
bam-7960	138	9	phase	phase	PROPN
bam-7960	138	10	ii	ii	PROPN
bam-7960	138	11	study	study	NOUN
bam-7960	138	12	of	of	ADP
bam-7960	138	13	the	the	DET
bam-7960	138	14	novel	novel	ADJ
bam-7960	138	15	peptide	peptide	NOUN
bam-7960	138	16	-	-	PUNCT
bam-7960	138	17	nucleic	nucleic	ADJ
bam-7960	138	18	acid	acid	NOUN
bam-7960	138	19	ohr118	ohr118	NOUN
bam-7960	138	20	non	non	PROPN
bam-7960	138	21	co	co	PROPN
bam-7960	138	22	mmerc	mmerc	PROPN
bam-7960	138	23	ial	ial	PROPN
bam-7960	138	24	us	us	PROPN
bam-7960	139	1	e	e	NOUN
bam-7960	139	2	o	o	PROPN
bam-7960	139	3	nly	nly	ADV
bam-7960	139	4	http://meetinglibrary.asco.org/content/	http://meetinglibrary.asco.org/content/	X
bam-7960	139	5	therapeutic	therapeutic	ADJ
bam-7960	139	6	strategies	strategy	NOUN
bam-7960	139	7	against	against	ADP
bam-7960	139	8	cancer	cancer	NOUN
bam-7960	139	9	cachexia	cachexia	PROPN
bam-7960	139	10	eur	eur	PROPN
bam-7960	139	11	j	j	PROPN
bam-7960	139	12	transl	transl	PROPN
bam-7960	139	13	myol	myol	ADV
bam-7960	139	14	29	29	NUM
bam-7960	139	15	(	(	PUNCT
bam-7960	139	16	1	1	NUM
bam-7960	139	17	):	):	PUNCT
bam-7960	139	18	4	4	NUM
bam-7960	139	19	-	-	SYM
bam-7960	139	20	13	13	NUM
bam-7960	139	21	,	,	PUNCT
bam-7960	139	22	2019	2019	NUM
bam-7960	139	23	10	10	NUM
bam-7960	139	24	in	in	ADP
bam-7960	139	25	the	the	DET
bam-7960	139	26	management	management	NOUN
bam-7960	139	27	of	of	ADP
bam-7960	139	28	cancer	cancer	NOUN
bam-7960	139	29	-	-	PUNCT
bam-7960	139	30	related	relate	VERB
bam-7960	139	31	anorexia	anorexia	NOUN
bam-7960	139	32	/	/	SYM
bam-7960	139	33	cachexia	cachexia	NOUN
bam-7960	139	34	.	.	PUNCT
bam-7960	140	1	j	j	PROPN
bam-7960	140	2	am	be	AUX
bam-7960	140	3	med	med	ADJ
bam-7960	140	4	dir	dir	NOUN
bam-7960	140	5	assoc	assoc	PROPN
bam-7960	140	6	2011;12:62–67	2011;12:62–67	NUM
bam-7960	140	7	.	.	PUNCT
bam-7960	141	1	16	16	NUM
bam-7960	141	2	.	.	PUNCT
bam-7960	142	1	greco	greco	PROPN
bam-7960	142	2	sh	sh	PROPN
bam-7960	142	3	,	,	PUNCT
bam-7960	142	4	tomkötter	tomkötter	PROPN
bam-7960	142	5	l	l	NOUN
bam-7960	142	6	,	,	PUNCT
bam-7960	142	7	vahle	vahle	DET
bam-7960	142	8	a	a	NOUN
bam-7960	142	9	-	-	PUNCT
bam-7960	142	10	k	k	NOUN
bam-7960	142	11	,	,	PUNCT
bam-7960	142	12	et	et	PROPN
bam-7960	142	13	al	al	PROPN
bam-7960	142	14	.	.	PUNCT
bam-7960	142	15	tgf	tgf	PROPN
bam-7960	142	16	-	-	PUNCT
bam-7960	142	17	β	β	PROPN
bam-7960	142	18	blockade	blockade	NOUN
bam-7960	142	19	reduces	reduce	VERB
bam-7960	142	20	mortality	mortality	NOUN
bam-7960	142	21	and	and	CCONJ
bam-7960	142	22	metabolic	metabolic	NOUN
bam-7960	142	23	changes	change	NOUN
bam-7960	142	24	in	in	ADP
bam-7960	142	25	a	a	DET
bam-7960	142	26	validated	validate	VERB
bam-7960	142	27	murine	murine	ADJ
bam-7960	142	28	model	model	NOUN
bam-7960	142	29	of	of	ADP
bam-7960	142	30	pancreatic	pancreatic	ADJ
bam-7960	142	31	cancer	cancer	NOUN
bam-7960	142	32	cachexia	cachexia	NOUN
bam-7960	142	33	.	.	PUNCT
bam-7960	143	1	plos	plos	PROPN
bam-7960	143	2	one	one	NUM
bam-7960	143	3	2015;10	2015;10	NUM
bam-7960	143	4	:	:	PUNCT
bam-7960	143	5	e0132786	e0132786	PROPN
bam-7960	143	6	.	.	PROPN
bam-7960	143	7	17	17	NUM
bam-7960	143	8	.	.	PUNCT
bam-7960	144	1	waning	wane	VERB
bam-7960	144	2	dl	dl	PROPN
bam-7960	144	3	,	,	PUNCT
bam-7960	144	4	mohammad	mohammad	PROPN
bam-7960	144	5	ks	ks	PROPN
bam-7960	144	6	,	,	PUNCT
bam-7960	144	7	reiken	reiken	VERB
bam-7960	144	8	s	s	PROPN
bam-7960	144	9	,	,	PUNCT
bam-7960	144	10	et	et	PROPN
bam-7960	144	11	al	al	PROPN
bam-7960	144	12	.	.	PROPN
bam-7960	144	13	excess	excess	PROPN
bam-7960	144	14	tgf	tgf	PROPN
bam-7960	144	15	-	-	PUNCT
bam-7960	144	16	β	β	PROPN
bam-7960	144	17	mediates	mediate	NOUN
bam-7960	144	18	muscle	muscle	NOUN
bam-7960	144	19	weakness	weakness	NOUN
bam-7960	144	20	associated	associate	VERB
bam-7960	144	21	with	with	ADP
bam-7960	144	22	bone	bone	NOUN
bam-7960	144	23	metastases	metastasis	NOUN
bam-7960	144	24	in	in	ADP
bam-7960	144	25	mice	mouse	NOUN
bam-7960	144	26	.	.	PUNCT
bam-7960	145	1	nat	nat	PROPN
bam-7960	145	2	med	me	VERB
bam-7960	145	3	2015;21:1262–1271	2015;21:1262–1271	NOUN
bam-7960	145	4	.	.	PUNCT
bam-7960	146	1	18	18	NUM
bam-7960	146	2	.	.	X
bam-7960	146	3	figueras	figueras	PROPN
bam-7960	146	4	m	m	PROPN
bam-7960	146	5	,	,	PUNCT
bam-7960	146	6	busquets	busquets	PROPN
bam-7960	146	7	s	s	PROPN
bam-7960	146	8	,	,	PUNCT
bam-7960	146	9	carbó	carbó	PROPN
bam-7960	146	10	n	n	CCONJ
bam-7960	146	11	,	,	PUNCT
bam-7960	146	12	et	et	PROPN
bam-7960	146	13	al	al	PROPN
bam-7960	146	14	.	.	PROPN
bam-7960	146	15	interleukin15	interleukin15	PROPN
bam-7960	146	16	is	be	AUX
bam-7960	146	17	able	able	ADJ
bam-7960	146	18	to	to	PART
bam-7960	146	19	suppress	suppress	VERB
bam-7960	146	20	the	the	DET
bam-7960	146	21	increased	increase	VERB
bam-7960	146	22	dna	dna	NOUN
bam-7960	146	23	fragmentation	fragmentation	NOUN
bam-7960	146	24	associated	associate	VERB
bam-7960	146	25	with	with	ADP
bam-7960	146	26	muscle	muscle	NOUN
bam-7960	146	27	wasting	waste	VERB
bam-7960	146	28	in	in	ADP
bam-7960	146	29	tumour	tumour	NOUN
bam-7960	146	30	-	-	PUNCT
bam-7960	146	31	bearing	bear	VERB
bam-7960	146	32	rats	rat	NOUN
bam-7960	146	33	.	.	PUNCT
bam-7960	147	1	febs	febs	VERB
bam-7960	147	2	lett	lett	PROPN
bam-7960	147	3	2004;569:201–6	2004;569:201–6	NUM
bam-7960	147	4	.	.	PROPN
bam-7960	148	1	19	19	NUM
bam-7960	148	2	.	.	PUNCT
bam-7960	148	3	argilés	argilés	PROPN
bam-7960	148	4	jm	jm	PROPN
bam-7960	148	5	,	,	PUNCT
bam-7960	148	6	lópez	lópez	PROPN
bam-7960	148	7	-	-	PUNCT
bam-7960	148	8	soriano	soriano	PROPN
bam-7960	148	9	fj	fj	PROPN
bam-7960	148	10	,	,	PUNCT
bam-7960	148	11	busquets	busquets	PROPN
bam-7960	148	12	s.	s.	PROPN
bam-7960	148	13	therapeutic	therapeutic	ADJ
bam-7960	148	14	potential	potential	NOUN
bam-7960	148	15	of	of	ADP
bam-7960	148	16	interleukin-15	interleukin-15	PROPN
bam-7960	148	17	:	:	PUNCT
bam-7960	148	18	a	a	DET
bam-7960	148	19	myokine	myokine	NOUN
bam-7960	148	20	involved	involve	VERB
bam-7960	148	21	in	in	ADP
bam-7960	148	22	muscle	muscle	NOUN
bam-7960	148	23	wasting	wasting	NOUN
bam-7960	148	24	and	and	CCONJ
bam-7960	148	25	adiposity	adiposity	NOUN
bam-7960	148	26	.	.	PUNCT
bam-7960	149	1	drug	drug	NOUN
bam-7960	149	2	discov	discov	PROPN
bam-7960	149	3	today	today	NOUN
bam-7960	149	4	2009;14:208–13	2009;14:208–13	NUM
bam-7960	149	5	.	.	PROPN
bam-7960	149	6	20	20	NUM
bam-7960	149	7	.	.	PUNCT
bam-7960	150	1	busquets	busquets	PROPN
bam-7960	150	2	s	s	PROPN
bam-7960	150	3	,	,	PUNCT
bam-7960	150	4	figueras	figueras	PROPN
bam-7960	150	5	mt	mt	PROPN
bam-7960	150	6	,	,	PUNCT
bam-7960	150	7	meijsing	meijse	VERB
bam-7960	150	8	s	s	PART
bam-7960	150	9	,	,	PUNCT
bam-7960	150	10	et	et	PROPN
bam-7960	150	11	al	al	PROPN
bam-7960	150	12	.	.	PUNCT
bam-7960	151	1	interleukin-15	interleukin-15	PROPN
bam-7960	151	2	decreases	decrease	VERB
bam-7960	151	3	proteolysis	proteolysis	NOUN
bam-7960	151	4	in	in	ADP
bam-7960	151	5	skeletal	skeletal	ADJ
bam-7960	151	6	muscle	muscle	NOUN
bam-7960	151	7	:	:	PUNCT
bam-7960	151	8	a	a	DET
bam-7960	151	9	direct	direct	ADJ
bam-7960	151	10	effect	effect	NOUN
bam-7960	151	11	.	.	PUNCT
bam-7960	152	1	int	int	PROPN
bam-7960	152	2	j	j	PROPN
bam-7960	152	3	mol	mol	ADP
bam-7960	152	4	med	med	PROPN
bam-7960	152	5	2005;16:471	2005;16:471	PROPN
bam-7960	152	6	–	–	PUNCT
bam-7960	152	7	6	6	NUM
bam-7960	152	8	.	.	NOUN
bam-7960	152	9	21	21	NUM
bam-7960	152	10	.	.	PUNCT
bam-7960	153	1	martínez	martínez	PROPN
bam-7960	153	2	-	-	PUNCT
bam-7960	153	3	hernández	hernández	PROPN
bam-7960	153	4	pl	pl	PROPN
bam-7960	153	5	,	,	PUNCT
bam-7960	153	6	hernanz	hernanz	NOUN
bam-7960	153	7	-	-	PUNCT
bam-7960	153	8	macías	macías	PROPN
bam-7960	153	9	á	á	PROPN
bam-7960	153	10	,	,	PUNCT
bam-7960	153	11	gómez	gómez	NOUN
bam-7960	153	12	-	-	PUNCT
bam-7960	153	13	candela	candela	NOUN
bam-7960	153	14	c	c	NOUN
bam-7960	153	15	,	,	PUNCT
bam-7960	153	16	et	et	PROPN
bam-7960	153	17	al	al	PROPN
bam-7960	153	18	.	.	PROPN
bam-7960	153	19	serum	serum	PROPN
bam-7960	153	20	interleukin-15	interleukin-15	PROPN
bam-7960	153	21	levels	level	NOUN
bam-7960	153	22	in	in	ADP
bam-7960	153	23	cancer	cancer	NOUN
bam-7960	153	24	patients	patient	NOUN
bam-7960	153	25	with	with	ADP
bam-7960	153	26	cachexia	cachexia	PROPN
bam-7960	153	27	.	.	PUNCT
bam-7960	154	1	oncol	oncol	PROPN
bam-7960	154	2	rep	rep	PROPN
bam-7960	154	3	2012;28:1443–52	2012;28:1443–52	NUM
bam-7960	154	4	.	.	PUNCT
bam-7960	154	5	22	22	NUM
bam-7960	154	6	.	.	PUNCT
bam-7960	155	1	argilés	argilés	PROPN
bam-7960	155	2	jm	jm	PROPN
bam-7960	155	3	,	,	PUNCT
bam-7960	155	4	anguera	anguera	NOUN
bam-7960	155	5	a	a	PRON
bam-7960	155	6	,	,	PUNCT
bam-7960	155	7	stemmler	stemmler	PROPN
bam-7960	155	8	b.	b.	PROPN
bam-7960	156	1	a	a	DET
bam-7960	156	2	new	new	ADJ
bam-7960	156	3	look	look	NOUN
bam-7960	156	4	at	at	ADP
bam-7960	156	5	an	an	DET
bam-7960	156	6	old	old	ADJ
bam-7960	156	7	drug	drug	NOUN
bam-7960	156	8	for	for	ADP
bam-7960	156	9	the	the	DET
bam-7960	156	10	treatment	treatment	NOUN
bam-7960	156	11	of	of	ADP
bam-7960	156	12	cancer	cancer	NOUN
bam-7960	156	13	cachexia	cachexia	NOUN
bam-7960	156	14	:	:	PUNCT
bam-7960	156	15	megestrol	megestrol	NOUN
bam-7960	156	16	acetate	acetate	NOUN
bam-7960	156	17	.	.	PUNCT
bam-7960	157	1	clin	clin	PROPN
bam-7960	157	2	nutr	nutr	PROPN
bam-7960	157	3	2013;32:319–24	2013;32:319–24	PROPN
bam-7960	157	4	.	.	PROPN
bam-7960	157	5	23	23	NUM
bam-7960	157	6	.	.	PUNCT
bam-7960	158	1	busquets	busquets	PROPN
bam-7960	158	2	s	s	PROPN
bam-7960	158	3	,	,	PUNCT
bam-7960	158	4	serpe	serpe	PROPN
bam-7960	158	5	r	r	PROPN
bam-7960	158	6	,	,	PUNCT
bam-7960	158	7	sirisi	sirisi	PROPN
bam-7960	158	8	s	s	PROPN
bam-7960	158	9	,	,	PUNCT
bam-7960	158	10	et	et	PROPN
bam-7960	158	11	al	al	PROPN
bam-7960	158	12	.	.	PUNCT
bam-7960	159	1	megestrol	megestrol	PROPN
bam-7960	159	2	acetate	acetate	NOUN
bam-7960	159	3	:	:	PUNCT
bam-7960	159	4	its	its	PRON
bam-7960	159	5	impact	impact	NOUN
bam-7960	159	6	on	on	ADP
bam-7960	159	7	muscle	muscle	NOUN
bam-7960	159	8	protein	protein	NOUN
bam-7960	159	9	metabolism	metabolism	NOUN
bam-7960	159	10	supports	support	VERB
bam-7960	159	11	its	its	PRON
bam-7960	159	12	use	use	NOUN
bam-7960	159	13	in	in	ADP
bam-7960	159	14	cancer	cancer	NOUN
bam-7960	159	15	cachexia	cachexia	NOUN
bam-7960	159	16	.	.	PUNCT
bam-7960	160	1	clin	clin	PROPN
bam-7960	160	2	nutr	nutr	PROPN
bam-7960	160	3	2010;29:733–7	2010;29:733–7	PROPN
bam-7960	160	4	.	.	PUNCT
bam-7960	160	5	24	24	NUM
bam-7960	160	6	.	.	PUNCT
bam-7960	161	1	jang	jang	PROPN
bam-7960	161	2	k	k	PROPN
bam-7960	161	3	,	,	PUNCT
bam-7960	161	4	yoon	yoon	PROPN
bam-7960	161	5	s	s	PROPN
bam-7960	161	6	,	,	PUNCT
bam-7960	161	7	kim	kim	PROPN
bam-7960	161	8	s	s	PROPN
bam-7960	161	9	-	-	PUNCT
bam-7960	161	10	e	e	NOUN
bam-7960	161	11	,	,	PUNCT
bam-7960	161	12	et	et	PROPN
bam-7960	161	13	al	al	PROPN
bam-7960	161	14	.	.	PROPN
bam-7960	161	15	novel	novel	PROPN
bam-7960	161	16	nanocrystal	nanocrystal	ADJ
bam-7960	161	17	formulation	formulation	NOUN
bam-7960	161	18	of	of	ADP
bam-7960	161	19	megestrol	megestrol	NOUN
bam-7960	161	20	acetate	acetate	NOUN
bam-7960	161	21	has	have	AUX
bam-7960	161	22	improved	improve	VERB
bam-7960	161	23	bioavailability	bioavailability	NOUN
bam-7960	161	24	compared	compare	VERB
bam-7960	161	25	with	with	ADP
bam-7960	161	26	the	the	DET
bam-7960	161	27	conventional	conventional	ADJ
bam-7960	161	28	micronized	micronized	ADJ
bam-7960	161	29	formulation	formulation	NOUN
bam-7960	161	30	in	in	ADP
bam-7960	161	31	the	the	DET
bam-7960	161	32	fasting	fast	VERB
bam-7960	161	33	state	state	NOUN
bam-7960	161	34	.	.	PUNCT
bam-7960	162	1	drug	drug	NOUN
bam-7960	162	2	des	des	PROPN
bam-7960	162	3	devel	devel	NOUN
bam-7960	162	4	ther	ther	PROPN
bam-7960	162	5	2014;8:851	2014;8:851	NOUN
bam-7960	162	6	.	.	PUNCT
bam-7960	163	1	25	25	NUM
bam-7960	163	2	.	.	PUNCT
bam-7960	163	3	segura	segura	PROPN
bam-7960	163	4	a	a	PROPN
bam-7960	163	5	,	,	PUNCT
bam-7960	163	6	pardo	pardo	PROPN
bam-7960	163	7	j	j	PROPN
bam-7960	163	8	,	,	PUNCT
bam-7960	163	9	jara	jara	PROPN
bam-7960	163	10	c	c	PROPN
bam-7960	163	11	,	,	PUNCT
bam-7960	163	12	et	et	PROPN
bam-7960	163	13	al	al	PROPN
bam-7960	163	14	.	.	PUNCT
bam-7960	164	1	an	an	DET
bam-7960	164	2	epidemiological	epidemiological	ADJ
bam-7960	164	3	evaluation	evaluation	NOUN
bam-7960	164	4	of	of	ADP
bam-7960	164	5	the	the	DET
bam-7960	164	6	prevalence	prevalence	NOUN
bam-7960	164	7	of	of	ADP
bam-7960	164	8	malnutrition	malnutrition	NOUN
bam-7960	164	9	in	in	ADP
bam-7960	164	10	spanish	spanish	ADJ
bam-7960	164	11	patients	patient	NOUN
bam-7960	164	12	with	with	ADP
bam-7960	164	13	locally	locally	ADV
bam-7960	164	14	advanced	advanced	ADJ
bam-7960	164	15	or	or	CCONJ
bam-7960	164	16	metastatic	metastatic	ADJ
bam-7960	164	17	cancer	cancer	NOUN
bam-7960	164	18	.	.	PUNCT
bam-7960	165	1	clin	clin	PROPN
bam-7960	165	2	nutr	nutr	PROPN
bam-7960	165	3	2005;24:801–14	2005;24:801–14	PROPN
bam-7960	165	4	.	.	PROPN
bam-7960	165	5	26	26	NUM
bam-7960	165	6	.	.	PUNCT
bam-7960	165	7	tesauro	tesauro	PROPN
bam-7960	165	8	m	m	PROPN
bam-7960	165	9	,	,	PUNCT
bam-7960	165	10	schinzari	schinzari	ADJ
bam-7960	165	11	f	f	X
bam-7960	165	12	,	,	PUNCT
bam-7960	165	13	caramanti	caramanti	PROPN
bam-7960	165	14	m	m	PROPN
bam-7960	165	15	,	,	PUNCT
bam-7960	165	16	et	et	PROPN
bam-7960	165	17	al	al	PROPN
bam-7960	165	18	.	.	PUNCT
bam-7960	166	1	cardiovascular	cardiovascular	ADJ
bam-7960	166	2	and	and	CCONJ
bam-7960	166	3	metabolic	metabolic	NOUN
bam-7960	166	4	effects	effect	NOUN
bam-7960	166	5	of	of	ADP
bam-7960	166	6	ghrelin	ghrelin	NOUN
bam-7960	166	7	.	.	PUNCT
bam-7960	167	1	curr	curr	PROPN
bam-7960	167	2	diabetes	diabete	NOUN
bam-7960	167	3	rev	rev	VERB
bam-7960	167	4	2010;6:228–35	2010;6:228–35	NUM
bam-7960	167	5	.	.	PROPN
bam-7960	167	6	27	27	NUM
bam-7960	167	7	.	.	PUNCT
bam-7960	168	1	argilés	argilés	PROPN
bam-7960	168	2	jm	jm	PROPN
bam-7960	168	3	,	,	PUNCT
bam-7960	168	4	stemmler	stemmler	PROPN
bam-7960	168	5	b.	b.	PROPN
bam-7960	169	1	the	the	DET
bam-7960	169	2	potential	potential	NOUN
bam-7960	169	3	of	of	ADP
bam-7960	169	4	ghrelin	ghrelin	NOUN
bam-7960	169	5	in	in	ADP
bam-7960	169	6	the	the	DET
bam-7960	169	7	treatment	treatment	NOUN
bam-7960	169	8	of	of	ADP
bam-7960	169	9	cancer	cancer	NOUN
bam-7960	169	10	cachexia	cachexia	NOUN
bam-7960	169	11	.	.	PUNCT
bam-7960	170	1	expert	expert	NOUN
bam-7960	170	2	opin	opin	NOUN
bam-7960	170	3	biol	biol	NOUN
bam-7960	170	4	ther	ther	ADV
bam-7960	170	5	2013;13:67–76	2013;13:67–76	NUM
bam-7960	170	6	.	.	PUNCT
bam-7960	171	1	28	28	NUM
bam-7960	171	2	.	.	PUNCT
bam-7960	172	1	deboer	deboer	PROPN
bam-7960	172	2	md	md	PROPN
bam-7960	172	3	,	,	PUNCT
bam-7960	172	4	zhu	zhu	PROPN
bam-7960	172	5	xx	xx	NUM
bam-7960	172	6	,	,	PUNCT
bam-7960	172	7	levasseur	levasseur	NOUN
bam-7960	172	8	p	p	NOUN
bam-7960	172	9	,	,	PUNCT
bam-7960	172	10	et	et	PROPN
bam-7960	172	11	al	al	PROPN
bam-7960	172	12	.	.	PROPN
bam-7960	172	13	ghrelin	ghrelin	NOUN
bam-7960	172	14	treatment	treatment	NOUN
bam-7960	172	15	causes	cause	VERB
bam-7960	172	16	increased	increase	VERB
bam-7960	172	17	food	food	NOUN
bam-7960	172	18	intake	intake	NOUN
bam-7960	172	19	and	and	CCONJ
bam-7960	172	20	retention	retention	NOUN
bam-7960	172	21	of	of	ADP
bam-7960	172	22	lean	lean	ADJ
bam-7960	172	23	body	body	NOUN
bam-7960	172	24	mass	mass	NOUN
bam-7960	172	25	in	in	ADP
bam-7960	172	26	a	a	DET
bam-7960	172	27	rat	rat	NOUN
bam-7960	172	28	model	model	NOUN
bam-7960	172	29	of	of	ADP
bam-7960	172	30	cancer	cancer	NOUN
bam-7960	172	31	cachexia	cachexia	NOUN
bam-7960	172	32	.	.	PUNCT
bam-7960	173	1	endocrinology	endocrinology	NOUN
bam-7960	173	2	2007;148:3004	2007;148:3004	NUM
bam-7960	173	3	–	–	PUNCT
bam-7960	173	4	3012	3012	NUM
bam-7960	173	5	.	.	PUNCT
bam-7960	174	1	29	29	NUM
bam-7960	174	2	.	.	PUNCT
bam-7960	175	1	garcia	garcia	PROPN
bam-7960	175	2	jm	jm	PROPN
bam-7960	175	3	,	,	PUNCT
bam-7960	175	4	cata	cata	PROPN
bam-7960	175	5	jp	jp	PROPN
bam-7960	175	6	,	,	PUNCT
bam-7960	175	7	dougherty	dougherty	PROPN
bam-7960	175	8	pm	pm	PROPN
bam-7960	175	9	,	,	PUNCT
bam-7960	175	10	smith	smith	PROPN
bam-7960	175	11	rg	rg	PROPN
bam-7960	175	12	.	.	PROPN
bam-7960	175	13	ghrelin	ghrelin	PROPN
bam-7960	175	14	prevents	prevent	VERB
bam-7960	175	15	cisplatin	cisplatin	NOUN
bam-7960	175	16	-	-	PUNCT
bam-7960	175	17	induced	induce	VERB
bam-7960	175	18	mechanical	mechanical	ADJ
bam-7960	175	19	hyperalgesia	hyperalgesia	NOUN
bam-7960	175	20	and	and	CCONJ
bam-7960	175	21	cachexia	cachexia	NOUN
bam-7960	175	22	.	.	PUNCT
bam-7960	176	1	endocrinology	endocrinology	NOUN
bam-7960	176	2	2008;149:455–460	2008;149:455–460	NUM
bam-7960	176	3	.	.	PUNCT
bam-7960	177	1	30	30	NUM
bam-7960	177	2	.	.	NUM
bam-7960	178	1	yakabi	yakabi	PROPN
bam-7960	178	2	k	k	PROPN
bam-7960	178	3	,	,	PUNCT
bam-7960	178	4	sadakane	sadakane	VERB
bam-7960	178	5	c	c	PROPN
bam-7960	178	6	,	,	PUNCT
bam-7960	178	7	noguchi	noguchi	PROPN
bam-7960	178	8	m	m	PROPN
bam-7960	178	9	,	,	PUNCT
bam-7960	178	10	et	et	PROPN
bam-7960	178	11	al	al	PROPN
bam-7960	178	12	.	.	PROPN
bam-7960	179	1	reduced	reduce	VERB
bam-7960	179	2	ghrelin	ghrelin	NOUN
bam-7960	179	3	secretion	secretion	NOUN
bam-7960	179	4	in	in	ADP
bam-7960	179	5	the	the	DET
bam-7960	179	6	hypothalamus	hypothalamus	NOUN
bam-7960	179	7	of	of	ADP
bam-7960	179	8	rats	rat	NOUN
bam-7960	179	9	due	due	ADP
bam-7960	179	10	to	to	ADP
bam-7960	179	11	cisplatin	cisplatin	NOUN
bam-7960	179	12	-	-	PUNCT
bam-7960	179	13	induced	induce	VERB
bam-7960	179	14	anorexia	anorexia	NOUN
bam-7960	179	15	.	.	PUNCT
bam-7960	180	1	endocrinology	endocrinology	NOUN
bam-7960	180	2	2010;151:3773–3782	2010;151:3773–3782	PROPN
bam-7960	180	3	.	.	PUNCT
bam-7960	181	1	31	31	NUM
bam-7960	181	2	.	.	PUNCT
bam-7960	182	1	garcia	garcia	PROPN
bam-7960	182	2	jm	jm	PROPN
bam-7960	182	3	,	,	PUNCT
bam-7960	182	4	boccia	boccia	PROPN
bam-7960	182	5	r	r	NOUN
bam-7960	182	6	v	v	NOUN
bam-7960	182	7	,	,	PUNCT
bam-7960	182	8	graham	graham	PROPN
bam-7960	182	9	cd	cd	PROPN
bam-7960	182	10	,	,	PUNCT
bam-7960	182	11	y	y	PROPN
bam-7960	182	12	et	et	PROPN
bam-7960	182	13	al	al	PROPN
bam-7960	182	14	.	.	PROPN
bam-7960	182	15	anamorelin	anamorelin	PROPN
bam-7960	182	16	for	for	ADP
bam-7960	182	17	patients	patient	NOUN
bam-7960	182	18	with	with	ADP
bam-7960	182	19	cancer	cancer	NOUN
bam-7960	182	20	cachexia	cachexia	NOUN
bam-7960	182	21	:	:	PUNCT
bam-7960	182	22	an	an	DET
bam-7960	182	23	integrated	integrated	ADJ
bam-7960	182	24	analysis	analysis	NOUN
bam-7960	182	25	of	of	ADP
bam-7960	182	26	two	two	NUM
bam-7960	182	27	phase	phase	NOUN
bam-7960	182	28	2	2	NUM
bam-7960	182	29	,	,	PUNCT
bam-7960	182	30	randomised	randomise	VERB
bam-7960	182	31	,	,	PUNCT
bam-7960	182	32	placebo	placebo	NOUN
bam-7960	182	33	-	-	PUNCT
bam-7960	182	34	controlled	control	VERB
bam-7960	182	35	,	,	PUNCT
bam-7960	182	36	double	double	ADJ
bam-7960	182	37	-	-	PUNCT
bam-7960	182	38	blind	blind	ADJ
bam-7960	182	39	trials	trial	NOUN
bam-7960	182	40	.	.	PUNCT
bam-7960	183	1	lancet	lancet	VERB
bam-7960	183	2	oncol	oncol	ADJ
bam-7960	183	3	2015;16:108–16	2015;16:108–16	NUM
bam-7960	183	4	.	.	PROPN
bam-7960	184	1	32	32	NUM
bam-7960	184	2	.	.	PUNCT
bam-7960	185	1	temel	temel	PROPN
bam-7960	185	2	js	js	PROPN
bam-7960	185	3	,	,	PUNCT
bam-7960	185	4	currow	currow	PROPN
bam-7960	185	5	dc	dc	PROPN
bam-7960	185	6	,	,	PUNCT
bam-7960	185	7	fearon	fearon	PROPN
bam-7960	185	8	k	k	PROPN
bam-7960	185	9	,	,	PUNCT
bam-7960	185	10	et	et	PROPN
bam-7960	185	11	al	al	PROPN
bam-7960	185	12	.	.	PROPN
bam-7960	185	13	anamorelin	anamorelin	PROPN
bam-7960	185	14	in	in	ADP
bam-7960	185	15	patients	patient	NOUN
bam-7960	185	16	with	with	ADP
bam-7960	185	17	advanced	advanced	ADJ
bam-7960	185	18	non	non	ADJ
bam-7960	185	19	-	-	ADJ
bam-7960	185	20	small	small	ADJ
bam-7960	185	21	cell	cell	NOUN
bam-7960	185	22	lung	lung	NOUN
bam-7960	185	23	cancer	cancer	NOUN
bam-7960	185	24	and	and	CCONJ
bam-7960	185	25	cachexia	cachexia	NOUN
bam-7960	185	26	:	:	PUNCT
bam-7960	185	27	results	result	NOUN
bam-7960	185	28	from	from	ADP
bam-7960	185	29	the	the	DET
bam-7960	185	30	phase	phase	NOUN
bam-7960	185	31	iii	iii	NUM
bam-7960	185	32	studies	study	NOUN
bam-7960	185	33	romana	romana	NOUN
bam-7960	185	34	1	1	NUM
bam-7960	185	35	and	and	CCONJ
bam-7960	185	36	2	2	NUM
bam-7960	185	37	.	.	X
bam-7960	186	1	j	j	PROPN
bam-7960	186	2	clin	clin	PROPN
bam-7960	186	3	oncol	oncol	PROPN
bam-7960	186	4	2015;33:175	2015;33:175	NUM
bam-7960	186	5	.	.	PUNCT
bam-7960	187	1	33	33	NUM
bam-7960	187	2	.	.	PUNCT
bam-7960	188	1	temel	temel	PROPN
bam-7960	188	2	js	js	PROPN
bam-7960	188	3	,	,	PUNCT
bam-7960	188	4	abernethy	abernethy	PROPN
bam-7960	188	5	ap	ap	PROPN
bam-7960	188	6	,	,	PUNCT
bam-7960	188	7	currow	currow	PROPN
bam-7960	188	8	dc	dc	PROPN
bam-7960	188	9	,	,	PUNCT
bam-7960	188	10	et	et	PROPN
bam-7960	188	11	al	al	PROPN
bam-7960	188	12	.	.	PROPN
bam-7960	188	13	anamorelin	anamorelin	PROPN
bam-7960	188	14	in	in	ADP
bam-7960	188	15	patients	patient	NOUN
bam-7960	188	16	with	with	ADP
bam-7960	188	17	non	non	ADJ
bam-7960	188	18	-	-	ADJ
bam-7960	188	19	small	small	ADJ
bam-7960	188	20	-	-	PUNCT
bam-7960	188	21	cell	cell	NOUN
bam-7960	188	22	lung	lung	NOUN
bam-7960	188	23	cancer	cancer	NOUN
bam-7960	188	24	and	and	CCONJ
bam-7960	188	25	cachexia	cachexia	PROPN
bam-7960	188	26	(	(	PUNCT
bam-7960	188	27	romana	romana	PROPN
bam-7960	188	28	1	1	NUM
bam-7960	188	29	and	and	CCONJ
bam-7960	188	30	romana	romana	PROPN
bam-7960	188	31	2	2	NUM
bam-7960	188	32	):	):	PUNCT
bam-7960	188	33	results	result	NOUN
bam-7960	188	34	from	from	ADP
bam-7960	188	35	two	two	NUM
bam-7960	188	36	randomised	randomised	ADJ
bam-7960	188	37	,	,	PUNCT
bam-7960	188	38	double	double	ADJ
bam-7960	188	39	-	-	PUNCT
bam-7960	188	40	blind	blind	ADJ
bam-7960	188	41	,	,	PUNCT
bam-7960	188	42	phase	phase	NOUN
bam-7960	188	43	3	3	NUM
bam-7960	188	44	trials	trial	NOUN
bam-7960	188	45	.	.	PUNCT
bam-7960	189	1	lancet	lancet	VERB
bam-7960	189	2	oncol	oncol	ADJ
bam-7960	189	3	2016;17:519–531	2016;17:519–531	NUM
bam-7960	189	4	.	.	PUNCT
bam-7960	190	1	34	34	NUM
bam-7960	190	2	.	.	PUNCT
bam-7960	191	1	takayama	takayama	PROPN
bam-7960	191	2	k	k	PROPN
bam-7960	191	3	,	,	PUNCT
bam-7960	191	4	katakami	katakami	PROPN
bam-7960	191	5	n	n	CCONJ
bam-7960	191	6	,	,	PUNCT
bam-7960	191	7	yokoyama	yokoyama	PROPN
bam-7960	191	8	t	t	PROPN
bam-7960	191	9	,	,	PUNCT
bam-7960	191	10	et	et	PROPN
bam-7960	191	11	al	al	PROPN
bam-7960	191	12	.	.	PROPN
bam-7960	191	13	anamorelin	anamorelin	PROPN
bam-7960	191	14	(	(	PUNCT
bam-7960	191	15	ono-7643	ono-7643	PROPN
bam-7960	191	16	)	)	PUNCT
bam-7960	191	17	in	in	ADP
bam-7960	191	18	japanese	japanese	ADJ
bam-7960	191	19	patients	patient	NOUN
bam-7960	191	20	with	with	ADP
bam-7960	191	21	non	non	ADJ
bam-7960	191	22	-	-	ADJ
bam-7960	191	23	small	small	ADJ
bam-7960	191	24	cell	cell	NOUN
bam-7960	191	25	lung	lung	NOUN
bam-7960	191	26	cancer	cancer	NOUN
bam-7960	191	27	and	and	CCONJ
bam-7960	191	28	cachexia	cachexia	NOUN
bam-7960	191	29	:	:	PUNCT
bam-7960	191	30	results	result	NOUN
bam-7960	191	31	of	of	ADP
bam-7960	191	32	a	a	DET
bam-7960	191	33	randomized	randomized	ADJ
bam-7960	191	34	phase	phase	NOUN
bam-7960	191	35	2	2	NUM
bam-7960	191	36	trial	trial	NOUN
bam-7960	191	37	.	.	PUNCT
bam-7960	192	1	support	support	NOUN
bam-7960	192	2	care	care	NOUN
bam-7960	192	3	cancer	cancer	PROPN
bam-7960	192	4	2016;24:3495–3505	2016;24:3495–3505	PROPN
bam-7960	192	5	.	.	PROPN
bam-7960	193	1	35	35	NUM
bam-7960	193	2	.	.	PUNCT
bam-7960	194	1	nct01614990	nct01614990	PROPN
bam-7960	194	2	clinical	clinical	ADJ
bam-7960	194	3	trial	trial	NOUN
bam-7960	194	4	national	national	PROPN
bam-7960	194	5	cancer	cancer	PROPN
bam-7960	194	6	institute	institute	PROPN
bam-7960	194	7	.	.	PUNCT
bam-7960	195	1	https://www.cancer.gov/about-cancer/	https://www.cancer.gov/about-cancer/	PROPN
bam-7960	195	2	treatment	treatment	NOUN
bam-7960	195	3	/	/	SYM
bam-7960	195	4	clinical	clinical	NOUN
bam-7960	195	5	-	-	PUNCT
bam-7960	195	6	trials	trial	NOUN
bam-7960	195	7	/	/	SYM
bam-7960	195	8	search	search	NOUN
bam-7960	195	9	/	/	SYM
bam-7960	195	10	view?cdrid=	view?cdrid=	PROPN
bam-7960	195	11	735314	735314	NUM
bam-7960	195	12	.	.	PUNCT
bam-7960	196	1	accessed	access	VERB
bam-7960	196	2	10	10	NUM
bam-7960	196	3	april	april	PROPN
bam-7960	196	4	2017	2017	NUM
bam-7960	196	5	.	.	PUNCT
bam-7960	197	1	36	36	NUM
bam-7960	197	2	.	.	PUNCT
bam-7960	198	1	levinson	levinson	PROPN
bam-7960	198	2	b	b	PROPN
bam-7960	198	3	,	,	PUNCT
bam-7960	198	4	gertner	gertner	PROPN
bam-7960	198	5	j.	j.	PROPN
bam-7960	198	6	randomized	randomized	PROPN
bam-7960	198	7	study	study	NOUN
bam-7960	198	8	of	of	ADP
bam-7960	198	9	the	the	DET
bam-7960	198	10	efficacy	efficacy	NOUN
bam-7960	198	11	and	and	CCONJ
bam-7960	198	12	safety	safety	NOUN
bam-7960	198	13	of	of	ADP
bam-7960	198	14	sun11031	sun11031	NOUN
bam-7960	198	15	(	(	PUNCT
bam-7960	198	16	synthetic	synthetic	ADJ
bam-7960	198	17	human	human	ADJ
bam-7960	198	18	ghrelin	ghrelin	NOUN
bam-7960	198	19	)	)	PUNCT
bam-7960	198	20	in	in	ADP
bam-7960	198	21	cachexia	cachexia	NOUN
bam-7960	198	22	associated	associate	VERB
bam-7960	198	23	with	with	ADP
bam-7960	198	24	chronic	chronic	ADJ
bam-7960	198	25	obstructive	obstructive	ADJ
bam-7960	198	26	pulmonary	pulmonary	ADJ
bam-7960	198	27	disease	disease	NOUN
bam-7960	198	28	.	.	PUNCT
bam-7960	199	1	espen	espen	PROPN
bam-7960	199	2	j	j	PROPN
bam-7960	199	3	2012;7	2012;7	NOUN
bam-7960	199	4	:	:	PUNCT
bam-7960	199	5	e171	e171	NUM
bam-7960	199	6	–	–	PUNCT
bam-7960	199	7	e175	e175	PROPN
bam-7960	199	8	.	.	PROPN
bam-7960	200	1	37	37	NUM
bam-7960	200	2	.	.	PUNCT
bam-7960	201	1	toledo	toledo	PROPN
bam-7960	201	2	m	m	PROPN
bam-7960	201	3	,	,	PUNCT
bam-7960	201	4	springer	springer	PROPN
bam-7960	201	5	j	j	PROPN
bam-7960	201	6	,	,	PUNCT
bam-7960	201	7	busquets	busquets	PROPN
bam-7960	201	8	s	s	PART
bam-7960	201	9	,	,	PUNCT
bam-7960	201	10	et	et	PROPN
bam-7960	201	11	al	al	PROPN
bam-7960	201	12	.	.	PROPN
bam-7960	201	13	formoterol	formoterol	PROPN
bam-7960	201	14	in	in	ADP
bam-7960	201	15	the	the	DET
bam-7960	201	16	treatment	treatment	NOUN
bam-7960	201	17	of	of	ADP
bam-7960	201	18	experimental	experimental	ADJ
bam-7960	201	19	cancer	cancer	NOUN
bam-7960	201	20	cachexia	cachexia	NOUN
bam-7960	201	21	:	:	PUNCT
bam-7960	201	22	effects	effect	NOUN
bam-7960	201	23	on	on	ADP
bam-7960	201	24	heart	heart	NOUN
bam-7960	201	25	function	function	NOUN
bam-7960	201	26	.	.	PUNCT
bam-7960	202	1	j	j	PROPN
bam-7960	202	2	cachexia	cachexia	PROPN
bam-7960	202	3	sarcopenia	sarcopenia	PROPN
bam-7960	202	4	muscle	muscle	PROPN
bam-7960	202	5	2014;5:315–320	2014;5:315–320	PROPN
bam-7960	202	6	.	.	PROPN
bam-7960	203	1	38	38	NUM
bam-7960	203	2	.	.	PUNCT
bam-7960	204	1	busquets	busquets	PROPN
bam-7960	204	2	s	s	PROPN
bam-7960	204	3	,	,	PUNCT
bam-7960	204	4	figueras	figueras	PROPN
bam-7960	204	5	mt	mt	PROPN
bam-7960	204	6	,	,	PUNCT
bam-7960	204	7	fuster	fuster	NOUN
bam-7960	204	8	g	g	PROPN
bam-7960	204	9	,	,	PUNCT
bam-7960	204	10	et	et	PROPN
bam-7960	204	11	al	al	PROPN
bam-7960	204	12	.	.	PUNCT
bam-7960	205	1	anticachectic	anticachectic	ADJ
bam-7960	205	2	effects	effect	NOUN
bam-7960	205	3	of	of	ADP
bam-7960	205	4	formoterol	formoterol	NOUN
bam-7960	205	5	:	:	PUNCT
bam-7960	205	6	a	a	DET
bam-7960	205	7	drug	drug	NOUN
bam-7960	205	8	for	for	ADP
bam-7960	205	9	potential	potential	ADJ
bam-7960	205	10	treatment	treatment	NOUN
bam-7960	205	11	of	of	ADP
bam-7960	205	12	muscle	muscle	NOUN
bam-7960	205	13	wasting	waste	VERB
bam-7960	205	14	.	.	PUNCT
bam-7960	206	1	cancer	cancer	NOUN
bam-7960	206	2	res	re	NOUN
bam-7960	206	3	2004;64:6725–31	2004;64:6725–31	NUM
bam-7960	206	4	.	.	PROPN
bam-7960	206	5	39	39	NUM
bam-7960	206	6	.	.	PUNCT
bam-7960	207	1	ametller	ametller	NOUN
bam-7960	207	2	e	e	PROPN
bam-7960	207	3	,	,	PUNCT
bam-7960	207	4	busquets	busquets	PROPN
bam-7960	207	5	s	s	PROPN
bam-7960	207	6	,	,	PUNCT
bam-7960	207	7	fuster	fuster	NOUN
bam-7960	207	8	g	g	PROPN
bam-7960	207	9	,	,	PUNCT
bam-7960	207	10	et	et	PROPN
bam-7960	207	11	al	al	PROPN
bam-7960	207	12	.	.	PROPN
bam-7960	207	13	formoterol	formoterol	PROPN
bam-7960	207	14	may	may	AUX
bam-7960	207	15	activate	activate	VERB
bam-7960	207	16	rat	rat	NOUN
bam-7960	207	17	muscle	muscle	NOUN
bam-7960	207	18	regeneration	regeneration	NOUN
bam-7960	207	19	during	during	ADP
bam-7960	207	20	cancer	cancer	NOUN
bam-7960	207	21	cachexia	cachexia	NOUN
bam-7960	207	22	.	.	PUNCT
bam-7960	208	1	insciences	inscience	NOUN
bam-7960	208	2	j	j	PROPN
bam-7960	208	3	2011;1:1–17	2011;1:1–17	NUM
bam-7960	208	4	.	.	PUNCT
bam-7960	209	1	40	40	NUM
bam-7960	209	2	.	.	PUNCT
bam-7960	210	1	toledo	toledo	PROPN
bam-7960	210	2	m	m	PROPN
bam-7960	210	3	,	,	PUNCT
bam-7960	210	4	busquets	busquets	PROPN
bam-7960	210	5	s	s	PROPN
bam-7960	210	6	,	,	PUNCT
bam-7960	210	7	penna	penna	PROPN
bam-7960	210	8	f	f	PROPN
bam-7960	210	9	,	,	PUNCT
bam-7960	210	10	et	et	PROPN
bam-7960	210	11	al	al	PROPN
bam-7960	210	12	.	.	PROPN
bam-7960	211	1	complete	complete	ADJ
bam-7960	211	2	reversal	reversal	NOUN
bam-7960	211	3	of	of	ADP
bam-7960	211	4	muscle	muscle	NOUN
bam-7960	211	5	wasting	waste	VERB
bam-7960	211	6	in	in	ADP
bam-7960	211	7	experimental	experimental	ADJ
bam-7960	211	8	cancer	cancer	NOUN
bam-7960	211	9	cachexia	cachexia	NOUN
bam-7960	211	10	:	:	PUNCT
bam-7960	211	11	additive	additive	ADJ
bam-7960	211	12	effects	effect	NOUN
bam-7960	211	13	of	of	ADP
bam-7960	211	14	activin	activin	PROPN
bam-7960	211	15	type	type	PROPN
bam-7960	211	16	ii	ii	PROPN
bam-7960	211	17	receptor	receptor	NOUN
bam-7960	211	18	inhibition	inhibition	NOUN
bam-7960	211	19	and	and	CCONJ
bam-7960	211	20	β-2	β-2	ADJ
bam-7960	211	21	agonist	agonist	NOUN
bam-7960	211	22	.	.	PUNCT
bam-7960	212	1	int	int	PROPN
bam-7960	212	2	j	j	PROPN
bam-7960	212	3	cancer	cancer	NOUN
bam-7960	212	4	2016;138:2021–2029	2016;138:2021–2029	NUM
bam-7960	212	5	.	.	PUNCT
bam-7960	212	6	41	41	NUM
bam-7960	212	7	.	.	PUNCT
bam-7960	213	1	greig	greig	PROPN
bam-7960	213	2	ca	ca	PROPN
bam-7960	213	3	,	,	PUNCT
bam-7960	213	4	johns	johns	PROPN
bam-7960	213	5	n	n	CCONJ
bam-7960	213	6	,	,	PUNCT
bam-7960	213	7	gray	gray	ADJ
bam-7960	213	8	c	c	NOUN
bam-7960	213	9	,	,	PUNCT
bam-7960	213	10	et	et	PROPN
bam-7960	213	11	al	al	PROPN
bam-7960	213	12	.	.	PROPN
bam-7960	213	13	phase	phase	PROPN
bam-7960	213	14	i	i	PROPN
bam-7960	213	15	/	/	SYM
bam-7960	213	16	ii	ii	PROPN
bam-7960	213	17	trial	trial	NOUN
bam-7960	213	18	of	of	ADP
bam-7960	213	19	formoterol	formoterol	NOUN
bam-7960	213	20	fumarate	fumarate	NOUN
bam-7960	213	21	combined	combine	VERB
bam-7960	213	22	with	with	ADP
bam-7960	213	23	megestrol	megestrol	NOUN
bam-7960	213	24	acetate	acetate	NOUN
bam-7960	213	25	in	in	ADP
bam-7960	213	26	cachectic	cachectic	ADJ
bam-7960	213	27	patients	patient	NOUN
bam-7960	213	28	with	with	ADP
bam-7960	213	29	advanced	advanced	ADJ
bam-7960	213	30	malignancy	malignancy	NOUN
bam-7960	213	31	.	.	PUNCT
bam-7960	214	1	support	support	NOUN
bam-7960	214	2	care	care	NOUN
bam-7960	214	3	cancer	cancer	NOUN
bam-7960	214	4	2014;22:1269	2014;22:1269	PROPN
bam-7960	214	5	–	–	PUNCT
bam-7960	214	6	1275	1275	NUM
bam-7960	214	7	.	.	PUNCT
bam-7960	215	1	42	42	NUM
bam-7960	215	2	.	.	PUNCT
bam-7960	216	1	kanzaki	kanzaki	PROPN
bam-7960	216	2	m	m	PROPN
bam-7960	216	3	,	,	PUNCT
bam-7960	216	4	soda	soda	PROPN
bam-7960	216	5	k	k	NOUN
bam-7960	216	6	,	,	PUNCT
bam-7960	216	7	gin	gin	NOUN
bam-7960	216	8	pt	pt	PROPN
bam-7960	216	9	,	,	PUNCT
bam-7960	216	10	et	et	PROPN
bam-7960	216	11	al	al	PROPN
bam-7960	216	12	.	.	PUNCT
bam-7960	217	1	erythropoietin	erythropoietin	PROPN
bam-7960	217	2	attenuates	attenuate	VERB
bam-7960	217	3	cachectic	cachectic	ADJ
bam-7960	217	4	events	event	NOUN
bam-7960	217	5	and	and	CCONJ
bam-7960	217	6	decreases	decrease	VERB
bam-7960	217	7	production	production	NOUN
bam-7960	217	8	of	of	ADP
bam-7960	217	9	interleukin-6	interleukin-6	NUM
bam-7960	217	10	,	,	PUNCT
bam-7960	217	11	a	a	DET
bam-7960	217	12	cachexia	cachexia	NOUN
bam-7960	217	13	-	-	PUNCT
bam-7960	217	14	inducing	induce	VERB
bam-7960	217	15	cytokine	cytokine	NOUN
bam-7960	217	16	.	.	PUNCT
bam-7960	218	1	cytokine	cytokine	NOUN
bam-7960	218	2	2005;32:234–239	2005;32:234–239	NUM
bam-7960	218	3	.	.	PUNCT
bam-7960	219	1	non	non	PROPN
bam-7960	219	2	co	co	PROPN
bam-7960	219	3	mmerc	mmerc	PROPN
bam-7960	219	4	ial	ial	PROPN
bam-7960	219	5	us	us	PROPN
bam-7960	220	1	e	e	NOUN
bam-7960	220	2	o	o	PROPN
bam-7960	220	3	nly	nly	ADV
bam-7960	220	4	https://www.cancer.gov/about-cancer/	https://www.cancer.gov/about-cancer/	VERB
bam-7960	220	5	therapeutic	therapeutic	ADJ
bam-7960	220	6	strategies	strategy	NOUN
bam-7960	220	7	against	against	ADP
bam-7960	220	8	cancer	cancer	NOUN
bam-7960	220	9	cachexia	cachexia	PROPN
bam-7960	220	10	eur	eur	PROPN
bam-7960	220	11	j	j	PROPN
bam-7960	220	12	transl	transl	PROPN
bam-7960	220	13	myol	myol	ADV
bam-7960	220	14	29	29	NUM
bam-7960	220	15	(	(	PUNCT
bam-7960	220	16	1	1	NUM
bam-7960	220	17	):	):	PUNCT
bam-7960	220	18	4	4	NUM
bam-7960	220	19	-	-	SYM
bam-7960	220	20	13	13	NUM
bam-7960	220	21	,	,	PUNCT
bam-7960	220	22	2019	2019	NUM
bam-7960	220	23	11	11	NUM
bam-7960	220	24	43	43	NUM
bam-7960	220	25	.	.	PUNCT
bam-7960	221	1	pin	pin	NOUN
bam-7960	221	2	f	f	PROPN
bam-7960	221	3	,	,	PUNCT
bam-7960	221	4	busquets	busquets	PROPN
bam-7960	221	5	s	s	PROPN
bam-7960	221	6	,	,	PUNCT
bam-7960	221	7	toledo	toledo	PROPN
bam-7960	221	8	m	m	PROPN
bam-7960	221	9	,	,	PUNCT
bam-7960	221	10	et	et	PROPN
bam-7960	221	11	al	al	PROPN
bam-7960	221	12	.	.	PROPN
bam-7960	221	13	combination	combination	NOUN
bam-7960	221	14	of	of	ADP
bam-7960	221	15	exercise	exercise	NOUN
bam-7960	221	16	training	training	NOUN
bam-7960	221	17	and	and	CCONJ
bam-7960	221	18	erythropoietin	erythropoietin	NOUN
bam-7960	221	19	prevents	prevent	VERB
bam-7960	221	20	cancer	cancer	NOUN
bam-7960	221	21	-	-	PUNCT
bam-7960	221	22	induced	induce	VERB
bam-7960	221	23	muscle	muscle	NOUN
bam-7960	221	24	alterations	alteration	NOUN
bam-7960	221	25	.	.	PUNCT
bam-7960	222	1	oncotarget	oncotarget	NOUN
bam-7960	222	2	2014;6:43202–15	2014;6:43202–15	NUM
bam-7960	222	3	.	.	PUNCT
bam-7960	223	1	44	44	NUM
bam-7960	223	2	.	.	PUNCT
bam-7960	224	1	murphy	murphy	PROPN
bam-7960	224	2	kt	kt	PROPN
bam-7960	224	3	,	,	PUNCT
bam-7960	224	4	chee	chee	NOUN
bam-7960	224	5	a	a	NOUN
bam-7960	224	6	,	,	PUNCT
bam-7960	224	7	trieu	trieu	PROPN
bam-7960	224	8	j	j	PROPN
bam-7960	224	9	,	,	PUNCT
bam-7960	224	10	et	et	PROPN
bam-7960	224	11	al	al	PROPN
bam-7960	224	12	.	.	PROPN
bam-7960	224	13	inhibition	inhibition	NOUN
bam-7960	224	14	of	of	ADP
bam-7960	224	15	the	the	DET
bam-7960	224	16	renin	renin	ADJ
bam-7960	224	17	-	-	PUNCT
bam-7960	224	18	angiotensin	angiotensin	NOUN
bam-7960	224	19	system	system	NOUN
bam-7960	224	20	improves	improve	VERB
bam-7960	224	21	physiological	physiological	ADJ
bam-7960	224	22	outcomes	outcome	NOUN
bam-7960	224	23	in	in	ADP
bam-7960	224	24	mice	mouse	NOUN
bam-7960	224	25	with	with	ADP
bam-7960	224	26	mild	mild	ADJ
bam-7960	224	27	or	or	CCONJ
bam-7960	224	28	severe	severe	ADJ
bam-7960	224	29	cancer	cancer	NOUN
bam-7960	224	30	cachexia	cachexia	NOUN
bam-7960	224	31	.	.	PUNCT
bam-7960	225	1	int	int	NOUN
bam-7960	225	2	j	j	PROPN
bam-7960	225	3	cancer	cancer	NOUN
bam-7960	225	4	2013;133:1234–1246	2013;133:1234–1246	PROPN
bam-7960	225	5	.	.	PUNCT
bam-7960	226	1	45	45	NUM
bam-7960	226	2	.	.	PUNCT
bam-7960	226	3	springer	springer	PROPN
bam-7960	226	4	j	j	PROPN
bam-7960	226	5	,	,	PUNCT
bam-7960	226	6	tschirner	tschirner	NOUN
bam-7960	226	7	a	a	PRON
bam-7960	226	8	,	,	PUNCT
bam-7960	226	9	haghikia	haghikia	NOUN
bam-7960	226	10	a	a	X
bam-7960	226	11	,	,	PUNCT
bam-7960	226	12	et	et	PROPN
bam-7960	226	13	al	al	PROPN
bam-7960	226	14	.	.	PROPN
bam-7960	226	15	prevention	prevention	NOUN
bam-7960	226	16	of	of	ADP
bam-7960	226	17	liver	liver	NOUN
bam-7960	226	18	cancer	cancer	NOUN
bam-7960	226	19	cachexia	cachexia	NOUN
bam-7960	226	20	-	-	PUNCT
bam-7960	226	21	induced	induce	VERB
bam-7960	226	22	cardiac	cardiac	ADJ
bam-7960	226	23	wasting	wasting	NOUN
bam-7960	226	24	and	and	CCONJ
bam-7960	226	25	heart	heart	NOUN
bam-7960	226	26	failure	failure	NOUN
bam-7960	226	27	.	.	PUNCT
bam-7960	227	1	eur	eur	ADJ
bam-7960	227	2	heart	heart	NOUN
bam-7960	227	3	j	j	PROPN
bam-7960	227	4	2013	2013	NUM
bam-7960	227	5	doi:10.1093	doi:10.1093	NOUN
bam-7960	227	6	/	/	SYM
bam-7960	227	7	eurheartj	eurheartj	ADJ
bam-7960	227	8	/	/	SYM
bam-7960	227	9	eht302	eht302	NOUN
bam-7960	227	10	.	.	PUNCT
bam-7960	228	1	46	46	NUM
bam-7960	228	2	.	.	PUNCT
bam-7960	229	1	schanze	schanze	PROPN
bam-7960	229	2	n	n	CCONJ
bam-7960	229	3	,	,	PUNCT
bam-7960	229	4	springer	springer	NOUN
bam-7960	229	5	j.	j.	PROPN
bam-7960	229	6	evidence	evidence	NOUN
bam-7960	229	7	for	for	ADP
bam-7960	229	8	an	an	DET
bam-7960	229	9	effect	effect	NOUN
bam-7960	229	10	of	of	ADP
bam-7960	229	11	ace	ace	ADJ
bam-7960	229	12	inhibitors	inhibitor	NOUN
bam-7960	229	13	on	on	ADP
bam-7960	229	14	cancer	cancer	NOUN
bam-7960	229	15	cachexia	cachexia	NOUN
bam-7960	229	16	.	.	PUNCT
bam-7960	230	1	j	j	PROPN
bam-7960	230	2	cachexia	cachexia	PROPN
bam-7960	230	3	sarcopenia	sarcopenia	PROPN
bam-7960	230	4	muscle	muscle	PROPN
bam-7960	230	5	2012;3:139	2012;3:139	NOUN
bam-7960	230	6	.	.	PUNCT
bam-7960	231	1	47	47	NUM
bam-7960	231	2	.	.	PUNCT
bam-7960	231	3	sukumaran	sukumaran	PROPN
bam-7960	231	4	s	s	PROPN
bam-7960	231	5	,	,	PUNCT
bam-7960	231	6	patel	patel	PROPN
bam-7960	231	7	hj	hj	PROPN
bam-7960	231	8	,	,	PUNCT
bam-7960	231	9	patel	patel	PROPN
bam-7960	231	10	bm	bm	PROPN
bam-7960	231	11	.	.	PUNCT
bam-7960	232	1	evaluation	evaluation	NOUN
bam-7960	232	2	of	of	ADP
bam-7960	232	3	role	role	NOUN
bam-7960	232	4	of	of	ADP
bam-7960	232	5	telmisartan	telmisartan	NOUN
bam-7960	232	6	in	in	ADP
bam-7960	232	7	combination	combination	NOUN
bam-7960	232	8	with	with	ADP
bam-7960	232	9	5fluorouracil	5fluorouracil	NUM
bam-7960	232	10	in	in	ADP
bam-7960	232	11	gastric	gastric	ADJ
bam-7960	232	12	cancer	cancer	NOUN
bam-7960	232	13	cachexia	cachexia	NOUN
bam-7960	232	14	.	.	PUNCT
bam-7960	233	1	life	life	NOUN
bam-7960	233	2	sci	sci	PROPN
bam-7960	233	3	2016;154:15–23	2016;154:15–23	PROPN
bam-7960	233	4	.	.	PROPN
bam-7960	233	5	48	48	NUM
bam-7960	233	6	.	.	PUNCT
bam-7960	234	1	patel	patel	PROPN
bam-7960	234	2	bm	bm	PROPN
bam-7960	234	3	,	,	PUNCT
bam-7960	234	4	damle	damle	VERB
bam-7960	234	5	d.	d.	PROPN
bam-7960	234	6	combination	combination	NOUN
bam-7960	234	7	of	of	ADP
bam-7960	234	8	telmisartan	telmisartan	NOUN
bam-7960	234	9	with	with	ADP
bam-7960	234	10	cisplatin	cisplatin	NOUN
bam-7960	234	11	controls	control	VERB
bam-7960	234	12	oral	oral	ADJ
bam-7960	234	13	cancer	cancer	NOUN
bam-7960	234	14	cachexia	cachexia	NOUN
bam-7960	234	15	in	in	ADP
bam-7960	234	16	rats	rat	NOUN
bam-7960	234	17	.	.	PUNCT
bam-7960	235	1	biomed	biome	VERB
bam-7960	235	2	res	re	NOUN
bam-7960	235	3	int	int	NOUN
bam-7960	235	4	2013;2013:1–10	2013;2013:1–10	NUM
bam-7960	235	5	.	.	PROPN
bam-7960	236	1	49	49	NUM
bam-7960	236	2	.	.	PUNCT
bam-7960	237	1	ichiki	ichiki	PROPN
bam-7960	237	2	t	t	PROPN
bam-7960	237	3	,	,	PUNCT
bam-7960	237	4	tian	tian	PROPN
bam-7960	237	5	q	q	NOUN
bam-7960	237	6	,	,	PUNCT
bam-7960	237	7	imayama	imayama	PROPN
bam-7960	238	1	i	i	PRON
bam-7960	238	2	,	,	PUNCT
bam-7960	238	3	sunagawa	sunagawa	PROPN
bam-7960	238	4	k.	k.	PROPN
bam-7960	238	5	abstract	abstract	PROPN
bam-7960	238	6	5249	5249	NUM
bam-7960	238	7	:	:	PUNCT
bam-7960	238	8	telmisartan	telmisartan	NOUN
bam-7960	238	9	manifests	manifest	VERB
bam-7960	238	10	powerful	powerful	ADJ
bam-7960	238	11	antiinflammatory	antiinflammatory	NOUN
bam-7960	238	12	effects	effect	NOUN
bam-7960	238	13	beyond	beyond	ADP
bam-7960	238	14	class	class	NOUN
bam-7960	238	15	effects	effect	NOUN
bam-7960	238	16	of	of	ADP
bam-7960	238	17	angiotensin	angiotensin	NOUN
bam-7960	238	18	ii	ii	PROPN
bam-7960	238	19	type	type	NOUN
bam-7960	238	20	1	1	NUM
bam-7960	238	21	blocker	blocker	NOUN
bam-7960	238	22	by	by	ADP
bam-7960	238	23	inhibiting	inhibit	VERB
bam-7960	238	24	tumor	tumor	NOUN
bam-7960	238	25	necrosis	necrosis	NOUN
bam-7960	238	26	factor	factor	NOUN
bam-7960	238	27	α	α	NOUN
bam-7960	238	28	-	-	PUNCT
bam-7960	238	29	induced	induce	VERB
bam-7960	238	30	interleukin	interleukin	NOUN
bam-7960	238	31	6	6	NUM
bam-7960	238	32	expressions	expression	NOUN
bam-7960	238	33	through	through	ADP
bam-7960	238	34	ppar	ppar	NOUN
bam-7960	238	35	.	.	PUNCT
bam-7960	239	1	circulation	circulation	NOUN
bam-7960	239	2	2016;118	2016;118	NUM
bam-7960	239	3	.	.	PUNCT
bam-7960	240	1	50	50	NUM
bam-7960	240	2	.	.	PUNCT
bam-7960	241	1	miao	miao	NOUN
bam-7960	241	2	c	c	PROPN
bam-7960	241	3	,	,	PUNCT
bam-7960	241	4	lv	lv	PROPN
bam-7960	241	5	y	y	PROPN
bam-7960	241	6	,	,	PUNCT
bam-7960	241	7	zhang	zhang	PROPN
bam-7960	241	8	w	w	PROPN
bam-7960	241	9	,	,	PUNCT
bam-7960	241	10	et	et	PROPN
bam-7960	241	11	al	al	PROPN
bam-7960	241	12	.	.	PROPN
bam-7960	241	13	pyrrolidine	pyrrolidine	PROPN
bam-7960	241	14	dithiocarbamate	dithiocarbamate	NOUN
bam-7960	241	15	(	(	PUNCT
bam-7960	241	16	pdtc	pdtc	ADV
bam-7960	241	17	)	)	PUNCT
bam-7960	241	18	attenuates	attenuate	VERB
bam-7960	241	19	cancer	cancer	NOUN
bam-7960	241	20	cachexia	cachexia	NOUN
bam-7960	241	21	by	by	ADP
bam-7960	241	22	affecting	affect	VERB
bam-7960	241	23	muscle	muscle	NOUN
bam-7960	241	24	atrophy	atrophy	NOUN
bam-7960	241	25	and	and	CCONJ
bam-7960	241	26	fat	fat	ADJ
bam-7960	241	27	lipolysis	lipolysis	NOUN
bam-7960	241	28	.	.	PUNCT
bam-7960	242	1	front	front	ADJ
bam-7960	242	2	pharmacol	pharmacol	PROPN
bam-7960	242	3	2017;8:915	2017;8:915	NUM
bam-7960	242	4	.	.	PUNCT
bam-7960	243	1	51	51	NUM
bam-7960	243	2	.	.	PUNCT
bam-7960	243	3	lainscak	lainscak	PROPN
bam-7960	243	4	m	m	PROPN
bam-7960	243	5	,	,	PUNCT
bam-7960	243	6	laviano	laviano	PROPN
bam-7960	243	7	a.	a.	PROPN
bam-7960	243	8	act	act	PROPN
bam-7960	243	9	-	-	PUNCT
bam-7960	243	10	one	one	NUM
bam-7960	243	11	action	action	NOUN
bam-7960	243	12	at	at	ADP
bam-7960	243	13	last	last	ADV
bam-7960	243	14	on	on	ADP
bam-7960	243	15	cancer	cancer	NOUN
bam-7960	243	16	cachexia	cachexia	NOUN
bam-7960	243	17	by	by	ADP
bam-7960	243	18	adapting	adapt	VERB
bam-7960	243	19	a	a	DET
bam-7960	243	20	novel	novel	ADJ
bam-7960	243	21	action	action	NOUN
bam-7960	243	22	beta	beta	NOUN
bam-7960	243	23	-	-	PUNCT
bam-7960	243	24	blocker	blocker	NOUN
bam-7960	243	25	.	.	PUNCT
bam-7960	244	1	j	j	PROPN
bam-7960	244	2	cachexia	cachexia	PROPN
bam-7960	244	3	sarcopenia	sarcopenia	PROPN
bam-7960	244	4	muscle	muscle	PROPN
bam-7960	244	5	2016;7:400–2	2016;7:400–2	NUM
bam-7960	244	6	.	.	PUNCT
bam-7960	245	1	52	52	NUM
bam-7960	245	2	.	.	PUNCT
bam-7960	246	1	stewart	stewart	PROPN
bam-7960	246	2	coats	coats	PROPN
bam-7960	246	3	aj	aj	PROPN
bam-7960	246	4	,	,	PUNCT
bam-7960	246	5	ho	ho	PROPN
bam-7960	246	6	gf	gf	PROPN
bam-7960	246	7	,	,	PUNCT
bam-7960	246	8	et	et	PROPN
bam-7960	246	9	al	al	PROPN
bam-7960	246	10	.	.	PROPN
bam-7960	246	11	espindolol	espindolol	PROPN
bam-7960	246	12	for	for	ADP
bam-7960	246	13	the	the	DET
bam-7960	246	14	treatment	treatment	NOUN
bam-7960	246	15	and	and	CCONJ
bam-7960	246	16	prevention	prevention	NOUN
bam-7960	246	17	of	of	ADP
bam-7960	246	18	cachexia	cachexia	NOUN
bam-7960	246	19	in	in	ADP
bam-7960	246	20	patients	patient	NOUN
bam-7960	246	21	with	with	ADP
bam-7960	246	22	stage	stage	NOUN
bam-7960	246	23	iii	iii	SYM
bam-7960	246	24	/	/	SYM
bam-7960	246	25	iv	iv	NUM
bam-7960	246	26	non	non	ADJ
bam-7960	246	27	-	-	ADJ
bam-7960	246	28	small	small	ADJ
bam-7960	246	29	cell	cell	NOUN
bam-7960	246	30	lung	lung	NOUN
bam-7960	246	31	cancer	cancer	NOUN
bam-7960	246	32	or	or	CCONJ
bam-7960	246	33	colorectal	colorectal	ADJ
bam-7960	246	34	cancer	cancer	NOUN
bam-7960	246	35	:	:	PUNCT
bam-7960	246	36	a	a	DET
bam-7960	246	37	randomized	randomized	ADJ
bam-7960	246	38	,	,	PUNCT
bam-7960	246	39	double	double	ADJ
bam-7960	246	40	-	-	PUNCT
bam-7960	246	41	blind	blind	ADJ
bam-7960	246	42	,	,	PUNCT
bam-7960	246	43	placebo	placebo	NOUN
bam-7960	246	44	-	-	PUNCT
bam-7960	246	45	controlled	control	VERB
bam-7960	246	46	,	,	PUNCT
bam-7960	246	47	international	international	ADJ
bam-7960	246	48	multicentre	multicentre	NOUN
bam-7960	246	49	phase	phase	NOUN
bam-7960	246	50	ii	ii	PROPN
bam-7960	246	51	study	study	NOUN
bam-7960	246	52	(	(	PUNCT
bam-7960	246	53	the	the	DET
bam-7960	246	54	act	act	PROPN
bam-7960	246	55	-	-	PUNCT
bam-7960	246	56	one	one	NUM
bam-7960	246	57	trial	trial	NOUN
bam-7960	246	58	)	)	PUNCT
bam-7960	246	59	.	.	PUNCT
bam-7960	247	1	j	j	PROPN
bam-7960	247	2	cachexia	cachexia	PROPN
bam-7960	247	3	sarcopenia	sarcopenia	PROPN
bam-7960	247	4	muscle	muscle	PROPN
bam-7960	247	5	2016;7:355–65	2016;7:355–65	PROPN
bam-7960	247	6	.	.	PUNCT
bam-7960	248	1	53	53	NUM
bam-7960	248	2	.	.	PUNCT
bam-7960	249	1	bhattacharyya	bhattacharyya	PROPN
bam-7960	249	2	gs	gs	PROPN
bam-7960	249	3	.	.	PUNCT
bam-7960	250	1	vicus	vicus	PROPN
bam-7960	250	2	therapeutics	therapeutic	NOUN
bam-7960	250	3	announces	announce	VERB
bam-7960	250	4	safety	safety	NOUN
bam-7960	250	5	and	and	CCONJ
bam-7960	250	6	survival	survival	NOUN
bam-7960	250	7	benefit	benefit	NOUN
bam-7960	250	8	of	of	ADP
bam-7960	250	9	vt-122	vt-122	NOUN
bam-7960	250	10	in	in	ADP
bam-7960	250	11	combination	combination	NOUN
bam-7960	250	12	with	with	ADP
bam-7960	250	13	anti	anti	ADJ
bam-7960	250	14	-	-	ADJ
bam-7960	250	15	cancer	cancer	ADJ
bam-7960	250	16	therapies	therapy	NOUN
bam-7960	250	17	for	for	ADP
bam-7960	250	18	advanced	advanced	ADJ
bam-7960	250	19	liver	liver	NOUN
bam-7960	250	20	and	and	CCONJ
bam-7960	250	21	pancreatic	pancreatic	ADJ
bam-7960	250	22	cancers	cancer	NOUN
bam-7960	250	23	.	.	PUNCT
bam-7960	251	1	2015http://www.prnewswire.com/newsreleases/vicus-therapeutics-announces-safety-andsurvival-benefit-of-vt-122-in-combination-withanti-cancer-therapies-for-advanced-liver-andpancreatic-cancers-300021768.html	2015http://www.prnewswire.com/newsreleases/vicus-therapeutics-announces-safety-andsurvival-benefit-of-vt-122-in-combination-withanti-cancer-therapies-for-advanced-liver-andpancreatic-cancers-300021768.html	NUM
bam-7960	251	2	.	.	PUNCT
bam-7960	252	1	54	54	NUM
bam-7960	252	2	.	.	PUNCT
bam-7960	252	3	dobs	dob	NOUN
bam-7960	252	4	as	as	ADP
bam-7960	252	5	,	,	PUNCT
bam-7960	252	6	boccia	boccia	PROPN
bam-7960	252	7	r	r	NOUN
bam-7960	252	8	v	v	NOUN
bam-7960	252	9	,	,	PUNCT
bam-7960	252	10	croot	croot	NOUN
bam-7960	252	11	cc	cc	PROPN
bam-7960	252	12	,	,	PUNCT
bam-7960	252	13	et	et	PROPN
bam-7960	252	14	al	al	PROPN
bam-7960	252	15	.	.	PUNCT
bam-7960	253	1	effects	effect	NOUN
bam-7960	253	2	of	of	ADP
bam-7960	253	3	enobosarm	enobosarm	NOUN
bam-7960	253	4	on	on	ADP
bam-7960	253	5	muscle	muscle	NOUN
bam-7960	253	6	wasting	waste	VERB
bam-7960	253	7	and	and	CCONJ
bam-7960	253	8	physical	physical	ADJ
bam-7960	253	9	function	function	NOUN
bam-7960	253	10	in	in	ADP
bam-7960	253	11	patients	patient	NOUN
bam-7960	253	12	with	with	ADP
bam-7960	253	13	cancer	cancer	NOUN
bam-7960	253	14	:	:	PUNCT
bam-7960	253	15	a	a	DET
bam-7960	253	16	double	double	ADJ
bam-7960	253	17	-	-	PUNCT
bam-7960	253	18	blind	blind	ADJ
bam-7960	253	19	,	,	PUNCT
bam-7960	253	20	randomised	randomise	VERB
bam-7960	253	21	controlled	control	VERB
bam-7960	253	22	phase	phase	NOUN
bam-7960	253	23	2	2	NUM
bam-7960	253	24	trial	trial	NOUN
bam-7960	253	25	.	.	PUNCT
bam-7960	254	1	lancet	lancet	PROPN
bam-7960	254	2	oncol	oncol	PROPN
bam-7960	254	3	2013;14:335–45	2013;14:335–45	NUM
bam-7960	254	4	.	.	PUNCT
bam-7960	255	1	55	55	NUM
bam-7960	255	2	.	.	PUNCT
bam-7960	256	1	crawford	crawford	PROPN
bam-7960	256	2	j	j	PROPN
bam-7960	256	3	,	,	PUNCT
bam-7960	256	4	prado	prado	PROPN
bam-7960	256	5	cmm	cmm	PROPN
bam-7960	256	6	,	,	PUNCT
bam-7960	256	7	johnston	johnston	PROPN
bam-7960	256	8	ma	ma	PROPN
bam-7960	256	9	,	,	PUNCT
bam-7960	256	10	et	et	PROPN
bam-7960	256	11	al	al	PROPN
bam-7960	256	12	.	.	PROPN
bam-7960	256	13	study	study	NOUN
bam-7960	256	14	design	design	NOUN
bam-7960	256	15	and	and	CCONJ
bam-7960	256	16	rationale	rationale	NOUN
bam-7960	256	17	for	for	ADP
bam-7960	256	18	the	the	DET
bam-7960	256	19	phase	phase	NOUN
bam-7960	256	20	3	3	NUM
bam-7960	256	21	clinical	clinical	ADJ
bam-7960	256	22	development	development	NOUN
bam-7960	256	23	program	program	NOUN
bam-7960	256	24	of	of	ADP
bam-7960	256	25	enobosarm	enobosarm	PROPN
bam-7960	256	26	,	,	PUNCT
bam-7960	256	27	a	a	DET
bam-7960	256	28	selective	selective	ADJ
bam-7960	256	29	androgen	androgen	NOUN
bam-7960	256	30	receptor	receptor	NOUN
bam-7960	256	31	modulator	modulator	NOUN
bam-7960	256	32	,	,	PUNCT
bam-7960	256	33	for	for	ADP
bam-7960	256	34	the	the	DET
bam-7960	256	35	prevention	prevention	NOUN
bam-7960	256	36	and	and	CCONJ
bam-7960	256	37	treatment	treatment	NOUN
bam-7960	256	38	of	of	ADP
bam-7960	256	39	muscle	muscle	NOUN
bam-7960	256	40	wasting	waste	VERB
bam-7960	256	41	in	in	ADP
bam-7960	256	42	cancer	cancer	NOUN
bam-7960	256	43	patients	patient	NOUN
bam-7960	256	44	(	(	PUNCT
bam-7960	256	45	power	power	NOUN
bam-7960	256	46	trials	trial	NOUN
bam-7960	256	47	)	)	PUNCT
bam-7960	256	48	.	.	PUNCT
bam-7960	257	1	curr	curr	PROPN
bam-7960	257	2	oncol	oncol	PROPN
bam-7960	257	3	rep	rep	PROPN
bam-7960	257	4	2016;18:37	2016;18:37	NUM
bam-7960	257	5	.	.	PUNCT
bam-7960	258	1	56	56	NUM
bam-7960	258	2	.	.	PUNCT
bam-7960	259	1	srinath	srinath	PROPN
bam-7960	259	2	r	r	PROPN
bam-7960	259	3	,	,	PUNCT
bam-7960	259	4	dobs	dobs	PROPN
bam-7960	259	5	a.	a.	PROPN
bam-7960	259	6	enobosarm	enobosarm	PROPN
bam-7960	259	7	(	(	PUNCT
bam-7960	259	8	gtx-024	gtx-024	NOUN
bam-7960	259	9	,	,	PUNCT
bam-7960	259	10	s-22	s-22	PROPN
bam-7960	259	11	):	):	PUNCT
bam-7960	259	12	a	a	DET
bam-7960	259	13	potential	potential	ADJ
bam-7960	259	14	treatment	treatment	NOUN
bam-7960	259	15	for	for	ADP
bam-7960	259	16	cachexia	cachexia	NOUN
bam-7960	259	17	.	.	PUNCT
bam-7960	260	1	futur	futur	PROPN
bam-7960	260	2	oncol	oncol	PROPN
bam-7960	260	3	2014;10:187–194	2014;10:187–194	NUM
bam-7960	260	4	.	.	PUNCT
bam-7960	261	1	57	57	NUM
bam-7960	261	2	.	.	PUNCT
bam-7960	262	1	wang	wang	PROPN
bam-7960	262	2	q	q	PROPN
bam-7960	262	3	,	,	PUNCT
bam-7960	262	4	mcpherron	mcpherron	PROPN
bam-7960	262	5	ac	ac	PROPN
bam-7960	262	6	.	.	PUNCT
bam-7960	263	1	myostatin	myostatin	ADJ
bam-7960	263	2	inhibition	inhibition	NOUN
bam-7960	263	3	induces	induce	VERB
bam-7960	263	4	muscle	muscle	NOUN
bam-7960	263	5	fibre	fibre	NOUN
bam-7960	263	6	hypertrophy	hypertrophy	NOUN
bam-7960	263	7	prior	prior	ADV
bam-7960	263	8	to	to	ADP
bam-7960	263	9	satellite	satellite	NOUN
bam-7960	263	10	cell	cell	NOUN
bam-7960	263	11	activation	activation	NOUN
bam-7960	263	12	.	.	PUNCT
bam-7960	264	1	j	j	PROPN
bam-7960	264	2	physiol	physiol	PROPN
bam-7960	264	3	2012;590:2151–65	2012;590:2151–65	PROPN
bam-7960	264	4	.	.	PUNCT
bam-7960	265	1	58	58	NUM
bam-7960	265	2	.	.	PUNCT
bam-7960	266	1	smith	smith	PROPN
bam-7960	266	2	rc	rc	PROPN
bam-7960	266	3	,	,	PUNCT
bam-7960	266	4	lin	lin	PROPN
bam-7960	266	5	bk	bk	PROPN
bam-7960	266	6	.	.	PUNCT
bam-7960	267	1	myostatin	myostatin	ADJ
bam-7960	267	2	inhibitors	inhibitor	NOUN
bam-7960	267	3	as	as	ADP
bam-7960	267	4	therapies	therapy	NOUN
bam-7960	267	5	for	for	ADP
bam-7960	267	6	muscle	muscle	NOUN
bam-7960	267	7	wasting	waste	VERB
bam-7960	267	8	associated	associate	VERB
bam-7960	267	9	with	with	ADP
bam-7960	267	10	cancer	cancer	NOUN
bam-7960	267	11	and	and	CCONJ
bam-7960	267	12	other	other	ADJ
bam-7960	267	13	disorders	disorder	NOUN
bam-7960	267	14	.	.	PUNCT
bam-7960	268	1	curr	curr	PROPN
bam-7960	268	2	opin	opin	NOUN
bam-7960	268	3	support	support	NOUN
bam-7960	268	4	palliat	palliat	VERB
bam-7960	268	5	care	care	PROPN
bam-7960	268	6	2013;7:352–360	2013;7:352–360	NUM
bam-7960	268	7	.	.	PUNCT
bam-7960	269	1	59	59	NUM
bam-7960	269	2	.	.	PUNCT
bam-7960	270	1	amg	amg	PROPN
bam-7960	270	2	745	745	NUM
bam-7960	270	3	in	in	ADP
bam-7960	270	4	subjects	subject	NOUN
bam-7960	270	5	with	with	ADP
bam-7960	270	6	age	age	NOUN
bam-7960	270	7	-	-	PUNCT
bam-7960	270	8	associated	associate	VERB
bam-7960	270	9	muscle	muscle	NOUN
bam-7960	270	10	loss	loss	NOUN
bam-7960	270	11	full	full	ADJ
bam-7960	270	12	text	text	NOUN
bam-7960	270	13	view	view	NOUN
bam-7960	270	14	clinicaltrials.gov	clinicaltrials.gov	NOUN
bam-7960	270	15	.	.	PUNCT
bam-7960	271	1	https://clinicaltrials.gov/show/nct00975104	https://clinicaltrials.gov/show/nct00975104	PROPN
bam-7960	271	2	.	.	PROPN
bam-7960	272	1	accessed	access	VERB
bam-7960	272	2	10	10	NUM
bam-7960	272	3	april	april	PROPN
bam-7960	272	4	2017	2017	NUM
bam-7960	272	5	.	.	PUNCT
bam-7960	273	1	60	60	NUM
bam-7960	273	2	.	.	PUNCT
bam-7960	274	1	a	a	DET
bam-7960	274	2	safety	safety	NOUN
bam-7960	274	3	,	,	PUNCT
bam-7960	274	4	tolerability	tolerability	NOUN
bam-7960	274	5	,	,	PUNCT
bam-7960	274	6	pharmacokinetic	pharmacokinetic	ADJ
bam-7960	274	7	and	and	CCONJ
bam-7960	274	8	pharmacodynamic	pharmacodynamic	ADJ
bam-7960	274	9	study	study	NOUN
bam-7960	274	10	of	of	ADP
bam-7960	274	11	ace-031	ace-031	NOUN
bam-7960	274	12	(	(	PUNCT
bam-7960	274	13	actriibigg1)in	actriibigg1)in	ADP
bam-7960	274	14	healthy	healthy	ADJ
bam-7960	274	15	postmenopausal	postmenopausal	NOUN
bam-7960	274	16	volunteers	volunteer	NOUN
bam-7960	274	17	full	full	ADJ
bam-7960	274	18	text	text	NOUN
bam-7960	274	19	view	view	NOUN
bam-7960	274	20	clinicaltrials.gov	clinicaltrials.gov	X
bam-7960	274	21	.	.	PUNCT
bam-7960	274	22	https://clinical	https://clinical	PROPN
bam-7960	274	23	trials.gov/ct2/show/nct00755638?term=	trials.gov/ct2/show/nct00755638?term=	PROPN
bam-7960	274	24	nct007	nct007	PROPN
bam-7960	274	25	55638&rank=1	55638&rank=1	NUM
bam-7960	274	26	.	.	PUNCT
bam-7960	275	1	accessed	access	VERB
bam-7960	275	2	10	10	NUM
bam-7960	275	3	april	april	PROPN
bam-7960	275	4	2017	2017	NUM
bam-7960	275	5	.	.	PUNCT
bam-7960	276	1	61	61	NUM
bam-7960	276	2	.	.	PUNCT
bam-7960	277	1	abstracts	abstract	NOUN
bam-7960	277	2	of	of	ADP
bam-7960	277	3	the	the	DET
bam-7960	277	4	7th	7th	ADJ
bam-7960	277	5	cachexia	cachexia	PROPN
bam-7960	277	6	conference	conference	NOUN
bam-7960	277	7	,	,	PUNCT
bam-7960	277	8	kobe	kobe	PROPN
bam-7960	277	9	/	/	SYM
bam-7960	277	10	osaka	osaka	PROPN
bam-7960	277	11	,	,	PUNCT
bam-7960	277	12	japan	japan	PROPN
bam-7960	277	13	,	,	PUNCT
bam-7960	277	14	december	december	PROPN
bam-7960	277	15	9	9	NUM
bam-7960	277	16	-	-	SYM
bam-7960	277	17	11	11	NUM
bam-7960	277	18	,	,	PUNCT
bam-7960	277	19	2013	2013	NUM
bam-7960	277	20	.	.	PUNCT
bam-7960	278	1	j	j	PROPN
bam-7960	278	2	cachexia	cachexia	PROPN
bam-7960	278	3	sarcopenia	sarcopenia	PROPN
bam-7960	278	4	muscle	muscle	PROPN
bam-7960	278	5	2013;4:295–343	2013;4:295–343	PROPN
bam-7960	278	6	.	.	PROPN
bam-7960	279	1	62	62	NUM
bam-7960	279	2	.	.	PUNCT
bam-7960	280	1	lach	lach	NOUN
bam-7960	280	2	-	-	PUNCT
bam-7960	280	3	trifilieff	trifilieff	NOUN
bam-7960	280	4	e	e	NOUN
bam-7960	280	5	,	,	PUNCT
bam-7960	280	6	minetti	minetti	NOUN
bam-7960	280	7	gc	gc	PROPN
bam-7960	280	8	,	,	PUNCT
bam-7960	280	9	sheppard	sheppard	PROPN
bam-7960	280	10	k	k	PROPN
bam-7960	280	11	,	,	PUNCT
bam-7960	280	12	et	et	PROPN
bam-7960	280	13	al	al	PROPN
bam-7960	280	14	.	.	PUNCT
bam-7960	281	1	an	an	DET
bam-7960	281	2	antibody	antibody	NOUN
bam-7960	281	3	blocking	block	VERB
bam-7960	281	4	activin	activin	PROPN
bam-7960	281	5	type	type	PROPN
bam-7960	281	6	ii	ii	PROPN
bam-7960	281	7	receptors	receptor	NOUN
bam-7960	281	8	induces	induce	VERB
bam-7960	281	9	strong	strong	ADJ
bam-7960	281	10	skeletal	skeletal	ADJ
bam-7960	281	11	muscle	muscle	NOUN
bam-7960	281	12	hypertrophy	hypertrophy	NOUN
bam-7960	281	13	and	and	CCONJ
bam-7960	281	14	protects	protect	VERB
bam-7960	281	15	from	from	ADP
bam-7960	281	16	atrophy	atrophy	NOUN
bam-7960	281	17	.	.	PUNCT
bam-7960	282	1	mol	mol	ADP
bam-7960	282	2	cell	cell	NOUN
bam-7960	282	3	biol	biol	NOUN
bam-7960	282	4	2014;34:606–18	2014;34:606–18	NUM
bam-7960	282	5	.	.	PROPN
bam-7960	282	6	63	63	NUM
bam-7960	282	7	.	.	PUNCT
bam-7960	282	8	becker	becker	PROPN
bam-7960	283	1	c	c	PROPN
bam-7960	283	2	,	,	PUNCT
bam-7960	283	3	lord	lord	PROPN
bam-7960	283	4	sr	sr	PROPN
bam-7960	283	5	,	,	PUNCT
bam-7960	283	6	studenski	studenski	PROPN
bam-7960	283	7	sa	sa	PROPN
bam-7960	283	8	,	,	PUNCT
bam-7960	283	9	et	et	PROPN
bam-7960	283	10	al	al	PROPN
bam-7960	283	11	.	.	PROPN
bam-7960	284	1	myostatin	myostatin	PROPN
bam-7960	284	2	antibody	antibody	NOUN
bam-7960	284	3	(	(	PUNCT
bam-7960	284	4	ly2495655	ly2495655	NOUN
bam-7960	284	5	)	)	PUNCT
bam-7960	284	6	in	in	ADP
bam-7960	284	7	older	old	ADJ
bam-7960	284	8	weak	weak	ADJ
bam-7960	284	9	fallers	faller	NOUN
bam-7960	284	10	:	:	PUNCT
bam-7960	284	11	a	a	DET
bam-7960	284	12	proof	proof	NOUN
bam-7960	284	13	-	-	PUNCT
bam-7960	284	14	of	of	ADP
bam-7960	284	15	-	-	PUNCT
bam-7960	284	16	concept	concept	NOUN
bam-7960	284	17	,	,	PUNCT
bam-7960	284	18	randomised	randomise	VERB
bam-7960	284	19	,	,	PUNCT
bam-7960	284	20	phase	phase	NOUN
bam-7960	284	21	2	2	NUM
bam-7960	284	22	trial	trial	NOUN
bam-7960	284	23	.	.	PUNCT
bam-7960	285	1	lancet	lancet	NOUN
bam-7960	285	2	diabetes	diabetes	NOUN
bam-7960	285	3	endocrinol	endocrinol	VERB
bam-7960	285	4	2015;3:948–957	2015;3:948–957	NUM
bam-7960	285	5	.	.	PUNCT
bam-7960	286	1	64	64	NUM
bam-7960	286	2	.	.	PUNCT
bam-7960	287	1	a	a	DET
bam-7960	287	2	phase	phase	NOUN
bam-7960	287	3	2	2	NUM
bam-7960	287	4	study	study	NOUN
bam-7960	287	5	of	of	ADP
bam-7960	287	6	ly2495655	ly2495655	NOUN
bam-7960	287	7	in	in	ADP
bam-7960	287	8	participants	participant	NOUN
bam-7960	287	9	with	with	ADP
bam-7960	287	10	pancreatic	pancreatic	ADJ
bam-7960	287	11	cancer	cancer	NOUN
bam-7960	287	12	full	full	ADJ
bam-7960	287	13	text	text	NOUN
bam-7960	287	14	view	view	NOUN
bam-7960	287	15	clinicaltrials.gov.https://clinicaltrials.gov/ct2/	clinicaltrials.gov.https://clinicaltrials.gov/ct2/	INTJ
bam-7960	287	16	show	show	VERB
bam-7960	287	17	/nct01505530	/nct01505530	PUNCT
bam-7960	287	18	.	.	PUNCT
bam-7960	288	1	accessed	access	VERB
bam-7960	288	2	10	10	NUM
bam-7960	288	3	april	april	PROPN
bam-7960	288	4	2017	2017	NUM
bam-7960	288	5	.	.	PUNCT
bam-7960	289	1	65	65	NUM
bam-7960	289	2	.	.	PUNCT
bam-7960	290	1	argilés	argilés	PROPN
bam-7960	290	2	jm	jm	PROPN
bam-7960	290	3	,	,	PUNCT
bam-7960	290	4	lópez	lópez	PROPN
bam-7960	290	5	-	-	PUNCT
bam-7960	290	6	soriano	soriano	PROPN
bam-7960	290	7	fj	fj	PROPN
bam-7960	290	8	,	,	PUNCT
bam-7960	290	9	busquets	busquets	PROPN
bam-7960	290	10	s.	s.	PROPN
bam-7960	290	11	novel	novel	PROPN
bam-7960	290	12	approaches	approach	NOUN
bam-7960	290	13	to	to	ADP
bam-7960	290	14	the	the	DET
bam-7960	290	15	treatment	treatment	NOUN
bam-7960	290	16	of	of	ADP
bam-7960	290	17	cachexia	cachexia	NOUN
bam-7960	290	18	.	.	PUNCT
bam-7960	291	1	drug	drug	NOUN
bam-7960	291	2	discov	discov	PROPN
bam-7960	291	3	today	today	NOUN
bam-7960	291	4	2008;13:73–8	2008;13:73–8	NUM
bam-7960	291	5	.	.	PUNCT
bam-7960	292	1	66	66	NUM
bam-7960	292	2	.	.	PUNCT
bam-7960	293	1	penna	penna	PROPN
bam-7960	293	2	f	f	PROPN
bam-7960	293	3	,	,	PUNCT
bam-7960	293	4	bonetto	bonetto	NOUN
bam-7960	293	5	a	a	PROPN
bam-7960	293	6	,	,	PUNCT
bam-7960	293	7	aversa	aversa	PROPN
bam-7960	293	8	z	z	PROPN
bam-7960	293	9	,	,	PUNCT
bam-7960	293	10	et	et	PROPN
bam-7960	293	11	al	al	PROPN
bam-7960	293	12	.	.	PROPN
bam-7960	293	13	effect	effect	NOUN
bam-7960	293	14	of	of	ADP
bam-7960	293	15	the	the	DET
bam-7960	293	16	specific	specific	ADJ
bam-7960	293	17	proteasome	proteasome	NOUN
bam-7960	293	18	inhibitor	inhibitor	NOUN
bam-7960	293	19	bortezomib	bortezomib	NOUN
bam-7960	293	20	on	on	ADP
bam-7960	293	21	cancer	cancer	NOUN
bam-7960	293	22	-	-	PUNCT
bam-7960	293	23	related	relate	VERB
bam-7960	293	24	muscle	muscle	NOUN
bam-7960	293	25	wasting	waste	VERB
bam-7960	293	26	.	.	PUNCT
bam-7960	294	1	j	j	PROPN
bam-7960	294	2	cachexia	cachexia	PROPN
bam-7960	294	3	sarcopenia	sarcopenia	PROPN
bam-7960	294	4	muscle	muscle	PROPN
bam-7960	294	5	2016;7:345–354	2016;7:345–354	PROPN
bam-7960	294	6	.	.	PROPN
bam-7960	294	7	67	67	NUM
bam-7960	294	8	.	.	PUNCT
bam-7960	295	1	wang	wang	PROPN
bam-7960	295	2	q	q	PROPN
bam-7960	295	3	,	,	PUNCT
bam-7960	295	4	li	li	PROPN
bam-7960	295	5	c	c	PROPN
bam-7960	295	6	,	,	PUNCT
bam-7960	295	7	peng	peng	PROPN
bam-7960	295	8	x	x	PROPN
bam-7960	295	9	,	,	PUNCT
bam-7960	295	10	et	et	PROPN
bam-7960	295	11	al	al	PROPN
bam-7960	295	12	.	.	PROPN
bam-7960	296	1	combined	combined	ADJ
bam-7960	296	2	treatment	treatment	NOUN
bam-7960	296	3	of	of	ADP
bam-7960	296	4	carfilzomib	carfilzomib	NOUN
bam-7960	296	5	and	and	CCONJ
bam-7960	296	6	z	z	PROPN
bam-7960	296	7	-	-	PUNCT
bam-7960	296	8	vad	vad	PROPN
bam-7960	296	9	-	-	PUNCT
bam-7960	296	10	fmk	fmk	PROPN
bam-7960	296	11	inhibits	inhibit	VERB
bam-7960	296	12	skeletal	skeletal	ADJ
bam-7960	296	13	proteolysis	proteolysis	NOUN
bam-7960	296	14	and	and	CCONJ
bam-7960	296	15	apoptosis	apoptosis	NOUN
bam-7960	296	16	and	and	CCONJ
bam-7960	296	17	ameliorates	ameliorate	VERB
bam-7960	296	18	cancer	cancer	NOUN
bam-7960	296	19	cachexia	cachexia	NOUN
bam-7960	296	20	.	.	PUNCT
bam-7960	297	1	med	me	VERB
bam-7960	297	2	oncol	oncol	ADJ
bam-7960	297	3	2015;32:100	2015;32:100	NUM
bam-7960	297	4	.	.	PUNCT
bam-7960	298	1	68	68	NUM
bam-7960	298	2	.	.	PUNCT
bam-7960	299	1	finn	finn	PROPN
bam-7960	299	2	rs	rs	PROPN
bam-7960	299	3	,	,	PUNCT
bam-7960	299	4	ahn	ahn	PROPN
bam-7960	299	5	dh	dh	PROPN
bam-7960	299	6	,	,	PUNCT
bam-7960	299	7	javle	javle	PROPN
bam-7960	299	8	mm	mm	PROPN
bam-7960	299	9	,	,	PUNCT
bam-7960	299	10	et	et	PROPN
bam-7960	299	11	al	al	PROPN
bam-7960	299	12	.	.	PROPN
bam-7960	299	13	phase	phase	PROPN
bam-7960	299	14	1b	1b	NUM
bam-7960	299	15	investigation	investigation	NOUN
bam-7960	299	16	of	of	ADP
bam-7960	299	17	the	the	DET
bam-7960	299	18	mek	mek	PROPN
bam-7960	299	19	inhibitor	inhibitor	NOUN
bam-7960	299	20	binimetinib	binimetinib	NOUN
bam-7960	299	21	in	in	ADP
bam-7960	299	22	patients	patient	NOUN
bam-7960	299	23	with	with	ADP
bam-7960	299	24	advanced	advanced	ADJ
bam-7960	299	25	or	or	CCONJ
bam-7960	299	26	metastatic	metastatic	ADJ
bam-7960	299	27	biliary	biliary	ADJ
bam-7960	299	28	tract	tract	NOUN
bam-7960	299	29	cancer	cancer	NOUN
bam-7960	299	30	.	.	PUNCT
bam-7960	299	31	invest	invest	VERB
bam-7960	299	32	new	new	ADJ
bam-7960	299	33	drugs	drug	NOUN
bam-7960	299	34	2018	2018	NUM
bam-7960	299	35	;	;	PUNCT
bam-7960	299	36	36:1037	36:1037	NUM
bam-7960	299	37	-	-	SYM
bam-7960	299	38	1043	1043	NUM
bam-7960	299	39	.	.	PUNCT
bam-7960	300	1	non	non	PROPN
bam-7960	300	2	co	co	PROPN
bam-7960	300	3	mmerc	mmerc	PROPN
bam-7960	300	4	ial	ial	PROPN
bam-7960	300	5	us	us	PROPN
bam-7960	300	6	e	e	NOUN
bam-7960	300	7	o	o	NOUN
bam-7960	300	8	nly	nly	ADV
bam-7960	300	9	https://clinicaltrials.gov/ct2/	https://clinicaltrials.gov/ct2/	VERB
bam-7960	300	10	therapeutic	therapeutic	ADJ
bam-7960	300	11	strategies	strategy	NOUN
bam-7960	300	12	against	against	ADP
bam-7960	300	13	cancer	cancer	NOUN
bam-7960	300	14	cachexia	cachexia	PROPN
bam-7960	300	15	eur	eur	PROPN
bam-7960	300	16	j	j	PROPN
bam-7960	300	17	transl	transl	PROPN
bam-7960	300	18	myol	myol	ADV
bam-7960	300	19	29	29	NUM
bam-7960	300	20	(	(	PUNCT
bam-7960	300	21	1	1	NUM
bam-7960	300	22	):	):	PUNCT
bam-7960	300	23	4	4	NUM
bam-7960	300	24	-	-	SYM
bam-7960	300	25	13	13	NUM
bam-7960	300	26	,	,	PUNCT
bam-7960	300	27	2019	2019	NUM
bam-7960	300	28	12	12	NUM
bam-7960	300	29	69	69	NUM
bam-7960	300	30	.	.	PUNCT
bam-7960	301	1	oliveira	oliveira	PROPN
bam-7960	301	2	ag	ag	PROPN
bam-7960	301	3	,	,	PUNCT
bam-7960	301	4	gomes	gome	NOUN
bam-7960	301	5	-	-	PUNCT
bam-7960	301	6	marcondes	marconde	NOUN
bam-7960	301	7	mcc	mcc	PROPN
bam-7960	301	8	.	.	PROPN
bam-7960	301	9	metformin	metformin	PROPN
bam-7960	301	10	treatment	treatment	NOUN
bam-7960	301	11	modulates	modulate	VERB
bam-7960	301	12	the	the	DET
bam-7960	301	13	tumour	tumour	NOUN
bam-7960	301	14	-	-	PUNCT
bam-7960	301	15	induced	induce	VERB
bam-7960	301	16	wasting	wasting	NOUN
bam-7960	301	17	effects	effect	NOUN
bam-7960	301	18	in	in	ADP
bam-7960	301	19	muscle	muscle	NOUN
bam-7960	301	20	protein	protein	NOUN
bam-7960	301	21	metabolism	metabolism	NOUN
bam-7960	301	22	minimising	minimise	VERB
bam-7960	301	23	the	the	DET
bam-7960	301	24	cachexia	cachexia	NOUN
bam-7960	301	25	in	in	ADP
bam-7960	301	26	tumour	tumour	NOUN
bam-7960	301	27	-	-	PUNCT
bam-7960	301	28	bearing	bear	VERB
bam-7960	301	29	rats	rat	NOUN
bam-7960	301	30	.	.	PUNCT
bam-7960	302	1	bmc	bmc	ADJ
bam-7960	302	2	cancer	cancer	NOUN
bam-7960	302	3	2016;16:418	2016;16:418	PROPN
bam-7960	302	4	.	.	PUNCT
bam-7960	303	1	70	70	NUM
bam-7960	303	2	.	.	PUNCT
bam-7960	304	1	scott	scott	PROPN
bam-7960	304	2	ic	ic	PROPN
bam-7960	304	3	,	,	PUNCT
bam-7960	304	4	tomlinson	tomlinson	PROPN
bam-7960	304	5	w	w	PROPN
bam-7960	304	6	,	,	PUNCT
bam-7960	304	7	walding	walde	VERB
bam-7960	304	8	a	a	PRON
bam-7960	304	9	,	,	PUNCT
bam-7960	304	10	et	et	PROPN
bam-7960	304	11	al	al	PROPN
bam-7960	304	12	.	.	PUNCT
bam-7960	304	13	largescale	largescale	PROPN
bam-7960	304	14	isolation	isolation	NOUN
bam-7960	304	15	of	of	ADP
bam-7960	304	16	human	human	ADJ
bam-7960	304	17	skeletal	skeletal	ADJ
bam-7960	304	18	muscle	muscle	NOUN
bam-7960	304	19	satellite	satellite	NOUN
bam-7960	304	20	cells	cell	NOUN
bam-7960	304	21	from	from	ADP
bam-7960	304	22	post	post	ADJ
bam-7960	304	23	-	-	ADJ
bam-7960	304	24	mortem	mortem	ADJ
bam-7960	304	25	tissue	tissue	NOUN
bam-7960	304	26	and	and	CCONJ
bam-7960	304	27	development	development	NOUN
bam-7960	304	28	of	of	ADP
bam-7960	304	29	quantitative	quantitative	ADJ
bam-7960	304	30	assays	assay	NOUN
bam-7960	304	31	to	to	PART
bam-7960	304	32	evaluate	evaluate	VERB
bam-7960	304	33	modulators	modulator	NOUN
bam-7960	304	34	of	of	ADP
bam-7960	304	35	myogenesis	myogenesis	NOUN
bam-7960	304	36	.	.	PUNCT
bam-7960	305	1	j	j	PROPN
bam-7960	305	2	cachexia	cachexia	PROPN
bam-7960	305	3	sarcopenia	sarcopenia	PROPN
bam-7960	305	4	muscle	muscle	PROPN
bam-7960	305	5	2013;4:157–169	2013;4:157–169	PROPN
bam-7960	305	6	.	.	PROPN
bam-7960	305	7	71	71	NUM
bam-7960	305	8	.	.	PUNCT
bam-7960	306	1	rinaldi	rinaldi	PROPN
bam-7960	306	2	f	f	PROPN
bam-7960	306	3	,	,	PUNCT
bam-7960	306	4	perlingeiro	perlingeiro	NOUN
bam-7960	306	5	rcr	rcr	PROPN
bam-7960	306	6	.	.	PUNCT
bam-7960	307	1	stem	stem	NOUN
bam-7960	307	2	cells	cell	NOUN
bam-7960	307	3	for	for	ADP
bam-7960	307	4	skeletal	skeletal	ADJ
bam-7960	307	5	muscle	muscle	NOUN
bam-7960	307	6	regeneration	regeneration	NOUN
bam-7960	307	7	:	:	PUNCT
bam-7960	307	8	therapeutic	therapeutic	ADJ
bam-7960	307	9	potential	potential	NOUN
bam-7960	307	10	and	and	CCONJ
bam-7960	307	11	roadblocks	roadblock	NOUN
bam-7960	307	12	.	.	PUNCT
bam-7960	308	1	transl	transl	PROPN
bam-7960	308	2	res	re	NOUN
bam-7960	308	3	2014;163:409–417	2014;163:409–417	ADJ
bam-7960	308	4	.	.	PUNCT
bam-7960	309	1	72	72	NUM
bam-7960	309	2	.	.	PUNCT
bam-7960	310	1	palus	palus	PROPN
bam-7960	310	2	s	s	PROPN
bam-7960	310	3	,	,	PUNCT
bam-7960	310	4	von	von	PROPN
bam-7960	310	5	haehling	haehling	NOUN
bam-7960	310	6	s	s	PROPN
bam-7960	310	7	,	,	PUNCT
bam-7960	310	8	flach	flach	PROPN
bam-7960	310	9	vc	vc	PROPN
bam-7960	310	10	,	,	PUNCT
bam-7960	310	11	t	t	PROPN
bam-7960	310	12	et	et	PROPN
bam-7960	310	13	al	al	PROPN
bam-7960	310	14	.	.	PROPN
bam-7960	311	1	simvastatin	simvastatin	PROPN
bam-7960	311	2	reduces	reduce	VERB
bam-7960	311	3	wasting	waste	VERB
bam-7960	311	4	and	and	CCONJ
bam-7960	311	5	improves	improve	VERB
bam-7960	311	6	cardiac	cardiac	ADJ
bam-7960	311	7	function	function	NOUN
bam-7960	311	8	as	as	ADV
bam-7960	311	9	well	well	ADV
bam-7960	311	10	as	as	ADP
bam-7960	311	11	outcome	outcome	NOUN
bam-7960	311	12	in	in	ADP
bam-7960	311	13	experimental	experimental	ADJ
bam-7960	311	14	cancer	cancer	NOUN
bam-7960	311	15	cachexia	cachexia	NOUN
bam-7960	311	16	.	.	PUNCT
bam-7960	312	1	int	int	PROPN
bam-7960	312	2	j	j	PROPN
bam-7960	312	3	cardiol	cardiol	NOUN
bam-7960	312	4	2013;168:3412–3418	2013;168:3412–3418	PROPN
bam-7960	312	5	.	.	PUNCT
bam-7960	313	1	73	73	NUM
bam-7960	313	2	.	.	PUNCT
bam-7960	314	1	maschke	maschke	PROPN
bam-7960	314	2	j	j	PROPN
bam-7960	314	3	,	,	PUNCT
bam-7960	314	4	kruk	kruk	PROPN
bam-7960	314	5	u	u	PROPN
bam-7960	314	6	,	,	PUNCT
bam-7960	314	7	kastrati	kastrati	PROPN
bam-7960	314	8	k	k	PROPN
bam-7960	314	9	,	,	PUNCT
bam-7960	314	10	et	et	PROPN
bam-7960	314	11	al	al	PROPN
bam-7960	314	12	.	.	PUNCT
bam-7960	315	1	nutritional	nutritional	ADJ
bam-7960	315	2	care	care	NOUN
bam-7960	315	3	of	of	ADP
bam-7960	315	4	cancer	cancer	NOUN
bam-7960	315	5	patients	patient	NOUN
bam-7960	315	6	:	:	PUNCT
bam-7960	315	7	a	a	DET
bam-7960	315	8	survey	survey	NOUN
bam-7960	315	9	on	on	ADP
bam-7960	315	10	patients	patient	NOUN
bam-7960	315	11	’	'	PUNCT
bam-7960	315	12	needs	need	NOUN
bam-7960	315	13	and	and	CCONJ
bam-7960	315	14	medical	medical	ADJ
bam-7960	315	15	care	care	NOUN
bam-7960	315	16	in	in	ADP
bam-7960	315	17	reality	reality	NOUN
bam-7960	315	18	.	.	PUNCT
bam-7960	316	1	int	int	NOUN
bam-7960	317	1	j	j	PROPN
bam-7960	317	2	clin	clin	PROPN
bam-7960	317	3	oncol	oncol	PROPN
bam-7960	317	4	2017;22:200–206	2017;22:200–206	PROPN
bam-7960	317	5	.	.	PUNCT
bam-7960	318	1	74	74	NUM
bam-7960	318	2	.	.	PUNCT
bam-7960	319	1	ravasco	ravasco	PROPN
bam-7960	319	2	p.	p.	NOUN
bam-7960	319	3	nutritional	nutritional	ADJ
bam-7960	319	4	approaches	approach	NOUN
bam-7960	319	5	in	in	ADP
bam-7960	319	6	cancer	cancer	NOUN
bam-7960	319	7	:	:	PUNCT
bam-7960	319	8	relevance	relevance	NOUN
bam-7960	319	9	of	of	ADP
bam-7960	319	10	individualized	individualized	ADJ
bam-7960	319	11	counseling	counseling	NOUN
bam-7960	319	12	and	and	CCONJ
bam-7960	319	13	supplementation	supplementation	NOUN
bam-7960	319	14	.	.	PUNCT
bam-7960	320	1	nutrition	nutrition	NOUN
bam-7960	320	2	2015;31:603–604	2015;31:603–604	PROPN
bam-7960	320	3	.	.	PROPN
bam-7960	320	4	75	75	NUM
bam-7960	320	5	.	.	PUNCT
bam-7960	321	1	de	de	PROPN
bam-7960	321	2	waele	waele	PROPN
bam-7960	321	3	e	e	PROPN
bam-7960	321	4	,	,	PUNCT
bam-7960	321	5	mattens	mattens	PROPN
bam-7960	321	6	s	s	PART
bam-7960	321	7	,	,	PUNCT
bam-7960	321	8	honoré	honoré	NOUN
bam-7960	321	9	pm	pm	NOUN
bam-7960	321	10	,	,	PUNCT
bam-7960	321	11	et	et	PROPN
bam-7960	321	12	al	al	PROPN
bam-7960	321	13	.	.	PUNCT
bam-7960	321	14	nutrition	nutrition	NOUN
bam-7960	321	15	therapy	therapy	NOUN
bam-7960	321	16	in	in	ADP
bam-7960	321	17	cachectic	cachectic	ADJ
bam-7960	321	18	cancer	cancer	NOUN
bam-7960	321	19	patients	patient	NOUN
bam-7960	321	20	.	.	PUNCT
bam-7960	322	1	the	the	DET
bam-7960	322	2	tight	tight	ADJ
bam-7960	322	3	caloric	caloric	NOUN
bam-7960	322	4	control	control	NOUN
bam-7960	322	5	(	(	PUNCT
bam-7960	322	6	ticaco	ticaco	NOUN
bam-7960	322	7	)	)	PUNCT
bam-7960	322	8	pilot	pilot	NOUN
bam-7960	322	9	trial	trial	NOUN
bam-7960	322	10	.	.	PUNCT
bam-7960	323	1	appetite	appetite	NOUN
bam-7960	323	2	2015;91:298–301	2015;91:298–301	PRON
bam-7960	323	3	.	.	PUNCT
bam-7960	324	1	76	76	NUM
bam-7960	324	2	.	.	PUNCT
bam-7960	325	1	bourdel	bourdel	NOUN
bam-7960	325	2	-	-	PUNCT
bam-7960	325	3	marchasson	marchasson	NOUN
bam-7960	325	4	i	i	PROPN
bam-7960	325	5	,	,	PUNCT
bam-7960	325	6	blanc	blanc	NOUN
bam-7960	325	7	-	-	PUNCT
bam-7960	325	8	bisson	bisson	NOUN
bam-7960	325	9	c	c	PROPN
bam-7960	325	10	,	,	PUNCT
bam-7960	325	11	doussau	doussau	VERB
bam-7960	325	12	a	a	DET
bam-7960	325	13	,	,	PUNCT
bam-7960	325	14	et	et	PROPN
bam-7960	325	15	al	al	PROPN
bam-7960	325	16	.	.	PUNCT
bam-7960	325	17	nutritional	nutritional	ADJ
bam-7960	325	18	advice	advice	NOUN
bam-7960	325	19	in	in	ADP
bam-7960	325	20	older	old	ADJ
bam-7960	325	21	patients	patient	NOUN
bam-7960	325	22	at	at	ADP
bam-7960	325	23	risk	risk	NOUN
bam-7960	325	24	of	of	ADP
bam-7960	325	25	malnutrition	malnutrition	NOUN
bam-7960	325	26	during	during	ADP
bam-7960	325	27	treatment	treatment	NOUN
bam-7960	325	28	for	for	ADP
bam-7960	325	29	chemotherapy	chemotherapy	NOUN
bam-7960	325	30	:	:	PUNCT
bam-7960	325	31	a	a	DET
bam-7960	325	32	two	two	NUM
bam-7960	325	33	-	-	PUNCT
bam-7960	325	34	year	year	NOUN
bam-7960	325	35	randomized	randomize	VERB
bam-7960	325	36	controlled	control	VERB
bam-7960	325	37	trial	trial	NOUN
bam-7960	325	38	.	.	PUNCT
bam-7960	326	1	plos	plos	PROPN
bam-7960	326	2	one	one	NUM
bam-7960	326	3	2014;9	2014;9	NUM
bam-7960	326	4	:	:	PUNCT
bam-7960	326	5	e108687	e108687	PROPN
bam-7960	326	6	.	.	PROPN
bam-7960	326	7	77	77	NUM
bam-7960	326	8	.	.	PUNCT
bam-7960	327	1	fearon	fearon	PROPN
bam-7960	327	2	kch	kch	PROPN
bam-7960	327	3	,	,	PUNCT
bam-7960	327	4	von	von	PROPN
bam-7960	327	5	meyenfeldt	meyenfeldt	PROPN
bam-7960	327	6	mf	mf	PROPN
bam-7960	327	7	,	,	PUNCT
bam-7960	327	8	moses	moses	PROPN
bam-7960	327	9	agw	agw	VERB
bam-7960	327	10	,	,	PUNCT
bam-7960	327	11	et	et	PROPN
bam-7960	327	12	al	al	PROPN
bam-7960	327	13	.	.	PROPN
bam-7960	327	14	effect	effect	NOUN
bam-7960	327	15	of	of	ADP
bam-7960	327	16	a	a	DET
bam-7960	327	17	protein	protein	NOUN
bam-7960	327	18	and	and	CCONJ
bam-7960	327	19	energy	energy	NOUN
bam-7960	327	20	dense	dense	ADJ
bam-7960	327	21	n-3	n-3	ADJ
bam-7960	327	22	fatty	fatty	NOUN
bam-7960	327	23	acid	acid	NOUN
bam-7960	327	24	enriched	enrich	VERB
bam-7960	327	25	oral	oral	ADJ
bam-7960	327	26	supplement	supplement	NOUN
bam-7960	327	27	on	on	ADP
bam-7960	327	28	loss	loss	NOUN
bam-7960	327	29	of	of	ADP
bam-7960	327	30	weight	weight	NOUN
bam-7960	327	31	and	and	CCONJ
bam-7960	327	32	lean	lean	ADJ
bam-7960	327	33	tissue	tissue	NOUN
bam-7960	327	34	in	in	ADP
bam-7960	327	35	cancer	cancer	NOUN
bam-7960	327	36	cachexia	cachexia	NOUN
bam-7960	327	37	:	:	PUNCT
bam-7960	327	38	a	a	DET
bam-7960	327	39	randomised	randomised	ADJ
bam-7960	327	40	double	double	ADJ
bam-7960	327	41	blind	blind	ADJ
bam-7960	327	42	trial	trial	NOUN
bam-7960	327	43	.	.	PUNCT
bam-7960	328	1	gut	gut	PROPN
bam-7960	328	2	2003;52:1479–86	2003;52:1479–86	NUM
bam-7960	328	3	.	.	PUNCT
bam-7960	329	1	78	78	NUM
bam-7960	329	2	.	.	PUNCT
bam-7960	330	1	fearon	fearon	PROPN
bam-7960	330	2	kc	kc	PROPN
bam-7960	330	3	,	,	PUNCT
bam-7960	330	4	barber	barber	PROPN
bam-7960	330	5	md	md	PROPN
bam-7960	330	6	,	,	PUNCT
bam-7960	330	7	moses	moses	PROPN
bam-7960	330	8	ag	ag	PROPN
bam-7960	330	9	,	,	PUNCT
bam-7960	330	10	et	et	PROPN
bam-7960	330	11	al	al	PROPN
bam-7960	330	12	.	.	PROPN
bam-7960	330	13	doubleblind	doubleblind	PROPN
bam-7960	330	14	,	,	PUNCT
bam-7960	330	15	placebo	placebo	NOUN
bam-7960	330	16	-	-	PUNCT
bam-7960	330	17	controlled	control	VERB
bam-7960	330	18	,	,	PUNCT
bam-7960	330	19	randomized	randomized	ADJ
bam-7960	330	20	study	study	NOUN
bam-7960	330	21	of	of	ADP
bam-7960	330	22	eicosapentaenoic	eicosapentaenoic	ADJ
bam-7960	330	23	acid	acid	NOUN
bam-7960	330	24	diester	diester	NOUN
bam-7960	330	25	in	in	ADP
bam-7960	330	26	patients	patient	NOUN
bam-7960	330	27	with	with	ADP
bam-7960	330	28	cancer	cancer	NOUN
bam-7960	330	29	cachexia	cachexia	NOUN
bam-7960	330	30	.	.	PUNCT
bam-7960	331	1	j	j	PROPN
bam-7960	331	2	clin	clin	PROPN
bam-7960	331	3	oncol	oncol	PROPN
bam-7960	331	4	2006;24:3401–3407	2006;24:3401–3407	NUM
bam-7960	331	5	.	.	PUNCT
bam-7960	332	1	79	79	NUM
bam-7960	332	2	.	.	PUNCT
bam-7960	333	1	ries	rie	NOUN
bam-7960	333	2	a	a	PROPN
bam-7960	333	3	,	,	PUNCT
bam-7960	333	4	trottenberg	trottenberg	PROPN
bam-7960	333	5	p	p	NOUN
bam-7960	333	6	,	,	PUNCT
bam-7960	333	7	elsner	elsner	NOUN
bam-7960	333	8	f	f	NOUN
bam-7960	333	9	,	,	PUNCT
bam-7960	333	10	et	et	PROPN
bam-7960	333	11	al	al	PROPN
bam-7960	333	12	.	.	PUNCT
bam-7960	334	1	a	a	DET
bam-7960	334	2	systematic	systematic	ADJ
bam-7960	334	3	review	review	NOUN
bam-7960	334	4	on	on	ADP
bam-7960	334	5	the	the	DET
bam-7960	334	6	role	role	NOUN
bam-7960	334	7	of	of	ADP
bam-7960	334	8	fish	fish	NOUN
bam-7960	334	9	oil	oil	NOUN
bam-7960	334	10	for	for	ADP
bam-7960	334	11	the	the	DET
bam-7960	334	12	treatment	treatment	NOUN
bam-7960	334	13	of	of	ADP
bam-7960	334	14	cachexia	cachexia	NOUN
bam-7960	334	15	in	in	ADP
bam-7960	334	16	advanced	advanced	ADJ
bam-7960	334	17	cancer	cancer	NOUN
bam-7960	334	18	:	:	PUNCT
bam-7960	334	19	an	an	DET
bam-7960	334	20	epcrc	epcrc	NOUN
bam-7960	334	21	cachexia	cachexia	PROPN
bam-7960	334	22	guidelines	guideline	NOUN
bam-7960	334	23	project	project	NOUN
bam-7960	334	24	.	.	PUNCT
bam-7960	335	1	palliat	palliat	PROPN
bam-7960	335	2	med	med	PROPN
bam-7960	335	3	2012;26:294–304	2012;26:294–304	PROPN
bam-7960	335	4	.	.	PUNCT
bam-7960	336	1	80	80	NUM
bam-7960	336	2	.	.	PUNCT
bam-7960	337	1	jatoi	jatoi	PROPN
bam-7960	337	2	a	a	PROPN
bam-7960	337	3	,	,	PUNCT
bam-7960	337	4	rowland	rowland	PROPN
bam-7960	337	5	k	k	PROPN
bam-7960	337	6	,	,	PUNCT
bam-7960	337	7	loprinzi	loprinzi	PROPN
bam-7960	337	8	cl	cl	NOUN
bam-7960	337	9	,	,	PUNCT
bam-7960	337	10	et	et	PROPN
bam-7960	337	11	al	al	PROPN
bam-7960	337	12	.	.	PUNCT
bam-7960	338	1	an	an	DET
bam-7960	338	2	eicosapentaenoic	eicosapentaenoic	ADJ
bam-7960	338	3	acid	acid	NOUN
bam-7960	338	4	supplement	supplement	NOUN
bam-7960	338	5	versus	versus	ADP
bam-7960	338	6	megestrol	megestrol	NOUN
bam-7960	338	7	acetate	acetate	NOUN
bam-7960	338	8	versus	versus	ADP
bam-7960	338	9	both	both	PRON
bam-7960	338	10	for	for	ADP
bam-7960	338	11	patients	patient	NOUN
bam-7960	338	12	with	with	ADP
bam-7960	338	13	cancerassociated	cancerassociated	ADJ
bam-7960	338	14	wasting	waste	VERB
bam-7960	338	15	:	:	PUNCT
bam-7960	338	16	a	a	DET
bam-7960	338	17	north	north	ADJ
bam-7960	338	18	central	central	ADJ
bam-7960	338	19	cancer	cancer	NOUN
bam-7960	338	20	treatment	treatment	NOUN
bam-7960	338	21	group	group	NOUN
bam-7960	338	22	and	and	CCONJ
bam-7960	338	23	national	national	PROPN
bam-7960	338	24	cancer	cancer	PROPN
bam-7960	338	25	institute	institute	PROPN
bam-7960	338	26	of	of	ADP
bam-7960	338	27	canada	canada	PROPN
bam-7960	338	28	collaborative	collaborative	ADJ
bam-7960	338	29	effort	effort	NOUN
bam-7960	338	30	.	.	PUNCT
bam-7960	339	1	j	j	PROPN
bam-7960	339	2	clin	clin	PROPN
bam-7960	339	3	oncol	oncol	PROPN
bam-7960	339	4	2004;22:2469–2476	2004;22:2469–2476	NOUN
bam-7960	339	5	.	.	PUNCT
bam-7960	340	1	81	81	NUM
bam-7960	340	2	.	.	PUNCT
bam-7960	341	1	read	read	VERB
bam-7960	341	2	ja	ja	PROPN
bam-7960	341	3	,	,	PUNCT
bam-7960	341	4	beale	beale	PROPN
bam-7960	341	5	pj	pj	PROPN
bam-7960	341	6	,	,	PUNCT
bam-7960	341	7	volker	volker	PROPN
bam-7960	341	8	dh	dh	PROPN
bam-7960	341	9	,	,	PUNCT
bam-7960	341	10	et	et	PROPN
bam-7960	341	11	al	al	PROPN
bam-7960	341	12	.	.	PUNCT
bam-7960	342	1	nutrition	nutrition	NOUN
bam-7960	342	2	intervention	intervention	NOUN
bam-7960	342	3	using	use	VERB
bam-7960	342	4	an	an	DET
bam-7960	342	5	eicosapentaenoic	eicosapentaenoic	ADJ
bam-7960	342	6	acid	acid	NOUN
bam-7960	342	7	(	(	PUNCT
bam-7960	342	8	epa)containing	epa)containe	VERB
bam-7960	342	9	supplement	supplement	NOUN
bam-7960	342	10	in	in	ADP
bam-7960	342	11	patients	patient	NOUN
bam-7960	342	12	with	with	ADP
bam-7960	342	13	advanced	advanced	ADJ
bam-7960	342	14	colorectal	colorectal	ADJ
bam-7960	342	15	cancer	cancer	NOUN
bam-7960	342	16	.	.	PUNCT
bam-7960	343	1	effects	effect	NOUN
bam-7960	343	2	on	on	ADP
bam-7960	343	3	nutritional	nutritional	ADJ
bam-7960	343	4	and	and	CCONJ
bam-7960	343	5	inflammatory	inflammatory	ADJ
bam-7960	343	6	status	status	NOUN
bam-7960	343	7	:	:	PUNCT
bam-7960	343	8	a	a	DET
bam-7960	343	9	phase	phase	NOUN
bam-7960	343	10	ii	ii	NOUN
bam-7960	343	11	trial	trial	NOUN
bam-7960	343	12	.	.	PUNCT
bam-7960	344	1	support	support	NOUN
bam-7960	344	2	care	care	NOUN
bam-7960	344	3	cancer	cancer	NOUN
bam-7960	344	4	2007;15:301–307	2007;15:301–307	NOUN
bam-7960	344	5	.	.	PUNCT
bam-7960	345	1	82	82	NUM
bam-7960	345	2	.	.	PUNCT
bam-7960	345	3	ryan	ryan	PROPN
bam-7960	345	4	am	am	PROPN
bam-7960	345	5	,	,	PUNCT
bam-7960	345	6	reynolds	reynolds	PROPN
bam-7960	345	7	j	j	PROPN
bam-7960	345	8	v	v	PROPN
bam-7960	345	9	,	,	PUNCT
bam-7960	345	10	healy	healy	PROPN
bam-7960	345	11	l	l	PROPN
bam-7960	345	12	,	,	PUNCT
bam-7960	345	13	et	et	PROPN
bam-7960	345	14	al	al	PROPN
bam-7960	345	15	.	.	PROPN
bam-7960	346	1	enteral	enteral	ADJ
bam-7960	346	2	nutrition	nutrition	NOUN
bam-7960	346	3	enriched	enrich	VERB
bam-7960	346	4	with	with	ADP
bam-7960	346	5	eicosapentaenoic	eicosapentaenoic	ADJ
bam-7960	346	6	acid	acid	NOUN
bam-7960	346	7	(	(	PUNCT
bam-7960	346	8	epa	epa	PROPN
bam-7960	346	9	)	)	PUNCT
bam-7960	346	10	preserves	preserve	VERB
bam-7960	346	11	lean	lean	ADJ
bam-7960	346	12	body	body	NOUN
bam-7960	346	13	mass	mass	NOUN
bam-7960	346	14	following	follow	VERB
bam-7960	346	15	esophageal	esophageal	ADJ
bam-7960	346	16	cancer	cancer	NOUN
bam-7960	346	17	surgery	surgery	NOUN
bam-7960	346	18	:	:	PUNCT
bam-7960	346	19	results	result	NOUN
bam-7960	346	20	of	of	ADP
bam-7960	346	21	a	a	DET
bam-7960	346	22	doubleblinded	doubleblinde	VERB
bam-7960	346	23	randomized	randomize	VERB
bam-7960	346	24	controlled	control	VERB
bam-7960	346	25	trial	trial	NOUN
bam-7960	346	26	.	.	PUNCT
bam-7960	347	1	ann	ann	PROPN
bam-7960	347	2	surg	surg	PROPN
bam-7960	347	3	2009;249:355–363	2009;249:355–363	NUM
bam-7960	347	4	.	.	PUNCT
bam-7960	348	1	83	83	NUM
bam-7960	348	2	.	.	PUNCT
bam-7960	349	1	abe	abe	PROPN
bam-7960	349	2	k	k	PROPN
bam-7960	349	3	,	,	PUNCT
bam-7960	349	4	uwagawa	uwagawa	PROPN
bam-7960	349	5	t	t	PROPN
bam-7960	349	6	,	,	PUNCT
bam-7960	349	7	haruki	haruki	PROPN
bam-7960	349	8	k	k	PROPN
bam-7960	349	9	,	,	PUNCT
bam-7960	349	10	et	et	PROPN
bam-7960	349	11	al	al	PROPN
bam-7960	349	12	.	.	PUNCT
bam-7960	350	1	effects	effect	NOUN
bam-7960	350	2	of	of	ADP
bam-7960	350	3	ω-3	ω-3	NOUN
bam-7960	350	4	fatty	fatty	NOUN
bam-7960	350	5	acid	acid	NOUN
bam-7960	350	6	supplementation	supplementation	NOUN
bam-7960	350	7	in	in	ADP
bam-7960	350	8	patients	patient	NOUN
bam-7960	350	9	with	with	ADP
bam-7960	350	10	bile	bile	NOUN
bam-7960	350	11	duct	duct	NOUN
bam-7960	350	12	or	or	CCONJ
bam-7960	350	13	pancreatic	pancreatic	ADJ
bam-7960	350	14	cancer	cancer	NOUN
bam-7960	350	15	undergoing	undergo	VERB
bam-7960	350	16	chemotherapy	chemotherapy	NOUN
bam-7960	350	17	.	.	PUNCT
bam-7960	351	1	anticancer	anticancer	NOUN
bam-7960	351	2	res	re	VERB
bam-7960	351	3	2018;38:2369	2018;38:2369	PROPN
bam-7960	351	4	–	–	PUNCT
bam-7960	351	5	2375	2375	NUM
bam-7960	351	6	.	.	PUNCT
bam-7960	352	1	84	84	NUM
bam-7960	352	2	.	.	PUNCT
bam-7960	353	1	hiroux	hiroux	PROPN
bam-7960	353	2	c	c	NOUN
bam-7960	353	3	,	,	PUNCT
bam-7960	353	4	vandoorne	vandoorne	VERB
bam-7960	353	5	t	t	PROPN
bam-7960	353	6	,	,	PUNCT
bam-7960	353	7	koppo	koppo	PROPN
bam-7960	353	8	k	k	PROPN
bam-7960	353	9	,	,	PUNCT
bam-7960	353	10	et	et	PROPN
bam-7960	353	11	al	al	PROPN
bam-7960	353	12	.	.	PROPN
bam-7960	354	1	physical	physical	ADJ
bam-7960	354	2	activity	activity	NOUN
bam-7960	354	3	counteracts	counteract	VERB
bam-7960	354	4	tumor	tumor	NOUN
bam-7960	354	5	cell	cell	NOUN
bam-7960	354	6	growth	growth	NOUN
bam-7960	354	7	in	in	ADP
bam-7960	354	8	colon	colon	NOUN
bam-7960	354	9	carcinoma	carcinoma	NOUN
bam-7960	354	10	c26	c26	NOUN
bam-7960	354	11	-	-	PUNCT
bam-7960	354	12	injected	inject	VERB
bam-7960	354	13	muscles	muscle	NOUN
bam-7960	354	14	:	:	PUNCT
bam-7960	354	15	an	an	DET
bam-7960	354	16	interim	interim	ADJ
bam-7960	354	17	report	report	NOUN
bam-7960	354	18	.	.	PUNCT
bam-7960	355	1	eur	eur	PROPN
bam-7960	355	2	j	j	PROPN
bam-7960	355	3	transl	transl	PROPN
bam-7960	355	4	myol	myol	NOUN
bam-7960	355	5	2016;26:5958	2016;26:5958	NUM
bam-7960	355	6	.	.	PUNCT
bam-7960	355	7	85	85	NUM
bam-7960	355	8	.	.	PUNCT
bam-7960	355	9	barberi	barberi	PROPN
bam-7960	355	10	l	l	PROPN
bam-7960	355	11	,	,	PUNCT
bam-7960	355	12	scicchitano	scicchitano	ADJ
bam-7960	355	13	bm	bm	PROPN
bam-7960	355	14	,	,	PUNCT
bam-7960	355	15	musarò	musarò	VERB
bam-7960	355	16	a.	a.	NOUN
bam-7960	355	17	molecular	molecular	ADJ
bam-7960	355	18	and	and	CCONJ
bam-7960	355	19	cellular	cellular	ADJ
bam-7960	355	20	mechanisms	mechanism	NOUN
bam-7960	355	21	of	of	ADP
bam-7960	355	22	muscle	muscle	NOUN
bam-7960	355	23	aging	aging	NOUN
bam-7960	355	24	and	and	CCONJ
bam-7960	355	25	sarcopenia	sarcopenia	NOUN
bam-7960	355	26	and	and	CCONJ
bam-7960	355	27	effects	effect	NOUN
bam-7960	355	28	of	of	ADP
bam-7960	355	29	electrical	electrical	ADJ
bam-7960	355	30	stimulation	stimulation	NOUN
bam-7960	355	31	in	in	ADP
bam-7960	355	32	seniors	senior	NOUN
bam-7960	355	33	.	.	PUNCT
bam-7960	356	1	eur	eur	PROPN
bam-7960	356	2	j	j	PROPN
bam-7960	356	3	transl	transl	PROPN
bam-7960	356	4	myol	myol	NOUN
bam-7960	356	5	2015;25:231	2015;25:231	NUM
bam-7960	356	6	.	.	PROPN
bam-7960	356	7	86	86	NUM
bam-7960	356	8	.	.	PUNCT
bam-7960	357	1	sajer	sajer	PROPN
bam-7960	357	2	s.	s.	PROPN
bam-7960	357	3	mobility	mobility	PROPN
bam-7960	357	4	disorders	disorder	NOUN
bam-7960	357	5	and	and	CCONJ
bam-7960	357	6	pain	pain	NOUN
bam-7960	357	7	,	,	PUNCT
bam-7960	357	8	interrelations	interrelation	NOUN
bam-7960	357	9	that	that	PRON
bam-7960	357	10	need	need	VERB
bam-7960	357	11	new	new	ADJ
bam-7960	357	12	research	research	NOUN
bam-7960	357	13	concepts	concept	NOUN
bam-7960	357	14	and	and	CCONJ
bam-7960	357	15	advanced	advanced	ADJ
bam-7960	357	16	clinical	clinical	ADJ
bam-7960	357	17	commitments	commitment	NOUN
bam-7960	357	18	.	.	PUNCT
bam-7960	358	1	eur	eur	PROPN
bam-7960	358	2	j	j	PROPN
bam-7960	358	3	transl	transl	PROPN
bam-7960	358	4	myol	myol	NOUN
bam-7960	358	5	2017;27:7179	2017;27:7179	NUM
bam-7960	358	6	.	.	PUNCT
bam-7960	359	1	87	87	NUM
bam-7960	359	2	.	.	PUNCT
bam-7960	360	1	lira	lira	PROPN
bam-7960	360	2	fs	fs	PROPN
bam-7960	360	3	,	,	PUNCT
bam-7960	360	4	antunes	antunes	PROPN
bam-7960	360	5	bde	bde	PROPN
bam-7960	360	6	m	m	PROPN
bam-7960	360	7	,	,	PUNCT
bam-7960	360	8	seelaender	seelaender	PROPN
bam-7960	360	9	m	m	PROPN
bam-7960	360	10	,	,	PUNCT
bam-7960	360	11	rosa	rosa	PROPN
bam-7960	360	12	neto	neto	PROPN
bam-7960	360	13	jc	jc	PROPN
bam-7960	360	14	.	.	PUNCT
bam-7960	361	1	the	the	DET
bam-7960	361	2	therapeutic	therapeutic	ADJ
bam-7960	361	3	potential	potential	NOUN
bam-7960	361	4	of	of	ADP
bam-7960	361	5	exercise	exercise	NOUN
bam-7960	361	6	to	to	PART
bam-7960	361	7	treat	treat	VERB
bam-7960	361	8	cachexia	cachexia	NOUN
bam-7960	361	9	.	.	PUNCT
bam-7960	362	1	curr	curr	PROPN
bam-7960	362	2	opin	opin	NOUN
bam-7960	362	3	support	support	NOUN
bam-7960	362	4	palliat	palliat	VERB
bam-7960	362	5	care	care	NOUN
bam-7960	362	6	2015;9:317–324	2015;9:317–324	NUM
bam-7960	362	7	.	.	PUNCT
bam-7960	363	1	88	88	NUM
bam-7960	363	2	.	.	PUNCT
bam-7960	364	1	alves	alves	PROPN
bam-7960	364	2	crr	crr	PROPN
bam-7960	364	3	,	,	PUNCT
bam-7960	364	4	da	da	PROPN
bam-7960	364	5	cunha	cunha	NOUN
bam-7960	364	6	tf	tf	PROPN
bam-7960	364	7	,	,	PUNCT
bam-7960	364	8	da	da	PROPN
bam-7960	364	9	paixão	paixão	PROPN
bam-7960	364	10	na	na	ADP
bam-7960	364	11	,	,	PUNCT
bam-7960	364	12	brum	brum	ADJ
bam-7960	364	13	pc	pc	NOUN
bam-7960	364	14	.	.	PUNCT
bam-7960	365	1	aerobic	aerobic	ADJ
bam-7960	365	2	exercise	exercise	NOUN
bam-7960	365	3	training	training	NOUN
bam-7960	365	4	as	as	ADP
bam-7960	365	5	therapy	therapy	NOUN
bam-7960	365	6	for	for	ADP
bam-7960	365	7	cardiac	cardiac	ADJ
bam-7960	365	8	and	and	CCONJ
bam-7960	365	9	cancer	cancer	NOUN
bam-7960	365	10	cachexia	cachexia	NOUN
bam-7960	365	11	.	.	PUNCT
bam-7960	366	1	life	life	NOUN
bam-7960	366	2	sci	sci	PROPN
bam-7960	366	3	2015;125:9–14	2015;125:9–14	PROPN
bam-7960	366	4	.	.	PROPN
bam-7960	366	5	89	89	NUM
bam-7960	366	6	.	.	PUNCT
bam-7960	367	1	lønbro	lønbro	PROPN
bam-7960	367	2	s	s	PROPN
bam-7960	367	3	,	,	PUNCT
bam-7960	367	4	dalgas	dalgas	ADJ
bam-7960	367	5	u	u	PROPN
bam-7960	367	6	,	,	PUNCT
bam-7960	367	7	primdahl	primdahl	PROPN
bam-7960	367	8	h	h	PROPN
bam-7960	367	9	,	,	PUNCT
bam-7960	367	10	et	et	PROPN
bam-7960	367	11	al	al	PROPN
bam-7960	367	12	.	.	PROPN
bam-7960	368	1	progressive	progressive	ADJ
bam-7960	368	2	resistance	resistance	NOUN
bam-7960	368	3	training	training	NOUN
bam-7960	368	4	rebuilds	rebuild	VERB
bam-7960	368	5	lean	lean	ADJ
bam-7960	368	6	body	body	NOUN
bam-7960	368	7	mass	mass	NOUN
bam-7960	368	8	in	in	ADP
bam-7960	368	9	head	head	NOUN
bam-7960	368	10	and	and	CCONJ
bam-7960	368	11	neck	neck	NOUN
bam-7960	368	12	cancer	cancer	NOUN
bam-7960	368	13	patients	patient	NOUN
bam-7960	368	14	after	after	ADP
bam-7960	368	15	radiotherapy	radiotherapy	NOUN
bam-7960	368	16	–	–	PUNCT
bam-7960	368	17	results	result	VERB
bam-7960	368	18	from	from	ADP
bam-7960	368	19	the	the	DET
bam-7960	368	20	randomized	randomized	ADJ
bam-7960	368	21	dahanca	dahanca	NOUN
bam-7960	368	22	25b	25b	NOUN
bam-7960	368	23	trial	trial	NOUN
bam-7960	368	24	.	.	PUNCT
bam-7960	369	1	radiother	radiother	NOUN
bam-7960	369	2	oncol	oncol	ADJ
bam-7960	369	3	2013;108:314–319	2013;108:314–319	NUM
bam-7960	369	4	.	.	PUNCT
bam-7960	370	1	90	90	NUM
bam-7960	370	2	.	.	PUNCT
bam-7960	371	1	mcneely	mcneely	ADV
bam-7960	371	2	ml	ml	PROPN
bam-7960	371	3	,	,	PUNCT
bam-7960	371	4	parliament	parliament	NOUN
bam-7960	371	5	mb	mb	NOUN
bam-7960	371	6	,	,	PUNCT
bam-7960	371	7	seikaly	seikaly	NOUN
bam-7960	371	8	h	h	NOUN
bam-7960	371	9	,	,	PUNCT
bam-7960	371	10	et	et	PROPN
bam-7960	371	11	al	al	PROPN
bam-7960	371	12	.	.	PUNCT
bam-7960	371	13	sustainability	sustainability	NOUN
bam-7960	371	14	of	of	ADP
bam-7960	371	15	outcomes	outcome	NOUN
bam-7960	371	16	after	after	ADP
bam-7960	371	17	a	a	DET
bam-7960	371	18	randomized	randomized	ADJ
bam-7960	371	19	crossover	crossover	ADP
bam-7960	371	20	trial	trial	NOUN
bam-7960	371	21	of	of	ADP
bam-7960	371	22	resistance	resistance	NOUN
bam-7960	371	23	exercise	exercise	NOUN
bam-7960	371	24	for	for	ADP
bam-7960	371	25	shoulder	shoulder	NOUN
bam-7960	371	26	dysfunction	dysfunction	NOUN
bam-7960	371	27	in	in	ADP
bam-7960	371	28	survivors	survivor	NOUN
bam-7960	371	29	of	of	ADP
bam-7960	371	30	head	head	NOUN
bam-7960	371	31	and	and	CCONJ
bam-7960	371	32	neck	neck	NOUN
bam-7960	371	33	cancer	cancer	NOUN
bam-7960	371	34	.	.	PUNCT
bam-7960	372	1	physiother	physiother	PROPN
bam-7960	372	2	canada	canada	PROPN
bam-7960	372	3	2015;67:85–93	2015;67:85–93	NUM
bam-7960	372	4	.	.	PUNCT
bam-7960	373	1	91	91	NUM
bam-7960	373	2	.	.	PUNCT
bam-7960	374	1	peddle	peddle	PROPN
bam-7960	374	2	-	-	PUNCT
bam-7960	374	3	mcintyre	mcintyre	PROPN
bam-7960	374	4	cj	cj	PROPN
bam-7960	374	5	,	,	PUNCT
bam-7960	374	6	bell	bell	PROPN
bam-7960	374	7	g	g	PROPN
bam-7960	374	8	,	,	PUNCT
bam-7960	374	9	fenton	fenton	PROPN
bam-7960	374	10	d	d	PROPN
bam-7960	374	11	,	,	PUNCT
bam-7960	374	12	et	et	PROPN
bam-7960	374	13	al	al	PROPN
bam-7960	374	14	.	.	PUNCT
bam-7960	375	1	feasibility	feasibility	NOUN
bam-7960	375	2	and	and	CCONJ
bam-7960	375	3	preliminary	preliminary	ADJ
bam-7960	375	4	efficacy	efficacy	NOUN
bam-7960	375	5	of	of	ADP
bam-7960	375	6	progressive	progressive	ADJ
bam-7960	375	7	resistance	resistance	NOUN
bam-7960	375	8	exercise	exercise	NOUN
bam-7960	375	9	training	training	NOUN
bam-7960	375	10	in	in	ADP
bam-7960	375	11	lung	lung	NOUN
bam-7960	375	12	cancer	cancer	NOUN
bam-7960	375	13	survivors	survivor	NOUN
bam-7960	375	14	.	.	PUNCT
bam-7960	376	1	lung	lung	NOUN
bam-7960	376	2	cancer	cancer	NOUN
bam-7960	376	3	2012;75:126–132	2012;75:126–132	PROPN
bam-7960	376	4	.	.	PROPN
bam-7960	377	1	92	92	NUM
bam-7960	377	2	.	.	PUNCT
bam-7960	378	1	cheema	cheema	PROPN
bam-7960	378	2	b	b	NOUN
bam-7960	378	3	,	,	PUNCT
bam-7960	378	4	gaul	gaul	NOUN
bam-7960	378	5	ca	ca	NOUN
bam-7960	378	6	,	,	PUNCT
bam-7960	378	7	lane	lane	PROPN
bam-7960	378	8	k	k	PROPN
bam-7960	378	9	,	,	PUNCT
bam-7960	378	10	et	et	PROPN
bam-7960	378	11	al	al	PROPN
bam-7960	378	12	.	.	PROPN
bam-7960	379	1	progressive	progressive	PROPN
bam-7960	379	2	resistance	resistance	NOUN
bam-7960	379	3	training	training	NOUN
bam-7960	379	4	in	in	ADP
bam-7960	379	5	breast	breast	NOUN
bam-7960	379	6	cancer	cancer	NOUN
bam-7960	379	7	:	:	PUNCT
bam-7960	379	8	a	a	DET
bam-7960	379	9	systematic	systematic	ADJ
bam-7960	379	10	review	review	NOUN
bam-7960	379	11	of	of	ADP
bam-7960	379	12	clinical	clinical	ADJ
bam-7960	379	13	trials	trial	NOUN
bam-7960	379	14	.	.	PUNCT
bam-7960	380	1	breast	breast	NOUN
bam-7960	380	2	cancer	cancer	NOUN
bam-7960	380	3	res	re	NOUN
bam-7960	380	4	treat	treat	VERB
bam-7960	380	5	2008;109:9–26	2008;109:9–26	NOUN
bam-7960	380	6	.	.	PUNCT
bam-7960	381	1	93	93	NUM
bam-7960	381	2	.	.	PUNCT
bam-7960	382	1	muscaritoli	muscaritoli	PROPN
bam-7960	382	2	m	m	PROPN
bam-7960	382	3	,	,	PUNCT
bam-7960	382	4	molfino	molfino	PROPN
bam-7960	382	5	a	a	X
bam-7960	382	6	,	,	PUNCT
bam-7960	382	7	lucia	lucia	PROPN
bam-7960	382	8	s	s	PROPN
bam-7960	382	9	,	,	PUNCT
bam-7960	382	10	rossi	rossi	PROPN
bam-7960	382	11	fanelli	fanelli	PROPN
bam-7960	382	12	f.	f.	PROPN
bam-7960	382	13	cachexia	cachexia	PROPN
bam-7960	382	14	:	:	PUNCT
bam-7960	382	15	a	a	DET
bam-7960	382	16	preventable	preventable	ADJ
bam-7960	382	17	comorbidity	comorbidity	NOUN
bam-7960	382	18	of	of	ADP
bam-7960	382	19	cancer	cancer	NOUN
bam-7960	382	20	.	.	PUNCT
bam-7960	383	1	a	a	DET
bam-7960	383	2	t.a.r.g.e.t	t.a.r.g.e.t	PROPN
bam-7960	383	3	.	.	PUNCT
bam-7960	383	4	approach	approach	NOUN
bam-7960	383	5	.	.	PUNCT
bam-7960	384	1	crit	crit	PROPN
bam-7960	384	2	rev	rev	PROPN
bam-7960	384	3	oncol	oncol	ADJ
bam-7960	384	4	hematol	hematol	NOUN
bam-7960	384	5	2015;94:251–259	2015;94:251–259	NOUN
bam-7960	384	6	.	.	PUNCT
bam-7960	385	1	94	94	NUM
bam-7960	385	2	.	.	PUNCT
bam-7960	385	3	fossen	fossen	VERB
bam-7960	385	4	c.	c.	PROPN
bam-7960	385	5	pre	pre	ADJ
bam-7960	385	6	-	-	ADJ
bam-7960	385	7	menac	menac	ADJ
bam-7960	385	8	study	study	NOUN
bam-7960	385	9	presentation	presentation	NOUN
bam-7960	385	10	prc	prc	PROPN
bam-7960	385	11	.	.	PUNCT
bam-7960	386	1	ntnu	ntnu	PROPN
bam-7960	386	2	;	;	PUNCT
bam-7960	386	3	https://www.ntnu.edu/prc/pre-menacstudy-presentation	https://www.ntnu.edu/prc/pre-menacstudy-presentation	NOUN
bam-7960	386	4	non	non	X
bam-7960	386	5	co	co	X
bam-7960	386	6	mmerc	mmerc	PROPN
bam-7960	386	7	ial	ial	PROPN
bam-7960	386	8	us	us	PROPN
bam-7960	386	9	e	e	NOUN
bam-7960	386	10	o	o	NOUN
bam-7960	386	11	nly	nly	ADV
bam-7960	386	12	therapeutic	therapeutic	ADJ
bam-7960	386	13	strategies	strategy	NOUN
bam-7960	386	14	against	against	ADP
bam-7960	386	15	cancer	cancer	NOUN
bam-7960	386	16	cachexia	cachexia	PROPN
bam-7960	386	17	eur	eur	PROPN
bam-7960	386	18	j	j	PROPN
bam-7960	386	19	transl	transl	PROPN
bam-7960	386	20	myol	myol	ADV
bam-7960	386	21	29	29	NUM
bam-7960	386	22	(	(	PUNCT
bam-7960	386	23	1	1	NUM
bam-7960	386	24	):	):	PUNCT
bam-7960	386	25	4	4	NUM
bam-7960	386	26	-	-	SYM
bam-7960	386	27	13	13	NUM
bam-7960	386	28	,	,	PUNCT
bam-7960	386	29	2019	2019	NUM
bam-7960	386	30	13	13	NUM
bam-7960	386	31	95	95	NUM
bam-7960	386	32	.	.	PUNCT
bam-7960	387	1	multimodal	multimodal	NOUN
bam-7960	387	2	intervention	intervention	NOUN
bam-7960	387	3	for	for	ADP
bam-7960	387	4	cachexia	cachexia	NOUN
bam-7960	387	5	in	in	ADP
bam-7960	387	6	advanced	advanced	ADJ
bam-7960	387	7	cancer	cancer	NOUN
bam-7960	387	8	patients	patient	NOUN
bam-7960	387	9	undergoing	undergo	VERB
bam-7960	387	10	chemotherapy	chemotherapy	NOUN
bam-7960	387	11	full	full	ADJ
bam-7960	387	12	text	text	NOUN
bam-7960	387	13	view	view	NOUN
bam-7960	387	14	clinicaltrials.gov	clinicaltrials.gov	X
bam-7960	387	15	.	.	PROPN
bam-7960	387	16	https://clinicaltrials.gov/ct2/show/nct02330926	https://clinicaltrials.gov/ct2/show/nct02330926	PROPN
bam-7960	387	17	.	.	PUNCT
bam-7960	387	18	accessed	access	VERB
bam-7960	387	19	10	10	NUM
bam-7960	387	20	april	april	PROPN
bam-7960	387	21	2017	2017	NUM
bam-7960	387	22	.	.	PUNCT
bam-7960	388	1	96	96	NUM
bam-7960	388	2	.	.	PUNCT
bam-7960	388	3	madeddu	madeddu	PROPN
bam-7960	389	1	c	c	NOUN
bam-7960	389	2	,	,	PUNCT
bam-7960	389	3	gramignano	gramignano	NOUN
bam-7960	389	4	g	g	NOUN
bam-7960	389	5	,	,	PUNCT
bam-7960	389	6	tanca	tanca	PROPN
bam-7960	389	7	l	l	PROPN
bam-7960	389	8	,	,	PUNCT
bam-7960	389	9	et	et	PROPN
bam-7960	389	10	al	al	PROPN
bam-7960	389	11	.	.	PUNCT
bam-7960	390	1	a	a	DET
bam-7960	390	2	combined	combine	VERB
bam-7960	390	3	treatment	treatment	NOUN
bam-7960	390	4	approach	approach	NOUN
bam-7960	390	5	for	for	ADP
bam-7960	390	6	cachexia	cachexia	NOUN
bam-7960	390	7	and	and	CCONJ
bam-7960	390	8	cancer	cancer	NOUN
bam-7960	390	9	-	-	PUNCT
bam-7960	390	10	related	relate	VERB
bam-7960	390	11	anemia	anemia	NOUN
bam-7960	390	12	in	in	ADP
bam-7960	390	13	advanced	advanced	ADJ
bam-7960	390	14	cancer	cancer	NOUN
bam-7960	390	15	patients	patient	NOUN
bam-7960	390	16	:	:	PUNCT
bam-7960	390	17	a	a	DET
bam-7960	390	18	randomized	randomized	ADJ
bam-7960	390	19	placebo	placebo	NOUN
bam-7960	390	20	-	-	PUNCT
bam-7960	390	21	controlled	control	VERB
bam-7960	390	22	trial	trial	NOUN
bam-7960	390	23	.	.	PUNCT
bam-7960	391	1	j	j	PROPN
bam-7960	391	2	clin	clin	PROPN
bam-7960	391	3	oncol	oncol	PROPN
bam-7960	391	4	2014;32:189–189	2014;32:189–189	PROPN
bam-7960	391	5	.	.	PUNCT
bam-7960	392	1	97	97	NUM
bam-7960	392	2	.	.	PUNCT
bam-7960	393	1	maddocks	maddocks	PROPN
bam-7960	393	2	m	m	PROPN
bam-7960	393	3	,	,	PUNCT
bam-7960	393	4	hopkinson	hopkinson	PROPN
bam-7960	393	5	j	j	PROPN
bam-7960	393	6	,	,	PUNCT
bam-7960	393	7	conibear	conibear	PROPN
bam-7960	393	8	j	j	PROPN
bam-7960	393	9	,	,	PUNCT
bam-7960	393	10	et	et	PROPN
bam-7960	393	11	al	al	PROPN
bam-7960	393	12	.	.	PROPN
bam-7960	394	1	practical	practical	ADJ
bam-7960	394	2	multimodal	multimodal	NOUN
bam-7960	394	3	care	care	NOUN
bam-7960	394	4	for	for	ADP
bam-7960	394	5	cancer	cancer	NOUN
bam-7960	394	6	cachexia	cachexia	NOUN
bam-7960	394	7	.	.	PUNCT
bam-7960	395	1	curr	curr	PROPN
bam-7960	395	2	opin	opin	NOUN
bam-7960	395	3	support	support	NOUN
bam-7960	395	4	palliat	palliat	VERB
bam-7960	395	5	care	care	NOUN
bam-7960	395	6	2016;10:298–305	2016;10:298–305	NOUN
bam-7960	395	7	.	.	PUNCT
bam-7960	396	1	98	98	NUM
bam-7960	396	2	.	.	PUNCT
bam-7960	397	1	fearon	fearon	PROPN
bam-7960	397	2	k	k	PROPN
bam-7960	397	3	,	,	PUNCT
bam-7960	397	4	strasser	strasser	PROPN
bam-7960	397	5	f	f	PROPN
bam-7960	397	6	,	,	PUNCT
bam-7960	397	7	anker	anker	PROPN
bam-7960	397	8	sd	sd	PROPN
bam-7960	397	9	,	,	PUNCT
bam-7960	397	10	et	et	PROPN
bam-7960	397	11	al	al	PROPN
bam-7960	397	12	.	.	PUNCT
bam-7960	398	1	definition	definition	NOUN
bam-7960	398	2	and	and	CCONJ
bam-7960	398	3	classification	classification	NOUN
bam-7960	398	4	of	of	ADP
bam-7960	398	5	cancer	cancer	NOUN
bam-7960	398	6	cachexia	cachexia	NOUN
bam-7960	398	7	:	:	PUNCT
bam-7960	398	8	an	an	DET
bam-7960	398	9	international	international	ADJ
bam-7960	398	10	consensus	consensus	NOUN
bam-7960	398	11	.	.	PUNCT
bam-7960	399	1	lancet	lancet	PROPN
bam-7960	399	2	oncol	oncol	PROPN
bam-7960	399	3	2011;12:489–495	2011;12:489–495	NUM
bam-7960	399	4	.	.	PUNCT
bam-7960	400	1	99	99	NUM
bam-7960	400	2	.	.	PUNCT
bam-7960	401	1	stephens	stephens	PROPN
bam-7960	401	2	na	na	PROPN
bam-7960	401	3	,	,	PUNCT
bam-7960	401	4	skipworth	skipworth	PROPN
bam-7960	401	5	rje	rje	PROPN
bam-7960	401	6	,	,	PUNCT
bam-7960	401	7	gallagher	gallagher	PROPN
bam-7960	401	8	ij	ij	PROPN
bam-7960	401	9	,	,	PUNCT
bam-7960	401	10	et	et	PROPN
bam-7960	401	11	al	al	PROPN
bam-7960	401	12	.	.	PUNCT
bam-7960	402	1	evaluating	evaluate	VERB
bam-7960	402	2	potential	potential	ADJ
bam-7960	402	3	biomarkers	biomarker	NOUN
bam-7960	402	4	of	of	ADP
bam-7960	402	5	cachexia	cachexia	NOUN
bam-7960	402	6	and	and	CCONJ
bam-7960	402	7	survival	survival	NOUN
bam-7960	402	8	in	in	ADP
bam-7960	402	9	skeletal	skeletal	ADJ
bam-7960	402	10	muscle	muscle	NOUN
bam-7960	402	11	of	of	ADP
bam-7960	402	12	upper	upper	ADJ
bam-7960	402	13	gastrointestinal	gastrointestinal	ADJ
bam-7960	402	14	cancer	cancer	NOUN
bam-7960	402	15	patients	patient	NOUN
bam-7960	402	16	.	.	PUNCT
bam-7960	403	1	j	j	PROPN
bam-7960	403	2	cachexia	cachexia	PROPN
bam-7960	403	3	sarcopenia	sarcopenia	PROPN
bam-7960	403	4	muscle	muscle	PROPN
bam-7960	403	5	2015;6:53–61	2015;6:53–61	NUM
bam-7960	403	6	.	.	PROPN
bam-7960	403	7	100	100	NUM
bam-7960	403	8	.	.	PUNCT
bam-7960	404	1	fearon	fearon	PROPN
bam-7960	404	2	k	k	PROPN
bam-7960	404	3	,	,	PUNCT
bam-7960	404	4	argiles	argiles	PROPN
bam-7960	404	5	jm	jm	PROPN
bam-7960	404	6	,	,	PUNCT
bam-7960	404	7	baracos	baracos	PROPN
bam-7960	404	8	ve	ve	VERB
bam-7960	404	9	,	,	PUNCT
bam-7960	404	10	et	et	PROPN
bam-7960	404	11	al	al	PROPN
bam-7960	404	12	.	.	PROPN
bam-7960	404	13	request	request	NOUN
bam-7960	404	14	for	for	ADP
bam-7960	404	15	regulatory	regulatory	ADJ
bam-7960	404	16	guidance	guidance	NOUN
bam-7960	404	17	for	for	ADP
bam-7960	404	18	cancer	cancer	NOUN
bam-7960	404	19	cachexia	cachexia	PROPN
bam-7960	404	20	intervention	intervention	NOUN
bam-7960	404	21	trials	trial	NOUN
bam-7960	404	22	.	.	PUNCT
bam-7960	405	1	j	j	PROPN
bam-7960	405	2	cachexia	cachexia	PROPN
bam-7960	405	3	sarcopenia	sarcopenia	PROPN
bam-7960	405	4	muscle	muscle	PROPN
bam-7960	405	5	2015;6:272–4	2015;6:272–4	PROPN
bam-7960	405	6	.	.	PUNCT
bam-7960	406	1	submission	submission	NOUN
bam-7960	406	2	:	:	PUNCT
bam-7960	406	3	november	november	PROPN
bam-7960	406	4	11,2018	11,2018	NUM
bam-7960	406	5	revision	revision	NOUN
bam-7960	406	6	received	receive	VERB
bam-7960	406	7	:	:	PUNCT
bam-7960	406	8	december	december	PROPN
bam-7960	406	9	6	6	NUM
bam-7960	406	10	,	,	PUNCT
bam-7960	406	11	2018	2018	NUM
bam-7960	406	12	acceptance	acceptance	NOUN
bam-7960	406	13	:	:	PUNCT
bam-7960	406	14	december	december	PROPN
bam-7960	406	15	7	7	NUM
bam-7960	406	16	,	,	PUNCT
bam-7960	406	17	2018	2018	NUM
bam-7960	406	18	non	non	X
bam-7960	406	19	co	co	X
bam-7960	406	20	mmerc	mmerc	PROPN
bam-7960	406	21	ial	ial	PROPN
bam-7960	406	22	us	us	PROPN
bam-7960	407	1	e	e	NOUN
bam-7960	407	2	o	o	NOUN
bam-7960	407	3	nly	nly	ADV